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 Summary xiii 
Summary 
This thesis outlines the effects of ageing, calorie restriction and ageing-associated diseases on 
the mitochondrial proteome.  
Several techniques were tested to study the mitochondrial proteome: 
Techniques for visualisation of proteins after two dimensional (2D) blue native (BN) / sodium 
dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) were compared: staining 
of gels with Coomassie Brilliant Blue G-250 (CBBG), silver and the fluorescent dye 
SYPRO®Ruby as well as labelling of the proteins before gel run with fluorescent dyes from 
Refraction-2D™ Labeling Kit (differential gel electrophoresis, DIGE). A recommendation 
was elaborated either for staining with fluorescent dye, when enough amount of protein is 
available, or for labelling with fluorescent dye, when analysis of low amount of protein is 
needed. 
Quantitation of the amount of mitochondrial oxidative phosphorylation (OxPhos) complexes 
after BN PAGE and subsequent CBBG staining was compared to quantitation after 2D-
BN/SDS-PAGE and subsequent SYPRO®Ruby staining, using the rat brain tissue samples 
for the ageing and calorie restriction analyses (cerebellum, hippocampus and cerebrum). The 
results showed, that quantitation in CBBG stained BN gels is less accurate than in 2D-
BN/SDS gels and subsequent SYPRO®Ruby staining, and therefore not applicable for 
detailed quantitation studies. 
The effects of ageing and calorie restriction were studied on the mitochondrial proteome of 
three different brain tissues of Fischer 344 rats: cerebellum, hippocampus and cerebrum. 
Animals were fed ad libitum (AL) or calorie restricted (CR, intake about 60 % of ad libitum 
fed animals, start point: after the age of 6 weeks) and analysed at two ages: 6.5 months 
(young, Y) and 27 months (old, O). Mitochondria were isolated and the mitochondrial 
proteins were separated by 2D-BN/SDS PAGE and identified by peptide mass fingerprint 
(PMF) with MALDI-MS. The protein amount of the assigned subunits was quantified by 
SYPRO®Ruby staining. BN PAGE of mitochondrial proteins and subsequent in-gel activity 
tests were applied to analyse the specific activity of the respiratory chain complexes I and IV. 
The mitochondrial membrane “fluidity” was determined by measurement of the steady-state 
fluorescence anisotropy of the intercalated probe diphenyl-1,3,5-hexatriene (DPH).  
In general, it was found that animals of young age under CR (YCR) developed a smaller body 
weight than young AL ones (YAL). Ageing under AL increased the body weight to the same 
extent as under CR. Commonly for all three tissues, the results of PMF showed that the 
migration pattern of subunits of mitochondrial proteins from rat brain tissues in 2D-BN/SDS 
PAGE are highly comparable, also to other mammalian tissue such as bovine heart. Therefore 
analyses of the proteome of the different tissues could be compared. The mtDNA encoded 
protein subunits CYB of OxPhos complex III (CIII) and COX2 of complex IV (CIV) did not 
show specific changes during ageing neither AL nor CR. Their changes followed the trends of 
total CIII and total CIV. The highest activities of CI were found in supercomplex I1III2IV3 and 
of CIV in supercomplex I1III2IV2 for all three brain tissues. However, the changes during 
ageing and calorie restriction of specific CI and CIV activities were not very pronounced.  
In cerebellum ageing of AL fed rats reduced the tissue weight and total mitochondrial protein 
amount as well as the fluidity of the mitochondrial membranes. The amount of OxPhos 
complexes and the activity was not altered. Already at young age the tissue weight of 
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cerebellum decreased under CR and developed in the same way as in AL fed animals during 
ageing. The total mitochondrial protein amount in young and in old rats under CR was higher 
compared to AL fed rats, but it decreased during ageing under CR (YCR vs. OCR), thereof 
were proteins of cellular stress management, energy metabolism and neuronal composition. 
The amount of OxPhos complexes was decreased in young animals under CR compared to 
AL but increased during ageing to the same level of protein amount from animals under AL at 
old age. In general, the mitochondrial membrane fluidity decreased with ageing, even more in 
cerebellum of animals under CR than under AL. Already at young age under CR the fluidity 
was decreased compared to AL. 
For hippocampus the tissue weight, the total mitochondrial protein amount and CI activity in 
some (super-)complexes decreased by ageing independently from nutrition. Most of the 
analysed proteins decreased under AL and in young animals under CR. However, during 
ageing under CR the amounts of analysed proteins increased to a higher level in aged CR 
animals than aged AL animals. During ageing under AL the membrane “fluidity” did not 
change but in young and old animals under CR the membrane fluidity was decreased 
compared to the AL animals, even though the fluidity increased during age in CR animals. 
Decreased fluidity could be explained by increased cholesterol amount or increased 
membrane protein amounts and these could be needed to compensate for the decreased CI 
activity. 
In cerebrum the tissue weight decreased during ageing independently from nutrition. The 
amount of OxPhos complexes (excl. CV) decreased during ageing under AL while ageing 
under CR increased the protein amount of OxPhos complexes (excl. CV) in old rats. Ageing 
decreased the mitochondrial membrane “fluidity” in AL animals. Under CR the fluidity did 
not change, but was still increased in aged animals under CR compared to AL.  
In conclusion, ageing under AL decreased brain tissue weight, total protein amount and 
fluidity of mitochondrial membrane. The amount of the OxPhos complexes and their activity 
remained mainly unchanged. During ageing under CR the total protein amount increased and 
membrane fluidities decreased which, in terms of remained OxPhos complexes activities, 
seem to be part of compensation processes. 
Together with Dr. Koziel (IBA) the effects of ageing (senescence) were studied on a cell 
culture model, human umbilical vein endothelial cells, in which NADPH oxidase 4 (Nox4), 
known as producer of reactive oxygen species, was knocked down. The results showed a 
depleted CI amount and reduced CI activity under the influence of Nox4 which were both 
increased when Nox4 was knocked down.  
In collaboration with Dr. Kuter (IF-PAN) an early stage model of the ageing-associated 
disease Morbus Parkinson was studied. The effects of neuronal degradation in substantia 
nigra on the mitochondrial proteome were analysed in Wistar rats. For identification of 
proteins, 2D-BN/SDS PAGE and subsequent PMF were performed. Quantitation was 
achieved by application of DIGE. In-gel activities of OxPhos complexes I and IV were 
measured as well as membrane “fluidity”. The evaluation of the obtained results is still in 
progress. Some of the data were already submitted and are under review and for copyright 
reasons not described in this thesis.  
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Zusammenfassung 
Diese Arbeit befasst sich mit den Auswirkungen des Alterns, der Kalorienrestriktion und von 
altersassoziierten Krankheiten auf das mitochondriale Proteom. 
Verschiedene Techniken wurden verglichen, um das mitochondriale Proteom zu analysieren:  
Die Visualisierung der Proteine nach Auftrennung mit der zwei-dimensionalen (2D) blau-
nativen (BN) Natriumdodecylsulfat-(SDS) Polyacrylamid-Gelelektrophorese (PAGE) durch 
die Färbung der Gele mit Coomassie Brilliant Blau G-250 (CBBG), Silber oder dem Fluores-
zenzfarbstoff SYPRO®Ruby wurden mit der differentiellen Gelelektrophorese (DIGE) 
verglichen, bei der vor dem Gellauf die kovalente Markierung der Proteine mit Fluoreszenz-
farbstoffen (Refraction-2D™ Labeling Kit) stattfindet. Die Färbung mit Fluoreszenzfarbstoff 
wurde empfohlen, wenn genug Protein zur Verfügung steht und falls die Menge eingeschränkt 
ist für die Markierung der Proteine mit Fluoreszenzfarbstoff.  
Die Quantifizierung der Menge von mitochondrialen Proteinen der oxidativen Phosphory-
lierung (OxPhos) nach Auftrennung durch BN PAGE und anschließender CBBG Färbung 
wurde verglichen mit der Auftrennung mittels 2D-BN/SDS PAGE und SYPRO®Ruby 
Färbung. Hierfür wurden dieselben Proben verwendet, die auch für die Analyse der Einflüsse 
von Altern und Kalorienrestriktion auf das mitochondriale Proteom der unterschiedlichen 
Gehirngewebe verwendet wurden. Die Quantifizierung nach BN PAGE und CBBG Färbung 
lieferte weniger genaue Resultate als die 2D-BN/SDS PAGE und SYPRO®Ruby Färbung 
und ist daher nicht geeignet für quantitative Analysen.  
Die Einflüsse von Altern und Kalorienrestriktion wurden am mitochondrialen Proteom von 
den drei Fischer 344 Rattenhirngeweben Cerebellum, Hippocampus und Cerebrum analysiert. 
Die Tiere wurden ad libitum (AL) gefüttert oder unter Kalorienrestriktion (CR, Aufnahme-
menge etwa 60 % von AL, wurde nach Alter von 6 Wochen gestartet) gehalten. Zwei Alters-
gruppen wurden analysiert: 6,5 Monate (jung, Y) und 27 Monate (alt, O). Die Mitochondrien 
wurden isoliert und deren Gesamtproteinmenge  bestimmt. Die Proteine wurden mittels 2D-
BN/SDS PAGE aufgetrennt und die Untereinheiten im Gel durch Peptide Mass Fingerprint 
(PMF) mittels MALDI-MS identifiziert. Die Proteinmenge der Untereinheiten wurde nach 
SYPRO®Ruby Färbung der Gele quantifiziert. Die Auftrennung der mitochondrialen Proteine 
mittels BN PAGE und anschließender in-Gel Aktivitätstests lieferte die spezifische Aktivität 
der OxPhos-Komplexe I (CI) und IV (CIV). Durch die steady-state Fluoreszenz-Anisotropie 
Messung der interkalierten Fluoreszenzsonde Diphenyl-1,3,5-hexatrien (DPH) wurde die 
„Fluidität“ der Mitochondrienmembran bestimmt.  
Bereits im jungen Alter hatten die Tiere unter CR ein niedrigeres Körpergewicht, als die AL 
gefütterten Tiere. Mit dem Altern erhöhte sich das Körpergewicht beider Tiergruppen im 
gleichen Maße. Nach Identifizierung der Proteinuntereinheiten mittels PMF im 2D-BN/SDS-
Gel zeigte sich für Mitochondrien aus allen drei untersuchten Rattenhirngeweben, dass die 
elektrophoretische Mobilität der Untereinheiten annähernd identisch ist. Dies konnte ebenso 
für die untersuchten Rinderherzmitochondrien gezeigt werden. Daher konnten die Proteine 
der verschiedenen Gewebe miteinander verglichen werden. Die durch die mtDNS kodierten 
Untereinheiten CYB von OxPhos-Komplex III (CIII) und COX2 von CIV zeigten keine 
spezifischen Veränderungen beim Altern. Sie folgten den Veränderungen der Gesamt-
komplexe CIII und CIV. Die höchsten Aktivitäten wurden in allen drei Geweben für die 
Superkomplexe I1III2IV3 (CI-Aktivität) und I1III2IV2 (CIV-Aktivität) gefunden. Allerdings 
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waren die Veränderungen durch Altern und Kalorienrestriktion in den CI- und CIV-
Aktivitäten nur sehr geringfügig ausgeprägt. 
Das Gewicht des Cerebellum, dessen mitochondriale Gesamtproteinmenge und die Fluidität 
der Mitochondrienmembran nahm mit dem Altern von AL gefütterten Tieren ab. Die Menge 
der OxPhos-Komplexe und die Aktivität von CI und CIV waren nicht verändert. Bereits junge 
Tiere unter CR wiesen ein geringeres Gewicht des Cerebellum verglichen mit AL gefütterten 
Ratten auf. Mit dem Altern wuchs das Cerebellum beider Tiergruppen im gleichen Maße an. 
Die mitochondriale Gesamtproteinmenge in jungen und alten Ratten unter CR war jeweils 
höher als bei den AL gefütterten Tieren, verringerte sich jedoch auch während des Alterns. 
darunter die Proteine des zellulären Stressmanagements, des Energiemetabolismus und an der 
neuronalen Zusammensetzung und Funktion beteiligten Proteine. Die Menge der OxPhos-
Komplexe war in jungen Tieren unter CR verringert, erhöhte sich aber mit dem Altern unter 
CR auf dasselbe Niveau wie bei den Tieren unter AL. Die mitochondriale Membranfluidität 
verringerte sich im Cerebellum während des Alterns bei beiden Formen der Ernährung, 
allerdings bei den Tieren unter CR sogar stärker und bereits seit dem jungen Alter. 
Das Gewicht des Hippocampus, die mitochondriale Gesamtproteinmenge und die CI-Aktivität 
in einigen OxPhos-(Super-)Komplexen verringerten sich unabhängig von der Ernährung mit 
dem Altern, genauso wie die meisten analysierten Proteine unter AL und in jungen Tieren 
unter CR. Jedoch beim Altern unter CR stiegen die Proteinmengen sogar auf ein höheres Maß 
als bei den vergleichbaren AL Tieren an. Beim Altern unter AL veränderte sich die 
mitochondriale Membranfluidität nicht, aber bei den jungen und alten Tieren unter CR konnte 
eine verringerte Membranfluidität verglichen mit den Tieren unter AL festgestellt werden, 
obwohl sich sogar die Fluidität der Mitochondrienmembranen der jungen CR Tiere mit dem 
Altern etwas erhöhte. Die verringerte Fluidität könnte durch die erhöhte Proteinmenge erklärt 
werden oder einen erhöhten Cholesterinanteil und die damit verbundene Reaktion des 
Gewebes auf die verringerte CI Aktivität. 
Das Gewicht des Cerebrum verringerte sich mit dem Altern unabhängig von der Ernährung. 
Die Menge der OxPhos-Komplexe (exkl. CV) verringerte sich mit dem Altern unter AL aber 
unter CR erhöhte sich deren Menge. Die mitochondriale Membranfluidität verringerte sich 
unter dem Einfluss des Alterns und AL Fütterung, jedoch nicht unter CR. Die Fluidität der 
Membranen der CR gefütterten Tiere war stets höher als die der AL Tiere.  
Zusammengefasst verringerte das Altern das Hirngewebegewicht, die Gesamtproteinmenge 
und die Fluidität der Mitochondrienmembran von AL gefütterten Tieren. Die Menge der 
OxPhos-Komplexe und ihre Aktivität blieb größtenteils unverändert. Beim Altern unter CR 
erhöhte sich die Gesamtproteinmenge und die Membranfluidität verringerte sich, was im 
Zusammenhang mit gleichbleibenden CI- und CIV-Aktivitäten ein Teil von Kompensations-
mechanismen zu sein scheinen.  
In Zusammenarbeit mit Dr. Koziel (IBA) wurden die Effekte des Alterns anhand eines 
Zellkulturmodells (HUVEC) analysiert. Hierin wurden die Einflüsse von NADPH Oxidase 4 
(Nox4), ein Produzent von reaktiven Sauerstoffspezies, durch genetische Gen-Deaktivierung 
untersucht. Die Ergebnisse zeigten unter anderem, dass Nox4 für eine verringerte CI Menge 
und CI-Aktivität sorgte, was durch Gen-Deaktivierung umgekehrt wurde. 
Durch die Zusammenarbeit mit Dr. Kuter (IF-PAN) konnte ihr Modell der Parkinson 
Erkrankung in einem frühen Stadium analysiert werden. Die Effekte der Degeneration in 
Substantia nigra und Striatum von Wistar Ratten wurden beschrieben. Proteomanalysen 
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umfassten die Identifikation der mitochondrialen Proteine durch PMF von 2D-BN/SDS 
Gelen, Quantifizierung der Proteinuntereinheiten durch die DIGE-Technik, CI- und CIV in-
Gel Aktivitätstests und Messungen der Membranfluidität. Die Auswertungen sind noch in 
Bearbeitung. Teile der Daten wurden zur Veröffentlichung eingereicht und sind unter 
Begutachtung, weshalb unter Beachtung des Urheberrechts diese Daten in dieser Arbeit nicht 
beschrieben wurden. 
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 1 Introduction 1 
1 Introduction 
1.1 Ageing and statistics 
In the world as well as in Germany, the average age of the population is continuously 
increasing. The global life expectancy was about 71.5 years for both sexes in 2013 (The 
Lancet 2015). The prognosis of the age distribution in Germany (given for men and women) 
for the years 2015 (blue and magenta) and 2050 (green line) is depicted in Fig. 1.1 (Destatis 
Statistisches Bundesamt 18.07.2015). In 2050 the expected number of people > 65 years old 
would have increased (+11 %), while 20-64 years old (-9 %) and < 20 years (-2 %) would 
have decreased (Fig. 1.1, Table 1.1).  
 
Table 1.1: Prognosis for age distribution of the population 
(men+women) in Germany for the years 2015 and 2050. 
 2015 2050 
age millions fraction millions fraction 
65+ 17.3 21 % 22.7 32 % 
20-64 49.4 61 % 37.7 52 % 
< 20 14.6 18 % 11.4 16 % 
total 81.3 100 % 71.9 100 % 
Table 1.1 (modified) Destatis Statistisches Bundesamt (18.07.2015).  
 
Fig. 1.1: Prognosis of 
age distribution of 
population in Germany 
for 2015 and 2050. The 
prognosed number of 
men (blue) and women 
(magenta) is depicted in 
thousands for each age 
(year of birth) for 2015. 
The quantity for 2050 is 
presented by the green 
line. Diagram (modified) 
Destatis Statistisches 
Bundesamt (18.07.2015)  men (in thousands)  women (in thousands) 
year of birth age 
 2 1 Introduction 
44.4 million people suffered from dementia worldwide in 2013, 1.5 million people in 
Germany in 2014. Two third of them are older than 80 years while only 20,000 (less than 
2 %) are younger than 65 years. It is supposed that the incidence rate will be in average 
300,000 each year, and about three million people will be affected in Germany in 2050, and 
about 135 million people worldwide (Wortmann et al. 2014). It is estimated that about 
250,000 people, who have developed dementia, die in Germany each year (Deutsche 
Alzheimer Gesellschaft e.V. Selbsthilfe Demenz 2014). Of 54.9 million deaths worldwide in 
2013 about 2.0 million were caused by neurological disorders, thereof 1.7 million by 
Alzheimer’s disease and other dementias, and 102,500 by Parkinson’s (The Lancet 2015).  
The main cause of dementia with about two third is supposed to be caused by Morbus 
Alzheimer followed by vascular dementia (Deutsche Alzheimer Gesellschaft e.V. Selbsthilfe 
Demenz 2014). In Germany about 250,000 to 400,000 people were affected with Morbus 
Parkinson in 2007. The incidence rate is supposed 12,500 each year (Gerlach et al. 2007). The 
Rotterdam study by Ott et al. (1995) gives an overview about the distribution of several forms 
of dementia. 7,528 persons in the age of 55 to 106 years from a suburb of Rotterdam, NL, 
participated. Of this cohort, 6.3 % were demented. From all demented, 72 % suffered from 
Alzheimer’s disease, 16 % from vascular dementia, 6 % from Parkinson’s disease and 5 % 
from other forms of dementia.  
Health-care cost for dementia affected people were about 5.6 billion Euro in Germany in 2002 
(Weyerer 2005). In 2008 they already increased to 9.3 billion Euro (Destatis Statistisches 
Bundesamt 19.07.2015). Global cost was estimated at US$ 604 billion in 2010 and estimated 
to rise to US$ 1 trillion by 2030 (Wortmann et al. 2014). 
Because of these facts, it is of great interest to study the effects of ageing and causes of 
ageing-associated diseases, as well as possibilities to influence the process of ageing in a 
positive way, for example by calorie restriction. 
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1.2 “The free radical theory of ageing” and “The mitochondrial theory of 
ageing” 
Reactive oxygen species (ROS) are indispensable for life. For example, they are released by 
phagocytic cells in the context of the immune defence and they play an important role in cell 
signalling and apoptosis or necrosis (Hancock et al. 2001). ROS are produced by enzymes as 
NADPH oxidases or glycerol-3-phosphate dehydrogenase or are released as byproducts from 
the respiratory chain, by complex I (CI) , complex II (CII) or complex III (CIII) (Hamanaka 
and Chandel 2010).  
In Fig. 1.2, the chemical equations 
of formation and reaction of 
biologically relevant ROS are 
depicted. Oxygen reacts with a 
free electron to the superoxide 
radical anion (a), which is 
protonated to form the 
hydroperoxyl radical (b), which is 
more reactive than the superoxide 
radical anion. The superoxide 
radical anion can also react with 
hydrogen peroxide to form oxygen, water and the hydroxyl radical (c). Another generation of 
the hydroxyl radical is the oxidation of a metal cation by hydrogen peroxide. Hydroxyl anion 
is generated as side product (d). ROS are extremely reactive and therefore short-lived. They 
can interact with biomolecules like lipids from membranes, deoxyribonucleic acid (DNA) or 
proteins. Because of their point of origin in the mitochondria, it is supposed that mainly the 
mitochondrial lipids and proteins, as well as mitochondrial DNA (mtDNA) are oxidised by 
ROS. Degenerative diseases like Morbus Alzheimer, Morbus Huntington or Morbus 
Parkinson are supposed to be linked with oxidative modified mitochondria. (Voet et al. 2002, 
Murphy 2009) 
Harman (1956) proposed that free radicals could be the cause of ageing and ageing-related 
diseases. The “free radical theory of ageing” was founded. He expanded his theory in 1972 
and proposed that mitochondria are the main source and target of ROS at the same time 
(Harman 1972). Several subsequent publications lead to the findings that damage in 
mitochondria could accumulate. For example lipid (per-)oxidation leads to oxidised 
mitochondrial membranes, oxidation of mtDNA causes accumulated mutations changing the 
biosynthesis of mitochondrial proteins or proteins could be modified posttranslationally. The 
result could be that the oxidative phosphorylation (OxPhos) pathway produces a higher output 
of ROS or a declined output of adenosine triphosphate (ATP). The “mitochondrial theory of 
ageing” was postulated. Mitochondria were supposed to be the main trigger for ageing and 
age-related diseases (Lenaz 2012).  
However, there are also mechanisms to reduce the amount of ROS in the cell, like reaction 
with antioxidants (vitamins) or scavenging enzymes, like superoxide dismutases (SOD) (Voet 
et al. 2002).  
O2O2 + e
- superoxide radical anion
O2 + H
+ HO2
H2O2 + Fe
2+ OH + OH- + Fe3+
hydroxyl radical
hydroxyl
anion
O2 + H2O2 O2 + H2O +  OH
hydroperoxyl radical
(a)
(b)
(c)
(d)
Fig. 1.2: Biologically active reactive oxigen species (ROS).
Formation and reaction equations (modified: Voet et al. (2002)) 
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To study the effects of ROS in ageing, nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidases (Nox), as source of superoxide radicals and other ROS, can be analysed. 
They are involved in posttranslational modification of proteins, cellular signalling, regulation 
of gene expression, differentiation of cells, and in immunological defense (Bedard and Krause 
2007). Within the framework of this thesis the influence of Nox4 on the mitochondrial 
function was analysed with BN PAGE, 2D-BN/SDS PAGE and in-gel enzyme activity tests 
as part for the publication with Dr. R. Koziel (Institute for Biomedical Research (IBA), 
Innsbruck University, Austria) and other authors (Koziel et al. 2013). We could demonstrate 
that Nox4 inhibits CI of the respiratory chain. 
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1.3 Mitochondria 
Mitochondria are the organelles in the cells which provide chemical energy in form of ATP 
by the respiratory chain. They are also involved in degradation of fatty acids, heat production, 
calcium storage, provide second messengers e.g. ROS or Ca2+ for cellular signalling, trigger 
apoptosis, are location for the TCA cycle, and involved in heme and hormone synthesis (Voet 
et al. 2002). A large number of mitochondria are usually located in tissues, where high energy 
supply is necessary as in muscles and in the central nervous system (E and Swerdlow 2012). 
ATP synthesis 
For ATP synthesis, five OxPhos complexes are embedded in the inner mitochondrial 
membrane. A schematic of a mitochondrion as well as the OxPhos complexes are depicted in 
Fig. 1.3. OxPhos complexes exist as functional individual complexes, homooligomers and in 
so called supercomplexes, which are assemblies of different OxPhos complexes. Only com-
plex III occurs not as individual complex, the smallest entity found is the homodimer. The 
supercomplex formation leads to increased stability, activity and less dysfunction (Schäfer et 
al. 2006). Two theories have been discussed in literature for long time. The fluid or random 
collision model proposed that the complexes are individual entities that freely diffuse in the 
inner mitochondrial membrane, while the solid model proposed that all complexes except 
ATP synthase are organised in supercomplexes for increased efficiency of electron transport. 
The plasticity model unifies both theories and suggests a balanced dynamic distribution of 
individual complexes and supercomplexes (Acin-Perez and Enriquez 2014).  
In the respiratory chain electrons are translocated by redox reactions. Complex I (CI, NADH 
ubiquinone oxidoreductase) oxidises NADH 
to NAD+ and transfers protons and electrons 
to ubiquinone and reduces it to ubiquinol. 
Additional electrons are transferred by com-
plex II (CII, succinate dehydrogenase) from 
succinate to ubiquinone. CII serves therefore 
as a link between tricarboxylic acid (TCA) 
cycle and OxPhos. Ubiquinol transfers the 
electrons to complex III (CIII, cytochrome c 
oxidoreductase), which reduces cyto-
chrome c. From there electrons are trans-
ferred to complex IV (CIV, cytochrome c 
oxidase), where molecular oxygen is re-
duced to water. Connected to this, a proton 
gradient is build up by translocation of 
protons from the matrix into the inter-
membrane space by CI (4 e-), CIII (4 e-, 2 
from matrix and 2 from re-oxidation of 
ubiquinone) and CIV (4 e-, 4 additional pro-
tons are transferred to O2). This gradient is 
used by the ATP synthase (CV) to phos-
phorylate adenosine diphosphate (ADP) to 
the energy-rich ATP. (Voet et al. 2002)  
Fig. 1.3: Sketch of a mitochondrium with OxPhos 
complexes. Mitochondrium was drawn and OxPhos 
complexes were sketched in. Membranes and compart-
ments were assigned, as well as circular mtDNA. 
Mitochondrium: (modified) Voet et al. (2002), OxPhos: 
(modified) Dudkina et al. (2010) 
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Mitochondrial DNA 
Mitochondria have their own doublestranded circular DNA (mtDNA), organised in so called 
nucleoids. 13 peptides of the OxPhos complexes are encoded in the mtDNA, seven subunits 
of CI, one of CIII, three of CIV and two of CV. Additionally 22 transfer ribonucleic acids 
(tRNAs) and two ribosomal ribonucleic acids (rRNAs), which are involved in mitochondrial 
protein synthesis, are encoded. A control region, called D-loop, is also included. It contains 
the mtDNA replication origin and promotors for mtRNA transcription. Mitochondria are 
maternally inherited, hence mtDNA originates from the mother. Several copies of mtDNA 
can exist in each mitochondrium. They are mixed from wild-type and mutant mtDNA at the 
same time (heteroplasmy). It is supposed that a threshold of mutant mtDNA must be reached, 
before dysfunction appears. (Li et al. 2012)  
mtDNA even encodes for proteins, which do not belong to the OxPhos system. For example, 
additonal protein-coding genes were found for corals, cnidarians, sponges and even in human 
mtDNA: humanin encodes a neuroprotective peptide (Breton et al. 2014). 
Mitochondria underlie continuous fusion and fission processes. In this respect, the inner and 
outer membranes fuse and membrane lipids and matrix including content are exchanged, 
before fission takes place. Thereby circular mtDNA is exchanged as well (Chan 2006). 
mtDNA repair system 
Repair mechanisms for mtDNA depend on the kind of damage which occurred. For example, 
complex damages, which involve the whole double strand of the mtDNA like cross links, 
double strand breaks or formation of large adducts, are not repaired as known from nuclear 
DNA (nDNA) repair mechanisms (as nucleotide excision repair or homologous 
recombination). These repair mechanisms seem to be missing in mitochondria. But damages 
due to deamination, alkylation or oxidation of single bases are repaired by a conserved base 
excision repair mechanism. This makes mtDNA even more stable against oxidation from 
ROS than nDNA (Shokolenko et al. 2007). But it is known that genes of mtDNA have a 
higher mutation rate than of nDNA. It is supposed that the species only invests energy for 
maintaining the mtDNA for successful reproduction (Wallace 2010).  
Mitochondria in the neural network 
Neurons have a high energy demand, therefore mitochondria are found in axons, dendrites 
and mainly at the synapses. The energy is needed for maintain ionic gradients across the cell 
membranes, for transmission of signals through the synaptic cleft of neighbouring nerve cells, 
and for active axonal transport. (Schwarz 2013) 
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1.4 Ageing influences the brain structures 
Ageing makes the brain tissue shrink especially in the areas prefrontal cortex (front part of 
frontal lobe, Fig. 1.4) and hippocampus (Fig. 1.5). Neurons and neurotransmitters are 
changed. Axons (white matter, compare 1.4.1) are degraded. The blood vessels change as 
well. Tangles or plaques of protein deposition appear. Oxidation by ROS increase as well as 
inflammation processes. The consequences are that attention, memory and learning processes 
decline with age. In some cases so called “plasticity” is increased, which means brain areas 
are activated for compensation, when other parts degenerate (Brown Rodgers 2008).  
The changes in the brain can lead to cognitive impairment in different stages, up to 
neurodegenerative diseases as dementia. The changed properties of blood vessels increase the 
probability for development of vascular disease. To study the effects of ageing on the brain, 
cerebellum (Fig. 1.4), hippocampus and cerebrum of rats were analysed (4.1). In this thesis, 
cerebrum consisted of cerebral cortex (Fig. 1.4), basal ganglia (Fig. 1.6) and the limbic system 
(Fig. 1.5) from which the hippocampus was separated (for details see 2.6.1).  
1.4.1 Brain areas 
Description about anatomic structure and function of the areas of the human brain is based on 
Thews et al. (1999). Fig. 1.4, Fig. 1.5 and Fig. 1.6 show the sagittal plane of the human brain 
(drawn by hand, M. K., based upon webpage of Columbia University (15.07.2015)). In Fig. 
1.4 the areas of cerebral cortex and corpus callosum (red), midbrain (turquoise) and hindbrain 
(cerebellum, medulla oblongata, pons varolii, grey) are marked. In Fig. 1.5 parts of the limbic 
system (as from diagonally sagittal cut) have been sketched in front of the sagittal plane of 
projection (Thews et al. 1999) as well as in Fig. 1.6 parts of the basal ganglia (Buratovich 
15.07.2015). 
The brain consists mainly of grey matter and white matter, together with capillary blood 
vessels. The white appearance of white matter derives from the myelin sheath of the axons, 
while grey matter is formed by neuronal cell bodies or unmyelinated neurons. Grey matter is 
found on the surface of cerebral cortex and cerebellum, as well as inside cerebellum, 
diencephalon, basal ganglia, the brainstem and the spinal cord.  
Forebrain, Midbrain and Hindbrain 
The forebrain consists of the telencephalon (cerebral cortex (the four lobes in Fig. 1.4), the 
basal ganglia (Fig. 1.6) and the limbic system (Fig. 1.5)) and the diencephalon (thalamus and 
hypothalamus, not shown). The hindbrain is composed of medulla oblongata, pons varolii and 
cerebellum, and is located between the spinal cord and the two hemispheres. The midbrain 
(mesencephalon) is located between hindbrain and forebrain (Fig. 1.4). Midbrain, pons varolii 
and medulla oblongata are summarised as brainstem.  
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Cerebral cortex 
Cerebral cortex is divided into two 
hemispheres, which are connected 
via the corpus callosum. Four lobes 
can be distinguished: frontal, 
temporal, parietal and occipital 
lobe (Fig. 1.4). The functions of 
cerebral cortex are divided into 
motor, sensory and association 
areas. It is involved in attention, 
awareness, perception, language, 
memory, thought and conscious-
ness.  
The sensory areas receive the input 
from the sensory organs. Infor-
mation about vision, audition and 
touch is transferred from thalamus to the so called primary sensory areas (not shown). The 
information from each sensory organ, such as ear, eye or hand, is send to the opposite 
hemisphere. This is also the case for the motor areas in the two hemispheres. The motor areas 
are responsible for activation of muscles and control of movement. All sensoric and motor 
areas are connected for control of motor action. Secondary motor areas are supposed to 
participate in planning and control of complex movements. Motivation areas (frontal cortex 
and limbic system) provide information about upcoming movement. These are transformed 
into plans for movement by the associative cortex. Association areas of cerebral cortex are the 
parts, which are not primary sensory areas or motor areas. They process information only, and 
forward them to basal ganglia, cerebellum and to the motor areas of cerebral cortex. They are 
also involved in processes of abstract thinking and language.  
Limbic system 
The limbic system (Fig. 1.5) 
consists of the cortical parts: gyrus 
cinguli, gyrus hippocampi (= hip-
pocampus), gyrus parahippocam-
palis, parts of the olfactory system, 
as bulbus olfactorius, and of the 
subcortical parts: corpus amyg-
daloideum (= amygdala) and 
nucleus thalami anterior. The main 
parts are hippocampus and amyg-
dala. Neuronal circuits are 
stabilised, when their connections, 
the synapses, are strengthened. This is controlled by the limbic system via projections of 
choline and noradrenaline. Information is memorised only when emotional interaction occurs 
Fig. 1.4: Forebrain, midbrain and hindbrain. The four lobes 
(cerebral cortex) as well as the corpus callosum of forebrain are 
depicted in red, midbrain in turquoise and parts of hindbrain in grey. 
Image is based on Columbia University (15.07.2015).  
Fig. 1.5: Limbic system (as visible when brain is cut diagonally) is 
sketched in blue in front of the sagittal plane of projection. Image is 
based on Columbia University (15.07.2015) and Thews et al. (1999). 
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(so called affective memory) via connections of the amygdala to the association areas of the 
cerebral cortex. The connections of amygdala to the ventral striatum influence the motor 
control, while connections to hypothalamus and to the brainstem influence the autonomic 
nervous system and the endocrinal reactions. Cognition of new information and adaption of 
behaviour to new situations is achieved by connections from amygdala to the frontal cortex. 
Connections to hippocampus are important for development of memory. The main function of 
hippocampus is the consolidation of information from short-term memory to long-term. In 
animals, the limbic system is associated with instinct.  
 
Basal ganglia 
The basal ganglia (Fig. 1.6) consist of 
corpus striatum (nucleus caudatus + 
putamen), globus pallidus, nucleus 
subthalamicus and substantia nigra. 
These parts are involved in motivation-
dependent planning of motor-driven 
action, conception of movement 
program, control of movement and 
memory of motor activity. The striatum 
is the largest part of the basal ganglia. It 
receives incoming signals from wide 
areas of the cerebral cortex, from 
substantia nigra pars compacta (SNc) and the thalamus (nucleus centromedianus, not shown). 
The outgoing areas of basal ganglia are substantia nigra pars reticulata (SNr) and globus 
pallidus (pars interna). Both send signals to the nucleus ventrolateralis of the thalamus, and 
from there, signals are transmitted to the cortex areas involved in motor activitites. 
Additionally SNr has an inhibitory effect on the colliculi superiors, which controls the eye 
movement. Internal pathways for signalling in the basal ganglia are the direct connection of 
striatum with globus pallidus (pars interna) and SNr, and the indirect pathway from striatum 
via globus pallidus (pars externa) to the nucleus subthalamicus, which is connected with 
globus pallidus (pars interna) and SNr. Another internal pathway starts at striatum via SNc 
back to the input areas. In the basal ganglia the neurotransmitters are the inhibiting γ–
aminobutyric acid (GABA) and the excitatory glutamate. Axons from SNc to striatum release 
dopamine (DA), which stimulates the direct internal pathway and inhibits the indirect 
pathway. The basal ganglia are involved in the procedural long-term memory. (Thews et al. 
1999) 
Cerebellum 
Cerebellum (Fig. 1.4) consists of archicerebellum (balance and spatial orientation), 
palaeocerebellum (fine motor skills and limb movements) and neocerebellum (involved in 
planning movement, evaluation of sensory input for action and some cognitive funtions). 
Those three can be subdivided into smaller areas. The neocerebellum (cerebrocerebellum) 
receives input from the limbic system and from motor, sensory and posterior parietal cortex. 
The spinocerebellum (palaeocerebellum) receives input from motor and sensory cortex, spinal 
marrow and from visual and acoustic senses for comparison of the planned movement to its 
Fig. 1.6: Basal ganglia are sketched in green in front of the 
plane of projection. Image is combined, based on Columbia 
University (15.07.2015) and Buratovich (15.07.2015). 
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performance. Deviations are corrected by outgoing signalling. The cerebellum is connected to 
the midbrain, pons varolii and medulla oblongata. The cerebellum is involved in planning, 
execution and practice of motor action. It adjusts movement to new situations.  
Rat brain areas 
The allocation of the brain regions in 
rat brain differs from the allocation in 
human brain. In Fig. 1.7 cerebellum 
(dark grey), cerebral cortex (red) and 
hippocampus, together with olfactory 
bulb, as part of the limbic system 
(blue) are sketched into a three 
dimensional rat brain skematic (drawn 
by hand, M. K., based upon Cheung 
and Cardinal (2005)).  
 
1.4.2 Neurodegenerative diseases and role of mitochondria 
Characteristic for neurodegenerative diseases is the loss of neurons in specific brain areas 
such as hippocampus (Alzheimer’s disease), substantia nigra (Parkinson’s disease), striatum 
(Huntington’s disease) or in the structures of primary or secondary motor neurons 
(amyotrophic lateral sclerosis) (Plum et al. 2014).  
Abnormal mitochondrial function is often 
found in neurodegenerative diseases like 
Alzheimer’s, Parkinson’s, Huntington’s, 
as well as amyotrophic lateral sclerosis. 
The probability for incidence increases 
with age (E and Swerdlow 2012). E and 
Swerdlow (2012) suggest that dys-
functions of mitochondria, caused by 
defect proteins or mtDNA, increase ROS 
production and oxidative stress leading to 
neurodegeneration by neuronal necrosis. 
Likewise altered energy metabolism due 
to mitochondrial dysfunction decreases 
ATP production, impairs Ca2+ homeo-
stasis and leads finally to neuro-
degeneration caused by apoptosis Fig. 1.8. 
 
  
Fig. 1.7: Rat brain areas. Cerebral cortex (red), cerebellum and 
brainstem as regions of hindbrain (grey), hippocampus and 
olfactory bulb as parts of the limbic system (blue) are marked, 
based on: Cheung and Cardinal (2005) 
Fig. 1.8: Connections between mitochondrial dys-
function and neurodegeneration suggested by E and 
Swerdlow (2012) (modified) 
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Morbus Parkinson 
The trigger of Parkinson’s disease (PD) is not known in about 70-80% of the cases (idiopathic 
or primary parkinsonism) (Thews et al. 1999). Approximately 10-15 % of the cases are 
acquired by inheritance and the remaining cases are caused by side effects of other diseases, 
pharmaceuticals or contaminated addictive drugs (secondary parkinsonism).  
The underlying cause of PD is the degeneration of dopaminergic neurons of substantia nigra 
(SN), which project to striatum (STR, Fig. 1.6). Physical symptoms of the disease occur not 
until about 80 % of the dopaminergic neurons are lost. Typical disorders are motor symptoms, 
such as tremor, slowdown up to lack of movement, rigour of limbs and body, as well as 
disorders of the autonomic nervous system or psychic imbalances (Thews et al. 1999).  
Additionally to the degeneration of dopaminergic neurons, the aggregation of α-synuclein 
(appearance of Lewy bodies) is a pathological characteristic of idiopathic PD (Spillantini et 
al. 1997). α-Synuclein seems to impair mitochondrial function (E and Swerdlow 2012). It is 
known, that PD is accompanied by a mitochondrial dysfunction observed as a decline of 
mitochondrial CI activity in SN (E and Swerdlow 2012), resulting in an increased level of 
ROS, decreased production of ATP, increased intracellular Ca2+ concentration, excitotoxicity 
and degeneration of dopaminergic neurons in SN (E and Swerdlow 2012). Basso et al. (2004) 
observed an increased amount of CIII and CV in SN of patients with PD and suggested that 
this could be a compensatory mechanism for the decreased activity of CIII and CV.  
Besides the compensatory processes of the respiratory chain also functional changes are 
observed for the remaining dopaminergic neurons, such as increased firing rate and increased 
synthesis of tyrosine hydroxylase (Song and Haber 2000), the enzyme which catalyses the 
conversion of L-tyrosine into L-3,4-dihydroxyphenylalanine, a precursor for the neuro-
transmitter dopamine (DA) (Voet et al. 2002). Higher DA turnover and sprouting of axon 
terminals was also observed (Song and Haber 2000). Since the compensatory processes 
probably consume more energy, an enhanced energy production should be observable. 
Dopaminergic neurons have low mitochondrial mass, which makes them vulnerable to energy 
shortage (Liang et al. 2007). Defects of the energy providing OxPhos system could be the 
reason for breakdown of the compensatory mechanisms.  
The compensatory mechanisms mask the early motor symptoms of PD. The early diagnosis is 
difficult (Gaenslen and Berg 2010) and a halt of the progress of the disease or cure is not 
possible yet. Therefore, it is of great interest to study the changes of the assembly state and 
amount of OxPhos complexes and their activities during degeneration of dopaminergic 
neurons in SN and STR for a better understanding of the molecular mechanisms involved in 
Parkinson’s disease.  
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1.5 Calorie restriction 
The reduction of food intake without malnutrition compared to ad libitum intake is defined as 
calorie restriction (CR). As reported by McCay et al. (1935), rodents have a prolonged life 
span when their food is limited. Also for other animals such as worms, fish, rodents and 
monkeys an increased life span under calorie restriction was found (Fontana et al. 2010). A 
reduction of 30-60 % in calorie intake initiated in early life of rodents caused a 30-60 % 
increase in maximum life span compared to animals fed ad libitum, while CR started in 
adulthood (age of 12 months) maximised the life span by about 10-20 % (Omodei and 
Fontana 2011).  
CR delays the onset of age-associated diseases such as cardiovascular disease, several types 
of cancer, diabetes and ischemic injury as well as it should protect against neurodegenerative 
diseases. It is even proposed to induce neurogenesis in hippocampus and increase of plasticity 
effect besides other positive effects (Ribeiro et al. 2012). To explain all these effects, it is 
assumed, that the production of ROS by OxPhos is decreased, which occurs when CR without 
malnutrition is applied (Bevilacqua et al. 2005). During the 1950s, Harman (1956) found that 
free radicals attack cells as well as tissue and postulated that they cause ageing and 
degenerative diseases. Sohal et al. (2002) and Speakman (2005) assumed that ROS are 
continuously formed by the respiratory chain, but are scavenged by mitochondrial antioxidant 
enzymes. Speakman et al. (2004) and Speakman (2005) proposed that a dynamic and 
controlled uncoupling of respiration leads to a minimum of ROS production. OxPhos seems 
to be even more effective in the later years of life, as Silvestri et al. (2011) state “oxidative 
phosphorylation is more efficient in aged than in young [rat] skeletal muscle, since in old rats 
there is an increased respiratory control ratio”. In contrast to that Cocco et al. (2005) found 
that ageing decreases OxPhos in rat brain mitochondria (RBM). They also highlight that RBM 
“[…] have not been extensively studied. […]”  
The question arises, whether the positive effects on healthy ageing and prolonged lifespan for 
rodents and other short-lived animals are translatable to ageing in humans. Non-human 
primates, specified rhesus monkeys, show similar age-related changes as humans, such as 
redistribution of body fat, greying and thinning of hair, loss of vigour, loss of muscle tone and 
loss of skin tone. They develop age-related diseases such as diabetes, neoplasia, sarcopenia, 
bone loss and impaired immune function as observed in humans (Colman et al. 2014). Their 
media lifespan for living in captivity is about 27 years (Mattison et al. 2012). Therefore the 
results of studies of non-human primates provide a link to the effects on humans. In the 
studies on 76 adult rhesus monkeys at the Wisconsin National Primat Research Center 
(WNPRC) by Colman et al. (2014) it was found that 30 % calorie restriction reduces age-
related and all-cause mortality. The ad libitum fed control animals had a 2.9 times higher risk 
of death from an age-related cause and a 1.8 times higher risk for death form any cause, 
compared to the animals kept under CR. Another CR study on 120 rhesus monkeys was 
performed at the National Institute on Ageing (NIA) by Mattison et al. (2012). They analysed 
the metabolic health and the risk of death of young-onset and old-onset CR on the animals. 
They did not observe effects on lifespan of CR animals compared to controls, age-related 
deaths and all-cause mortality seemed to be the same. But they found that old-onset CR has a 
positive influence on metabolic health, they found triglycerides, cholesterol and fasting 
glucose levels reduced. However, a comparison between the studies of WNPRC and NIA 
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indicated different conditions of diet composition and amount of intake, as concluded from 
body weight and life time of animals. The missing difference in lifespan could be explained 
amongst others by the fact that even the control animals of NIA had been fed under conditions 
of mild restriction (Colman et al. 2014).  
It is difficult to implement CR in clinical trials for humans. But epidemiological studies 
enable to analyse CR similar influences. For example the inhabitants of Okinawa (Japan) 
were known to consume about 15 % less than mainland Japanese and about 40 % less than the 
average daily intake of inhabitants of the United States. In people above 65 years from 
Okinawa the death rate from coronary heart disease and cancer was lower than for the 
mainland Japanese and United States residents. And the rate of centenarians with about 50 per 
100,000 inhabitants is the highest in the world (Omodei and Fontana 2011). A volunteer 
group of people have founded the Calorie Restriction Society, practising self-imposed CR by 
reducing the calorie intake to about 30 % less than the control group. They eat a diet rich in 
nutrient dense foods while containing all essential nutrients. Protective effects on 
overweight/obesity, type 2 diabetes, inflammation and left ventricular diastolic dysfuntion are 
reported. Lower blood concentrations of cholesterol, low-density lipoprotein cholesterol, 
triglycerides, fasting glucose and fasting insulin were found as well as lower blood pressure 
and lower levels of inflammatory markers (Omodei and Fontana 2011). Omodei et al. (2015) 
analysed anorexic patients, as an extreme form of CR, to characterise the immune-metabolic 
profile, and found reduced amounts of immune cell populations, reduced glycolysis and 
OxPhos rates as well as higher anti-oxidant and anti-inflammatory levels. However, OxPhos 
capacity of mitochondria was on the same level as compared to healthy controls. They 
concluded that cells seem to be protected from biochemical stress.  
In human cohorts several diets were analysed on their influence on cognitive function. Diets 
with additional antioxidants such as vitamin B6, B12, C, E or folic acid, flavonoids, with 
omega-3 fatty acids or Mediterranean diet were analysed, but they did not give enough 
evidence for a relationship between nutrition and cognitive function (Ferri et al. 2014).  
The influences of CR on the ageing brain and the age-associated neurodegeneration have 
rarely been analysed yet. Therefore, it is of great interest to study the effects of CR during 
ageing on the mitochondrial proteome of brain tissue, for a better understanding of the 
mechanism, how CR triggers a longer and healthier life.  
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1.6 Motivation 
The desire to understand the processes which occur during ageing and the causes of ageing-
associated diseases is huge in our ageing society. It becomes more and more important to find 
possibilities to delay or even avoid the onset of ageing-associated diseases or at least to 
influence the health positively during ageing. Therefore, it is indispensable to find solutions 
for early diagnosis of the onset of ageing-associated diseases such as dementia and 
neurodegeration, especially because of irreversible degradation of neuronal cells. During 
ageing and development of ageing-associated diseases alterations of mitochondria, their 
genome, proteome, lipidome, metabolism and functions were observed (Groebe et al. 2007, 
Murphy 2009, Gilmer et al. 2010). The changed role of mitochondria in energy metabolism 
and in production of reactive oxygen species (ROS) amongst others has been widely 
discussed but still the causes for the observed changes in mitochondria during ageing and 
ageing-associated diseases are not understood, not to mention the attempts to influence the 
changes in a positive way. Mitochondria from late passage (senescent phenotype) human 
umbilical vein endothelial cells (HUVECs, 2.6.4) will be analysed in this thesis to understand 
the changes caused by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 
(Nox4) (4.3), which generates ROS (Koziel et al. 2013). ROS are supposed to affect 
mitochondrial oxidative phosphorylation (OxPhos) complexes besides mtDNA or lipids but 
they are also involved in cell signalling or immune defence amongst other functions (Hancock 
et al. 2001). Cell culture provides a good model system for experimental analyses but cannot 
reflect a whole organ system in which different tissues are in interaction with each other as 
found in mammals. Animal models were established for analyses of ageing and ageing-
associated diseases. Experiments were carried out to find general mechanisms and 
explanations for the causes of ageing and ageing-associated diseases in order to identify 
targets for delaying or avoiding onset of diseases, which might be transferred to humans in 
future. A lot of studies on rodents were performed using mitochondria of skeletal (Bevilacqua 
et al. 2005, Lombardi et al. 2009, Siegel et al. 2013) or heart muscle (Lee et al. 1999, Gómez 
et al. 2009, Tatarkova et al. 2011, Dai et al. 2014) or liver (Grinna 1977, Vorbeck et al. 1982, 
Dani et al. 2010) to analyse the effects of ageing or calorie restriction (CR). But the analyses 
of the OxPhos complexes from mitochondria of muscle or liver cannot be compared to the 
analyses of brain mitochondria. Even differences between interfibrillary and subsarcolemmal 
mitochondria of heart tissue exist (Thilmany 2013). Silvestri et al. (2011) stated “[…], it has 
emerged that the mitochondrial proteome differs greatly among tissues, depending on their 
functional requirements. […]”. Frenzel (2011) describes in her studies of ageing differences 
between the rat brain mitochondria from the tissues cerebral cortex, striatum and 
hippocampus. Also Haripriya et al. (2004) analysed these three brain areas. However, often 
mitochondria from whole brain (Filburn et al. 1996, Tian et al. 1998, Olgun et al. 2002, 
Groebe et al. 2007) or from cerebral cortex (Cocco et al. 2005, Gilmer et al. 2010, Cerqueira 
et al. 2012) were analysed. Therefore, it is of great interest to study the ageing brain and the 
impact of ageing on the different brain areas. In this thesis the mitochondria of cerebellum, 
hippocampus and cerebrum from young and old Fischer rats (2.6.1) are studied for analyses of 
ageing and the effects of calorie restriction (4.1). Substantia nigra and striatum from Wistar 
rats (2.6.2) are analysed in an animal model of early Parkinson’s disease (4.4). Cerebellum is 
involved in planning, execution and practice of motoric action. In new situations, the 
movement is adjusted there. The cerebrum contained the brain areas cerebral cortex, limbic 
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system excluding hippocampus, and the basal ganglia. Cerebral cortex contains the sensory, 
motor and association areas and is involved in planning and control of complex movements, 
attention, awareness, perception, language, memory, thought and consciousness. The limbic 
system is important for stabilisation of neuronal circuits. The transfer of information from 
short-term to long-term memory is mainly performed by hippocampus. Substantia nigra and 
striatum belong to the basal ganglia, which are involved in motivation-dependent conception 
of movement program and are thereby involved in the procedural long-term memory (Thews 
et al. 1999). Substantia nigra consists of dopaminergic neuron cell bodies projecting to 
striatum. Both areas are degenerated in consequence of Parkinson’s disease. Remarkable is, 
that about 80 % of the dopaminergic neurons are lost before first physical symptoms of the 
disease arise (Thews et al. 1999). Consequently, all these brain areas have specific important 
tasks to manage and each of them is indispensable for proper function of the interplay 
between brain and body. The supply with energy is extremely important for biological neural 
networks, therefore many mitochondria are located there and their proper function is essential 
(Schwarz 2013) as mitochondrial dysfunctions seem to trigger ageing-associated neuro-
degenerations (E and Swerdlow 2012). A trigger for a longer lifespan, a healthier life and to 
influence metabolism in a positive way is calorie restriction as shown for several animal 
models (Fontana et al. 2010, Ribeiro et al. 2012). CR is supposed to decrease the amount of 
produced ROS and therefore to prevent damage of the OxPhos complexes (Bevilacqua et al. 
2005), but even 80 years after discovery of the lifespan prolonging effects, the molecular 
mechanism is still unresolved. The effects of CR on the central nervous system have been 
rarely analysed yet. Therefore, it is important to study the effects of CR on the mitochondrial 
proteome of brain tissue, in order to gain a better understanding of the alterations at the 
protein level. In this thesis the influences of calorie restriction on the proteome of 
mitochondria from cerebellum, hippocampus and cerebrum of rats are studied (4.1).  
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2 Materials 
2.1 Chemicals 
substance abbrev. manufacturer p/o no. 
1,4-Dithiotreitol p.a. DTT Carl Roth 6908.2 
1,6-diphenyl-1,3,5-hexatriene DPH Sigma-Aldrich D208000 
3,3'-Diaminobenzidine DAB Sigma-Aldrich D5637 
4-Iodophenyl boronic acid 
 
Sigma-Aldrich 471933 
5-Bromo-4-chloro-3-indoylphosphate, 
disodiumsalt 
BCIP Carl Roth A155.2 
Acetic acid 100 %, p.a. AcOH Carl Roth 3738.5 
Acetonitrile, HPLC gradient grade ACN AppliChem A3189 
Acetonitrile,Rotisolv® HPLC ultra 
gradient grade 
ACN Carl Roth T195.2 
Adenosine-5'-triphosphate ATP Sigma-Aldrich A3377 
Ammonium bicarbonate ABC Fluka 09832 
Ammoniumperoxodisulphate APS Fluka 09915 
Ammoniumphosphate monobasic, 
ultra  
Fluka (BioChemika) 09709 
Bis(2-hydroxyethyl)-imino-tris-
(hydroxymethyl)-methane 
Bis-Tris Fluka 14880 
Bovine serum albumine, fraction V BSA Carl Roth 8076.2 
Bromophenol blue 
 
Fluka 18030 
CertiPUR® buffer solution 
pH(20°C)=4.00 
 Merck Millipore 109435 
CertiPUR® buffer solution 
pH(20°C)=7.00 
 Merck Millipore 109439 
CertiPUR® buffer solution 
pH(20°C)=9.00 
 Merck Millipore 109461 
Cytochrome c, bovine heart 
 
Sigma-Aldrich C2037 
Cytochrome c, equine heart 
 
Calbiochem 250600 
D-(-)-Mannitol 
 
Carl Roth 4175 
D-(+)-Sucrose 
 
Carl Roth 4621.2 
Digitonin  
 
Acros 
407560050  
(Charge A0280740)
Dimethylsulfoxide DMSO Carl Roth A994.2 
Disodium hydrogen phosphate, p.a. Na2HPO4 Fluka 71642 
Ethanol, denatured EtOH 
supply store,  
Chemistry department, 
TU Darmstadt 
 
Ethylendiamine tetraacetate, 
tetrasodiumsalt, dihydrate 
EDTA Sigma-Aldrich E-6511 
Formaldehyde solution, 37 % in H2O  
Sigma-Aldrich 252549 
Glycerol  
 
Carl Roth 3783.2 
Glycine p.a. 
 
Carl Roth 3908.2 
High molecular weight calibration kit 
for native electrophoresis 
HMW GE Healthcare 17-0445-01 
 18 2 Materials 
substance abbrev. manufacturer p/o no. 
Hydrochloric acid, 30 % Suprapur® HCl Merck 1.00318 
Hydrochloric acid, fuming 37 % p.a. HCl Carl Roth 4625.1 
Hydrogenperoxyde, 30 % H2O2 Merck 107209 
Imidazole 
 
Fluka 56750 
Isopropanol, denatured 
 
supply store,  
Chemistry department, 
TU Darmstadt 
 
Lead (II) nitrate 
 
Fluka 1533.4 
Low molecular weight calibration kit 
for SDS electrophoresis 
LMW GE Healthcare 17-0446-01 
Luminol 
 
Fluka 09253 
MagicMark™ XP Western Protein 
Standard 
MM Invitrogen LC5602 
Magnesium nitrate hexahydrate  Sigma-Aldrich 63087 
Magnesium sulphate 
 
Carl Roth P027.2 
Magnesium chloride hexahydrate p.a. MgCl2 Carl Roth A537.1 
Methanol, denatured MeOH 
supply store,  
Chemistry department, 
TU Darmstadt 
 
MOPS 
 
Carl Roth 6979.4 
N,N,N′,N′-
Tetramethylethylenediamine 
TEMED Sigma-Aldrich T9281 
N,N'-Dimethylformamide DMF Merck 2937 
N-[Tris(hydroxymethyl)-methyl]-
glycine, ≥99 % (titration) 
Tricine Sigma-Aldrich T0377 
N-2-Hydroxy piperazine-N'-2-
ethanesulfonic acid 
HEPES  Carl Roth 9105.4 
Nitrotetrazolium Blue chloride NBT Carl Roth 4421.4 
Peptide Mass Standards Kit for Cali-
bration of AB Sciex MALDI TOF  
AB Sciex P2-3143-00 
Potassium acetate  
 
Fluka 60034 
Potassium chloride KCl Carl Roth 6781.3 
Potassium dihydrogen phosphate KH2PO4 Carl Roth 3904 
Potassium hexacyanoferrate (III) 
 
Fluka 60300 
Potassium hydroxide KOH Fluka 60370 
Protease inhibitor cocktail for 
mammalian cell tissue use 
PIC  Sigma-Aldrich P8340 
Refraction-2D™ Labeling Kit 4G or 
8G 
G-Dyes NHDyeAGNOSTICS PR08 or PR08G 
Roti®-Block, 10x concentrate 
 
Carl Roth A151.2 
Roti®-Blot 2A, 10x concentrate 
 
Carl Roth P037.1 
Roti®-Blot 2K, 10x concentrate 
 
Carl Roth P038.1 
Roti®-Blue, 5x concentrate 
 
Carl Roth A152.1 
Roti®-Free 
 
Carl Roth 0083.1 
Roti®-Nanoquant, 5x concentrate 
 
Carl Roth K880.1 
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substance abbrev. manufacturer p/o no. 
Rotiphorese® Gel 40 
Acrylamide / Bisacrylamide 29:1 
Gel AB Carl Roth A515.1 
Rotiphorese® Gel A 
30 % Acrylamide solution 
Gel A Carl Roth 3037.1 
Rotiphorese® Gel B  
2 % Bisacrylamide solution 
Gel B Carl Roth 3039.1 
Serva Blue G  
(Coomassie Brilliant Blue G-250) 
CBBG Serva 35050 
Silver nitrate p.a. AgNO3 Carl Roth 7908.2 
Sodium carbonate, anhydrous, p.a. Na2CO3 Carl Roth A135.2 
Sodium chloride p.a. NaCl Carl Roth A3957.1 
Sodium dihydrogen phosphate 
dihydrate 
NaH2PO4
x 2 H2O 
Carl Roth T879.1 
Sodium dodecylsulphate, ultra pure SDS Carl Roth 2326.1 
Sodium hydroxide p.a. NaOH Carl Roth 6771.1 
Sodium phosphate dodecahydrate 
Na3PO4 
x 12 H2O 
Fluka 71642 
Sodium succinate dibasic hexahydrate 
 
Sigma-Aldrich S2378 
Sodium thiosulphate anhydrous Na2S2O3 Fluka 72049 
Sodium thiosulphate pentahydrate p.a.
Na2S2O3 
x 5 H2O 
Merck 6516 
SYPRO®Ruby protein gel stain SyRu Invitrogen S21900 
Trifluoroacetic acid TFA Fluka 91701 
Tris(hydroxymethyl)-aminomethane, 
≥99,9 %, p.a. 
Tris Carl Roth 4855.2 
Trypsin Resuspension Dilution Buffer 
 
Promega V5111 
Trypsin, lyophilised powder, 
proteomics grade  
Sigma-Aldrich T6567 
Trypsin, lyophilised powder, 
sequencing grade  
Promega V5111 
Tween® 20 
 
Carl Roth 9127.1 
α-Cyano-4-hydroxycinnamic acid HCCA Sigma-Aldrich C-2020 
β-Mercaptoethanol, 99 %, p.a. MeSH Carl Roth 4227.1 
β-Nicotinamide adenine dinucleotide, 
reduced disodium salt hydrate 
NADH Sigma-Aldrich N-6005 
ε-Aminocaproic acid 
 
AppliChem A7011 
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2.2 Antibodies 
Primary antibodies 
target protein host species manufacturer p/o no. 
α MTCO1 (CIV) mouse abcam® ab14705 
α NDUFS1 (CI) rabbit Proteintech 12444-1-AP 
α OxPhos V subunit alpha (CV) mouse Invitrogen 459240 
α SDHA (CII) mouse abcam® ab14715 
α UQCRC2 (CIII) mouse abcam® ab14745 
 
Secondary antibodies 
conjugate target protein host species manufacturer p/o no. 
IgG-HRP α mouse donkey Santa Cruz sc-2318 
IgG-HRP α rabbit donkey Santa Cruz sc-2317 
 
2.3 Consumables 
consumable manufacturer p/o no. 
0.2 mL Thin-walled Tubes with Flat Caps Thermo Scientific AB-0620 
alumina foil Aldi Süd  
Biopsy Punch diameter 2 mm, sterile Miltex 33-31 
cannula with Luer-Lock connection, 1.00 mm x 
200 mm 
neoLab 2-3113 
cannula with Luer-Lock connection, 1.50 mm x 
100 mm 
neoLab 2-3121 
Disposable Bags Carl Roth E706.1 
Disposable cuvettes, 1.5 mL semi-micro, PMMA Brand 7591 15 
Disposable pasteur pipettes, graduated, LDPE Carl Roth EA62.1 
filter wellplate MultiScreen Solvinert, 
hydrophilic, PTFE, 0.45 µm 
Millipore MSRLN0410 
G-Dye low retention tips (0.1-10 µL) NHDyeAGNOSTICS PR57 
G-Dye low retention tubes, 500 µL NHDyeAGNOSTICS 
 
Hand towel green, cellulose Tork Universal 290135 
Kapton® tape NHDyeAGNOSTICS PR51 
Kimtech Precision wipes 
Kimberly-Clark 
Professional 
05511 
Multi®-safety microcentrifuge tubes, 0.5 ml Carl Roth 7060.1 
membrane filters (regenerated cellulose) 0.2 µm, 
diameter 50 mm 
GE Healthcare, Whatman 10410314 
membrane filters (regenerated cellulose) 0.45 µm, 
diameter 50 mm 
Schleicher&Schuell 10410214 
Parafilm M Laboratory film Bemis Flexible Packaging 
 
Pasteur pipettes with long, thin tip, not graduated, 
LDPE 
Carl Roth EA58.1 
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consumable manufacturer p/o no. 
PE foil Aldi Süd  
pipette tips  Biozym 729025 
pipette tips 10 µL Biozym 720015 
pipette tips MµltiFlex® tips 1-200 µl  Carl Roth Y419.1 
pipette tips Omnitip™ Fastrack 10 µL ULPlast 81510 
pipette tips Standard MAKRO 1-5 ml  Carl Roth 5846.1 
pipette tips ultratips 1000 µL Greiner BIO-ONE 740290 
pipette tips ultratips 20-200 µL Greiner BIO-ONE 739290 
PP microplate, 96 well, Vshape Greiner BIO-ONE 651201 
PP-tube, 1.5 mL Glasgerätebau Ochs 10-00122 
PP-tube, 15 mL Greiner BIO-ONE 188271 
PP-tube, sterile, skirt, 50 mL Greiner BIO-ONE 210261 
Prespotted AnchorChipTarget PAC II 384 HCCA Eppendorf for Bruker 255682 
PS-microplate, 96 well, flat bottom Greiner BIO-ONE 655101 
reagent basin 60 mL Thermo Scientific 9510027 
Roti®-NC, nitrocellulose membrane Carl Roth HP40.1 
Rotilabo® -blotting paper, 1.5 mm Carl Roth CL75.1 
Rotiprotect®-latex gloves Type 2 powder free  Carl Roth L949.1 
Rotiprotect®-nitrile gloves eco  Carl Roth TC12.1 
Safe-Lock Tubes 2.0 mL Eppendorf 0030 120.094 
Sekuroka®-protective sleeves Carl Roth KP24.1 
Sequiblot™ PVDF membrane BioRad 162-0182 
Surgical Disposable Scalpels B Braun 5518083 
tubing Tygon® LFL, ID: 2.79 mm wall: 0.84 mm 
Saint-Gobain Performance 
plastics 
070602-18 
tubing Tygon® R3607, ID: 1.85 mm  
wall: 0.86 mm 
Saint-Gobain Performance 
plastics 
070534-20 
ZipTipC18 Millipore ZTC18M960 
ZipTipC4 Millipore ZTC04S096 
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2.4 Devices 
application device manufacturer 
balance research R 200D Sartorius 
balance universal U 4100S Sartorius 
centrifugation 5804R Eppendorf 
centrifugation 5810R Eppendorf 
centrifugation Biofuge pico Heraeus 
centrifugation rotor #3325B for Biofuge pico Heraeus 
centrifugation rotor A-2-DWP for Eppendorf 5804R Eppendorf 
centrifugation rotor A-4-62 for Eppendorf 5810R Eppendorf 
centrifugation rotor F-34-6-38 for Eppendorf 5804R Eppendorf 
centrifugation rotor F-45-30-11 for Eppendorf 5804R Eppendorf 
DIGE Typhoon 9400 Variable Mode Imager GE Healthcare 
gel electrophoresis 
Air-Cooled Vertical Electrophoresis Unit 
SE 400 
Hoefer 
gel electrophoresis Chroma Dual Cooled Vertical Unit SE 600 Hoefer 
gel electrophoresis Dual gel caster SE 245 Hoefer 
gel electrophoresis Dual gel caster SE 6015 Hoefer 
gel electrophoresis Electrophoresis power supply EPS 1001 Amersham Pharmacia Biotech 
gel electrophoresis Electrophoresis power supply EPS 301 Amersham Biosciences 
gel electrophoresis Electrophoresis power supply EPS 600 Pharmacia 
gel electrophoresis Electrophoresis power supply EPS 601 Amersham Pharmacia Biotech 
gel electrophoresis gradient maker 2x 34 mL and 2x 19 mL 
Workshop Chemistry 
department, TU Darmstadt 
gel electrophoresis Laminating machine SilverCrest 
gel electrophoresis lifting platform DIN 12897 Bochem 
gel electrophoresis light transilluminator G-2004 GEPE 
gel electrophoresis 
low fluorescent glass plates for SE 600, 
80-6442-14, 18 cm x 16 cm 
GE Healthcare 
gel electrophoresis peristaltic pump Minipuls® 3 Gilson 
gel electrophoresis shaker 3016 GFL 
gel electrophoresis 
Small Format Vertical Electrophoresis 
System SE 250, SE 260 
Hoefer 
imaging system Bio-Imaging-System ViewPix 900 Biostep/Epson 
imaging system fluorescent imaging system Typhoon 9400 GE Healthcare Life Sciences 
imaging system luminescent image analyser LAS-3000 Fujifilm 
mass spectrometry MALDI TOF/TOF Ultraflex I Bruker 
mass spectrometry 
steel target, sample plate, SS, V700666 
REV.C 
PerSeptive Biosystems 
mass spectrometry UniEquip, thermoshaker 
Laborgerätebau- 
und -vertriebs GmbH 
mass spectrometry 
Voyager DE™-Pro, BioSpectrometry™ 
Workstation 
Applied Biosystems 
mitochondria 
isolation 
homogeniser, glass/teflon, tight-fit, 2 mL Braun 
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application device manufacturer 
mitochondria 
isolation 
laboratory stirrer Eurostar digital Ika 
PC Lenovo G560 Model 0679 Lenovo 
pH adjustment pH electrode BlueLine 14 pH Schott 
pH adjustment 
pH electrode InLabMicro pH 0..14, 
0..80°C 
Mettler Toledo 
pH adjustment pH meter CG 842 Schott 
photometry 
cuvette 4 x 10 mm (emission x excitation) 
quartz SUPRASIL 
Hellma Analytics 
photometry Fluostar/Polarstar Galaxy BMG Labtechnologies 
photometry PTI M III fluorescence spectrometer 
Photon Technology 
International 
photometry UV/Vis spectral photometer UV-2401 PC Shimadzu 
photometry waterbath Lauda RCS, RC20 mgw 
pipettes 
8-channel pipettes Research,  
10 µL 100 µL 300 µL 
Eppendorf 
pipettes Pipetteman P2, P10, P20, P200 Gilson 
pipettes Research var. 1000 µL Eppendorf 
pipettes SL-Pette 10-100 µL SLG, Nichiryo 
PMF ultra sonic bath Sonorex TK 52 H Bandelin 
PMF 
Unijet II, refridgerated, equipped with 
Univapo 150H 
Uniequip 
PMF 
vacuum filtration system 
MultiScreen®HTS Vacuum Manifold 
Millipore 
print HP Color Laserjet 4700dn Hewlett Packard 
print HP Laserjet M1132 MFP Hewlett Packard 
solubilisation waterbath 1004 GFL 
stirring/mixing electronic stirrer multipoint HP6 Variomag 
stirring/mixing magnetic stirrer Combimag Reo Ika 
stirring/mixing magnetic stirrer Ikamag reo Ika 
stirring/mixing vortex mixer Reax 3000 Heidolph 
water 
lab water purification system Simplicity 
equipped with Simpak® 2 
Millipore 
water peristaltic liquiport knf lab 
water Water still distinction D4000 Stuart 
Western blot Shaker HS 260 basic Ika 
Western blot 
Trans-Blot® SD semi-dry electrophoretic 
transfer cell 
BioRad 
 
  
 24 2 Materials 
2.5 Software 
software originator 
Adobe Reader XI Version 11.0.1 Adobe Systems 
ChemDraw® Std Version 8.0.3 CambridgeSoft 
Cisco AnyConnect Secure Mobility-Client  
Version 3.1.05160 
Cisco Systems 
Compass 1.3 Bruker 
Corel DRAW® Home&Student X6 Corel Corporation 
Corel PHOTOPAINT® Home&Student X6 Corel Corporation 
Delta2D 4.3 Decodon 
Endnote X7 Adept Scientific 
Fluostar Galaxy V4.21-0 bmg 
Image Quant tools GE Healthcare 
Image Reader LAS-3000 2.1 Fuji 
ImageJ 1.47 National Institute of Health, USA 
LEO’s dictionaries www.leo.org, LEO GmbH, Germany 
Mascot database Matrix Science 
MS Office 2010 Professional Microsoft 
Pdf24 Creator Version 5.2.0 geek Software GmbH 
ProteinScape 3.1 Bruker 
PTI-Software Felix 1.42 Photon Technology International 
PubMed database 
National Center for Biotechnology 
Information, U.S. National Library of 
Medicine, USA 
Real Statistics Resource Pack, Release 3.5.1 Charles Zaiontz  
http://www.real-statistics.com/ 
Typhoon Scanner Control GE Healthcare 
UniProt databases 
European Bioinformatics Institute,  
Swiss Institute of Bioinformatics,  
Protein Information Resource 
UVProbe 1.11 Shimadzu 
Voyager Data Explorer™ Software Version 4 Applied Biosystems 
Voyager Instrument Control Panel Version 5.1 Applied Biosystems 
Voyager Sequence Control Panel Version 5.1 Applied Biosystems 
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2.6 Biological Samples 
2.6.1 Rat brain samples for analysis of ageing and calorie restriction  
The analysis of the effects of ageing and calorie restriction on rat brain samples was 
performed with the brain regions cerebellum (Fig. 1.4), cerebrum and hippocampus of male 
Fischer rats (Rattus norvegicus) (F344/DuCrlCrlj, from Charles River Laboratories Japan) 
which were provided by the research group of Prof. Dr. Sataro Goto, Juntendo University, 
Imbamura, Inbagun, Chiba 270-1695, Japan. The cerebrum consisted of the brain regions 
cerebral cortex (Fig. 1.4), basal ganglia (Fig. 1.6) and the limbic system (Fig. 1.5), from 
which the hippocampus was separated. Growth of animals and preparation was performed in 
Japan. Four animals were kept per cage. Samples were frozen in liquid nitrogen and 
transferred on dry ice to our lab, Technische Universität Darmstadt (TUD), Germany. They 
were stored at -80°C until isolation of mitochondria. Isolation of cerebrum mitochondria was 
performed by Dr. Diksha Dani in 2009, isolation of cerebellum and hippocampus 
mitochondria was performed by me in 2012 and in 2013, respectively. Isolated mitochondria 
were shock frozen in liquid nitrogen and stored at -80°C. 
The three different brain regions, as mentioned above, originated from the same animals. The 
age of the animals were 6.5 months (young) and 27 months (old). They were nourished on 
free access to food every day (ad libitum) or on calorie restriction, the latter means feeding ad 
libitum on Mondays, Wednesdays and Fridays (alternate day feeding). The amount of food 
they consumed was about 60 % as an average of the ad libitum fed levels. Calorie restricted 
animals were fed ad libitum every day from birth until the age of 6 weeks to ensure a normal 
growth before the calorie restriction started. Dr. Sandra C. Thilmany calculated the level of 
calorie restriction from the ratio of the body weight of calorie restricted animals and the body 
weight of ad libitum nourished animals. She found a level of 40 % for young animals and 
37 % for old animals (Thilmany 2013). Four groups of animals can be distinguished: young 
ad libitum fed rats (YAL), old ad libitum fed rats (OAL), young calorie restricted animals 
(YCR) and old calorie restricted animals (OCR). The brain regions originated from the same 
animals which Dr. Thilmany analysed in her dissertation (Thilmany 2013) together with her 
diploma student Michaela Söhn (2010). As described in Dr. Thilmany’s thesis for heart and 
brain tissue, the individual animals of each group did not show abnormalities. Therefore, for 
each brain region separately, the individual animal samples of one group were pooled for my 
studies. For details see Table 2.1. 
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Table 2.1: Rat brain samples for analysis of ageing and calorie restriction  
denotation, age and tissue weight 
rat 
age 
[months] 
date  
of death 
body  
weight [g]*1 
tissue  
weight [g] 
(cerebrum)*2 
pooled tissue 
weight [g] 
(cerebellum / 
hippocampus) 
6.5-1 (YAL1) 6.5 16.12.2008 350 0.81 
1.41 / 1.06 
6.5-2 (YAL2) 6.5 16.12.2008 351 1.02 
6.5-3 (YAL3) 6.5 16.12.2008 356 1.04 
6.5-4 (YAL4) 6.5 16.12.2008 381 1.07 
6.5-5 (YAL5) 6.5 16.12.2008 360 0.99 
6.5-1 CR (YCR1) 6.5 16.12.2008 217 0.61 
1.30 / 0.76 
6.5-2 CR (YCR2) 6.5 16.12.2008 196 1.03 
6.5-3 CR (YCR3) 6.5 16.12.2008 241 0.94 
6.5-4 CR (YCR4) 6.5 16.12.2008 208 0.98 
6.5-5 CR (YCR5) 6.5 16.12.2008 211 0.92 
27M-1 (OAL1) 27 27.02.2009 451 0.44*3 
1.70 / 1.27 
27M-2 (OAL2) 27 27.02.2009 314 0.36*3 
27M-3 (OAL3) 27 27.02.2009 417 0.50*3 
27M-4 (OAL4) 27 27.02.2009 389 0.54*3 
27M-5 (OAL5) 27 27.02.2009 416 0.47*3 
27M-6 (OAL6) 27 27.02.2009 425 0.39*3 
27M-1 CR (OCR1) 27 27.02.2009 211 0.50*3 
1.61 / 0.77 
27M-2 CR (OCR2) 27 27.02.2009 239 0.51*3 
27M-3 CR (OCR3) 27 27.02.2009 268 0.39*3 
27M-4 CR (OCR4) 27 27.02.2009 260 0.43*3 
27M-5 CR (OCR5) 27 27.02.2009 265 0.47*3 
27M-6 CR (OCR6) 27 27.02.2009 273 0.30*3 
*
1
 data from Söhn (2010), *
2
 data from Thilmany (2013) 
*
3
 marked samples: only halves of the cerebrum sections had been used for isolation of mitochondria by Dr. D. 
Dani, 2009 
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2.6.2 Rat brain samples for studies on Parkinson’s disease 
For studies of the neurodegenerative disease Parkinson’s, animal studies were performed by 
Dr. Katarzyna Kuter, at Department of Neuropsychopharmacology, Institute of Pharma-
cology, Polish Academy of Sciences (IF-PAN), Smętna 12, 31-343 Kraków, Poland. 
Male Wistar Han rats (Charles River, Germany) had free access to water and food and were 
kept in a twelve hour light/darkness cycle. All rats weighted between 250 and 300 g and were 
approximately 3 months old at the beginning of the experiment. The experiments were carried 
out in compliance with the Animal Experiments Bill of January 21, 2005; (published in 
Journal of Laws no. 33/2005 item 289, Poland), and according to the NIH Guide for the Care 
and Use of Laboratory Animals. They also received approval from the Local Ethical 
Committee. All efforts were made to minimize the number of animals and their suffering.  
Preparation of animal model by injection of selective anti-dopaminergic toxin 
Animals were stereotactically operated under deep ketamine/xylasine anaesthesia. 
6-hydroxydopamine (6-OHDA) (3 µg / 3 µL 0.2 % ascorbic acid, Sigma-Aldrich, Germany), 
was injected into the medial forebrain bundle (MFB) to destroy dopaminergic cells by 
generation of reactive oxygen species (ROS) (further details in Zigmond (1997)). MFB 
consists of the neuronal fibers, passing from dopaminergic neuronal cell bodies of substantia 
nigra pars compacta (SNc) to striatum (STR), where their terminal endings are localized. 
Injection of 6-OHDA induces selective degeneration of dopaminergic neurons in SNc and 
disturbs the dopaminergic transmission in STR, which causes motor disability similar to 
Parkinson’s disease based changes (Kolasiewicz et al. 2012). 30 minutes before toxin 
injection, the animals received desipramine (Sigma-Aldrich, Germany) to protect 
noradrenergic neurons. After the injection, animals woke up from anaesthesia and behavioural 
studies at different time-points were performed by Kuter et al. (submitted: September 2015).  
Tissue preparation 
4 days or 4 weeks after the injection, the animals were decapitated, and the tissues substantia 
nigra (SN) and striatum (STR) of both hemispheres were immediately dissected on an ice cold 
plate (4°C) and frozen on dry ice. The tissues were stored at -80°C, transported by Dr. Kuter 
on dry ice to TUD and stored again at -80°C until isolation of the mitochondria for proteome 
studies.  
Isolation of rat brain mitochondria (RBM) (see section 3.1) and proteome studies of SN were 
carried out by Dr. Kuter and myself at TUD. Subsequent analyses of STR were carried out by 
Dr. Kuter under my mentorship at TUD.  
Three groups of animals were analysed: a) sham operated rats (SH), as a control group, which 
had been injected solely with 0.2 % ascorbic acid, killed 4 weeks after injection, b) rats killed 
four days after injection of 6-OHDA in 0.2 % ascorbic acid (4DL) and c) rats killed four 
weeks after injection of 6-OHDA in 0.2 % ascorbic acid (4WL).  
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2.6.3 Bovine heart mitochondria 
During a student’s practical course in summer 2008 Dr. Monika Frenzel isolated 
mitochondria from a freshly prepared bovine heart obtained from a local slaughterhouse. The 
mitochondria were shockfrozen in liquid nitrogen and stored at -80°C. Age, sex and race of 
the animal are unknown. Bovine heart mitochondria are well-analysed and serve as a standard 
for molecular weight of oxidative phosphorylation (OxPhos) complexes and supercomplexes 
in our laboratory. Furthermore, they were used for peptide mass fingerprint analysis in my 
studies.  
2.6.4 Cell culture samples for analysis of NADPH oxidase 4 
Five types of NADPH oxidases (Nox1-5) are known yet. These enzymes contain six subunits 
and are membrane bound. Nox4 are located at the endoplasmatic reticulum, focal adhesions, 
in mitochondria and the nucleus. They produce superoxide radical anions by transfer of 
electrons to molecular oxygen and therefore provide ROS.  
Analyses of NADPH oxidase 4 (Nox4) induced mitochondrial dysfunctions during ageing 
were carried out, using human umbilical vein endothelial cells (HUVEC). Early-passage cells 
(below passage 12) were compared to late-passage cells (at or after passage 20), which 
showed senescent phenotype. HUVECs were isolated and treated by Dr. Rafal Koziel as 
described in the joint publication (Koziel et al. 2013). Nox4 was knocked out (Nox4 KD) in 
HUVEC cells by lentiviral small hairpin ribonucleic acid (shRNA) vectors. Control cells were 
infected with non Nox4 specific shRNA vectors (control). Mitochondria were freshly isolated 
and shock frozen in liquid nitrogen by Dr. Koziel at Institute for Biomedical Aging Research 
(IBA), Innsbruck University, Rennweg 10, 6020 Innsbruck, Austria. They were transported 
on dry ice to TUD, where proteome studies were carried out by Dr. Koziel and me after 
introduction in the methods by myself.  
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3 Methods 
3.1 Isolation of mitochondria from rat brain tissue 
The isolation of organelles, especially mitochondria, is based on Reifschneider (2006). Tissue 
samples were homogenised before crude mitochondrial fraction was isolated by a differential 
centrifugation protocol, compare Söhn (2010). In contrast to M. Söhn’s protocol, SCAVEGR, 
an antioxidant cocktail which contains albumin, was omitted because it would have artificially 
increased the protein amount (Thilmany 2013). 
The frozen tissue was weighed on an ice-cooled watchglas. Then it was cut into small pieces 
with an ice-cooled scalpel and transferred to an ice-cooled tight-fit homogeniser. 4 mL of 
homogenisation buffer (Table 3.1, with PIC) per 1 g of tissue were added. Homogenisation 
was performed with seven strokes at 750 rpm with a tight-fit micropistill homogeniser 
(laboratory stirrer Eurostar digital, Ika, equipped with homogeniser, glass/teflon, tight-fit, 
2 mL, Braun). The homogenate was centrifuged (Eppendorf 5804R, rotor: F34-6-38, 4°C, 
7 min, 1,400 g) and the supernatant, which contained the mitochondria, collected and stored 
on ice. The pellet was resuspended with homogenisation buffer as a washing step and 
centrifuged again (4°C, 7 min, 1,400 g). The washing was performed twice. The merged 
supernatants were centrifuged (4°C, 7 min, 1,400 g) and the resulting supernatant was 
centrifuged (4°C, 8 min, 12500 g) for pelleting the mitochondria. The mitochondrial pellet 
was resuspended in storage buffer (see Table 3.1, with PIC), resulting in a slightly white 
cloudy liquid and stored shock frozen (N2 (l)) in aliquots at -80°C. 
Table 3.1: Buffers for mitochondria isolation 
Homogenisation buffer  Storage buffer 
210.0 mM Mannitol  210.0 mM Mannitol 
70.0 mM Sucrose  70.0 mM Sucrose 
1.0 mM Na4 EDTA*2 H2O  5.0 mM HEPES / NaOH 
5.0 mM HEPES / NaOH   
in Milli-Q-H2O, pH 7.4, 
sterile-filtered, stored at -20°C 
 
in Milli-Q-H2O, pH 7.4, 
sterile-filtered, stored at -20°C 
0.5 % (v/v) Protease inhibitor cocktail (PIC) is added to all buffers 
directly before use. 
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3.2 Protein quantification – Bradford protein assay 
According to the Bradford 
protein assay (Marshall and 
Williams 2004) Coomassie 
Brilliant Blue G-250 (CBBG, 
compare Fig. 3.1) adsorbs to the 
amino acid side chains of proteins 
in a specific amount via charge 
based and hydrophobic π−π-
stacking interactions (Lottspeich 
and Engels 2012). Due to this 
adsorption, the colour of CBBG 
changes proportionally from 
λ=450 nm to λ=590 nm. This can 
be measured by UV/Vis-photometry. Additives like phosphoric acid or methanol support the 
process by denaturing membranes. In the present study, the premix Roti®-Nanoquant, 5x 
concentrate from Carl Roth, containing CBBG, was used.  
3.2.1 In cuvettes 
Using Bradford protein assay the protein amount of isolated mitochondria was determined. 
For absorbance measurements, the UV/Vis spectral photometer UV-2401 PC from Shimadzu 
was used. 0.4 mg/mL bovine serum albumine (BSA) in Milli-Q-H2O served as a stock 
solution of the standard test series. 800 µL of 1x Roti®-Nanoquant (Roti®-Nanoquant, 5x 
concentrate diluted 1:5 with Milli-Q-H2O) were added to each dilution of the standard and 
each dilution of the sample test series to a total volume of 1 mL. The final concentrations of 
the standard test series were 0, 1, 2, 4, 8, 12, 15, 20 and 25 µg/mL. The final dilutions of the 
sample test series were 1:2000, 1:1000, 1:2000/3, 1:400 and 1:800/3. Milli-Q-H2O and 
1x Roti®-Nanoquant (Thilmany 2013) served as a negative control. 
Each series was repeated once. Incubation time was 10 minutes.  
All samples were transferred into disposable poly(methyl methacrylate) (PMMA) cuvettes for 
measurement. Milli-Q-H2O served as blank for the baseline. The absorbance ratio of the 
standard series (λ=590 nm / λ=450 nm) was plotted versus the concentration of the BSA 
standard series. The linear equation from the fit was used to calculate the concentration of the 
different sample dilutions. The latter were combined by calculating the mean. 
3.2.2 In 96-wellplate 
For samples with small available total protein amount, consequently the substantia nigra and 
striatum samples, the Bradford protein assay in cuvettes mentioned above (3.2.1) was 
modified by using 96 well plates. Final concentrations of the BSA standard and the dilutions 
of the samples were triplicated. Final volume per well was 250 µL, combined of 50 µL 
sample dilution and 200 µL 1x Roti®-Nanoquant. After 10 minutes incubation time the 
wavelength ratio 590 nm / 485 nm was measured in a 96 well plate reader (Fluostar/Polarstar 
Galaxy from BMG Labtechnologies, settings: absorption mode, test type: plate mode, reading 
Fig. 3.1: Structure of Coomassie Brilliant Blue G-250, modified, 
Sigma-Aldrich (2014b) 
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direction: horizontal, gain 019 and 004, no. of flashes: 42) (Frenzel 2006). Mathematical 
evaluation was performed as described in 3.2.1. 
3.2.3 Control of protein quantification by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis  
For control of the described protein quantification (Bradford protein assay) 5 µL of isolated 
mitochondria were mixed 1:1 (v/v) with sodium dodecyl sulphate (SDS) loading buffer 
(compare Table 3.13). 10 µg calculated protein amount, based on the results of the antecedent 
Bradford test, of each sample-SDS loading buffer mix were loaded onto a 10 cm by 8 cm by 
1.5 mm ten or fifteen well SDS polyacrylamide gel. 2 µL low molecular weight calibration kit 
for SDS electrophoresis (LMW, from GE Healthcare Amersham (2006b), contents see Table 
3.2) served as standard. Details of SDS polyacrylamide gel electrophoresis (SDS PAGE) are 
described in 3.6. The gel was stained with Roti®-Blue (3.7.2) and the image scanned (compare 
3.7.3). Evaluation was visually (by eye). Intensities of protein bands and protein lanes of the 
different samples were compared to each other. This method was already established by 
Thilmany (2013) but there quantified with an analysis software.  
Table 3.2: Low molecular weight calibration kit (GE Healthcare Amersham 2006b) 
Marker proteins of Low molecular weight calibration kit  
molecular weight (Mr) protein 
97,000 Phosphorylase b, rabbit muscle 
66,000 Albumin, bovine serum 
45,000 Ovalbumin, chicken egg white 
30,000 Carbonic anhydrase, bovine erythrocyte 
20,100 Trypsin inhibitor, soybean, 
14,400 α-Lactalbumin, bovine milk 
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3.3 Solubilisation of mitochondrial proteins by detergent 
Mitochondrial proteins were isolated of their 
membranes by solubilisation with the mild 
detergent digitonin (Fig. 3.2). The optimal 
detergent to protein ratio for RBM with 8 g 
digitonin per 1 g protein (d/p: 8g/g) was 
already determined by Frenzel et al. (2010). 
Krause (2004) established d/p: 3g/g for 
bovine heart mitochondria in his thesis. A 
differential centrifugation protocol was used 
as described below.  
3.3.1 Solubilisation of tissue samples (bovine heart and rat brain) 
First, the frozen sample was thawed and 300 µL of 1x solubilisation buffer (2x solubilisation 
buffer diluted with Milli-Q-water, Table 3.3) were added. A centrifugation step (4°C, 8 min, 
20800 g) followed. The supernatant was removed and the pellet resuspended in the calculated 
amount of freshly prepared buffermix (Table 3.3, sample calculation in Fig. 3.3). The required 
volume of the 10 % (w/v) digitonin stock solution was added to result in a final volume of 
1 % (v/v) and a mass ratio of d/p: 8g/g for rat brain samples. For bovine heart mitochondria 
samples 3 d/p: 3g/g were used. The mixture was homogenised using a vortex mixer and 
incubated on ice for 30 min Every 10 min the mixture was homogenised again. The 
incubation was terminated with a centrifugation step (4°C, 10 min, 20800 g). The supernatant 
containing the solubilised proteins (1.25 µg/µL protein concentration) was transferred into an 
ice-cooled reaction tube. 
Table 3.3: Buffers for solubilisation of tissue samples 
2x Solubilisation buffer  buffermix  empty well solution 
60.0 mM  HEPES  2x solubilisation buffer 500 µL 180 µL buffermix 
300.0 mM Potassium acetate  PIC (0.5 % (v/v)) 5 µL 20 µL 
10 % 
Digitonin 
20 % Glycerol  Milli-Q-H2O 395 µL   
in Milli-Q-H2O,  
pH 7.4 (KOH), sterile filtered, 
stored at -20°C 
 10 % Digitonin 100 µL   
 total 1000 µL   
 
Empty well solution was prepared for filling empty wells in blue native (BN) gels to avoid 
perturbation of the neighboring lanes. 
  
Fig. 3.2: Structure of the mild detergent digitonin,  
(Roth et al. 1988) 
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3.3.2 Solubilisation of tissue samples for application of differential gel electrophoresis 
Solubilisation of mitochondrial proteins was performed according to solubilisation protocol in 
3.3.1. A final digitonin concentration of 2 % (v/v) was used to increase final protein 
concentration to 2.5 µg/µL for subsequent differential gel electrophoresis (DIGE) labelling 
protocol (see 3.7.5). Sample calculation is provided in Fig. 3.4.  
  
Sample calculation of digitonin amount for 260 µg protein and a final concentration 
of 2 % (v/v) digitonin and d/p: 8g/g: 
usage of 2 % (v/v) final digitonin concentration: 
83.2 µL buffermix + 20.8 µL 10 % (w/v) digitonin stock solution 
 = 104 µL total volume     → 2.5 µg/µL protein concentration 
Fig. 3.4: Sample calculation of 2% digitonin and buffermix amount, for solubilisation of rat brain 
mitochondria 
Fig. 3.3: Sample calculation of 1 % digitonin and buffermix amount for solubilisation of rat brain 
mitochondria 
Sample calculation of digitonin amount for 260 µg protein and a final concentration 
of 1 % (v/v) digitonin and d/p: 8g/g: 
 1 g/g 1 µL/100µg protein  10 % (w/v) digitonin stock solution 
↓·2.6 
 1 g/g 2.6 µL/260µg protein  10 % (w/v) digitonin stock solution 
↓·8 
 8 g/g 20.8 µL/260µg protein  10 % (w/v) digitonin stock solution 
↓·10 
 8 g/g 208 µL/260µg protein    1 % (v/v) digitonin solution 
 
 
187.2 µL buffermix +  20.8 µL 10 % (w/v) digitonin stock solution  
 → 1.25 µg/µL protein concentration 
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3.4 Imidazole blue native polyacrylamide electrophoresis 
Blue native gradient imidazole gels (BN gels) from total acrylamide concentration 
(% T) = 3 % to 13 % respectively 4 % to 13 % (compare 3.4.1) were used for separating 
proteins from tissue and cell culture samples. Total cross-linker concentration (% C) was 3 %. 
CBBG (Fig. 3.1), as a component of the cathode buffer (Table 3.7), provides negative charge 
for the gel run by non-denaturing charge based and hydrophobic π−π-stacking interaction 
with the native proteins (Krause and Seelert 2008), resulting in a separation of the native 
proteins according to their hydrodynamic radius and native mass.  
3.4.1 Preparation of imidazole BN gels 
Imidazole BN gel solutions were 
separately mixed together according to 
Table 3.5. The following steps were 
performed at +4°C. In case of 18 cm by 
16 cm sized gels the complete amount of 
separating gel solutions was transferred 
into the tanks of the 2x 34 mL gradient 
maker and in case of 10.0 cm by 10.5 cm 
sized gels only 5 mL of each separating gel 
solution was transferred into the tanks of the 2x 19 mL gradient maker for casting the gradient 
separating gel. For casting 18 cm by 16 cm sized gels dual gel caster SE 6015 and for 10.0 cm 
by 10.5 cm sized gels dual gel caster SE 245 from Hoefer were used. All gels had a thickness 
of 1.5 mm. The gradient gels were casted from bottom to top using a cannula with Luer-Lock 
connection from neoLab. Excess Milli-Q-H2O was initially in the tubing system, which 
covered the gradient gel at the end of casting. The set-up is shown in Fig. 3.5. The gel was 
moved for polymerisation of the separating gel from +4°C to room temperature (RT). After 
polymerisation, the excess water was removed and the stacking gel was casted above the 
separating gel including a 15 well comb for 18 cm by 16 cm gels or a 10 well comb for 
10.0 cm by 10.5 cm sized gels at RT. Polymerised gels were stored at +4°C at least 12 hours 
(h) to complete polymerisation until load of samples, followed by gel run.  
Table 3.4: Imidazole BN gel buffers 
Imidazole BN gel buffers 
1.5 M ε-aminocaproic acid 
75.0 mM imidazole 
(optional + 60 % (w/v) glycerol) 
pH 7.0 (HCl), sterile filtered, stored at +4°C 
 
Fig. 3.5: Set-up for casting gradient gels, modified, 
Krause and Seelert (2008) 
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Table 3.5: Imidazole BN gel composition 
Imidazole BN gel  size 18 cm x 16 cm size 10 cm x 10.5 cm 
  separating gels 
stacking 
gel 
separating gels 
stacking 
gel 
% T, % C [%] 13.0, 3.0 4.0, 3.0 3.5, 3.0 13.0, 3.0 3.0, 3.0 3.0, 3.0 
Rotiphorese® Gel A [mL] 6.230 1.92 0.849 0.357 0.719 0.7275 
Rotiphorese® Gel B [mL] 2.890 0.889 0.394 / 0.3336 0.3375 
Rotiphorese® Gel 40 
(Gel AB) 
[mL] / / / 2.140 / / 
Imidazole BN gel buffer (Table 3.4) [mL] / 4.940 2.500 / 2.470 2.500 
Imidazole BN gel buffer incl.  
60 % (w/v) glycerol(Table 3.4) 
[mL] 4.940 / / 2.470 / / 
Milli-Q-H2O [mL] 0.715 7.000 3.692 2.400 3.850 3.828 
TEMED [µL] 4.10 6.80 5.95 2.05 3.40 10.00 
10 % (w/v) APS [µL] 41.00 68.00 59.50 20.50 34.00 100.00 
total volume [mL] 14.820 14.820 7.500 7.390 7.410 7.500 
 
3.4.2 Imidazole BN gel run 
Mitochondria from tissue or cell culture samples were solubilised according to 3.3 and loaded 
into the wells of the imidazole BN gel. As protein standard for BN gels 4 µL (18 cm by 16 cm 
sized gels) or 2 µL (10.0 cm by 10.5 cm sized gels) of the high molecular weight calibration 
kit for native electrophoresis (Table 3.6, GE Healthcare Amersham (2006a)) were loaded. 
70 µg (18 cm by 16 cm sized gels) respectively 40 µg (10.0 cm by 10.5 cm sized gels) BHM 
were solubilised (d/p: 3g/g) and loaded as an additional protein standard.  
Table 3.6: High molecular weight calibration kit (GE Healthcare Amersham 2006a) 
Marker proteins of High molecular weight calibration kit  
molecular weight (Mr) protein 
669,000 Thyroglobulin, porcine thyroid 
440,000 Ferritin, equine spleen 
232,000 Catalase, bovine liver 
140,000 Lactate dehydrogenase, bovine heart 
66,000 Albumin, bovine serum 
 
Table 3.7: Buffers for imidazole BN gel run 
Cathode buffer (B) 
for imidazole BN PAGE 
 Cathode buffer (B:10) 
for imidazole BN PAGE 
 Anode buffer 
for imidazole BN PAGE 
7.5 mM imidazole  7.5 mM imidazole  25.0 mM imidazole 
50.0 mM Tricine  50.0 mM Tricine    
0.02 % (w/v) ServaBlue G  0.002 % (v/v) ServaBlueG    
pH 7.0 adjusts itself, filtered, 
stored at RT 
pH adjusts itself, diluted 
from B with cathode buffer 
without ServaBlue G, stored 
at +4°C 
pH 7.0 (HCl), stored at +4°C 
 
18 cm by 16 cm sized gels:  
Depending on the expected volume of the gels, Hoefer Air-Cooled Vertical Electrophoresis 
Unit SE 400 or Chroma Dual Cooled Vertical Unit SE 600 were used to run the loaded 18 cm 
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by 16 cm sized gels. At the beginning, anode buffer and cathode buffer B for imidazole BN 
gels (Table 3.7) were used. The run was started with 15 mA per gel and 100 V, until the dye 
front has left the stacking gel. Then 500V were applied till dye front has reached the midway 
of the separating gel. The cathode buffer B was then exchanged into cathode buffer B:10 and 
the gel was run till the dye front started to leave the separating gel. 
10.0 cm by 10.5 cm sized gels: 
The Small Format Vertical Electrophoresis System SE 250 and SE 260 were used to run 
10.0 cm by 10.5 cm sized gels. From the start, anode buffer and cathode buffer B:10 for 
imidazole BN gel system, as described in Table 3.7, were used. The settings for the run were 
15 mA per gel and 100 V until the dye front has left the stacking gel. Then the voltage was 
increased to 250 V and stopped when the dye front started to leave the separating gel. 
Immediately after gel run the gels were used for further experiments.  
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3.5 Two-dimensional BN/SDS PAGE 
Two-dimensional (2D) gel electrophoresis is achieved by BN polyacrylamide gel electro-
phoresis (PAGE) in the first dimension and subsequent SDS PAGE in the second dimension. 
Proteins hence are separated according to their native mass and hydrodynamic size in the first 
dimension. For the second dimension, SDS and β-mercaptoethanol (MeSH) denatures the 
proteins into negatively charged peptide chains, which are separated depending on their chain 
length (Reisinger and Eichacker 2007). In my studies Tris-Tricine SDS PAGE is applied for 
the second dimension as described in Schägger and von Jagow (1987). 
Two different sizes of 2D-BN/SDS gels were used: 18 cm by 16 cm sized and 10.0 cm by 
10.5 cm sized gels. 18 cm by 16 cm sized gels require BN gel lanes from an 18 cm by 16 cm 
sized BN gel and 10.0 cm by 10.5 cm sized 2D-BN/SDS gels require 10.0 cm by 10.5 cm 
sized BN gel lanes (3.4). The thickness was 1.5 mm for BN gels and 2D-BN/SDS gels. 
3.5.1 Denaturation of proteins in BN gel lanes  
BN gel lanes were cut immediately after gel run, sealed in disposable plastic bags and stored 
at +4°C for maximum 36 hours. Lanes were incubated twice for 30 minutes in 1 % (v/v) 
MeSH / 1 % (w/v) SDS (in Milli-Q-H2O) and washed three times with Milli-Q-H2O before 
placing close to upper edge between glassplates of Hoefer gel casting system.  
3.5.2 Casting of 2D-BN/SDS gels 
Hoefer dual gel caster were used for casting the 2D-
BN/SDS gel at RT. SDS separating gel and the two 
stacking gels (composition in Table 3.9) were casted 
around the denatured BN gel lane, compare sketch in 
Fig. 3.6. A single tooth of a comb was used to form one 
well for the molecular weight size marker. After 
polymerisation of the gel, the run was started 
immediately.  
 
Table 3.8: 2D-SDS gel buffers 
2D-SDS gel buffer 
3.0 M Tris 
0.15 % (w/v) SDS 
(optional + 30 % (w/v) glycerol) 
pH 8.5 (HCl), stored at RT 
 
Fig. 3.6: Scheme of 2D-BN/SDS gel 
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Table 3.9: 2D-BN/SDS gel composition 
2D-BN/SDS gel size 18 cm x 16 cm size 10 cm x 10.5 cm 
gel  separating 
SDS-like 
stacking 
BN-like 
stacking 
separating 
SDS-like 
stacking 
BN-like 
stacking 
% T, % C [%] 13.0, 3.0 5.0, 3.0 5.0, 3.0 13.0, 3.0 5.0, 3.0 5.0, 3.0 
Rotiphorese® Gel A [mL] 1.300 0.810 0.810 0.650 0.405 0.405 
Rotiphorese® Gel B [mL] / 0.375 0.375 / 0.188 0.188 
Rotiphorese® Gel 40 
(Gel AB) 
[mL] 8.800 / / 4.400 / / 
2D-SDS gel buffer 
(Table 3.8) 
[mL] / 1.650 / / 0.825 / 
2D-SDS gel buffer incl. 
30 % glycerol(Table 3.8) 
[mL] 10.000 / / 5.000 / / 
BN gel buffer (without 
glycerol)(Table 3.4) 
[mL] / / 1.650 / / 0.825 
Milli-Q-H2O [mL] 9.750 2.140 2.065 4.875 1.070 1.033 
20 % (w/v) SDS [µL] / / 50.00 / / 25.00 
TEMED [µL] 15.00 2.50 3.50 7.50 1.25 1.75 
10 % (w/v) APS [µL] 150.00 25.00 35.00 75.00 12.50 17.50 
total volume [mL] 30.015 5.000 4.989 15.010 2.500 2.495 
 
3.5.3 2D-BN/SDS gel run 
3 µL of LMW (Table 3.2) were loaded as a standard into the well before gel run started. The 
gel run was performed with electrophoresis buffers (see Table 3.10) using Hoefer 
electrophoresis units applying 50 V and 80 mA per gel until the dye front reached the 
separating gel. Voltage was then increased up to 95 V and left for 10-14 h. When dye front 
was still visible, voltage was increased up to 175 V till dye front had left the gel and run was 
finished. 
In case of DIGE labelled protein samples (compare 3.7.5) special fluorescent free glass plates 
(GE Healthcare) were used and the gels were covered with alumina foil to avoid light 
exposure. 
The finished 2D-BN/SDS gel was directly used for its further application.  
Table 3.10: Buffers for 2D-BN/SDS PAGE run 
Anode buffer for 2D-
BN/SDS PAGE 
 Cathode buffer for 2D-
BN/SDSPAGE 
100.0 mM Tris  100.0 mM Tris 
   100.0 mM Tricine 
pH 8.9 (HCl),  
stored at +4°C 
 0.05 % (w/v) SDS 
 pH 8.25 adjusts itself, 
stored at +4°C 
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3.6 SDS PAGE 
The detergent SDS (Fig. 3.7) denatures 
proteins by destroying non-covalent bonds and 
covering the native charge by a negative 
charge proportional to the mass of the number 
of amino acids. It surrounds the peptides like 
stretched clouds. Subsequently, protein complexes lose their quaternary structure and are 
disassembled into their subunits, which are separated in SDS PAGE depending on their mass. 
In this thesis SDS PAGE is performed based on the system of U. K. Laemmli (Laemmli 
1970), which is also explained in detail in Lottspeich and Engels (2012). 
3.6.1 Casting of SDS gels 
SDS gels were casted according to recipe quoted in Table 3.12 using a dual gel caster SE 245 
from Hoefer. For 0.75 mm thick gels the gel solutions had to be degassed before adding SDS, 
N,N,N′,N′-tetramethylethylenediamine (TEMED) and ammoniumperoxodisulphate (APS). 
After casting the separating gel, the surface was covered with denatured isopropanol to avoid 
air contact. After polymerisation of the separating gel, the isopropanol was removed and the 
stacking gel casted. Usually, 10 well combs were used while casting the stacking gel.  
SDS gels could be stored at +4°C for several days wrapped in wet cellulose towels and 
polyethylene (PE) foil.  
Table 3.11: SDS gel buffers 
SDS separating gel buffer  SDS stacking gel buffer 
1.5 M Tris  1.0 M Tris 
pH 8.8 (HCl), stored at RT  pH 6.8 (HCl), stored at RT 
 
Table 3.12: SDS gel composition 
SDS gel size: 10 cm x 8 cm 
amount of gels and thickness  
2x 0.75 mm or  
1x 1.5 mm 
2x 0.75 mm or  
1x 1.5 mm 
  separating gel stacking gel 
% T, % C [%] 13.0, 4.0 5.0, 3.3 
Rotiphorese® Gel A [mL] 4.160 / 
Rotiphorese® Gel B [mL] 2.600 / 
Rotiphorese® Gel 40 (Gel AB) [mL] / 0.625 
SDS separating gel buffer (Table 3.11) [mL] 2.500 / 
SDS stacking gel buffer (Table 3.11) [mL] / 0.625 
Dist.-H2O [mL] 0.600 3.670 
important information:  
degas solution when casting  
0.75 mm thick gels 
20 % (w/v) SDS [µL] 50.0 25.0 
TEMED [µL] 7.5 5.0 
10 % (w/v) APS [µL] 75.0 50.0 
total volume [mL] 9.993 5.000 
 
  
Fig. 3.7: Structure of SDS, modified (Sigma-Aldrich 
2014c) 
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3.6.2 SDS gel run 
Before SDS gel run the samples were mixed 1:1 (v/v) with SDS loading buffer (Table 3.13) 
and loaded into the wells of the 10 cm by 8 cm sized SDS gel (Table 3.12). As a marker 
1.5 µL of LMW (Table 3.2) were loaded. If needed 40 µg (b. sol. d/p: 3g/g) of BHM were 
loaded as an additional marker. For the run, the gels were fixed in the Small Format Vertical 
Electrophoresis System SE 250 or SE 260, which was connected to water cooling. Glycine 
electrophoresis buffer (Table 3.13) was used for the run. 50 mA per gel and 100 V were 
applied until the dye front left the stacking gel. Then the voltage was increased to 200 V and 
turned off when the dye front has left the separating gel.  
Finished gels were treated immediately after run according to their purpose. 
Table 3.13: SDS loading buffer and Glycine SDS electrophoresis buffer 
SDS loading buffer  Glycine SDS electrophoresis buffer 
15 % (w/v) Sucrose  0.4 M Glycine 
2.5 % (w/v) SDS  50.0 mM Tris 
0.25 % (w/v) Na2CO3  0.1 % (w/v) SDS 
0.04 % (w/v) Bromophenol blue   
25.0 mM DTT   
stored at -20°C  pH 8.5 adjusts itself, stored at RT 
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3.7 Methods for visualisation and quantitation of proteins after 2D BN/SDS 
PAGE 
In this thesis different methods for visualisation and quantitation of the proteins after PAGE 
were used. Silver staining according to Blum et al. (1987) is extremely sensitive but is not 
useful for protein quantification (Table 3.14), however very effective for visualisation of the 
protein spots in 2D-BN/SDS gels, which is important for cutting protein spots before peptide 
mass fingerprint (PMF, see 3.9). For quantification of protein spots in 2D-BN/SDS gels 
(compare 3.11.1) highly sensitive (Table 3.14) fluorescent staining with SYPRO® Ruby (Bio-
Rad 2000) or fluorescent labelling with G-Dyes, Refraction-2D™ (NHDyeAGNOSTICS 2012-
2013) was applied. After quantitation the 2D-BN/SDS gels were additionally stained with 
silver for visualisation of the protein spots. Furthermore Roti® Blue (Carl Roth 2011) as a 
colloidal CBBG staining method with a similar dynamic range and an only slightly lower 
sensitivity (Table 3.14) was used for visual control of protein quantification (3.2.3) and for 
staining of first dimensional gels (3.4).  
Table 3.14: Different visualisation methods and their properties 
Method  Silver  Roti
®-Blue  SYPRO
® Ruby  Refraction-2D™ 
Protocol, 
Manufacturer 
 Blum et al., 
Electrophoresis, 
5, 1987, 93-99. 
 
Carl Roth 
Roti® Blue 
A152.1 
 
BIO RAD 
SYPRO® Ruby 
protein gel stain 
170-3138 
 
NH
DyeAGNOSTICS 
G-Dyes 
PR08, PR08G 
Sensitivity / spot  0.5 ng  < 30 ng  1-10 ng  < 0.03 ng 
Quantitative  no  yes  yes  yes 
Linear dynamic 
range 
 
no  103  103  104-5 
MS compatibility yes  yes  yes  yes 
Reference 
 Blum et al. 
(1987) 
 
Carl Roth 
(2011) 
 Bio-Rad (2000)  
NH
DyeAGNOSTICS 
(2012-2013) 
 
3.7.1 Silver stain 
Silver staining is divided into several steps as depicted in Table 3.15. The fixing steps cause 
lower background staining. Thiosulphate containing sensitizer increases the affinity of silver 
to the proteins by silver sulphide formation and leads to a faster and more sensitive reduction 
of silver later on. During silver impregnation step, the proteins form complexes with silver 
ions. The latter are reduced by formaldehyde in alkaline solution in the development step 
(staining solution in Table 3.15). Thiosulphate forms soluble silver complexes, preventing 
high background staining. Last steps are stop and storage, preventing overdevelopment. 
Washing steps between the incubation steps remove excess chemicals from previous steps. 
(For details see Blum et al. (1987) and Rabilloud et al. (1994)). 
 42 3 Methods 
Table 3.15: Solutions for silver staining 
solution  quantity  component 
Fixing I 
 50 % (v/v) 
12 % (v/v) 
 MeOH  
AcOH 
Fixing II  50 % (v/v)  EtOH 
Sensitizer  0,81 mM  Na2S2O3 x 5 H2O 
Silver 
 11,77 mM 
0,028 % (v/v) 
 AgNO3 
Formaldehyde 
Stain 
 0,57 M 
0,20 mM 
0,019 % (v/v) 
 Na2CO3 
Na2S2O3 x 5 H2O 
Formaldehyde 
Stop  10 % (v/v)  AcOH 
Storage  1 % (v/v)  AcOH 
 
All solutions for silver staining were made with distilled water. Silver staining of 2D-BN/SDS 
gels (3.5) was performed by shaking the gels in different solutions (Table 3.15) in the 
following order:  
• minimum 60 min Fixing I solution 
• minimum 60 min Fixing II solution 
• 1 min Sensitizer solution 
• 1 min dist. H2O 
• 20 min Silver solution 
• 1 min dist. H2O 
• staining solution, until the protein spots on the gel start to become dark brown (not 
black) 
• 1 min dist. H2O 
• 10 min Stop solution 
• minimum 30 min storage solution 
After shaking the gel in storage solution, the gel image was scanned according to 3.7.3.  
3.7.2 Colloidal Coomassie Brilliant Blue G-250 stain 
As already described in 3.2, CBBG binds to proteins and peptides through charge based and 
hydrophobic π−π-stacking interaction. Unspecific background staining was removed by 
destain solution. 
Colloidal CBBG staining of polyacrylamide gels was performed by application of Roti®-Blue 
according to the provided manual from Carl Roth (2011). Roti®-Blue was diluted as specified 
with 20 % (v/v) denatured methanol (MeOH) and 60 % (v/v) Milli-Q-H2O. Gels were soaked 
in diluted Roti®-Blue solution until lanes and background were saturated with blue colour. 
Then the gels were put into Roti®-Blue destain solution (25 % MeOH, denatured, in Milli-Q-
H2O) until the background of the gel was free of CBBG. Subsequently the gel was shaken in 
water to remove MeOH before scanning the image (3.7.3).  
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SDS gels have to be put in Roti®-Blue destain solution at least for 30 min before staining with 
Roti®-Blue as described above.  
3.7.3 Scanned gel images 
Silver or CBBG stained gels were scanned with the Bio-Imaging-System ViewPix 900 
(Biostep/Epson) after staining. The settings were 600 dpi and 24 bit colour depth for coloured 
images and 600 dpi and 16 bit grey scale for grey scale images. File format was tiff, no 
compression.  
Gels were sealed in foil and stored at +4°C after scan. 
3.7.4 SyproRuby stain 
The fluorescent stain SYPRO® Ruby binds non-covalently to basic amino acids and the 
polypeptide backbone (Molecular Probes Invitrogen detection technologies 2007). It is an 
organic complex containing ruthenium (Berggren et al. 2000). Excitation maxima are found at 
~280 nm and ~450 nm. Emission maximum is at ~610 nm (Bio-Rad 2000). 
2D-BN/SDS gels (3.5) were stained with fluorescent dye for subsequent quantification of the 
protein spots with evaluation software (Delta2D, Decodon, compare 3.11.1). Therefore, 
immediately after gel run, 2D-BN/SDS gels were bathed in SyproRuby fixing solution (10 % 
(v/v) denatured MeOH, 7 % (v/v) acetic acid (AcOH)) at least for one hour (Bio-Rad 2000). 
Afterwards, the gels were stained with SYPRO® Ruby protein gel stain (Invitrogen) for 3 
hours followed by 10 min shaking in SyproRuby fixing solution. Subsequently, the gel was 
washed for 10 min in Milli-Q-H2O.  
Images were taken with a CCD camera system (luminescent image analyser LAS-3000, 
Fujifilm) and the accessory software Image Reader LAS-3000 2.1. The settings were: blue 
light, 605 nm filter, iris F=0.85, tray position 4, exposure type: increment, interval time: 
10 sec. The software alarmed, when the images are oversaturated. The image, before 
oversaturation appeared, was saved as “.inf” and “.img” files for later quantification (compare 
3.11.1) and as “.tif” file for visualisation. 
After the images were taken, the gels were stained with silver (3.7.1) or wrapped in foil for 
storage at +4°C. 
3.7.5 DIGE labelling technique 
In contrary to all staining techniques mentioned before, the DIGE labelling technique has to 
be applied to proteins before loading and run of the polyacrylamide gel. Samples must have a 
pH between 8.0 to 8.5 for labelling (NHDyeAGNOSTICS 2012). Minimal labelling of the 
protein sample’s lysine residues with N-hydroxysuccinimide ester activated fluorescent dyes 
is applied. GE Healthcare (2005) describes that on average 1-2 % of the lysine residues of a 
protein are labelled. It can be found in the product guide of NHDyeAGNOSTICS (2012), that 
about 3 % of all proteins are covalently labelled with exactly one molecule of fluorescent dye. 
The mass of one molecule fluorescent dye is about 450 Da (GE Healthcare 2005). Usually 
three fluorescent dyes, emitting at different wavelengths, are used for labelling the samples 
which shall be compared (Table 3.16).  
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Table 3.16: Excitation and emission wavelengths for the 
different G-Dyes (
NH
DyeAGNOSTICS 2011) 
G-Dye  excitation max  emission max 
G-Dye100  498 nm  524 nm 
G-Dye200  554 nm  575 nm 
G-Dye300  648 nm  663 nm 
 
This enables to load three different samples onto one gel for the gel run. G-Dye100 usually is 
used for labelling the internal standard (IS), which consists of all different samples, pooled at 
the same protein amounts. The labelled IS is loaded on each gel for normalisation to get rid of 
gel to gel variation. G-Dye200 and G-Dye300 are applied to the samples which shall be 
compared. Special is the so called “dye-swap”. Each sample is at least used two times, each 
time labelled with a different dye (G Dye200 or G Dye300), to level out different labelling 
efficiencies (Karp et al. 2004). After gel run, the gels were scanned with a fluorescent 
imaging system (Typhoon 9400, see below). 
Sample preparation 
Samples were solubilised with d/p: 8g/g and final digitonin concentration of 2 % (v/v) 
according to 3.3.2. To prepare the samples for the fluorescent dye covalent labelling step 
(minimal lysine labelling), they were transferred into low retention tubes. Low retention tips 
were used from this point. Next, the pH was adjusted with 1.0 M potassium hydroxide (KOH) 
to 8.0 - 8.5 (final KOH concentration: 17.56 mM), then vortex mixed and short spun. 
The necessary volume of 1 M KOH was tested in a larger reaction batch (approx. 140 µL) as 
follows. A defined volume of 1x solubilisation buffer, pH 7.4, was provided and using a 2 µL 
pipette (Pipetteman G2, Gilson) a defined volume of 1.0 M KOH was added until pH meter 
(CG 842, Schott, equipped with pH electrode InLabMicro, Mettler Toledo), calibrated with 
CertiPUR® buffer solutions pH 7.00 and pH 9.00, Merck Millipore) showed a pH of 8.5. 
Quadruplication verified this.  
Labelling and gel run conditions 
Labelling was performed according to protocol for Refraction-2D™ Labeling Kit (4G or 8G) 
from NHDyeAGNOSTICS with 50 µg (b. sol.) protein per 1G unit and without additional 
sample buffer. The samples were covered with alumina foil to avoid direct light exposure.  
To the pH adjusted sample 1 µL of G-Dye working solution was added, the solution was 
vortex mixed and spun down. This was followed by incubation on ice for 30 min and then the 
reaction stopped by adding 1 µL stop solution (lysine solution in excess), mixed and short 
centrifugation. After 10 min incubation on ice, the samples were ready for the gel run. Gel run 
was performed for the first dimension as described in 3.4 and for the second dimension as 
outlined in 3.5 using special fluorescent free glass plates. Contact to direct light was avoided 
by covering the samples or the electrophoresis units with alumina foil. Gels were stored at 
+4°C until transport to research group of Prof. Dr. K.-D. Entian, where the fluorescent 
imaging system (Typhoon 9400, GE Healthcare Life Sciences) was located. 
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Settings Typhoon scanner and image recording 
Stripes of Kapton® tape were placed as described on page p8-11 in GE Healthcare (2006) be-
low the spacers of the gel sandwich, providing a defined space between glass plate of the gel 
and the surface of the scanner, which was filled with distilled water for matching refractive 
index. Then a Multiple Sample Scan was performed for four gels at the same time, running 
the software Typhoon Scanner Control. Settings: acquisition mode: fluorescence, pixel size: 
100 microns, focal plane +3 mm (because of scan between glass plates of the sandwich), 
channel 1: filter 520BP40, blue laser 488 nm, channel 2: filter 580BP30, green laser 532 nm 
and channel 3: filter 670BP30, red laser 633 nm. 600 V were applied per channel. 
Evaluation software 
After the scan, the Typhoon Scanner Control software provided “.ds” and “.gel” files which 
were saved and uploaded to the evaluation software Delta2D from Decodon for 2D-gel spot 
quantification (see 3.11.1). To create overlaid coloured images (“.tif” format) from the “.gel” 
files, the software tools ImageQuantTools and ImageJ have been used.  
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3.8 In-gel activity tests 
BN PAGE was performed according to 3.4 for qualitative or quantitative in-gel activity tests 
of the mitochondrial OxPhos complexes I (CI: NADH: ubiquinone oxidoreductase), IV (CIV: 
cytochrome c oxidase) and the reverse reaction (hydrolysis of ATP) of complex V (CV: ATP 
synthase). Directly after gel run, the gels were washed in Milli-Q-H2O and placed into the 
appropriate activity test solution. The accumulation of precipitate during in-gel activity tests 
can be followed by taking time dependent images. Grey scale images can be evaluated 
quantitatively by the software Delta2D (3.11.2). Coloured images reflect the formation of the 
precipitate qualitatively. Images were scanned according to 3.7.3. For CV in-gel activity test 
images, a black glass plate was used as background.  
For CI in-gel activity test, nitrotetrazolium blue chloride (NBT) was reduced by NADH 
dehydrogenase and forms an insoluble blue/purple precipitate of NBT diformazan (Grandier-
Vazeille and Guérin 1996) (Fig. 3.8). 
  
Fig. 3.8: Reactions of CI in-gel activity test, NADH dehydrogenase oxidises NADH+H
+
 to NAD
+
 and 
reduces yellow NBT to NBT diformazan, yielding an insoluble blue/purple precipitate. Modified: Image 
from the RCSB PDB (www.rcsb.org) of PDB ID 3M9S (Efremov et al. 2010), modified: structures of 
NBT and NBT diformazan (Sigma-Aldrich 2008), whole image modified from Heidrich (2011). 
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In CIV activity test, cytochrome c was oxidised by CIV. Cytochrome c is reduced by 3,3'-
diaminobenzidine (DAB), which was oxidised and polymerised in parallel. A brownish 
precipitate was formed. The exact mechanism of this reaction is not known yet (Fig. 3.9) 
(Sabar et al. 2005).  
 
 
The hydrolysis of ATP is the reverse 
reaction to the energy providing function 
of ATP synthase (ATP synthesis) in the 
respiratory chain. This can be followed 
in-gel by the formation of white 
precipitate of lead phosphate evolved 
from the reaction of lead (II) nitrate with 
phosphate residues, the latter derived 
from the hydrolysis of ATP by CV (Fig. 
3.10)(Wittig et al. 2007).  
  
Fig. 3.9: Reactions of CIV in-gel activity test, CIV oxidises cytochrome c, which is 
reduced by DAB. The latter forms a brownish precipitate of polymerised and oxidised 
DAB. Modified: Image from the RCSB PDB (www.rcsb.org) of PDB ID 2OCC 
(Tsukihara et al. 1996), whole image modified from Heidrich (2011). 
Fig. 3.10: CV in-gel activity test: reactions for hydrolysis 
of ATP by ATP synthase. CV hydrolises ATP to ADP+Pi. 
The nitrate of Pb(NO3)2 is substituted by PO4
3-
, forming white 
(Pb3(PO4)2), which precipitates.Modified: Image from the 
RCSB PDB (www.rcsb.org) of PDB ID 2XND (Watt et al. 
2010), whole image modified from Heidrich (2011). 
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3.8.1 Complex I and complex IV in-gel activity test 
Immediately after BN gel run (3.4) the fresh gel was shaken for 15 min in Milli-Q-H2O. For 
quantitative in-gel activity test, an image was scanned immediately (3.7.3) to serve as time 
point “zero”. The gel was afterwards put into the activity test solution (Table 3.17) and shaken 
for 120 min (CI test) or 150 min (CIV test), respectively. tiff images in grey scale were taken 
as described in 3.7.3 at intervals listed in Table 3.18. For visualisation only, coloured images 
were recorded at several time-points. After the last image was taken, the gel was placed into 
activity test stop solution (Table 3.17) for 30 min before sealing in disposable plastic bags and 
storage at +4°C. The scanned images were evaluated according to 3.11.2. 
Table 3.17: CI and CIV in-gel activity test solutions and activity test stop solution 
Activity test solution CI  Activity test solution CIV  Activity test 
stop solution 
100.0 mM Tris 
}pH 7.4 
 50.0 mM Na3PO4x12H2O }pH 7.2  50 % (v/v) MeOH 
768.0 mM Glycine  25.0 µM Cytochrome C   10 % (v/v) AcOH 
0.49 mM NBT   1.58 mM DAB     
0.1 mM NADH         
stored at -20°C  stored at -20°C  stored at RT 
 
Table 3.18: Scanned time intervals for quantitative 
in-gel activity test 
time points of image scan 
time [min] time interval [min] 
0 / 
5-60 5 
70-90 10 
105-120 15 
  135-150*  15* 
*(only CIV test) 
 
3.8.2 Complex V in-gel activity test 
The CV in-gel activity test was performed similar to the activity tests of complexes I and IV 
(3.8.1). The contents of the CV in-gel activity test solution and the stop solution are compiled 
in Table 3.19. The test was performed only qualitatively for identification of homooligomers. 
Coloured images of the gel lanes were taken (3.7.3). A black glass plate served as background 
for gaining better contrast to the white precipitate on the bands, exhibiting hydrolysis activity.  
Table 3.19: CV in-gel activity test solution and stop solution 
Activity test solution CV  CV activity test 
stop solution 
35.0 mM Tris 
} pH 7.8 (HNO3) 
 50 % (v/v) MeOH 
270.0 mM Glycine    
14.0 mM Mg(NO3)2x6H2O    
0.2% (w/v) Pb(NO3)2    
8.0 mM ATP     
stored at -20°C  stored at RT 
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3.9 Peptide mass fingerprinting, MALDI-TOF-MS identification of protein spots  
With the bioanalytical method “peptide mass fingerprinting” (PMF), protein spots of 2D gels 
can be identified. In order to do so, spots are cut out of the silver stained 2D-BN/SDS gel (3.5 
and 3.7.1), destained and prepared for a digest with the protease trypsin. This enzyme cuts 
proteins selectively into defined peptides at the carboxyl side of each lysine and arginine, if 
the following residue is not a proline (Voet et al. 2002). The resulting peptides are eluated 
from the gel spots and loaded onto a target for the matrix assisted laser desorption / ionisation 
(MALDI) time of flight (TOF) mass spectrometry analysis. The peptides are cocrystallised 
with the electron transferring matrix α-Cyano-4-hydroxycinnamic acid (HCCA) at the steel 
target. The target is then loaded into the MALDI-TOF mass spectrometer (MALDI-TOF-MS) 
evacuated chamber and the analysis started. The laser of the MS excites the matrix molecules 
and energy and protons are transferred to the cocrystallised peptides, which are ionized and 
evaporated. An electric field accelerates the charged peptides before entering the evacuated 
TOF chamber. The ions fly with a defined velocity, depending on their mass to charge ratio 
(m/z) through the TOF chamber. Their needed time to pass the chamber is measured with a 
detector. The software calculates the specific m/z for each hitting ion and plots the intensity 
against the m/z in a spectrum (Lottspeich and Engels 2012). Each ionized peptide shows a 
specific peak, which can be identified with the help of references in databases like Mascot 
(Matrix Science). The peptides found in the spectra can be assigned to the proteins, which 
have been in the protein spot of the 2D gel. For external calibration of the system, Peptide 
Mass Standards Kit for Calibration (AB Sciex) is also loaded onto the target and measured 
(Table 3.20). Self-digested trypsin peaks serve as internal standard (Table 3.21). 
18 cm by 16 cm sized 2D-BN/SDS gels were prepared according to section 3.5. 150 µg 
protein sample were solubilised and loaded into one well on the 1st dimension gel. After 2nd 
dimension gel run, the gels were stained with silver as described in section 3.7.1. The gels 
were wrapped in plastic bags and stored at +4°C.  
Milli-Q-H2O was used for solubilisation, for all silver stain solutions and during the complete 
peptide mass fingerprint procedure (see below), and apart from that, distilled water was used.  
To avoid keratin contamination in all steps latex gloves and sleeve guards were worn.  
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3.9.1 Peptide mass fingerprinting, applied by AG Dencher, TUD 
Excision of the protein containing gel spots 
The 2D gel was placed onto a glass plate on a light table inside a laminar airflow cabinet. 
Each protein spot of interest was cut into small pieces (about 1-4 mm³) using a scalpel and 
transferred into a well of a filter wellplate (MultiScreen Solvinert, Millipore) using a V-
bottom 96-well polypropylene (PP) microplate (Greiner BIO-ONE) as bottom.  
Destaining the protein spots 
To each well of the filter wellplate, 30.0 mM potassium hexacyanoferrate (III) solution and 
100.0 mM sodium thiosulphate solution (1:1) were added. The gel pieces were incubated until 
the brownish colour of the silver stain disappeared. Then the supernatant solution was sucked 
through the filter plate with a special vacuum filtration system (MultiScreen®HTS, Vacuum 
Manifold, Millipore) connected to a vacuum pump (Unijet II, refridgerated, equipped with 
Univapo 150H). The now yellow coloured gel pieces were washed with Milli-Q-H2O once 
and incubated one time in Milli-Q-H2O for 15 min, followed by multiple short washing steps 
with Milli-Q-H2O until the gel pieces were free from colour.  
Tryptic digest of the proteins 
Before start of tryptic digest, the destained gel pieces were incubated for 20 min in 50.0 mM 
ammonium bicarbonate solution. The solution was removed and two incubation steps with 
25.0 mM ammonium bicarbonate in 50 % (v/v) acetonitrile solution for 20 min followed. 
After removal of the solution, the gel pieces were incubated for 5 min in acetonitrile and dried 
by application of vacuum (3 in Hg vac) to the filter plate with the MultiScreen®HTS.  
Trypsin solution was prepared by dissolving the lyophilised trypsin powder from Sigma in 
1.0 mM hydrochloric acid (HCl, ultrapure, in Milli-Q-H2O) resulting in a final concentration 
of 20 µg/mL. This trypsin solution was stored in aliquots at -20°C. The hydrochloric acid 
trypsin solution was diluted with 25 mM ammonium bicarbonate solution to a final 
concentration of 2.22 µg/mL trypsin, shortly before adding to the dried protein containing gel 
pieces. The gel pieces were incubated in this 2.22 µg/mL trypsin solution at +4°C for 20 min 
and then at +37°C for 8 hours in a thermoshaker UniEquip (Laborgerätebau- und -vertriebs 
GmbH). 
A new V-bottom 96-well PP microplate was put beneath the filter wellplate. To extract the 
peptides, 1 % (v/v) trifluoroacetic acid (TFA) in 50 % (v/v) acetonitrile (ACN) was added and 
sonication was applied for 20 min at RT. Then the peptide solution was sucked into the V-
bottom plate beneath the filter plate. (In later trials this step was replaced by using the Speed-
Vak to centrifuge the solution from the filter plate into the V-bottom plate.) Afterwards, the 
V-bottom plate was centrifuged in the heated and evacuated Speed-Vak, until the solution 
evaporated completely. The peptides were resolubilised in 1 % (v/v) TFA (in Milli-Q-H2O) 
by application of ultrasound.  
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Desalting of the peptides by using ZipTips 
Resolubilised peptides were desalted by using ZipTipC18 from Millipore. ZipTipC18 were 
preconditioned by washing twice with 100 % (v/v) ACN, twice with 1 % (v/v) TFA in 
50 % (v/v) ACN and twice with 0.5 % (v/v) TFA (in Milli-Q-H2O). Peptides were bound by 
aspirating and dispensing of the trypsin peptide solution through the ZipTipC18. Salts were 
extracted by a threefold washing step with 0.5 % (v/v) TFA (in Milli-Q-H2O).  
Extraction of peptides and loading of the target 
Peptides were eluted from the ZipTipC18 with 0.1 % (v/v) TFA in 50 % (v/v) ACN and 
directly placed onto the MALDI steel target (PerSeptive Biosystems). A ratio of 1:5 (v/v) 
matrix solution / peptide solution was added for cocrystallisation. α-Cyano-4-
hydroxycinnamic acid (HCCA, 5mg/mL in 0.1 % (v/v) TFA in 50 % (v/v) ACN) was used as 
matrix. 
For external calibration, a mixture of Calibration mixture 1 and Calibration mixture 2 (each 
1:50 (v/v) in 50 % (v/v) ACN with 0.1 % (v/v) TFA) from Peptide Mass Standards Kit for 
Calibration of AB Sciex MALDI TOF MS (Table 3.20) was also cocrystallised with HCCA 
on the target.  
The loaded target was dried at RT. 
Table 3.20: Peptide Mass Standards Kit for Calibration of AB Sciex MALDI TOF MS 
Calibration mixture 1   Calibration mixture 2 
protein charge 
monoisotopic 
mass [Da] 
 protein charge 
monoisotopic 
mass [Da] 
des-Arg1-Bradykinin +1 904.4681 Angiotensin I +1 1,296.6853
Angiotensin I +1 1,296.6853 ACTH (1–17 clip) +1 2,093.0867
Glu1-Fibrinopeptide B +1 1,570.6774 ACTH (18–39 clip) +1 2,465.1989
Neurotensin +1 1,672.9175 ACTH (7–38 clip) +1 3,657.9294
   Insulin (bovine) +1 5,730.6087
    +2 2,865.8083
 
Internal calibration was achieved using the trypsin peaks (Table 3.21). 
Table 3.21: Typical peptides and masses form self-digested trypsin, often found 
peptides are marked in blue (modified Schrattenholz (2001)) 
Peaks of trypsin self-digest 
Aminoacids MI sequence 
3-6 514.32 IQVR 
57-64 841.50 VATVSLPR 
47-56 1044.56 LSSPATLNSR 
65-82 1767.79 SCAAAGTECLISGWGNTK 
7-26 2210.10 LGEHNIDVLGNEQFINAAK 
27-46 2282.17 IITHPNFNGNTLDNDIMLIK 
27-56 3308.72 IITHPNFNGNTLDNDIMLIKLSSPATLNSR 
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MALDI-TOF MS Measurements 
Measurements of m/z of the peptides were performed using a MALDI-TOF MS Voyager 
DE™-Pro, BioSpectrometry™ Workstation. The following settings were applied (Table 
3.22). 
Table 3.22: Settings for Voyager MALDI-TOF MS measurement 
Settings for MALDI-TOF MS measurement 
instrument mode: reflector, positive 
shots / spectrum: 150 
mass range / Da: 500 to 5000 
low mass gate / Da: 500 
calibration, matrix: HCCA 
laser intensity: 2100 
 
Evaluation with Software / Settings 
Spectra were edited with the Software Voyager Data Explorer™. Mass calibration, baseline 
correction and noise reduction were performed. A peak list of the monoisotopic masses was 
created and transferred into Mascot database search engine (Matrix Science). The settings for 
the search of the peptides are listed in Table 3.23. 
Table 3.23: Settings for peptide identification in Mascot database 
Settings for peptide identification 
Database: SwissProt  
Enzyme: trypsin allow up to 1 missed cleavages 
Taxonomy: Rattus rat brain samples 
 Mammalia (mammals) bovine heart 
Fixed modifications: none selected  
Variable modifications Oxidation (M)  
Peptide tolerance: ± 150 ppm  
Significance threshold: p < 0.05  
Mass values: MH+ monoisotopic 
 
The results were copied into Excel datasheet and formatted for visualisation.  
3.9.2 Peptide mass fingerprinting, applied by Proteome Analysis Unit, DDZ 
Excision and destaining of the protein spots was performed at TUD. The destained spots were 
then transferred to the collaborating research laboratory at Deutsches Diabetes Zentrum 
Düsseldorf (DDZ), where tryptic digest and analysis of the peptides by MALDI-TOF/TOF-
MS was carried out.  
Excision of the protein containing gel spots 
The gel was transferred to a glass plate on a light table inside a laminar airflow cabinet. The 
protein spots of interest were cut out with a skin punch (Ø 2.0 mm), which was moistened 
with water, and placed into a free well of a special 96-hole-wellplate (with well containing a 
hole at the bottom of Ø 0.8 mm). From time to time the gel and the cut gel spots were wetted 
with water, keeping them from drying out. 
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Destaining the protein spots 
The wellplate with the protein spots was centrifuged with an Eppendorf 5804R, equipped with 
a wellplate rotor A-2-DWP at room temperature for 2 minutes at 1000 rpm to remove 
supernatant water. To each well 30 mM potassium hexacyanoferrate (III) solution and 
100 mM sodium thiosulphate solution were added. The spots were incubated until the gel 
pieces were free from silver (no brownish colour). Supernatant liquid was removed by 
centrifugation (settings as above). The yellow gel pieces were washed with water twice. 
Incubation time for the first washing was one to two minutes, for the second wash 15 minutes. 
The one minute washing was repeated until the gel spots were colourless.  
After the last centrifugation step some water was added to each well. The hole-wellplate was 
covered with a cover plate and a new standard 96 wellplate was placed below it. Both plates 
were sealed with Parafilm® for storage at +4°C until transportation (at RT) to the 
collaborating laboratory at DDZ, Düsseldorf, where the subsequent steps were performed. 
Tryptic digest of the proteins 
To prepare the tryptic digest, the gel spots were washed three times alternately with 25 mM 
ammonium bicarbonate solution and 25 mM ammonium bicarbonate solution containing 
50 % acetonitrile. Incubation time was 10 minutes for each wash. After each washing step the 
supernatant liquid was removed by a 2 minute centrifugation step at 1000 rpm with an 
Eppendorf 5810R equipped with a wellplate rotor A-4-62 at room temperature. 
After the last removal of supernatant, acetonitrile was added to each well and incubated for 
10 minutes with closed cover plate. After incubation, the liquid was carefully removed with a 
micropipette from the dried gel pieces. The wellplate was allowed to stand without lid for 
15 minutes at RT in order to let the remaining solvent evaporate.  
Lyophilised trypsin (Promega) was dissolved in enclosed “Trypsin Resuspension Dilution 
Buffer” (1 µg/µL), incubated 15 minutes at 30°C. This solution was diluted with 25 mM 
ammonium bicarbonate solution containing 2 % acetonitrile resulting in a final trypsin 
concentration of 5 ng/µL and stored on ice bath. With that solution the protein gel spots were 
covered and the wellplate was capped and incubated at 4°C for 30 minutes, then left over 
night (at least 4 hours) at 37°C for the tryptic digest.  
Extraction of peptides and loading of the target 
1 % trifluoroacetic acid (TFA) solution was added to each well and incubated for 30 minutes 
at RT. The sample solution was loaded onto an HCCA Prespotted AnchorChip (PAC) II 
Target (Eppendorf) using “HCCA Affinity Preparation” technique as described by the 
manufacturer Bruker Daltonik (2012). After 3 min incubation of the sample solution on the 
target, the washing solution, consisting of 10.0 mM ammoniumphosphate monobasic in 0.1 % 
(v/v) TFA, was added to the sample spot. After short incubation, the whole spot was removed 
with a pipette. 
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MALDI-TOF/TOF MS measurements and evaluation with Software / Settings 
Measurements of m/z of the peptides were carried out using a MALDI-TOF/TOF MS 
Ultraflex I from Bruker. Settings are listed in Table 3.24.  
Table 3.24: Settings for MALDI-TOF/TOF MS measurement 
Settings for MALDI-TOF/TOF MS measurement 
instrument mode: reflector, positive 
shots / spectrum: sum up 600 in 100 shot steps (fuzzy logic) 
mass range / Da: 680-4000, peak selection for evaluation (900 to 2300) 
low mass gate / Da: 680 
calibration, matrix: PAC II, HCCA 
laser frequency: 50 Hz 
laser intensity: automatically adapted by fuzzy logic control module 
 
The PAC II target was equipped with an external calibration standard by the manufacturer 
Bruker Daltonik (2012) (Table 3.25). Trypsin peaks served as internal standard. Acquired 
spectra were calibrated and saved automatically with the software Compass 1.3 (Bruker).  
Table 3.25: Masses of external calibration 
standard, provided on PAC II target. 
PAC II Peptide Calibration Standard  
protein monoisotopic mass [Da] 
Calibrant 1 757.39916 
Calibrant 2 1,046.54180 
Calibrant 3 1,296.68480 
Calibrant 4 1,672.91700 
Calibrant 5 1,758.93261
Calibrant 6 2,016.98860
Calibrant 7 2,406.28880
Calibrant 8 2,981.58570
Calibrant 9 3,574.87650
 
Peaklists, formatted in “.xml”, were transferred to the software ProteinScape 3.1 (Bruker), 
which converted the spectra into peaklists of monoisotopic masses and automatically started 
search in Mascot database. Search parameters are listed in Table 3.26. Evaluated data was 
transferred into Excel sheets and processed for visualisation.  
Table 3.26: Settings for peptide identification with Bruker MALDI-TOF/TOF MS Ultraflex I 
Settings for peptide identification 
Database: SwissProt  
Enzyme: trypsin, allow up to 1 missed cleavages  
Taxonomy: Rattus rat brain samples 
 Mammalia (mammals) bovine heart 
Fixed modifications: none selected  
Variable modifications: 
Oxidation (M) 
Carbamidomethyl (C) 
 
Peptide tolerance: ± 100 ppm  
Significance threshold: p < 0.05  
Mass values: MH+ monoisotopic 
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3.10 Western blot analysis of OxPhos complexes 
The method for Western blot (WB) analysis of proteins on 2D-BN/SDS gels was established 
in our laboratory by Dipl. Biochem. Victoria Decker together with her bachelor student 
Stefanie Eckes and her internship student Elisabeth Krämer.  
M. Sc. Olga Ankudin performed the WB analysis of the RBM on her own as contract work. I 
provided her with isolated RBM from cerebellum (OAL) for solubilisation (with d/p: 8g/g, 
3.3.1), followed by 2D-BN/SDS PAGE with 10.0 cm by 10.5 cm sized 2D-BN/SDS gels 
(3.5). As protein standards, MagicMark™ XP Western Protein Standard (MM, 3 µL) was 
loaded additionally to LMW (2 µL, Table 3.2) into the well of 2D-BN/SDS gels. After PAGE, 
M. Sc. Ankudin performed WB as follows: 
Nitrocellulose membrane and Rotilabo®-blotting paper (two pieces) were cut according to the 
size of the 2D-BN/SDS gel (the blotting paper: +3 mm extra in horizontal and vertical 
dimensions). Membrane and papers were wetted in Towbin buffer (Table 3.27) and gel as 
well as membrane were sandwiched and placed between anode and cathode of the Trans-
Blot® SD semi-dry electrophoretic transfer cell (BioRad) for protein transfer at 20 V, 400 mA, 
for one hour. After finished protein transfer, incubation of the membrane with primary (Table 
3.28) and secondary (Table 3.29) antibody solutions and washing steps were performed on a 
shaker as in Table 3.30.  
Table 3.27: Towbin buffer and PBST buffer for WB analysis 
Towbin buffer  Phosphate buffered saline Tween (PBST) 
25.0 mM Tris 
}pH 7.4 
 140 mM NaCl 
192.0 mM Glycine  10 mM Na2HPO4 
20 % (v/v) MeOH   2.7 mM KCl 
    2.0 mM KH2PO4 
stored at RT  0.1 % (w/v) Tween® 20 
   
  pH 7.4 (HCl), stored at RT 
 
Table 3.28: Primary antibodies for WB analysis of OxPhos complexes 
target protein 
 
target name as in  
UniProt database 
host species 
 
concentration 
[µg/mL] 
α NDUFS1 (CI) NDUS1 rabbit 1.0 
α SDHA (CII) DHSA mouse 0.1 
α UQCRC2 (CIII) QCR2 mouse 1.0 
α MTCO1 (CIV) COX1 mouse 0.5 
α OxPhos V subunit alpha (CV) ATPA mouse 1.0 
 
Table 3.29: Secondary antibodies for WB analysis 
conjugate 
 
target protein 
 
host species 
 
concentration 
[µg/mL] 
IgG-HRP α rabbit donkey 0.4 
IgG-HRP α mouse donkey 0.4 
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Table 3.30: Incubation steps of nitrocellulose membrane for WB analysis of OxPhos complexes 
n times time [min] incubation solution condition 
1 30 1:10 diluted Roti®-Block (10x concentrate) RT 
1 over night primary antibody solution (Table 3.28) +4°C 
3 5 PBST (Table 3.27) RT 
1 120 secondary antibody solution (Table 3.29) RT 
3 5 PBST (Table 3.27) RT 
 
Enhanced chemiluminescence (ECL, Table 3.31) reaction (Haan and Behrmann 2007) of 
immune globuline G horseradish peroxidase (IgG-HRP) conjugated secondary antibody 
enabled the protein detection. Images were taken with the CCD camera system (luminescent 
image analyser LAS-3000, Fujifilm) and the accessory software Image Reader LAS-3000 2.1. 
The settings were: light none, filter blank, iris F=0.85, tray position 1, exposure type: 
increment, interval time: 10 sec. The software alarmed, when the images were oversaturated. 
The image, before oversaturation appeared, was saved as “.tif” file. 
Table 3.31: ECL reagent for protein detection for WB analysis 
reagent for enhanced chemiluminescence of HRP 
100 mM Tris }pH 8.8 (HCl) 
1.25 mM Luminol in DMSO  
2.0 mM 4-iodophenylboronic acid  
30 % (v/v) Hydrogenperoxide  
 
The membrane of CI WB analysis was stripped once for subsequent analysis of CII. Stripping 
of the membrane was performed as in Table 3.32, followed by washing and incubation steps 
as listed in Table 3.30. 
Table 3.32: Steps of membrane stripping for WB analysis 
n times time [min] incubation solution condition 
2 10 mild stripping buffer (Table 3.33) RT 
2 10 1xPBS (same as PBST without Tween® 20) RT 
2 5 PBST (Table 3.27) RT 
1 30 1:10 diluted Roti®-Block (10x concentrate) RT 
 
Table 3.33: Mild stripping buffer for stripping of WB membrane 
mild stripping buffer 
200 mM Glycine 
}pH 2.2 (HCl) 0.1 % (w/v) SDS 
1.0 % (v/v) Tween® 20 
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3.11 Quantitative analysis of protein bands/spots on gels 
For quantitation of gel images, it is important to note that the printed images in this 
publication differ optically from the evaluated original grey scale images, as obtained from 
scanning system “Bio-Imaging-System ViewPix 900” (3.7.3) or CCD camera “LAS-3000” 
(3.7.4) or fluorescent imaging system “Typhoon 9400” (3.7.5). The differences originate from 
losses of resolution due to saving, use of coloured images for visualisation instead of grey 
scale images and lower print quality. Even the “fused image” obtained from the software 
“Delta2D” (3.11.1 and 3.11.2) does not reflect the original staining intensities, it is just a tool 
for visualisation on screen.  
3.11.1 Quantitative evaluation of 2D-BN/SDS gels 
SyproRuby, CBBG and silver stained gels 
Samples were solubilised as described in 3.3.1. 18 cm by 16 cm sized 2D-BN/SDS gels were 
prepared according to 3.5 and stained with SyproRuby (3.7.4), CBBG (3.7.2) or silver (3.7.1). 
Images of SyproRuby stained gels were gained from CCD camera system, LAS-3000 (3.7.4), 
CBBG and silver stained gel images from Bio-Imaging-System ViewPix 900 (3.7.3). 
DIGE gels 
After solubilisation (3.3.2), proteins were labelled (3.7.5), and according to 3.5 18 cm by 
16 cm sized 2D-BN/SDS gels were prepared. After gel run, 
images were scanned by me at the research group of Prof. Dr. 
K.-D. Entian, who provided the fluorescent imaging system 
(Typhoon 9400), for details see 3.7.5. 
Evaluation of 2D-BN/SDS gels with Delta2D 
The protein spots were quantified with the software Delta2D 
4.3 from Decodon. Gel images from one project, such as all 
2D-gels from one rat brain region, were imported into the 
software as described by the software provider in the 
guidelines “Getting Started” by Decodon (2011a) and 
“Getting Started DIGE” by Decodon (2011b). Gel images 
were grouped and warped. During warping, a connection via 
mathematical vectors between identical protein spots of 
different gels is generated. A fusion image of all gels, based 
on the warping, was created by forming an overlay. In this 
fusion image, a set of gel spots was marked and each spot 
labelled with a number. This set of labelled spots was trans-
ferred to all single gel images. The software calculates the 
grey values within the area of a marked protein spot. Protein 
spots are illustrated as 3D spots. As example for the 
evaluation, one spot of a silver stained gel (subunit COX1) is 
depicted in Fig. 3.11A. The same spot, but from previous 
SyproRuby staining of that gel, is visible as 3D spot, as 
illustrated by the software Delta2D in Fig. 3.11B. The image 
Fig. 3.11: Example for illustration
of protein spots in Delta2D.  
A: Image of silver stained 2D-
BN/SDS gel. 
B: 3D spot illustration in Rollups 
3D Spots tool, Delta2D. 
A & B: One spot (COX1) is marked 
in orange as example for the 3D 
illustration in Delta2D. 
A 
B 
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shows the Rollups tool 3D Spots. The quantification of the spot is achieved by calculating the 
absolute grey value pixel volume V of all grey value pixels from the spot. A total absolute 
grey value volume is calculated in the background of the software, for the whole set of 
marked spots of one gel. It is used for normalisation of staining differences between gels by 
calculating the ratio from the absolute grey value pixel volume V of one spot to the total 
absolute grey value pixel volume V of all spots. This evaluation results for each spot in the 
value “V %”, the relative grey value pixel volume. These relative grey units are directly 
proportional to the protein amount of the spot. Delta2D software transfers all data for each 
spot into an Excel sheet, for example V % and the label. Further evaluation was carried out as 
follows: 
Evaluation of 2D-BN/SDS gels with Excel 
Spot values (in V %) were combined into meaningful entities (4.2.5) e.g. ATP synthase’s 
subunits alpha, beta, gamma, FoB1/b and Fo/O/d, representing ATP synthase monomer. The 
sum was calculated for each technical repeat, therefore for each 2D-BN/SDS gel. The mean 
and the standard error of means were calculated for all technical repeats. Statistics were 
performed as described in 3.11.3. 
3.11.2 Quantitative evaluation of in-gel activity tests and CBBG stained BN gels 
Samples were solubilised as described in 3.3.1 and separated with BN PAGE (3.4). The 
prepared BN gel was placed into activity test solution for respective OxPhos complexes as 
mentioned in 3.8 or into diluted Roti®-Blue solution as described in 3.7.2 and tiff images were 
recorded (3.7.3). 
Evaluation of in-gel activity tests and CBBG stained BN gels with Delta2D 
As described for protein spots in the guidelines of Decodon (2011a), the grey scale images of 
one in-gel activity test at different time points or the grey scale images of the CBBG stained 
BN gels were uploaded into the software Delta2D. The gel images were warped together and 
fused. On the fusion image, bands were detected and labelled. All detected bands and labels 
were transferred onto the single gel images.  
As explained above for protein spots in 2D-gels (3.11.1), Delta2D calculates for each marked 
band likewise the absolute grey value pixel volume V. These grey units are proportional to the 
protein amount of the spots. For every marked band on each image, label and V were 
transferred into an Excel sheet for further evaluation. 
Evaluation of CBBG stained BN gels with Excel 
The mean and the standard error of the V values of the technical repeats were calculated for 
each detected band. Mean and standard error were outlined in a bar plot. Statistical evaluation 
was performed as described in 3.11.3. 
Evaluation of in-gel activity test gels with Excel 
In-gel activity tests were evaluated similar to Thilmany (2013). The growth of precipitate had 
to be correlated to the specific activity (aspec) of the OxPhos (super-)complexes in the 
considered band.  
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The V value at time point t0 represents the background staining of the band due to CBBG 
bound to the proteins from previous gel run. At this time point, precipitate from the activity 
test solution has not yet formed, which means that the CBBG staining originates only from 
the staining of the protein amount in the band. Therefore it serves also as a relative measure of 
protein amount. 
To calculate the growth of precipitate of one band, the V value at t0 is subtracted from the V 
values of the same band from all other time points tx. The development of precipitate is 
proportional to the protein amount, so it needs to be divided by the protein amount of the band 
at t0 to result in the specific activity per protein amount in the band:  
=
 − 



 
An additional factor (f1) has to be considered for the specific activity of supercomplexes. In 
supercomplexes, the precipitate is formed only by a part of the supercomplex, namely the 
active subunit of the individual complex. f1 is calculated by the quotient of the masses of the 
complexes and supercomplexes according to Schägger and Pfeiffer (2000) (Table 4.7). As an 
example for CI activity test, f1 for the supercomplex I1III2IV2 is calculated as follows: 
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Therefore f1 is included into the equation for calculation of the specific activity: 
=
 − 


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Supercomplexes can contain more than one copy of CIV. Thus for CIV activity test, it is 
essential to divide by another factor (f2), representing the number of copies of individual CIV 
to compare with the individual complex:  
=
 − 


 ∙  ∙ 
 
The obtained V values were plotted against time and the regression line was sketched. The 
slope represents the specific activity in grey units per minute for each selected band.  
The band of ATP synthase monomer was used as control for unspecific precipitate 
development. The slope of its specific activity must not increase with time for activity test of 
CI and CIV.  
The mathematical procedure was performed for each technical repeat. Mean and standard 
error of the technical repeats were calculated and outlined in a bar plot. Statistics were applied 
according to 3.11.3. 
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3.11.3 Statistics 
Significant changes were determined using the Excel 2010 add-in “Real Statistics Resource 
Pack”, Release 3.5.1 by Charles Zaiontz (http://www.real-statistics.com/). The unpaired, two 
tailed t test for unequal variances (also called “Welch t test”, GraphPad Software Inc. (1995-
2014) or “Smith/Welch/Satterthwaite (SWS) test”, Moser and Stevens (1992)) was 
performed, since it is simple to apply, it is appropriateness for small sample sizes, due to the 
fact that no previous test routine is needed and because of its robustness. According to de 
Winter (2013) small sample sizes are feasible in t tests when the effect size is large. The t test 
for unequal variances is recommended by Moser and Stevens (1992) for equal sample sizes. 
They state that the SWS test and the t test “[…] all have the same sizes and powers whenever 
the sample sizes are equal. Therefore, a preliminary variance test is superfluous, as it simply 
adds an extra analysis step. Thus, in the equal sample size case, either the t test or the SWS 
test is appropriate.” The GraphPad Statistics Guide (GraphPad Software Inc. 1995-2014) 
describes for the standard unpaired t test and the unequal variance t test: “When the two 
groups have the same sample size, the standard error is identical for the two t tests.” Another 
reason for choosing the t test for unequal variances is its robustness against small violations of 
assumptions (particularly normal distribution) as Weiß (2013) states: “[…] t-Tests [sind] 
robust: Wie mit Monte-Carlo Studien nachgewiesen wurde, sind geringfügige Verletzungen 
der Prämissen (insbesondere der Normalverteilung) tolerierbar.”  
The null hypothesis H0 is based on the assumption that there are no changes between both 
samples (µ1
2 = µ2
2). The null hypothesis is rejected, when p < α (0.05) (statistically significant 
(stat. sig.), marked with “*”), or if p < α (0.01) (statistically highly significant (stat. high. 
sig.), marked with “**”) in the bar plots. The latter stand for the mean of the technical repeats 
and the error bars show the standard error of means.  
Changes were marked in text with (not stat. sig.), when error bars of the compared samples in 
bar plots do not overlap along the lines of Cumming et al. (2007).  
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3.12 Measurement of mitochondrial membrane “fluidity” 
M. Sc. Stefanie Kern carried out all anisotropy 
measurements and evaluations during and after her 
master thesis. For details of the measurement and 
evaluations see Kern (2013). As samples I provided her 
with isolated mitochondria of the rat brain parts 
cerebellum, cerebrum and hippocampus as described in 
2.6.1.  
For the analysis of the membrane “fluidity” of mitochondria, the fluorescence probe, 1,6-
diphenyl-1,3,5-hexatriene (DPH, Fig. 3.12), was intercalated into the hydrophobic domain of 
membranes of mitochondria. For this purpose, a stock of 2.0 mM DPH (Sigma-Aldrich) in 
tetrahydrofuran (THF) was diluted with phosphate buffered saline (PBS, Table 3.34) and 
stirred in the dark at 42°C for evaporation of THF. The final concentration of DPH in PBS 
was 10.0 µM. Intercalation was possible by incubation of the mitochondria with the 
fluorescence probe DPH in PBS for one hour in the dark (composition as in Table 3.34, 
anisotropy labelling mixture). 
Table 3.34: Solutions for fluorescence anisotropy measurement 
Phosphate buffered saline (PBS)  Anisotropy labelling mixture 
140 mM NaCl  86.0 nM ≡ 0.02 ng/µL DPH 
8.1 mM Na2HPO4  0.01 µg/µL mitochondria 
2.7 mM KCl  in PBS 
1.5 mM KH2PO4  1.25 mL total volume 
pH 7.4 (HCl), stored at RT    
 
The steady-state fluorescence polarisation was measured, resulting in general information on 
the physical state of the lipid phase of mitochondrial membranes (Shinitzky and Barenholz 
1978). Assuming that the anisotropy r of DPH is proportional to the order parameter and the 
viscosity of the surrounding membrane (Heyn 1979), and viscosity is inversely proportional 
to the “fluidity” of the membrane (Eckmann et al. 2014), changes of anisotropy can be 
oversimplified interpreted as changes of membrane “fluidity”. 
A PTI M III fluorescence spectrometer (Photon Technology International) in T-configuration 
was used by S. Kern for the measurements. For temperature control, a waterbath (Lauda RCS, 
RC20 from mgw) at 37°C was connected to the sample holder. The measurement was 
repeated ten-times in a 4 x 10 mm (emission x excitation) quartz cuvette (SUPRASIL, Hellma 
Analytics). The analysis was performed with the software Felix (Photon Technology 
International) in the acquisition mode “timebased” with the following settings:  
Fig. 3.12: Structure of 1,6-diphenyl-
1,3,5-hexatriene (DPH), (Sigma-Aldrich 
2014a) 
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Table 3.35: Settings for anisotropy measurement (Kern 2013) 
Settings for PTI M III fluorescence spectrometer 
Excitation: 376 nm (DPH)  
Emission 1: 455 nm (DPH)  
Emission 2: OD 1; KV 418 
Points/sec: 1  
Duration: 10 sec.  
Repeats: 0  
Shutter: Automatic  
Slit width: slit 1, 2 12 nm 
 slit 3 2 nm 
 slit 4, 5 6 nm 
Voltage range: detector A 1050 V - 1150 V 
 detector B 650-700 V 
 
Excitation was performed with vertically polarised (V) monochromatic light and the emission 
intensity I was measured horizontally (H) and vertically (V). The anisotropy r can then be 
calculated with the equation  =
−∙
+2∙
 with the G-factor of the instrument  =


.  
IHH: polarizer horizontal, analyser horizontal; IHV: polarizer horizontal, analyser vertical;  
IVH: polarizer vertical, analyser horizontal; IVV: polarizer vertical, analyser vertical 
Before each measurement of the anisotropy r, the G-factor of the instrument was determined 
(Kern 2013). Evaluation was performed with Microsoft Office 2007 (Excel) by Stefanie Kern 
as described (Kern 2013).  
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4 Results and discussion 
4.1 Comparison of methods for protein quantitation in 2D-BN/SDS gels 
For quantitation of protein amount after separation with 2D-BN/SDS PAGE, different 
methods were applied as explained in 3.7 and compared. Together with my practical course 
student B. Sc. Stefanie Kern, I prepared and stained the gels. Quantitation was performed by 
me. A few results were previously shown at my posters at Molecular Life Sciences 2013, Int. 
Symposium of the GBM in Frankfurt am Main, Germany, at GBS Jahrestagung 2013 in 
Darmstadt, Germany and at GDCH Wissenschaftsforum Chemie 2013, in Darmstadt, 
Germany.  
For each staining method (CBBG, SyproRuby and silver), 100 µg BHM protein were 
solubilised with a d/p ratio of 3 respectively 6g/g (3.3.1). After solubilisation the mitochon-
drial proteins were separated by 2D-BN/SDS PAGE (3.5) on 18 cm by 16 cm sized gels. 
After PAGE, the gels were stained with CBBG (3.7.2), SyproRuby (3.7.4) or silver (3.7.1) 
and grey-scale images were recorded (see 3.7.3 for scanned images of CBBG and silver 
stained images and 3.7.4 for images from CCD camera of gels stained with fluorescent dye 
SyproRuby). 
For DIGE experiment, 75 µg of BHM protein were solubilised with a ratio of d/p: 3 
respectively 6g/g. Thereof 50 µg (b. sol.) were labelled with G-200 and 50 µg (b. sol.) with 
G-300, while 25 µg (b. sol.) of each sample were combined and labelled with G-100 as 
internal standard (IS) (3.7.5). Thereafter separation by 2D-BN/SDS PAGE followed, and grey 
scale images had been taken (3.7.5 for DIGE images from fluorescent imaging system).  
Please keep in mind, that printed gel images, as presented below, differ from quantitatively 
analysed original grey scale images (as explained in 3.11). 
In Fig. 4.1A the images of the CBBG and in Fig. 4.1B the images of the silver stained gels are 
depicted. Fig. 4.1A1 and Fig. 4.1B1 show the images of the gels from solubilisation with d/p: 
3g/g BHM, and Fig. 4.1A2 and Fig. 4.1B2 with d/p: 6g/g.  
By eye, differences are visible for ATP synthase subunit alpha and beta for the dimer (marked 
with orange rectangle). Both spots appear to be more intense in CBBG stained gel image after 
sol. with d/p: 6g/g BHM than for d/p: 3g/g and vice versa for the SyproRuby stained gel 
images. Different background staining of the two CBBG stained gel images is visible, but in 
case of quantitation the software Delta2D provides a tool for background substraction (3.11). 
Quantitation in spite of different migration pattern of the protein spots is possible by warping 
the gels (3.11). 
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In Fig. 4.2A the images of the DIGE gels are depicted and in Fig. 4.2B the images of the 
silver stained gels. In Fig. 4.2A1 the gel image of BHM, sol. with d/p: 3g/g and labelled with 
G-200 is depicted, while in Fig. 4.2A2 the gel image of BHM, sol. with d/p: 6g/g and labelled 
with G-300 is shown. In Fig. 4.2A3 the internal standard (IS), labelled with G-100, is 
depicted. In Fig. 4.2A4 the overlay of all three images is shown. As already observed for 
SyproRuby stained gels (Fig. 4.1), both spots of subunits alpha and beta of ATP synthase 
dimer (marked with orange rectangle) seem to be more intense in the gel image after sol. with 
d/p: 3g/g BHM than for d/p: 6g/g. Increased intensity is proportional to the protein amount in 
protein spots. Therefore the protein amount of subunits alpha and beta of CV dimer sol. with 
d/p: 6 g/g is smaller than sol. with d/p: 3g/g. This can be explained by a higher amount of 
digitonin, leading to stronger dissociation of the dimers into monomers. 
When the images of the DIGE gels are compared with images of all other stained gels, it is 
observable that subunit COX1 of CIV (purple rectangle in Fig. 4.2) is missing. 
Fig. 4.1: Images of CBBG and SyproRuby stained 2D-BN/SDS gels. For each gel 100 µg (b. sol. d/p: 3 
respectively 6g/g) BHM were separated by 2D-BN/SDS PAGE (18 cm by 16 cm sized gels) and stained with 
CBBG or SyproRuby for comparison. A1: BHM, d/p: 3g/g, CBBG stained A2: BHM, d/p: 6g/g, CBBG stained 
B1: BHM, d/p: 3g/g, SyproRuby stained B2: BHM, d/p: 6g/g, SyproRuby stained  
The image of the CBBG stained BN gel lane was arranged horizontally above the 2D-BN/SDS gel images for 
assignment of bands. LMW was marked. Subunits alpha and beta of ATP synthase dimer were marked with 
orange rectangle.  
A1 A2 
B1 B2 
3 g / g 
3 g / g 
6 g / g 
6 g / g 
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A1 A2 
A3 A4 
B1 B2 
3 g / g 
3 g / g 
6 g / g 
6 g / g 
IS overlay 
Fig. 4.2: Images of DIGE 2D-BN/SDS gels and silver stained 2D-BN/SDS gels (all 18 cm by 16 cm in 
size). A1-A4: DIGE gel images of the same 2D-BN/SDS gel, A1 & A2: 50 µg BHM each were solubilised 
with a d/p ratio of 3 respectively 6g/g, labelled with G-Dye 200 or G-Dye 300 and separated together with 
internal standard (IS) by 2D-BN/SDS PAGE. A3: Two times 25 µg BHM were solubilised with d/p: 3 and 
6g/g, mixed and labelled. G-Dye 100 served as IS. A4: Image of the overlay of images A1-A3. B1-B2: For 
each gel 100 µg BHM were solubilised and separated by 2D/BN-SDS PAGE and stained with silver. LMW 
was marked. B1: BHM, d/p: 3g/g B2: BHM, d/p: 6g/g BHM. The image of the CBBG stained BN gel lane was 
arranged horizontally above the 2D-BN/SDS gel images for assignment of bands. CV dimer, subunits alpha 
and beta were marked with orange rectangle. Subunit COX1 of CIV was marked with purple rectangle. 
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In Fig. 4.2B1 the silver stained image after sol. with d/p: 3g/g is depicted and in Fig. 4.2B2 
after sol. with d/p: 6g/g. As observed for SyproRuby stained and DIGE labelled gels, both 
protein spots of subunits alpha and beta for ATP synthase dimer (orange rectangle) appear to 
be more intense in the gel image after sol. with d/p: 3g/g than for d/p: 6g/g.  
In Fig. 4.3 the fused image from 
Delta2D of all ten analysed grey scale 
images for the different staining and 
labelling techniques is depicted. Ten 
proteins spots, used for quantitation, 
are marked in orange (Fig. 4.3) and 
listed in Table 4.1. Spots of CI, CIII, 
CIV and CV as well as the heat shock 
protein CH60 were selected for 
quantitation. The spots were identified 
by PMF or Western blot (see 4.2.3). 
The results are presented in Fig. 4.4 
and Fig. 4.5. 
 
 
 
Table 4.1: Selected protein spots for quantitative 
comparison of staining and labelling methods 
spot no. complex subunit 
10 CV(dimer) alpha 
11 CV(dimer) beta 
12 CV(monomer) alpha 
13 CV(monomer) beta 
35b CV(monomer) b 
04, 05, 06 CI NDUFS1 
17 CIII QCR2 
47 CIV COX1 
53 CIV COX4_1 
43 heat shock protein CH60 
 
In Fig. 4.4 the intensities (in rel. grey units) for the ten analysed protein spots (Table 4.1) are 
depicted for each staining (CBBG, SyproRuby, silver) and labelling (DIGE) method. The 
intensities are directly related to the protein amount of the spot (3.11). The results for sol. 
with d/p: 3g/g BHM are depicted in Fig. 4.4A and for sol. with d/p: 6g/g BHM in Fig. 4.4B. It 
is observable that in both cases the intensities, respective protein amounts, of the DIGE spots 
are mostly smaller than the intensities of the other staining methods. This is also independent 
of the analysed OxPhos complexes.  
Fig. 4.3: Fused image for analysis of different staining 
methods. Images of CBBG, SyproRuby, silver stained and 
DIGE 2D-BN/SDS gels were fused for quantitation with 
software Delta2D. Ten spots were picked for comparison 
(orange). The image of the CBBG stained BN gel lane was 
arranged horizontally above the fused image for assignment of 
bands. LMW was marked. 
fused  
image 
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When the various staining methods are compared, CBBG and SyproRuby staining follow 
mainly the same trends, while silver staining differs (as well as from trend of DIGE), for 
example for spot no. 12, 04, 05, 06 the intensity is lower than CBBG and SyproRuby while 
for 13, 35b, and 47 it is higher than for both. 
When the trend of DIGE labelling is compared to the trends of the staining methods, it seems 
to follow the trends but the intensities are all over smaller, with the exception of spot no. 47 
(COX1), whose intensity is much smaller than the intensities of all staining methods.  
  
A 
B 
Fig. 4.4: Quantitation of ten BHM protein spots, solubilised with d/p: 3g/g or 6g/g, for different 
stained or labelled 2D-BN/SDS gels. Bars show intensities in rel. grey units for spots from CBBG and 
SyproRuby stained, DIGE (G-200 and G-300) labelled and silver stained 2D-BN/SDS gels. A: Results for 
solubilisation with 3 g dig. / g B:
 68 4 Results and discussion 
Usually, quantitation is used for comparison of two different samples like treated and 
untreated sample or young and old sample. This should be simulated by calculating the ratios 
of the results from sol. with d/p: 3g/g BHM and d/p: 6g/g BHM for each spot. The results are 
depicted in Fig. 4.5. Provided that solubilisation and PAGE do not influence the results, the 
staining and labelling methods would be perfectly matchable, when the bars in Fig. 4.5 have 
exact the same height. This is not the case. But most of the bars are in the same range. It is 
noticable that for CV dimer, alpha and beta (spot no. 10 and 11) in CBBG stained gel show a 
much smaller ratio (about one third) than all the other visualisation methods. CBBG, 
SyproRuby and silver stainings seem to follow the similar trends, although CBBG shows 
slightly higher ratios than the other staining techniques for all spots except 10, 11 and 47. For 
spot 47 (CIV, COX1) silver staining shows a higher ratio. The DIGE labelling technique 
shows a higher ratio for CV monomer alpha and beta (spot no. 12 and 13) as well as for CI 
NDUFS1 (spots 04, 05, 06) and CIII QCR2 (spot no. 17) than the other staining methods. In 
spot no. 35b, 47, 53 and 43 the ratio for DIGE is smaller than the ratios of the other methods.  
Subunits alpha and beta in monomer and dimer of CV should be present in the same amount. 
Therefore their comparison in Fig. 4.5 should provide another indication for the 
appropriateness of the staining method. The bars depicting the ratios of spot no. 10 and 11 as 
well as spot no. 12 and 13 should be of the same height. CBBG and SyproRuby show only 
slight differences in these ratios, while DIGE shows a higher difference for the ratios of spot 
no. 10 and 11. Silver does not show the same ratios at all. The differences between alpha and 
beta are large.  
 
As expected, silver staining is not suitable for quantitative evaluation of protein spots. 
Rabilloud et al. (1994) describe in detail the mechanism of silver staining and explain, that 
reduction of silver ions to metallic silver is an autocatalytic process, which means, that at a 
spot were more silver ions are in complex with protein, the reduction is faster than at another 
spot with less complexed silver ions. But when too much silver ions are complexed, e.g. in the 
middle of a large protein spot, the reduction is faster at the borders of the spot, due to 
Fig. 4.5: Change detection of different solubilisation ratios for ten BHM spots for comparison of 
different gel staining methods. Bars show ratios (rel. grey units) of sol. with d/p: 3g/g and d/p: 6g/g for 
spots from CBBG and SyproRuby stained, DIGE (G-200/G-300) labelled and silver stained 2D-BN/SDS 
gels.  
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diffusion processes, and results in a spot with light colour in the center and dark borders. The 
development of the silver staining is therefore irregular and not quantitative. This is 
observable by the deviant purple bars in Fig. 4.4 and Fig. 4.5.  
It was expected that CBBG and SyproRuby staining seem to provide the most comparable 
results. According to Smejkal et al. (2004) both stainings seem to bind in similar way to 
proteins. They suppose that both bind “[…] primarily through the electrostatic interaction of 
protonated amines with sulfonates.” From the manufacturer it is known that SyproRuby binds 
non-covalently to basic amino acids and the polypeptide backbone and Lottspeich and Engels 
(2012) provide the information that CBBG binds through charge based and hydrophobic 
π−π-stacking interaction to proteins. The similarity is quite good observable in Fig. 4.4A 
and B, however a difference becomes visible when the ratios are calculated and depicted as in 
Fig. 4.5 (especially for spots 10 and 11). Might be, that the different sensitivities of the 
stainings become important here (Table 3.14). 
Finally, DIGE labelling technique gives different results. The trends are the same as for 
SyproRuby and CBBG staining, but with much lower all-over intensities (Fig. 4.4A and B). 
However, when the trends of the ratios are compared (Fig. 4.5), a quite different pattern 
becomes obvious. There are several reasons, which could explain this finding:  
One reason could be, that a labelling step has to be performed before gel run takes place. This 
could have led to loss of protein amount due to additional pipetting steps or due to changed 
hydrophobicity of the labelled protein in the test tube, although special low retention tubes 
and tips were used.  
Even though rather unlikely, another reason could be, that the threshold of the sensitivity had 
been exceeded, because only half of the amount of solubilised proteins (50 µg) were labelled 
with one dye and loaded on the DIGE gel for comparison with the stained gels, for which 
100 µg of solubilised proteins were loaded.  
Another fact is, that in acrylamide gels, the different labelling dyes show slightly unequal 
quantum yields for small protein spots, which effect is diminished by the application of a so 
called “dye-swap” (compare 3.7.5) (Karp et al. 2004). Here, the dye-swap was not applied, 
which could have led to errors, as reflected in Fig. 4.5.  
In general, it is difficult to decide, which method is the best to visualise and quantify the 
protein spots in 2D gels. Each stain or label has its own characteristics for protein binding and 
visualisation. Certainly, a method which is reproducible and provides a linear range as well as 
enough large sensitivity, as SyproRuby staining or DIGE labelling, is the right way to go. It 
depends on the experimental setup and the analysed samples, especially on the available 
amount of analysable protein. However, it is important to stay with the same method for 
conclusions about compared analyses.  
Of course, another fact for the decision is the price for the experiment. For example, when 
two samples should be compared to each other (three technical repeats each), how much 
would be the price (only for visualisation of proteins)? Assumed, the samples would be 
comparable in treatment with the RBM samples used in this thesis:  
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For SyproRuby staining six 18 cm by 16 cm sized gels would have to be prepared and stained 
with 750 mL of SYPRO®Ruby Protein Gel Stain (now: life technologies). 100 µg (b. sol.) of 
protein would be needed for each gel, in total 300 µg per sample.  
For the DIGE minimal labelling technique only three 18 cm by 16 cm sized gels would have 
to be prepared, but the samples would have to be labelled before. Onto each gel 75 µg (b. sol.) 
of each protein sample would be loaded (25 µg for internal standard (IS) + 50 µg labelled 
with one dye), in total 225 µg of each sample for all three gels. 
The list prices (homepages from 28.07.2015) for 1 L SYPRO®Ruby Protein Gel Stain (S-
12000, life technologies) are 369 €, compared to 680 € for one Refraction-2D™ Labeling Kit 
4G (NHDyeAGNOSTICS). This means, calculated to the needed amount for the experiment, 
that SyproRuby staining would cost 276.75 € compared to 510.00 € for the DIGE labelling.  
SyproRuby staining would save 233.25 €, but 75 µg of each sample would be needed extra.  
The experiments for analyses of effects of ageing and calorie restriction were performed by 
staining with SYPRO®Ruby Protein Gel Stain, on the one hand because of the more 
favourable price for staining and on the other hand for the reason, that enough protein 
quantity was available from the analysed tissues.  
The experiments for analysis of the Parkinson’s model were performed with DIGE dyes, 
because of the only small amount of protein from the very tiny tissues substantia nigra and 
striatum.  
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4.2 Proteome changes caused by age and calorie restriction  
4.2.1 Isolation of mitochondrial proteins and quantification by Bradford protein assay 
Mitochondria from the rat brain areas cerebellum and hippocampus (2.6.1) were isolated 
according to 3.1. Weight of pooled tissue and volume of isolated mitochondrial suspension of 
the different animal groups (YAL: young ad libitum, YCR: young calorie restricted, OAL: old 
ad libitum, OCR: old calorie restricted) are listed in Table 4.2.  
Table 4.2: Weight of pooled tissue and volume of isolated mitochondrial suspension from cerebellum 
and hippocampus for ageing and calorie restriction analysis 
rats 
age 
[months] 
tissue 
pooled tissue weight 
[g] 
volume of isolated 
mitochondrial suspension 
[µL] 
YAL1-5 6.5 
cerebellum 1.41 2200 
hippocampus 1.06 2535 
YCR1-5 6.5 
cerebellum 1.30 2100 
hippocampus 0.76 2125 
OAL1-6 27 
cerebellum 1.70 2185 
hippocampus 1.27 2625 
OCR1-6 27 
cerebellum 1.61 2200 
hippocampus 0.77 2045 
YAL: young ad libitum, YCR: young calorie restricted, OAL: old ad libitum, OCR: old calorie restricted 
 
The protein quantification was performed in cuvettes with the Bradford protein assay (3.2.1). 
The rat brain samples of cerebellum and hippocampus were analysed as pool. Results are 
given in Table 4.3.  
Table 4.3: Determined protein concentration of mitochondrial suspension and total protein 
content of hippocampus and cerebellum mitochondria 
rats 
age 
[months] 
tissue 
protein concentration 
[mg/mL] 
total protein content of 
isolated mitochondria 
[mg] 
YAL1-5 6.5 
cerebellum 2.49   5.47 
hippocampus 5.60 14.20 
YCR1-5 6.5 
cerebellum 3.44   7.22 
hippocampus 5.43 11.54 
OAL1-6 27 
cerebellum 2.20   4.81 
hippocampus 6.08 15.89 
OCR1-6 27 
cerebellum 3.05   6.72 
hippocampus 6.71 13.72 
 
Cerebrum mitochondria of each individual animal were isolated by Dr. Diksha Dani in 2009. 
Data are listed in Table 2.1. Dr. Dani determined the protein amount for the cerebrum 
samples, but the total mitochondrial protein content of cerebrum was not documented by her. 
However, problems with the protein quantitation occurred, for which reason Söhn (2010) 
calculated a correction factor, determined by SDS PAGE. To re-approve these results, the 
mitochondrial proteins of cerebrum of each individual animal were quantified by Bradford 
protein assay separately and the determined protein amounts are listed in Table 4.4.  
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Table 4.4: Determined protein concentration of mitochondrial 
suspension from cerebrum 
rat 
age 
[months] 
protein concentration 
[mg/mL] 
6.5-1 (YAL1) 6.5 3.02 
6.5-2 (YAL2) 6.5 4.70 
6.5-3 (YAL3) 6.5 3.27 
6.5-4 (YAL4) 6.5 2.31 
6.5-5 (YAL5) 6.5 2.46 
6.5-1 CR (YCR1) 6.5 2.15 
6.5-2 CR (YCR2) 6.5 3.74 
6.5-3 CR (YCR3) 6.5 4.66 
6.5-4 CR (YCR4) 6.5 3.88 
6.5-5 CR (YCR5) 6.5 4.54 
27M-1 (OAL1) 27 2.20 
27M-2 (OAL2) 27 1.80 
27M-3 (OAL3) 27 1.90 
27M-4 (OAL4) 27 2.85 
27M-5 (OAL5) 27 2.86 
27M-6 (OAL6) 27 2.29 
27M-1 CR (OCR1) 27 2.32 
27M-2 CR (OCR2) 27 2.21 
27M-3 CR (OCR3) 27 2.33 
27M-4 CR (OCR4) 27 2.64 
27M-5 CR (OCR5) 27 2.47 
27M-6 CR (OCR6) 27 1.20 
 
Deviations to the determined protein amounts of Söhn (2010) were in average at -33.0 % for 
single values (maxima at +11.8 % and -62.1 %). Therefore, the new protein quantitation was 
controlled by SDS PAGE, in addition to the quantitation of the cerebellum and hippocampus 
samples (see this chapter, below).  
For comparison of the cerebrum samples with pooled hippocampus and pooled cerebellum 
samples, the identical amount in µg of each individual cerebrum mitochondria sample for 
each animal group (YAL; YCR; OAL, OCR) was pooled. From the individual protein 
concentration (Table 4.4) the mean was calculated as “pooled” protein concentration for 
cerebrum mitochondria (Table 4.5). 
Table 4.5: Calculated protein concentration of pooled mitochondrial 
suspension from cerebrum  
rats 
age 
[months] 
tissue 
protein concentration 
[mg/mL] 
YAL1-5 6.5 cerebrum 3.15 
YCR1-5 6.5 cerebrum 3.79 
OAL1-6 27 cerebrum 2.32 
OCR1-6 27 cerebrum 2.19 
  
 4 Results and discussion 73 
Control of protein quantification by SDS PAGE 
The results of the protein quantification with Bradford assay were controlled as described in 
3.2.3. Therefor 10 µg mitochondrial protein (as determined by Bradford assay) of each RBM 
sample were incubated in SDS containing SDS-loading buffer and separated by SDS PAGE. 
The SDS gels were stained with CBBG and examined by eye.  
In Fig. 4.6 images of CBBG stained SDS gels with RBM of the regions cerebellum (left gel) 
and hippocampus (right gel) are depicted. Cerebellum and hippocampus samples were loaded 
as pooled samples of each group (YAL, YCR, OAL and OCR).  
Visual examination of the lanes shows similar staining intensities between the lanes of the 
different groups (YAL, YCR, OAL and OCR) for each respective brain region (cerebellum 
and hippocampus, Fig. 4.6). For the respective brain area, the staining intensities of the lanes 
of the four animal groups are similar. 
  
Fig. 4.6: Control of protein quantification for cerebellum and hippocampus by CBBG stained SDS gels. 
10 µg (before solubilisation with SDS included in SDS loading buffer) pooled mitochondrial proteins of each 
group (YAL, YCR, OAL OCR) were loaded into the wells of the SDS gel. 2 µL of LMW were also loaded. Left 
gel image: cerebellum mitochondria, right gel image: hippocampus mitochondria. For the respective brain 
area, staining intensities are similar for lanes and bands. 
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The mitochondria from the rat brain region cerebrum were isolated from individual animal 
samples of the groups YAL, YCR, OAL and OCR. 10 µg of each individual sample were 
incubated in SDS loading buffer and loaded on SDS gels, for control of protein quantification. 
The images of the CBBG stained gels are shown in Fig. 4.7.  
When visually compared to each other, the lanes of each individual mitochondria sample of 
cerebrum have similar CBBG staining intensities. Also the bands of the different samples 
show similar staining intensities.  
Because of the similar staining intensities, an application of a correction factor as described 
by Söhn (2010) was not applied. 
 
  
Fig. 4.7: Control of protein quantification for cerebrum by CBBG stained SDS gels. 10 µg (before 
solubilisation with SDS included in SDS loading buffer) mitochondrial proteins of each individual animal from the 
different groups (YAL, YCR, OAL OCR) were loaded into the wells of the SDS gel. 2 µL of LMW were also 
loaded. Left gel image: YAL and YCR, Right gel image: OAL and OCR. Similar staining intensities of bands and 
lanes are visible. 
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4.2.2 Effects of ageing and calorie restriction on body and tissue weight and amount 
of isolated mitochondrial proteins 
In Table 4.6 the average body and tissue weight as well as the average protein content of the 
isolated mitochondria from the respective tissues are listed for cerebellum and hippocampus. 
It is observable that in average 0.4 % (w/w) mitochondrial proteins of the average tissue 
weight were isolated from cerebellum and 1.5 % (w/w) from hippocampus. Cerebrum 
mitochondria of each individual animal were isolated by Dr. Diksha Dani in 2009. Data are 
shown in Table 2.1. The average tissue weight before isolation of mitochondria was 
mathematically doubled in case of OAL and OCR samples for comparison in Table 4.6 and 
Fig. 4.8, because Dr. D. Dani used only cerebrum halves. The total mitochondrial protein 
content of cerebrum was not documented by Dr. D. Dani.  
Table 4.6: Average body and tissue weight and average protein content of isolated mitochondria from 
cerebellum and hippocampus 
animal 
group 
age 
[months] 
Ø body 
weight [g] 
tissue 
Ø tissue weight 
[g] 
Ø total protein content of 
isolated mitochondria [mg] 
YAL 6.5 360 
cerebellum 0.28 1.09 
hippocampus 0.21 2.84 
cerebrum 0.99 / 
YCR 6.5 215 
cerebellum 0.26 1.45 
hippocampus 0.15 2.31 
cerebrum 0.90 / 
OAL 27 402 
cerebellum 0.28 0.80 
hippocampus 0.21 2.65 
cerebrum 0.90 / 
OCR 27 253 
cerebellum 0.27 1.12 
hippocampus 0.13 2.29 
cerebrum 0.87 / 
 
 
In Fig. 4.8 the average body weight per animal of the analysed rats is depicted as well as the 
average tissue weight for cerebellum, hippocampus and cerebrum and the average total 
protein content for cerebellum and hippocampus. Ageing leads to increased average body 
weight of the animals under ad libitum nutrition (YAL vs. OAL, +12 %) and under calorie 
restriction (YCR vs. OCR, +18 %). It is observable that the average body weight decreases 
under short-term (YAL vs. YCR, -40 %) and long-term (OAL vs. OCR, -37 %) calorie 
restriction. This is similar to the findings of Matsuo et al. (1993) for Fischer rats at age of 6-9 
months (young) and 28-30 months (old): YAL vs. OAL +9.4 %, YCR vs. OCR +13.3 %, 
YAL vs. YCR -36 % and OAL vs. OCR -33.1 %. Young animals under calorie restriction 
start with a lower body weight than ad libitum ones, but both animal groups gain 
approximately the same percentage of additional body weight with age.  
Average tissue weight of cerebellum, hippocampus and cerebrum is decreased by ageing 
under ad libitum nutrition (YAL vs. OAL, +0 %, -1 %, -9 %). This was also observed by 
Coffey et al. (1992) for healthy adult humans. They found by magnetic resonance imaging 
that ageing is associated with diminishment of the volumes of cerebral hemispheres (0.23% 
per year), the frontal lobes (0.55% per year), the temporal lobes (0.28% per year), and the 
amygdala-hippocampal complex (0.30% per year).  
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Ageing under calorie restriction influences the average tissue weight of cerebellum, 
hippocampus and cerebrum in a different way (YCR vs. OCR, +4%, -15 %, -3 %). The 
decrease of hippocampus tissue is larger in animals under calorie restriction, while cerebrum 
is less reduced and cerebellum is even increased. 
It is observable that the average tissue weight decreases under short-term (YAL vs. 
YCR, -8 %, -29 %, -9 %) and long-term (OAL vs. OCR, -5 %, -39 %, -3 %) calorie 
restriction. This seems to be related to the diminished body weight of the animals. It is 
noticeable that the reduction of the weight of hippocampus is much stronger than the 
reduction of the weight of cerebellum and cerebrum.  
The reducing effect of calorie restriction on tissue weight is stronger for hippocampus of aged 
calorie restricted animals and is intensified by the effect of ageing as well. However long-term 
calorie restriction seems to compensate the reducing effect of ageing in cerebellum and 
cerebrum. However, also inaccurate dissection of the tissues might have contributed to the 
different tissue weights but the good expertise of the Goto laboratory minimizes this factor. 
Average total protein content of mitochondria from cerebellum and hippocampus decreases 
with age under ad libitum nutrition (YAL vs. OAL, -27 %, -7 %) just as under calorie 
restriction (YCR vs. OCR, -23%, -1 %), while short-term calorie restriction (ST) (YAL vs. 
YCR) and long-term calorie restriction (LT) (OAL vs. OCR) increases the average total 
protein content of mitochondria from cerebellum (ST: +32 %, LT: +40 %) and decreases it for 
hippocampus (ST: -19 %, LT: -14 %). This means, that ageing has the same effects on both, 
ad libitum nourished animals and calorie restricted animals for both tissues, while in young 
animals under calorie restriction the amount of mitochondrial proteins in cerebellum is 
increased compared to those ad libitum nourished and stays at similar level until age of 
27 months. The finding of increased mitochondrial protein amount for cerebellum is in line 
with the conclusion of Cerqueira et al. (2012), that a large increase of mitochondrial mass 
occurs under calorie restriction in their experiments on mice brain. For hippocampus, the 
mitochondrial proteins are decreased in young animals under calorie restriction and stay at 
Fig. 4.8: Average body and tissue weight and average protein content. The average of the body weight 
from the individual animals, the average tissue weight of cerebellum, hippocampus and cerebrum and the 
average total mitochondrial protein content for cerebellum and hippocampus were calculated and depicted. 
Error bars are standard error of means from n=5 animals for YAL and YCR and n=6 for OAL and OCR. In 
case of cerebellum and hippocampus no standard error is given, because of pooled handling.  
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similar level until age of 27 months.  
In Fig. 4.9 the ratio of the average tissue 
weight to the average body weight is 
depicted for cerebellum, hippocampus and 
cerebrum in % (w/w) (Table 4.6).  
Ageing decreases the ratio for cerebellum 
and cerebrum in the same way for animals 
kept under ad libitum feeding (YAL vs. 
OAL, -10 %, -11 %, -18 %) and under 
calorie restriction (YCR vs. OCR,  
-12 %, -28 %, -18 %), while under calorie 
restriction the ratio is even more decreased 
for hippocampus.  
Short-term calorie restriction (YAL vs. 
YCR) increases the ratio in all three tissues 
(+54 %, +19 %, +52 %) as well as long-
term calorie restriction (OAL vs. OCR) for cerebellum and cerebrum (+51 %, +54 %), while 
for hippocampus the ratio slightly decreased (-4 %). In summary, the ratio of average tissue 
weight to average body weight decreases with age independently from nutrition and in all 
three tissues. Short-term and long-term calorie restriction show similar (increasing) effects on 
the ratios for all three tissues, what means, that already in young animals the changes occurred 
and are kept until age of 27 months.  
In fact, the tissue had been frozen before analysis and this could have an influence on the 
tissue weight and quality of mitochondria (Frenzel 2011). Loss of tissue weight, maybe 
caused by loss of water, could have influenced the ratio of the average tissue weight to the 
average body weight to smaller values for all tissues. But the storage time and the procedure 
of freezing and thawing were the same for all tissues and therefore should have influenced all 
tissue samples in the same manner. Therefore the results can still be compared relatively to 
each other. 
  
Fig. 4.9: Ratio of average tissue weight divided by 
average body weight in % (w/w). For cerebellum, 
hippocampus and cerebrum the ratios were calculated 
and depicted for the pooled animal groups YAL, YCR, 
OAL and OCR. 
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4.2.3 Identification of proteins in BN gels and 2D-BN/SDS gels 
Mitochondrial proteins were solubilised (3.3) and separated by BN-PAGE (3.4), using 18 cm 
by 16 cm sized gels. Afterwards, the BN gel lanes were stained with CBBG (3.7.2) and by in-
gel activity test solutions (3.8), for identification of the bands containing respiratory chain 
complex I, IV and V (CI, CIV and CV). The scanned images (3.7.3) of the lanes were 
compared in parallel, and the complexes of oxidative phosphorylation (OxPhos) were 
assigned to the bands in the BN gels as described by Schägger and Pfeiffer (2000), Schäfer et 
al. (2006), Wittig (2008), with the experience of the Dencher laboratory (Reifschneider 2006, 
Frenzel 2011, Thilmany 2013) and with the results of the PMF and WB analysis (see below). 
Schägger and Pfeiffer (2000) published the approximate masses for OxPhos complexes from 
bovine heart with ~130 kDa for complex II1, ~200 kDa for complex IV1, ~500 kDa for 
complex III2, ~750 kDa for complex V1 and ~1000 kDa for complex I1. According to these 
values, the masses of the homo- and heterooligomers were calculated and listed in Table 4.7.  
Table 4.7: Calculated approximate masses of OxPhos complexes 
 complex /  
supercomplex 
mass 
[kDa] 
complex /  
supercomplex 
abbrev. 
mass 
[kDa] 
II1 130 I1IV2  1400 
IV1 200 V2  1500 
IV2 400 I1III2 a 1500 
III2 500 I1III2IV1 b 1700 
V1 750 I1III2IV2 c 1900 
III2IV1 700 I1III2IV3 d 2100 
I1 1000    
 
The mass standard HMW (Table 3.6) served as indication for the assignment, too. However it 
has to be considered, that the running behaviour of water soluble proteins, which served as 
standard, is different from membrane proteins.  
For the identification of protein spots in 2D-BN/SDS gels, the solubilised proteins were 
separated by 2D-BN/SDS PAGE (3.5). The gel was stained with silver (3.7.1) before 
identification of the protein spots by PMF (3.9). Identified proteins are listed in following 
tables, sorted according to the assignment to the OxPhos complexes or different metabolic 
pathways, as TCA cycle, glycolysis or proteins of cellular stress management. The given 
colours for these groups are the same for all analysed samples. The tables contain information 
about the “spot no.”, as illustrated in the gel image, the “MS type”, “accession” and “protein” 
name, as listed in UniProt databases, molecular weight “MW” in kDa, the “Mascot Score”, 
identified no. of “peptides” and the protein sequence coverage “SC” in %. The “MS type” is 
divided into three types according to the applied method: “MS DDZ” stands for MS analysis 
at Deutsches Diabetes Zentrum, Düsseldorf (DDZ) and “MS/MS DDZ” for MS/MS analysis 
at DDZ. For both types, the method described in 3.9.2 was used. “MS TUD” reflects 
measurements at the TUD, where the method 3.9.1 was applied. The column “accession” 
contains information about the found protein subunit, abbreviated as in UniProt database and 
additional information about the applied taxonomy database. If spots were identified several 
times, they are listed for each measurement. This is indicated by more than one listed Mascot 
score in the table.  
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In general, spots of the same subunit, but from different complex assemblies, can be found in 
horizontal positions on the 2D gel, whereas different subunits of the same complex can be 
detected in vertical positions.  
WB analyses of the OxPhos complexes were used as verification of the MS results.  
The combination of images of BN gel lanes and 2D-BN/SDS gels gives a reliable basis for 
identification and assignment of bands and spots for further analysis, e.g. for quantitation.  
 
Bovine heart mitochondria 
BHM is an often used standard, therefore, the bands in BN gels and spots in 2D-BN/SDS gels 
were analysed and assigned first. Furthermore, the protein pattern of BHM and RBM should 
be compared with the aim to assign the unknown bands and spots of RBM with the help of the 
known bands and spots of the standard BHM. 
For qualitative analysis of BN gel bands, 70 µg before solubilisation with a digitonin to 
protein ratio of 3 g/g (b. sol. d/p: 3g/g) of BHM were separated with BN PAGE and stained 
with CBBG or placed into in-gel activity test solutions for visualisation of bands containing 
CI, CIV and CV (hydrolysis activity of ATP synthase). Additionally a lane with HMW was 
loaded for CBBG staining. For the 2D-BN/SDS PAGE, 100 µg (b. sol. d/p: 3g/g) of BHM 
were solubilised before gel run. Afterwards the gel was stained with silver, followed by PMF.  
The composed image, of stained BN gel lanes and the 2D gel image, is illustrated in Fig. 4.10. 
HMW (orange) is marked on the CBBG gel lane and LMW (black) on the silver stained 2D 
gel. Bands for the OxPhos complexes are marked from lower to higher mass range as follows: 
II1, IV1, IV2, III2, V1, III2IV1, I1, I1IV2, V2 and supercomplexes a = I1III2, b = I1III2IV1, 
c = I1III2IV2 and d = I1III2IV3. The approximate masses of the OxPhos complexes are given in 
Table 4.7. It is important to note, that these masses do not reflect the exact masses of the 
complexes according to their amino acid composition.  
The protein spots are marked with diverse colours, dependent on the classification of the 
proteins. The legend of Fig. 4.10 presents the assignment. Subunits of  are marked in 
, subunits of CII in pink, subunits of CIII in green, subunits of CIV in orange and 
subunits of ATP synthase (CV) in blue. Proteins which could be assigned to the TCA cycle 
were coloured in purple, proteins of cellular stress management were depicted in dark 
green. Other proteins, which were identified, are marked in grey. Protein spots marked in 
black were identified by Western blot (WB) analysis by Decker (presumably 2016) or by 
referring to PMF of RBM (see below). This colour code is also used in the tables below, 
which list the identified protein spots.  
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The settings for the search in Mascot database are listed in Table 3.23 and Table 3.26. The 
taxonomy “Mammalia (mammals)” was chosen as search parameter in Mascot database for 
the analysis of BHM (3.9). Therefore the column “accession” reflects in which taxonomy 
database the protein was found. In most cases, “BOVIN” or “HUMAN” could be assigned. 
Especially in the case of MS/MS analysis, the coverage of the database for “BOVIN” is not 
yet sufficient, hence the search revealed successful results for “HUMAN”, as a genetically 
related mammal, whose database counts currently a larger number of entries. Additionally, the 
abbreviation for the identified subunit according to UniProt database is listed in the column 
“accession”. For significant MS results, the “Mascot Score” for “Mammalia” has to be greater 
than 61 (p<0.05). MS/MS results are significant, when verifying the MS result.  
  
Fig. 4.10: BHM: 2D-gel for PMF analysis, 100 µg proteins of BHM (b. sol. d/p: 3g/g) were separated with 
2D-BN/SDS PAGE and analysed according to 3.9. The images of the CBBG stained BN gel lane and the in-
gel activity test lanes (CI, CIV and CV) (70 µg BHM each, b. sol. d/p: 3g/g) were arranged horizontal above 
the image of the silver stained second dimensional SDS gel for assignment of bands. Masses of LMW and 
HMW were marked. Identified spots were marked in colour as depicted in the legend. Spots, marked in 
black, were identified by WB analysis of BHM (Decker presumably 2016) or by similarity of identified protein 
spots of RBM (see below). a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3 
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For CI, eleven protein spots of six different subunits could be identified, as listed in Table 4.8. 
Most of them seem to be located along a vertical line, originating from supercomplex 
I1III2IV1. Mammalian CI consists of 45 different subunits. Seven are encoded by the 
mitochondrial genome (ND1, ND2, ND3, ND4, ND5, ND6 and ND4L) (Papa et al. 2012), but 
were not identified in this analysis of BHM. 
Table 4.8: BHM: identified subunits of CI 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
MS DDZ 
NDUS1_
BOVIN 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial OS=Bos taurus 
GN=NDUFS1 PE=1 SV=1 
79.4 142.0 19 38.5 
MS/MS DDZ 
NDUS1_
HUMAN 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial OS=Homo sapiens 
GN=NDUFS1 PE=1 SV=3 
79.4 45.5 1 2.2 
MS DDZ 
NDUS1_
BOVIN 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial OS=Bos taurus 
GN=NDUFS1 PE=1 SV=1 
79.4 109.0 22 32.0 
MS/MS DDZ 
NDUS1_
HUMAN 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial OS=Homo sapiens 
GN=NDUFS1 PE=1 SV=3 
79.4 38.4 1 2.6 
MS DDZ 
NDUS1_
BOVIN 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial OS=Bos taurus 
GN=NDUFS1 PE=1 SV=1 
79.4 82.0 16 19.4 
MS/MS DDZ 
NDUS1_
HUMAN 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial OS=Homo sapiens 
GN=NDUFS1 PE=1 SV=3 
79.4 52.1 1 1.7 
MS TUD 
NDUS1_
BOVIN 
NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial OS=Bos taurus 
GN=NDUFS1 PE=1 SV=1 
79.4 131.0 18 30.0 
MS DDZ 
NDUS2_
BOVIN 
NADH dehydrogenase [ubiquinone] iron-
sulfur protein 2, mitochondrial OS=Bos 
taurus GN=NDUFS2 PE=1 SV=2 
52.5 79.4 17 36.7 
MS DDZ 
NDUS2_
BOVIN 
NADH dehydrogenase [ubiquinone] iron-
sulfur protein 2, mitochondrial OS=Bos 
taurus GN=NDUFS2 PE=1 SV=2 
52.5 75.5 16 29.6 
MS DDZ 
NDUS2_
HUMAN 
NADH dehydrogenase [ubiquinone] iron-
sulfur protein 2, mitochondrial OS=Homo 
sapiens GN=NDUFS2 PE=1 SV=2 
52.5 65.8 16 26.3 
MS DDZ 
NDUA9_
BOVIN 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 9, mitochondrial OS=Bos 
taurus GN=NDUFA9 PE=1 SV=1 
42.8 100.0 13 45.8 
MS DDZ 
NDUS3_
BOVIN 
NADH dehydrogenase [ubiquinone] iron-
sulfur protein 3, mitochondrial OS=Bos 
taurus GN=NDUFS3 PE=1 SV=1 
30.3 116.0 14 48.1 
MS DDZ 
NDUS3_
MESAU 
NADH dehydrogenase [ubiquinone] iron-
sulfur protein 3, mitochondrial (Fragments) 
OS=Mesocricetus auratus GN=NDUFS3 
PE=1 SV=1 
11.1 72.9 7 66.0 
MS/MS DDZ 
NDUV2_
HUMAN 
NADH dehydrogenase [ubiquinone] 
flavoprotein 2, mitochondrial OS=Homo 
sapiens GN=NDUFV2 PE=1 SV=2 
27.4 62.0 1 5.2 
MS/MS DDZ 
NDUB8_
HUMAN 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 8, mitochondrial OS= 
Homo sapiens GN=NDUFB8 PE=1 SV=1 
21.8 44.2 1 5.9 
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Two nearby spots of CII were identified, but only from one subunit (Table 4.9). In mammals, 
CII consists of four subunits, all nuclear encoded (Papa et al. 2012). 
Table 4.9: BHM: identified subunits of CII 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
49 MS DDZ 
DHSA_ 
BOVIN 
Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial OS=Bos 
taurus GN=SDHA PE=1 SV=3 
72.9 71.4 13 23.3 
81 MS/MS DDZ 
DHSA_ 
HUMAN 
Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
OS=Homo sapiens GN=SDHA PE=1 SV=2 
72.6 59.4 1 2.1 
 
Six spots of three different subunits from CIII were found (Table 4.10). In total the 
mammalian CIII is composed of eleven subunits. Only one subunit is encoded by 
mitochondrial genome (CYB) (Papa et al. 2012). Identified spot no. 35a belongs to CYB. 
Three of the identified subunits are located in a horizontal line, representing one subunit 
(QCR2). Spot no. 103 was identified as CY1 from CIII in MS/MS spectra, while the 
corresponding MS analysis identified it as NDUS3 of CI. Spot no. 103 lies on a vertical line 
below the supercomplex I1III2IV1. This could indicate an association of the subunits. 
Table 4.10: BHM: identified subunits of CIII 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
16 MS DDZ 
QCR2_ 
BOVIN 
Cytochrome b-c1 complex subunit 2, 
mitochondrial OS=Bos taurus GN=UQCRC2 
PE=1 SV=2 
48.1 
91.2 12 36.2 
17 
MS DDZ 
QCR2_ 
BOVIN 
102.0 11 35.1 
MS DDZ 
QCR2_ 
BOVIN 
60.0 12 33.0 
20 MS DDZ 
QCR2_ 
BOVIN 
63.9 8 19.9 
35a MS/MS DDZ 
CYB_ 
HUMAN 
Cytochrome b OS=Homo sapiens GN=MT-
CYB PE=1 SV=2 
42.7 46.6 1 2.4 
34 MS/MS DDZ 
CY1_ 
HUMAN Cytochrome c1, heme protein, mitochondrial 
OS=Homo sapiens GN=CYC1 PE=1 SV=3 
35.4 
68.8 1 3.7 
103 MS/MS DDZ 
CY1_ 
HUMAN 
55.9 1 3.7 
 
Only one subunit of CIV could be identified by PMF for BHM (Table 4.11). CIV in mammals 
has 13 subunits, three of them are encoded by mitochondrial DNA (Cox1, Cox2, Cox3) (Papa 
et al. 2012), but these were not identified for BHM. Four of the subunits could be assigned 
with the help of WBs and the analysis of RBM by PMF (see this chapter below). 
Table 4.11: BHM: identified subunits of CIV 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
53 MS DDZ 
COX41_
BOVIN 
Cytochrome c oxidase subunit 4 isoform 1, 
mitochondrial OS=Bos taurus GN=COX4I1 
PE=1 SV=1 
19.6 148.0 13 57.4 
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For ATP synthase (CV), eleven spots of six subunits were detected (Table 4.12). In mammals 
it consists of 16 different subunits, two of them are encoded by the mitochondrial genes 
(ATPase6, A6L) (Papa et al. 2012), but both were not identified in this analysis of BHM. ATP 
synthase subunit alpha and beta were identified in three spots each in a horizontal line, for 
monomer, dimer and next higher multimer, perhaps trimer or tetramer. Other subunits were 
found below the monomer and dimer in a vertical line, shifted to lower masses. 
Table 4.12: BHM: identified subunits of CV 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
02 MS DDZ 
ATPA_ 
BOVIN 
ATP synthase subunit alpha, mitochondrial 
OS=Bos taurus GN=ATP5A1 PE=1 SV=1 
59.7 162.0 16 36.7 
03 MS/MS DDZ 
ATPB_ 
HUMAN 
ATP synthase subunit beta, mitochondrial 
OS=Homo sapiens GN=ATP5B PE=1 SV=3 
56.5 99.4 2 5.5 
10 
MS DDZ 
ATPA_ 
BOVIN 
ATP synthase subunit alpha, mitochondrial 
OS=Bos taurus GN=ATP5A1 PE=1 SV=1 
59.7 267.0 30 51.0 
MS/MS DDZ 
ATPA_ 
HUMAN 
ATP synthase subunit alpha, mitochondrial 
OS=Homo sapiens GN=ATP5A1 PE=1 SV=1 
59.7 41.4 1 2.9 
11 MS DDZ 
ATPB_ 
BOVIN 
ATP synthase subunit beta, mitochondrial 
OS=Bos taurus GN=ATP5B PE=1 SV=2 
56.2 70.7 12 26.1 
12 
MS DDZ 
ATPA_ 
BOVIN 
ATP synthase subunit alpha, mitochondrial 
OS=Bos taurus GN=ATP5A1 PE=1 SV=1 
59.7 183.0 25 47.7 
MS/MS DDZ 
ATPA_ 
HUMAN 
ATP synthase subunit alpha, mitochondrial 
OS=Homo sapiens GN=ATP5A1 PE=1 SV=1 
59.7 40.8 1 2.7 
MS DDZ 
ATPA_ 
BOVIN 
ATP synthase subunit alpha, mitochondrial 
OS=Bos taurus GN=ATP5A1 PE=1 SV=1 
59.7 156.0 20 35.0 
13 MS/MS DDZ 
ATPB_ 
HUMAN 
ATP synthase subunit beta, mitochondrial 
OS=Homo sapiens GN=ATP5B PE=1 SV=3 
56.5 160.0 2 5.5 
33 
MS DDZ 
ATPG_ 
BOVIN 
ATP synthase subunit gamma, mitochondrial 
OS=Bos taurus GN=ATP5C1 PE=1 SV=3 
33.1 139.0 18 42.6 
MS/MS DDZ 
ATPG_ 
HUMAN 
ATP synthase subunit gamma, mitochondrial 
OS=Homo sapiens GN=ATP5C1 PE=1 SV=1 
33.0 47.6 1 5.0 
35b 
MS DDZ 
AT5F1_ 
BOVIN 
ATP synthase subunit b, mitochondrial 
OS=Bos taurus GN=ATP5F1 PE=1 SV=2 
28.8 185.0 29 59.4 
MS/MS DDZ 
AT5F1_
HUMAN 
ATP synthase subunit b, mitochondrial 
OS=Homo sapiens GN=ATP5F1 PE=1 SV=2 
28.9 69.3 1 3.1 
39 MS TUD 
ATP5O_
BOVIN 
ATP synthase subunit O, mitochondrial 
OS=Bos taurus GN=ATP5O PE=1 SV=2 
23.3 89.0 12 53.0 
40 
MS DDZ 
AT5F1_ 
BOVIN 
ATP synthase subunit b, mitochondrial 
OS=Bos taurus GN=ATP5F1 PE=1 SV=2 
28.8 123.0 17 50.0 
MS/MS DDZ 
AT5F1_
HUMAN 
ATP synthase subunit b, mitochondrial 
OS=Homo sapiens GN=ATP5F1 PE=1 SV=2 
28.9 67.0 1 3.1 
41 MS DDZ 
ATP5H_
BOVIN 
ATP synthase subunit d, mitochondrial 
OS=Bos taurus GN=ATP5H PE=1 SV=2 
18.7 62.8 7 38.5 
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In addition to the proteins of oxidative phosphorylation, proteins belonging to other metabolic 
pathways were identified, too.  
Seven subunits or proteins belonging to the TCA cycle were identified: 2-oxoglutarate 
dehydrogenase (ODO1), dihydrolipoyllysine-residue succinyl-transferase (ODO2), NAD(P) 
transhydrogenase (NNTM), malate dehydrogenase (MDHM), citrate synthase (CISY), 
fumarate hydratase (FUMH) and aconitate hydratase (ACON). They are marked in purple in 
Fig. 4.10 and listed in Table 4.13.  
Table 4.13: BHM: identified proteins of TCA cycle 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
01 MS DDZ 
ODO1_ 
BOVIN 
2-oxoglutarate dehydrogenase, mitochondrial 
OS=Bos taurus GN=OGDH PE=2 SV=1 
115.7 200.0 33 30.8 
14 
MS DDZ 
ODO2_ 
BOVIN 
Dihydrolipoyllysine-residue succinyl-
transferase component of 2-oxoglutarate 
dehydrogenase complex, mitochondrial 
OS=Bos taurus GN=DLST PE=1 SV=2 
48.9 92.9 19 34.5 
MS/MS DDZ 
ODO2_ 
HUMAN 
Dihydrolipoyllysine-residue succinyl-
transferase component of 2-oxoglutarate 
dehydrogenase complex, mitochondrial 
OS=Homo sapiens GN=DLST PE=1 SV=4 
48.7 67.5 1 3.8 
48 
MS DDZ 
NNTM_
BOVIN 
NAD(P) transhydrogenase, mitochondrial 
OS=Bos taurus GN=NNT PE=1 SV=3 
113.8 158.0 28 24.7 
MS/MS DDZ 
NNTM_
HUMAN 
NAD(P) transhydrogenase, mitochondrial 
OS=Homo sapiens GN=NNT PE=1 SV=3 
113.8 45.2 1 1.2 
57 
MS DDZ 
MDHM_
BOVIN 
Malate dehydrogenase, mitochondrial 
OS=Bos taurus GN=MDH2 PE=1 SV=1 
35.6 85.1 10 39.6 
MS/MS DDZ 
MDHM_
HUMAN 
Malate dehydrogenase, mitochondrial 
OS=Homo sapiens GN=MDH2 PE=1 SV=3 
35.5 42.8 1 3.3 
60 MS/MS DDZ 
CISY_ 
HUMAN 
Citrate synthase, mitochondrial OS=Homo 
sapiens GN=CS PE=1 SV=2 
51.7 109.7 2 3.9 
61 
MS DDZ 
FUMH_ 
PIG 
Fumarate hydratase, mitochondrial OS=Sus 
scrofa GN=FH PE=1 SV=1 
50.0 108.0 13 30.7 
MS DDZ 
FUMH_
MACFA 
Fumarate hydratase, mitochondrial 
OS=Macaca fascicularis GN=FH PE=2 SV=1 
54.7 96.0 12 29.8 
MS/MS DDZ 
FUMH_
HUMAN 
Fumarate hydratase, mitochondrial 
OS=Homo sapiens GN=FH PE=1 SV=3 
54.6 72.8 1 3.5 
63 
MS DDZ 
ACON_ 
BOVIN Aconitate hydratase, mitochondrial OS=Bos 
taurus GN=ACO2 PE=1 SV=4 
85.3 
161.0 23 33.7 
MS DDZ 
ACON_ 
BOVIN 
161.0 23 33.7 
 
Three proteins of cellular stress management were identified (Table 4.14): 60 kDa heat shock 
protein (CH60), 78 kDa glucose-regulated protein (GRP78) and endoplasmin (ENPL). 
Table 4.14: BHM: identified proteins of stress management 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
43 MS DDZ 
CH60_ 
HUMAN 
60 kDa heat shock protein, mitochondrial 
OS=Homo sapiens GN=HSPD1 PE=1 SV=2 
61.0 75.8 16 27.7 
62 
MS DDZ 
GRP78_
HUMAN 78 kDa glucose-regulated protein OS=Homo 
sapiens GN=HSPA5 PE=1 SV=2 
72.3 89.8 15 32.1 
MS/MS DDZ 
GRP78_
HUMAN 
72.3 60.2 1 2.6 
109 
MS DDZ 
ENPL_ 
BOVIN 
Endoplasmin OS=Bos taurus GN=HSP90B1 
PE=2 SV=1 
92.4 144.0 27 34.1 
MS/MS DDZ 
ENPL_ 
HUMAN 
Endoplasmin OS=Homo sapiens 
GN=HSP90B1 PE=1 SV=1 
92.4 53.6 1 1.7 
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A few other proteins were also identified as listed in Table 4.15. Medium-chain specific acyl-
CoA dehydrogenase (ACADM) and trifunctional enzyme subunit beta (ECHB) are involved 
in mitochondrial fatty-acid beta oxidation (Uniprot databases). Mitochondrial NADP+-
dependent isocitrate dehydrogenase (IDHP) catalyses the decarboxylation of isocitrate into 2-
oxoglutarate, while reducing NADP+ to NADPH. NADPH is needed for regeneration of 
reduced glutathione in the mitochondria. Glutathione functions as antioxidant and therefore as 
a scavenger of ROS (Jo et al. 2001).  
Table 4.15: BHM: varying identified proteins 
spot 
no. 
MS type 
acces-
sion 
protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
73 MS DDZ 
ACADM
_BOVIN 
Medium-chain specific acyl-CoA 
dehydrogenase, mitochondrial OS=Bos taurus 
GN=ACADM PE=2 SV=1 
46.5 217.0 17 43.2 
107 
MS DDZ 
ECHB_ 
BOVIN 
Trifunctional enzyme subunit beta, 
mitochondrial OS=Bos taurus GN=HADHB 
PE=2 SV=1 
51.3 113.0 17 32.4 
MS/MS DDZ 
ECHB_ 
HUMAN 
Trifunctional enzyme subunit beta, 
mitochondrial OS=Homo sapiens 
GN=HADHB PE=1 SV=3 
51.3 41.6 1 4.2 
108 MS DDZ 
IDHP_ 
BOVIN 
Isocitrate dehydrogenase [NADP], 
mitochondrial OS=Bos taurus GN=IDH2 
PE=1 SV=2 
50.7 148.0 20 40.9 
 
From WB analysis as part of the dissertation of Decker (presumably 2016), BHM protein spot 
numbers 04, 05, 06 and 07 can be assigned to subunit NDUS1 from CI in line with the 
findings from PMF (Table 4.8). Also, the subunit DHSA of CII was identified by PMF for 
spots 49 and 81 (Table 4.9), which are in agreement with Decker’s findings. The spot 
numbers 16, 17, 20, 22 and 24, could be assigned to subunit QCR2 from CIII according to 
Decker’s WB analysis. For the spots 16, 17 and 20, this could be verified by PMF (Table 
4.10). CIV subunit COX1 was not identified by PMF. However, the spot numbers 28, 29, 30, 
47, 79 and 112 could be assigned to COX1 in Decker’s WB analysis, as also indicated by the 
respective staining differences. Spot no. 79 was identified as subunit NDUA9 (from CI) by 
PMF (Table 4.8). For the latter, a mass of 42.8 kDa is given in UniProt database, versus 
57.0 kDa for subunit COX1. Probably, the spots overlap, because spot no. 79 could be a 
mixture of subunits of CI and CIV, due to its origin from the supercomplex I1III2IV1, if the 
vertical line is followed up to the appropriate BN gel band. For ATP synthase, the subunits 
alpha (spots 02, 10, 12, Table 4.12) and beta (spots 03, 11, 13, Table 4.12) were identified by 
PMF. This is in line with Decker’s WB analysis, where the alpha subunit can be assigned to 
spots 02, 10, 12 and 110, and the beta subunit to spots 03, 11, 13 and 111.  
Additional to the OxPhos complexes, the heat shock protein CH60 was identified in spot no. 
43 by PMF (Table 4.14), which can also be found in the WB for CH60 by Decker.  
Other spots, marked in black, were assigned by comparison with the results of PMF for RBM. 
These include spot numbers 46, 50, 54, 57, 58, 68, 69, and 71 (see below). Spots 36 and 42a 
were assigned by relating the results from PMF of RBM by Reifschneider et al. (2006) to the 
current results of RBM (see below). 
Not all of the identified proteins are assumed mitochondrial (membrane) proteins. This is in 
line with the isolation of crude mitochondrial fraction from tissue (3.1).   
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Assignment of protein bands from Rat brain mitochondria in BN gels 
RBM were analysed by BN 
PAGE and 2D-BN/SDS PAGE, 
using 18 cm by 16 cm sized gels. 
Assignment of bands in BN gels 
and spots in 2D gels is a pre-
requisite for all further analyses, 
e.g. quantitation. The already 
assigned bands and spots of 
BHM, as a related mammal, 
served as standard for compar-
ison (see above).  
For assignment of bands in BN 
gels, 100 µg (b. sol. d/p: 8g/g, 
3.3.1) proteins of RBM (cerebel-
lum, hippocampus and cerebrum) 
were separated by BN PAGE 
(3.4). After gel run, the lanes 
were stained with CBBG (3.7.2) 
or by performing in-gel activity tests of CI, CIV and CV (3.8). The latter was only applied to 
cerebellum mitochondria for qualitative identification of homooligomers of ATP synthase. 
Images were taken (3.7.3) and analysed visually. 
Fig. 4.11 shows a combination of images of differently stained BN gel lanes for cerebellum 
mitochondria (YAL). The image of the CBBG stained gel lanes includes an additional lane 
with 70 µg (b. sol. d/p: 3g/g) proteins of BHM as a reference (marked in green). The other 
lanes show the typical blue / purple precipitate (NBT diformazan) for CI in-gel activity, the 
brownish precipitate (poly-DAB) for CIV in-gel activity and the white precipitate (Pb3(PO4)2) 
for CV in-gel activity, the latter reflects the hydrolysis activity of ATP synthase. The 
assignment of the bands is shown in black for RBM and in green for BHM. 
The lane from CV activity test depicts two distinct white bands (with blue background 
staining from CBBG, originated from the cathode buffer) of ATP synthase after 72 hours of 
staining. Due to the fact that the BN gels were gradient gels with 4 % T on top and 13 % T on 
the bottom, the masses of proteins should decrease from top to bottom. The band with lower 
mass can be assigned to the ATP synthase monomer V1 and the one shifted to higher masses 
should be the dimer V2. Both bands are also observable as distinct blueish bands in the other 
stained gel lanes, if followed in horizontal direction. It is apparent, that V1 from RBM 
migrated approximately the same distance as V1 from BHM, while V2 of BHM is shifted to 
slightly higher mass than V2 from RBM. A difference in intensities is visible since the band of 
V1 is more intense than the one of V2. 
When hydrolysis active bands are compared with the CI in-gel activity test staining (Fig. 
4.11), both bands, V1 and V2, can be allocated as distinct blueish bands amongst the blue / 
purple CI containing bands. Between V1 and V2, two blue / purple bands, containing active 
CI, could be assigned. The lower band should be complex I1 (approx. 1000 kDa). This band is 
Fig. 4.11: Assignment of 
bands in BN gel for rat 
mitochondria of cerebellum
(YAL), 100 µg (b. sol. d/p: 8g/g)
proteins of RBM (cerebellum, 
YAL) were separated on each 
depicted lane. CBBG staining 
and in-gel activity tests were 
performed. 70 µg (b. sol. 
d/p: 3g/g) proteins of BHM were 
loaded as standard. The images 
of the stained lanes were 
arranged side by side (left to 
right: CBBG, in-gel activity test 
of CI (120 min), CIV (150 min) 
and CV (72 h, = hydrolysis 
activity of CV). Assignment of 
bands is given for BHM (green) 
and RBM (black).  
*: additional unspecific stained 
band, a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3 
* 
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not present in CIV in-gel activity test lane, while the upper one should be a combination of CI 
and IV, because it is apparent in both lanes, albeit just a slight brownish smear in CIV in-gel 
activity lane, which might be caused by low in-gel activity. Probably it can be assigned as 
supercomplex I1IV2, due to its mass of 1400 kDa, which is below 1500 kDa of V2. Above the 
band of V2 in CI in-gel activity test lane, there are four intense blue / purple bands allocated to 
the supercomplexes a = I1III2, b = I1III2IV1, c = I1III2IV2 and d = I1III2IV3. The most intense 
supercomplex band in CBBG and CI in-gel activity test for RBM is the one of I1III2, while for 
BHM it is I1III2IV1. 
As expected, in CIV in-gel activity test the band of I1III2 exhibits just blueish staining. But 
unexpected was, that also the band of supercomplex I1III2IV1 seems to lack CIV in-gel 
activity, because no brownish stain is observable. Referring to the quantitative analysis of 
CIV in-gel activity test (4.2.6), I1III2IV1 exhibits at least slight activity, not visible by eye. 
Supercomplexes I1III2IV2 and I1III2IV3 appear as distinct bands in CIV in-gel activity test, but 
the one of I1III2IV2 is the most intense distinct brownish band of that gel lane. 
Additional bands with higher masses appear above the assigned supercomplex I1III2IV3 for CI 
and CIV in-gel activity test. They are more distinct in CI in-gel activity test and more smeared 
in CIV in-gel activity test. Those could not be assigned to specific stoichiometries of 
complexes. Hence they were disregarded for further analysis.  
Just above the blueish band of complex V1 in CIV in-gel activity test, an additional weak 
brownish, smeared band is observable. It does not show CI activity. It is supposed to be 
III2IV1, according to its apparent mass (700 kDa). 
Below the band of complex V1 in CIV in-gel activity test, two more smeared brownish bands 
are apparent. The one with higher mass is less intense than the one with lower mass. Both 
cannot be found in CI in-gel activity test. By reason of their location in the gradient gel, they 
were assigned to the dimer IV2 and monomer IV1, respectively  
In CI in-gel activity test, an additional band is stained in blue / purple (marked with *). It is 
located below the corresponding IV1 band of CIV in-gel activity test. Due to the facts, that it 
appears usually after a longer incubation time than the other bands, that it exhibits only weak 
intensity and could not be allocated to a specific complex, this band is also disregarded for 
further analysis. 
All of these assignments are transferred to the CBBG stained BN gel lane (Fig. 4.11). Three 
additional bands are marked there: II1, F1 and III2. Those were assigned with the help of 
identified protein spots by PMF and WB analysis from 2D-BN/SDS gels (see below).  
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Fig. 4.12 depicts a 
combined image of 
CBBG stained BN gel 
lanes. The intersec-
tions of the images 
are indicated by verti-
cal zig-zag lines. 
100 µg (b. sol. d/p: 
8g/g) of mitochon-
drial proteins from 
YAL groups of the 
three brain areas cere-
bellum (black), hippo-
campus (blue) and 
cerebrum (red) were 
loaded per lane. 70 g 
(b. sol. d/p: 3g/g) pro-
teins of BHM (green) 
were loaded for com-
parison. HMW served 
as mass standard (orange). The OxPhos complexes were assigned to BHM and RBM as ex-
plained above for Fig. 4.11. The original images of the CBBG stained BN gels (BN1-3) are 
illustrated in “7 Supplements”, Fig. 7.1 and Fig. 7.2.  
In Fig. 4.12 it is visible, that the marked (super)complexes of the different tissues 
(cerebellum, hippocampus and cerebrum) show the same electrophoretic migration pattern on 
BN gels. Only the intensities of the different gel lanes differ slightly, which is caused by 
different background staining. The same migration behaviour is also found for the other 
sample groups (YCR, OAL, OCR) of all three tissues, e.g. when loaded on the same BN gel 
(observable at BN1-3 in “7 Supplements”, Fig. 7.1 and Fig. 7.2). 
The migration behaviour of the (super)complexes of RBM in BN gel differs compared to 
BHM, as visible in Fig. 4.12 and all other BN gel images. BHM complexes of higher mass 
than IV1 seem to migrate slower through the BN gel than the corresponding complexes of the 
RBM samples, therefore the equivalent bands are located slightly higher in the gel. This effect 
can be explained on the one hand, that protein complexes of RBM differ in molecular weight 
and on the other hand that different ratios of digitonin to protein amount during solubilisation 
were applied (d/p: 3g/g for BHM and d/p: 8g/g for RBM) resulting in different degree of 
delipidation. Probably, the micelles with the solubilised protein complexes contain different 
amounts of remaining lipids and digitonin, for solubilised RBM and BHM. 
  
Fig. 4.12: Comparison of 
band positions in CBBG 
stained BN gel for RBM
from the three different 
brain areas cerebellum, 
hippocampus and cere-
brum (all YAL). 100 µg 
(b. sol. d/p: 8g/g) proteins of 
RBM were loaded on each 
lane. 70 µg (b. sol. d/p: 3g/g) 
proteins of the standard 
BHM as well as 4 µL of 
HMW were loaded into addi-
tional lanes. Gel run was 
followed by CBBG staining. 
Bands are assigned for cer-
ebellum YAL (black), BHM
(green) and HMW (orange). 
RBM samples are colour 
coded as follows: cerebellum 
in black, hippocampus in 
blue, cerebrum in red. Ver-
tical zig-zag lines mark the 
intersections made in the 
original images which are 
attached in “7 Supplements” 
(BN1-3, Fig. 7.1, Fig. 7.2).
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3 
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Fig. 4.13 depicts images of BN gel 
lanes, which were stained with CI 
in-gel activity test solution. 70 µg 
(b. sol. d/p: 3g/g) proteins of BHM 
were loaded on one lane, additional 
to lanes with 100 µg (b. sol. 
d/p: 8g/g) proteins of RBM for each 
brain area. Images of lanes depicted 
in Fig. 4.13 are separated RBM 
proteins from cerebellum, hippo-
campus and cerebrum, each from 
respective YAL groups. The original 
images show all groups for each 
brain area (see “7 Supplements”, 
Fig. 7.10). For BHM and cerebrum, 
the bands are assigned to OxPhos 
complexes as in Fig. 4.11. It is 
obvious, that the migration 
behaviour for all shown RBM 
samples is similar. Only in the area 
above supercomplex I1III2IV3, the 
pattern of the bands differs slightly. 
But the complex composition of these bands is unknown, therefore they were not assigned. 
The differences in the migration pattern of the proteins from BHM compared to RBM, as 
already observed and explained for CBBG stained BN gels (Fig. 4.12), is also visible in Fig. 
4.13. 
Fig. 4.14 illustrates a composed 
picture of images of BN gel lanes, 
incubated in CIV in-gel activity 
test solution. The lanes include 
mitochondrial proteins of the three 
different rat brain areas of the 
respective YAL groups and BHM. 
The lane with proteins of cere-
bellum is marked in black, of 
hippocampus in blue, of cerebrum 
in red and of BHM in green.  
The original gel images (attached 
in “7 Supplements”, Fig. 7.12) 
contain lanes of all animal groups 
(YAL, YCR, OAL, OCR) of each 
brain area. In Fig. 4.14 the 
OxPhos complexes are assigned to 
the protein bands of BHM and 
cerebrum as explained above (Fig. 
Fig. 4.13: CI in-gel 
activity test, band 
positions for RBM of 
different brain areas
(cerebellum, hippo-
campus, cerebrum, all 
YAL), 100 µg (b. sol. 
d/p: 8g/g) proteins of 
RBM were loaded on 
each lane. 70 µg (b. sol. 
d/p: 3g/g) of the 
standard BHM were 
loaded into an additional 
lane. After gel run, CI in-
gel activity test was 
performed. Bands are 
assigned for cerebrum 
YAL (black) and BHM
(green). RBM samples 
are colour coded as 
follows: cerebellum in 
black, hippocampus in 
blue, cerebrum in red. 
The vertical zig-zag lines 
mark the intersections, 
made in the original 
images, which are pre-
sent at “7 Supplements”, 
Fig. 7.10. 
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3  
Fig. 4.14: CIV in-gel acti-
vity test, band positions 
for RBM of different 
brain areas (cerebellum, 
hippocampus, cerebrum, 
all YAL), 100 µg (b. sol. 
d/p: 8g/g) proteins of RBM 
were loaded on each lane. 
70 µg (b. sol. d/p: 3g/g) of 
the protein standard BHM 
were loaded into an addi-
tional lane. After gel run, 
CIV in-gel activity test was 
performed. Bands are as-
signed for cerebrum YAL 
(black) and BHM (green). 
RBM samples are colour 
coded as follows: cere-
bellum in black, hippo-
campus in blue, cerebrum 
in red. The zig-zag lines 
mark the intersections, 
made in the original imag-
es, which are attached in 
“7 Supplements”, Fig. 
7.12.  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3  
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4.11). The running behaviour of the (super)complexes is similar for all three lanes of RBM. 
This is also observable for the other animal groups (YCR, OAL, OCR, not shown here), when 
the entire image as in “7 Supplements”, Fig. 7.12 is considered. The staining intensities differ 
for each lane of Fig. 4.14. The brownish precipitate is the weakest for mitochondrial proteins 
of hippocampus, followed by cerebellum and the lane of cerebrum shows the most intense 
staining. The explanation for this observation is, that different gels and solutions were used 
for each CIV in-gel activity test of respective brain area.  
As well as observed and explained for CBBG stained gels (Fig. 4.12), the difference in 
migration behaviour of the proteins from BHM compared to RBM is visible in Fig. 4.14.  
 
Identification of protein spots from RBM in 2D-BN/SDS gels 
For identification of protein spots of RBM (cerebellum, hippocampus and cerebrum), 200 µg 
proteins (b. sol. d/p: 8g/g, 3.3.1) of each brain area were separated by 2D-BN/SDS PAGE 
(3.5). Gels were stained with silver (3.7.1) and PMF (3.9) was performed. 
The images of the gels are depicted in Fig. 4.15 (cerebellum), Fig. 4.16 (hippocampus) and 
Fig. 4.17 (cerebrum). A CBBG stained BN gel lane with the assigned OxPhos complexes as 
in Fig. 4.11 and Fig. 4.12 was placed horizontally above the silver stained second dimensional 
SDS gel. The protein spots are marked with diverse colours, dependent on the classification of 
the proteins. The legends of Fig. 4.15, Fig. 4.16 and Fig. 4.17 illustrate the assignment. 
Subunits of  are marked in , subunits of CII in pink, subunits of CIII in green, 
subunits of CIV in orange and subunits of ATP synthase (CV) in blue. Proteins which were 
assigned to the TCA cycle are coloured in purple, proteins belonging to glycolysis in brown, 
those related to both, , in . Proteins of cellular 
stress management are depicted in dark green. Spots / subunits of Na+/K+ ATPase are 
marked in red. Other identified proteins are marked in grey. Protein spots assigned in black 
were not identified by PMF of the respective brain area, but at least identified for one of the 
other brain areas, or by WB analysis of RBM (see below), or they were assigned by referring 
to PMF of BHM or WB analysis of BHM as described by Decker (presumably 2016). This 
colour code is also used in the tables below, which list the identified subunits of the proteins.  
 
The assignment of complexes II1, III2 and F1 portion in BN gel lanes was performed on the 
basis of the identification of protein spots by PMF. By comparison of Fig. 4.15, Fig. 4.16 and 
Fig. 4.17, spot numbers 49 and 81 can be assigned to CII (Table 4.17) and following in 
vertical direction to a slightly blueish band in the BN gel lane. Complex III2 was marked in 
the BN gel lane on vertical direction through the spot numbers 23, 24, 35a, 36 and 42a. 23 and 
24 were identified by PMF of RBM as subunits of CIII (Table 4.18), as well as spot no. 35a 
by PMF of BHM (Table 4.10) and spots 36 and 42a were assigned according to Reifschneider 
et al. (2006) (see below). The spots 44 and 46 were identified as subunits alpha and beta of 
ATP synthase (Table 4.20) and due to their position in the 2D gel should be part of the 
separated F1 portion. F1 was assigned in the BN gel lane by following the spots in vertical 
direction to a very weak blueish band in the BN gel.   
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47 protein spots were identified by PMF for cerebellum mitochondria and coloured in the 
image of the 2D-BN/SDS gel (Fig. 4.15).  
 
  
Fig. 4.15: Cerebellum
RBM: 2D-gel for PMF 
analysis, 200 µg (b. sol. 
d/p: 8g/g) proteins of 
RBM from cerebellum 
were separated by 2D-
BN/SDS PAGE and ana-
lysed according to 3.9. 
The image of the CBBG 
stained BN gel lane was 
arranged horizontally 
above the image of the 
silver stained second di-
mensional SDS gel, for 
assignment of bands. 
Masses of LMW were 
marked. Identified spots 
were marked in colour 
as depicted in the leg-
end. Protein spots 
marked in black were 
not identified by PMF of 
this brain area, but iden-
tified for at least one of 
the other areas or as-
signed by comparison 
with the standard BHM 
or the publication of 
Reifschneider et al. 
(2006),  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3 
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For hippocampus RBM 35 protein spots were identified by PMF and marked in colour in the 
2D-BN/SDS gel image (Fig. 4.16). 
 
  
Fig. 4.16: Hippocam-
pus RBM: 2D-gel for 
PMF analysis, 200 µg 
(b. sol. d/p: 8g/g) pro-
teins of RBM from hip-
pocampus were sepa-
rated by 2D-BN/SDS 
PAGE and analysed 
according to 3.9. The 
image of the CBBG 
stained BN gel lane 
was arranged horizon-
tally above the image 
of the silver stained 
second dimensional 
SDS gel, for assign-
ment of bands. Masses 
of LMW were marked. 
Identified spots were 
marked in colour as 
depicted in the legend. 
Protein spots marked 
in black were not iden-
tified by PMF of this 
brain area, but identi-
fied for at least one of 
the other areas or as-
signed by comparison 
with the standard BHM 
or the publication of 
Reifschneider et al. 
(2006) 
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, 
d = I1III2IV3 
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33 protein spots were identified by PMF for rat cerebrum mitochondria and marked in colour 
in Fig. 4.17.  
The settings for the search in Mascot database are listed in Table 3.23 and Table 3.26. The 
taxonomy “Rattus” was chosen as search parameter in Mascot database for the analysis of 
RBM (for details see 3.9). Therefore, the column “accession” reflects the taxonomy database 
in which the protein was found, namely “RAT”, besides the information about the the 
identified protein subunit as listed in UniProt database. For significant MS results, the 
“Mascot Score” for “Rattus” has to be greater than 52 (p<0.05). MS/MS results are significant 
when verifying the MS result. The abbreviations used in column “tissue” are Cer = 
cerebellum, Hip = hippocampus and Cbrum = Cerebrum. They indicate from which brain area 
the identified protein spots originated. 
 
Four subunits of CI were identified and assigned to 13 proteins spots, of which seven spots 
were identically identified for all brain areas and five identical for cerebellum and cerebrum 
(Table 4.16). These five spots gave no result for the analysed hippocampus samples. Only one 
protein spot was identified unique for cerebellum, while respective spots of hippocampus and 
cerebrum mitochondria gave no results. 
Fig. 4.17: Cerebrum
RBM: 2D-gel for PMF 
analysis, 200 µg 
(b. sol. d/p: 8g/g) pro-
teins of RBM from cer-
ebrum were separated 
by 2D-BN/SDS PAGE 
and analysed accord-
ing to 3.9. The image 
of the CBBG stained 
BN gel lane was ar-
ranged horizontally 
above the image of the 
silver stained second 
dimensional SDS gel, 
for assignment of 
bands. Masses of LMW 
were marked. Identified 
spots were marked in 
colour as depicted in 
the legend. Protein 
spots marked in black 
were not identified by
PMF of this brain area, 
but identified for at 
least one of the other 
areas or assigned by 
comparison with the 
standard BHM or the 
publication of 
Reifschneider et al. 
(2006)  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, 
d = I1III2IV3 
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Table 4.16: RBM: identified subunits of CI 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
Cer MS DDZ NDUS1_RAT 
NADH-ubiquinone 
oxidoreductase  
75 kDa subunit, mitochondrial  
OS=Rattus norvegicus 
GN=Ndufs1  
PE=1 SV=1 
79.4 
216.0 29 33.4 
Cer MS/MS DDZ NDUS1_RAT 44.5 1 1.2 
Hip MS DDZ NDUS1_RAT 116.0 20 34.9 
Hip MS/MS DDZ NDUS1_RAT 41.6 1 2.2 
Cbrum MS DDZ NDUS1_RAT 62.7 15 22.8 
Cer MS DDZ NDUS1_RAT 190.0 25 40.6 
Cer MS DDZ NDUS1_RAT 94.8 9 15.7 
Cer MS TUD NDUS1_RAT 75.0 13 26.0 
Hip MS DDZ NDUS1_RAT 155.0 25 44.7 
Hip MS/MS DDZ NDUS1_RAT 43.9 1 2.2 
Cbrum MS DDZ NDUS1_RAT 138.0 26 36.3 
Cer MS DDZ NDUS1_RAT 159.0 15 21.3 
Hip MS DDZ NDUS1_RAT 163.0 24 36.2 
Hip MS/MS DDZ NDUS1_RAT 39.1 1 2.6 
Cbrum MS DDZ NDUS1_RAT 108.0 18 29.2 
Cer MS DDZ NDUS1_RAT 152.0 14 20.8 
Cer MS/MS DDZ NDUS1_RAT 29.8 1 1.2 
Hip MS DDZ NDUS1_RAT 79.6 18 27.6 
Cbrum MS DDZ NDUS1_RAT 58.1 13 22.0 
Cer MS DDZ NDUS2_RAT 
NADH dehydrogenase 
[ubiquinone]  
iron-sulfur protein 2, 
mitochondrial  
OS=Rattus norvegicus 
GN=Ndufs2  
PE=1 SV=1 
52.5 
116.0 22 48.4 
Cer MS/MS DDZ NDUS2_RAT 44.3 1 1.9 
Hip MS DDZ NDUS2_RAT 121.0 23 42.1 
Hip MS/MS DDZ NDUS2_RAT 45.7 1 1.9 
Cbrum MS DDZ NDUS2_RAT 110.0 19 33.5 
Cer MS DDZ NDUS2_RAT 183.0 28 61.1 
Cer MS DDZ NDUS2_RAT 146.0 18 32.2 
Cbrum MS DDZ NDUS2_RAT 81.7 18 29.8 
Cer MS DDZ NDUS2_RAT 76.7 10 19.9 
Cer MS/MS DDZ NDUS2_RAT 87.5 3 9.7 
Cbrum MS DDZ NDUS2_RAT 102.0 21 34.3 
Cer MS DDZ NDUS2_RAT 59.8 9 19.9 
Cbrum MS DDZ NDUS2_RAT 59.7 12 20.5 
Cer MS DDZ NDUA9_RAT 
NADH dehydrogenase 
[ubiquinone]  
1 alpha subcomplex subunit 9,  
mitochondrial  
OS=Rattus norvegicus 
GN=Ndufa9  
PE=1 SV=2 
42.5 
82.6 9 18.6 
Hip MS DDZ NDUA9_RAT 82.9 13 33.7 
Hip MS/MS DDZ NDUA9_RAT 45.3 1 3.4 
Cbrum MS DDZ NDUA9_RAT 136 18 42.4 
Cer MS DDZ NDUA9_RAT 126.0 13 27.3 
Cer MS/MS DDZ NDUA9_RAT 73.5 1 3.4 
Hip MS DDZ NDUA9_RAT 208.0 18 49.9 
Cbrum MS DDZ NDUA9_RAT 163.0 21 48.5 
Cer MS DDZ NDUA9_RAT 130.0 18 40.8 
Cer MS/MS DDZ NDUA9_RAT 42.6 1 2.4 
Cbrum MS DDZ NDUA9_RAT 105.0 15 38.7 
Cer MS DDZ NDUA9_RAT 126.0 17 46.4 
Cer MS/MS DDZ NDUA9_RAT 34.2 1 2.4 
Cer MS DDZ NDUAA_RAT 
NADH dehydrogenase 
[ubiquinone] 1 alpha subcom-
plex subunit 10, mitochondrial 
OS=Rattus norvegicus 
GN=Ndufa10 PE=1 SV=1 
40.5 
77.8 13 47.6 
Cbrum MS DDZ NDUAA_RAT 83.5 10 36.3 
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Only one subunit of CII could be identified. Mitochondrial succinate dehydrogenase 
[ubiquinone] flavoprotein subunit (DHSA) was found for spot no. 49 of all brain areas (Table 
4.17). 
Table 4.17: RBM: identified subunits of CII 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
49 
Cer MS DDZ DHSA_RAT Succinate dehydrogenase 
[ubiquinone] flavoprotein 
subunit, mitochondrial 
OS=Rattus norvegicus 
GN=Sdha PE=1 SV=1 
71.6 
181.0 23 31.7 
Cer MS/MS DDZ DHSA_RAT 31.2 1 1.8 
Hip MS DDZ DHSA_RAT 117.0 19 28.0 
Cbrum MS DDZ SDHA_RAT 125.0 19 26.8 
 
Three subunits of CIII were identified in seven spots, of which three spots were identically 
identified for all brain parts and one for both, cerebellum and hippocampus, and another one 
for both, cerebellum and cerebrum, and two spots only for hippocampus (Table 4.18).  
Table 4.18: RBM: identified subunits of CIII 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
16 
Cer MS DDZ QCR2_RAT 
Cytochrome b-c1 complex 
subunit 2, mitochondrial  
OS=Rattus norvegicus 
GN=Uqcrc2  
PE=1 SV=2 
48.4 
270.0 25 46.5 
Cer MS/MS DDZ QCR2_RAT 197.9 4 10.2 
Hip MS DDZ QCR2_RAT 143.0 19 45.1 
Hip MS/MS DDZ QCR2_RAT 38.5 1 3.5 
Cbrum MS DDZ QCR2_RAT 144.0 13 35.8 
Cbrum MS/MS DDZ QCR2_RAT 95.8 1 3.1 
17 
Cer MS DDZ QCR2_RAT 167.0 19 48.0 
Cer MS/MS DDZ QCR2_RAT 55.2 1 3.1 
Hip MS/MS DDZ QCR2_RAT 135.1 3 9.1 
Cbrum MS DDZ QCR2_RAT 116.0 16 40.7 
Cbrum MS/MS DDZ QCR2_RAT 96.6 1 3.1 
20 Hip MS DDZ QCR2_RAT 65.0 12 36.3 
21 
Cer MS DDZ QCR1_RAT 
Cytochrome b-c1 complex 
subunit 1, mitochondrial  
OS=Rattus norvegicus 
GN=Uqcrc1 PE=1 SV=1 
52.8 
54.2 8 16.0 
Hip MS DDZ QCR1_RAT 62.8 10 27.9 
22 
Cer MS DDZ QCR2_RAT Cytochrome b-c1 complex 
subunit 2, mitochondrial  
OS=Rattus norvegicus 
GN=Uqcrc2 PE=1 SV=2 
48.4 
198.0 17 42.5 
Cer MS DDZ QCR2_RAT 162.0 16 36.1 
Cbrum MS DDZ QCR2_RAT 68.3 11 33.0 
23 Hip MS DDZ QCR1_RAT 
Cytochrome b-c1 complex 
subunit 1, mitochondrial  
OS=Rattus norvegicus 
GN=Uqcrc1 PE=1 SV=1 
52.8 119.0 15 24.2 
24 
Cer MS DDZ QCR2_RAT 
Cytochrome b-c1 complex 
subunit 2, mitochondrial  
OS=Rattus norvegicus 
GN=Uqcrc2 PE=1 SV=2 
48.4 
189.0 16 36.9 
Cer MS TUD QCR2_RAT 70.0 7 20.0 
Hip MS DDZ QCR2_RAT 111.0 10 25.9 
Hip MS/MS DDZ QCR2_RAT 53.4 1 3.1 
Cbrum MS DDZ QCR2_RAT 118.0 17 41.6 
Cbrum MS/MS DDZ QCR2_RAT 75.8 1 3.1 
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Three subunits of CIV were found in three protein spots. Only one of these spots was 
identified for two brain areas, cerebellum and hippocampus, while the other two were only 
identified for one brain area each. One of the identified subunits, COX2, is encoded by 
mtDNA (Table 4.19).  
Table 4.19: RBM: identified subunits of CIV 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
50 Hip MS/MS DDZ COX2_RAT 
Cytochrome c oxidase subunit 
2 OS=Rattus norvegicus 
GN=Mtco2 PE=2 SV=2 
25.9 24.2 1 7.5 
53 
Cer MS DDZ COX41_RAT 
Cytochrome c oxidase subunit 
4 isoform 1, mitochondrial 
OS=Rattus norvegicus 
GN=Cox4i1 PE=1 SV=1 
19.5 
96.3 12 58.6 
Cer MS DDZ COX41_RAT 73.7 6 38.5 
Hip MS DDZ COX41_RAT 142.0 14 66.3 
Hip MS/MS DDZ COX41_RAT 31.0 1 6.5 
54 Cer MS/MS DDZ COX5A_RAT 
Cytochrome c oxidase subunit 
5A, mitochondrial OS=Rattus 
norvegicus GN=Cox5a PE=1 
SV=1 
16.1 27.2 1 11.6 
 
Six subunits from CV were identified in 15 spots (Table 4.20). Six of these protein spots were 
identified for all three brain areas, while three of them were identified for cerebellum and 
hippocampus, two for cerebellum and cerebrum, one for hippocampus and cerebrum, and the 
remaining spots only for one brain area. In spot no. 39, the subunits O (ATPO) and d 
(ATP5H) were identified. Their protein spots seem to overlap, as both subunits are, besides 
subunits b and F6, part of the peripheral stalk of ATP synthase (Papa et al. 2012).  
Table 4.20: RBM: identified subunits of CV 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
02 
Cer MS DDZ ATPA_RAT ATP synthase subunit alpha, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5a1 PE=1 
SV=2 
59.7 
269.0 24 39.1 
Cer MS/MS DDZ ATPA_RAT 132.6 3 6.1 
Hip MS/MS DDZ ATPA_RAT 89.2 2 4.2 
03 
Cer MS DDZ ATPB_RAT 
ATP synthase subunit beta, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5b PE=1 
SV=2 
56.3 
116.0 23 40.3 
Cer MS/MS DDZ ATPB_RAT 202.9 3 8.5 
Hip MS DDZ ATPB_RAT 74.9 15 37.2 
Hip MS/MS DDZ ATPB_RAT 56.4 1 3.6 
Cbrum MS DDZ ATPB_RAT 69.3 10 19.8 
10 
Cer MS DDZ ATPA_RAT 
ATP synthase subunit alpha, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5a1 PE=1 
SV=2 
59.7 
119.0 17 31.5 
Cer MS/MS DDZ ATPA_RAT 34.3 1 2.4 
Cer MS DDZ ATPA_RAT 130.0 22 45.6 
Cer MS DDZ ATPA_RAT 61.2 12 25.9 
Hip MS DDZ ATPA_RAT 196.0 31 51.9 
Hip MS/MS DDZ ATPA_RAT 41.1 1 2.7 
Cbrum MS DDZ ATPA_RAT 162.0 17 35.6 
11 
Cer MS DDZ ATPB_RAT ATP synthase subunit beta, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5b PE=1 
SV=2 
56.3 
235.0 28 62.2 
Cer MS/MS DDZ ATPB_RAT 350.3 4 12.3 
Hip MS/MS DDZ ATPB_RAT 39.6 1 2.6 
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Table 4.21: RBM: identified subunits of CV (continued) 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
12 
Cer MS DDZ ATPA_RAT 
ATP synthase subunit alpha, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5a1 PE=1 
SV=2 
59.7 
132.0 18 31.6 
Cer MS/MS DDZ ATPA_RAT 33.8 1 2.4 
Cer MS DDZ ATPA_RAT 107.0 17 33.3 
Cer MS DDZ ATPA_RAT 94.0 16 29.8 
Hip MS DDZ ATPA_RAT 211.0 28 51.0 
Hip MS/MS DDZ ATPA_RAT 43.5 1 3.8 
Cbrum MS DDZ ATPA_RAT 91.4 10 19.7 
13 
Cer MS DDZ ATPB_RAT 
ATP synthase subunit beta, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5b PE=1 
SV=2 
56.3 
252.0 34 62.2 
Cer MS/MS DDZ ATPB_RAT 403.3 5 12.9 
Hip MS DDZ ATPB_RAT 197.0 27 50.5 
Hip MS/MS DDZ ATPB_RAT 59.3 1 2.8 
Cbrum MS DDZ ATPB_RAT 86.3 10 22.9 
31 Cer MS DDZ ATPG_RAT 
ATP synthase subunit gamma, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5c1 PE=1 
SV=2 
30.2 
136 13 42.9 
32 Cer MS/MS DDZ ATPG_RAT 40.4 1 3.7 
33 
Cer MS DDZ ATPG_RAT 170.0 18 48.4 
Cer MS DDZ ATPG_RAT 86.4 11 36.6 
Hip MS DDZ ATPG_RAT 71.7 8 22.7 
Hip MS/MS DDZ ATPG_RAT 39.6 1 5.5 
Cbrum MS DDZ ATPG_RAT 66.5 9 31.5 
Cbrum MS/MS DDZ ATPG_RAT 72.0 1 4.4 
35b 
Cer MS DDZ AT5F1_RAT 
ATP synthase subunit b, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5f1 PE=1 
SV=1 
28.9 
106.0 16 35.5 
Cer MS/MS DDZ AT5F1_RAT 39.5 1 3.1 
Cer MS DDZ AT5F1_RAT 61.2 5 19.1 
Hip MS DDZ AT5F1_RAT 86.1 13 36.3 
Hip MS/MS DDZ AT5F1_RAT 69.4 1 3.1 
Cbrum MS DDZ AT5F1_RAT 82.6 13 27.3 
39 
Cer MS DDZ ATP5H_RAT 
ATP synthase subunit d, mito-
chondrial OS=Rattus norve-
gicus GN=Atp5h PE=1 SV=3 
18.8 80.9 8 47.8 
Cer MS DDZ ATPO_RAT ATP synthase subunit O, mito-
chondrial OS=Rattus norve-
gicus GN=Atp5o PE=1 SV=1 
23.4 
69.1 10 52.6 
Cer MS DDZ ATPO_RAT 55.5 5 29.1 
Hip MS DDZ ATPO_RAT 68.9 12 48.4 
Hip MS DDZ ATP5H_RAT 
ATP synthase subunit d, mito-
chondrial OS=Rattus norve-
gicus GN=Atp5h PE=1 SV=3 
18.8 58.7 8 55.3 
Hip MS/MS DDZ ATPO_RAT 
ATP synthase subunit O, mito-
chondrial OS=Rattus norve-
gicus GN=Atp5o PE=1 SV=1 
23.4 34.3 1 6.6 
40 
Hip MS DDZ AT5F1_RAT ATP synthase subunit b, mito-
chondrial OS=Rattus norve-
gicus GN=Atp5f1 PE=1 SV=1 
28.9 
62.3 7 27.7 
Hip MS/MS DDZ AT5F1_RAT 73.2 1 3.1 
Cbrum MS DDZ AT5F1_RAT 105.0 21 41.8 
41 Cer MS DDZ ATPO_RAT 
ATP synthase subunit O, mito-
chondrial OS=Rattus norve-
gicus GN=Atp5o PE=1 SV=1 
23.4 57.3 5 29.1 
44 
Cer MS DDZ ATPA_RAT ATP synthase subunit alpha, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5a1 PE=1 
SV=2 
59.7 
185.0 19 26.9 
Cer MS/MS DDZ ATPA_RAT 65.9 2 5.2 
Cbrum MS DDZ ATPA_RAT 157.0 23 47.2 
46 
Cer MS DDZ ATPB_RAT ATP synthase subunit beta, 
mitochondrial OS=Rattus 
norvegicus GN=Atp5b PE=1 
SV=2 
56.3 
89.5 13 27.2 
Cer MS/MS DDZ ATPB_RAT 143.4 3 9.1 
Cbrum MS DDZ ATPB_RAT 64.5 13 23.4 
Cbrum MS/MS DDZ ATPB_RAT 71.6 1 2.6 
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Four proteins of the TCA cycle were identified and listed in Table 4.22. Mitochondrial 
aconitase (ACON) was found for all brain areas, while citrate synthase (CISY) was identified 
in cerebellum and hippocampus, and malate dehydrogenase (MDHM) and 2-oxoglutarate 
dehydrogenase (ODO1) only for one brain area.  
The chemical reactions of the TCA cycle take place in the mitochondrial matrix and can be 
divided into eight steps, where acetyl residues are oxidised into carbon dioxide, while energy-
rich compounds as reduced nicotinamide adenine dinucleotide (NADH), hydroquinone form 
of flavin adenine dinucleotide (FADH2) and guanosine-5'-triphosphate (GTP) are formed. 
Each of the eight steps is catalysed by an enzyme, four of whom were identified.  
CISY catalyses the first step of the TCA cycle, in which the acetyl residue of acetyl 
coenzyme A (CoA) is transferred to oxaloacetate together with water to form citric acid. 
ACON catalyses the second step, where citrate is isomerised into iso-citrate via the 
intermediate cis-aconitate. The fourth enzyme of the TCA cycle is the oxoglutarate 
dehydrogenase complex (or α-ketoglutarate dehydrogenase complex), which is assembled of 
three subunits: oxoglutarate dehydrogenase (ODO1), dihydrolipoyl succinyltransferase and 
dihydrolipoyl dehydrogenase (DLDH, Table 4.23). The oxoglutarate dehydrogenase complex 
catalyses the oxidative decarboxylation of α-ketoglutarate into succinyl-CoA, while NAD+ is 
reduced to NADH+H+. MDHM catalyses the last step of the TCA cycle and completes the 
circuit. Hereby malate is oxidised into oxaloacetate and NAD+ is reduced to NADH+H+. 
(Voet et al. 2002) 
 
Table 4.22: RBM: identified proteins of TCA cycle 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
57 Cbrum MS DDZ MDHM_RAT 
Malate dehydrogenase, mito-
chondrial OS=Rattus norve-
gicus GN=Mdh2 PE=1 SV=2 
35.7 63.5 10 36.4 
60 
Cer MS DDZ CISY_RAT 
Citrate synthase, mitochondrial 
OS=Rattus norvegicus GN=Cs 
PE=1 SV=1 
51.8 
61.0 10 22.7 
Cer MS/MS DDZ CISY_RAT 76.5 1 2.4 
Hip MS DDZ CISY_RAT 104.0 20 30.9 
Hip MS/MS DDZ CISY_RAT 61.4 1 2.1 
63 
Cer MS DDZ ACON_RAT 
Aconitate hydratase, 
mitochondrial OS=Rattus 
norvegicus GN=Aco2 PE=1 
SV=2 
85.4 
136.0 19 25.5 
Cer MS/MS DDZ ACON_RAT 49.3 1 2.1 
Hip MS DDZ ACON_RAT 135.0 24 35.8 
Hip MS/MS DDZ ACON_RAT 50.8 1 2.1 
Cbrum MS DDZ ACON_RAT 117.0 20 34.2 
84 Cer MS DDZ ODO1_RAT 
2-oxoglutarate dehydrogenase, 
mitochondrial OS=Rattus 
norvegicus GN=Ogdh PE=1 
SV=1 
116.2 55.2 9 11.2 
 
 
The protein spots 71 (cerebellum) and 82 (hippocampus) could be assigned to dihydrolipoyl 
dehydrogenase (DLDH), a common component (E3) of three alpha-ketoacid dehydrogenase 
complexes, which oxidise pyruvate (pyruvate dehydrogenase complex), α-ketoglutarate (α-
ketoglutarate dehydrogenase complex) and the branched-chain α-ketoacids (branched-chain 
amino acid-dehydrogenase complex) (Carothers et al. 1989). Thereby it is involved in 
glycolysis and the TCA cycle and therefore was marked in brown and purple (Table 4.23).  
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Table 4.23: RBM: identified proteins, occurring in TCA cycle and glycolysis 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
Cer MS DDZ DLDH_RAT 
Dihydrolipoyl dehydrogenase, 
mitochondrial OS=Rattus 
norvegicus GN=Dld PE=1 
SV=1 
54.0 
86.6 11 27.3 
Cer MS DDZ DLDH_RAT 73.4 9 24.6 
Cer MS DDZ DLDH_RAT 61.5 12 21.8 
Hip MS DDZ DLDH_RAT 67.9 12 36.0 
Hip MS/MS DDZ DLDH_RAT 41.1 1 3.7 
 
Two proteins involved in the metabolic pathway “glycolysis”, which takes place in the 
cytosol, were identified and listed in Table 4.24. ALDOA/C are found in brain and catalyse 
the fragmentation of fructose-1,6-bisphosphate into dihydroxyacetone phosphate and 
glyceraldehyde 3-phosphate in glycolysis. KPYM transfers a phosphate residue from 
phosphoenolpyruvate to ADP, resulting in ATP and pyruvate. The latter is transported by 
carriers into the mitochondrial matrix, where it is converted into acetyl-CoA by the pyruvate 
dehydrogenase complex (Table 4.23).(Voet et al. 2002) 
 
Table 4.24: RBM: identified proteins of glycolysis 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
67 Hip MS DDZ KPYM_RAT 
Pyruvate kinase isozymes 
M1/M2 OS=Rattus norvegicus 
GN=Pkm PE=1 SV=3 
57.8 60.5 12 29.6 
73 
Hip MS DDZ ALDOA_RAT Fructose-bisphosphate aldolase 
A OS=Rattus norvegicus 
GN=Aldoa PE=1 SV=2 
39.3 
88.8 11 29.7 
Hip MS/MS DDZ ALDOA_RAT 36.9 1 3.3 
Hip MS DDZ ALDOC_RAT Fructose-bisphosphate aldolase 
C OS=Rattus norvegicus 
GN=Aldoc PE=1 SV=3 
39.3 
84.3 11 28.4 
Cbrum MS DDZ ALDOC_RAT 107.0 16 43.0 
Cbrum MS DDZ ALDOA_RAT 
Fructose-bisphosphate aldolase 
A OS=Rattus norvegicus 
GN=Aldoa PE=1 SV=2 
39.3 99.2 13 35.7 
 
 
Four proteins involved in stress management of the cell were identified and listed in Table 
4.25. In protein spot no. 43, the heat shock protein CH60 seems to overlap with the excitatory 
amino acid transporter (EAA1), both were identified there, but EAA1 with a lower score than 
CH60. EAA1 is a sodium-dependent glutamate/aspartate transporter, located at the synaptic 
cleft and found in cerebellum and cerebrum (Storck et al. 1992). The 78 kDa glucose-
regulated protein (GRP78) is a heat shock protein, which is associated with the endoplasmatic 
reticulum (ER). The protein disulfide-isomerase A4 (PDIA4) rearranges disulfide bonds in 
proteins and is likewise associated with the ER (both UniProt databases). Protein disulfide-
isomerases A1 and A3 as well as GRP78 are associated with mitochondria-associated ER 
membranes (MAM) (Schon and Area-Gomez 2013). Therefore it is supposable that A4 is 
associated with MAMs too.  
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Table 4.25: RBM: identified proteins of stress management 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
43 
Cer MS DDZ CH60_RAT 
60 kDa heat shock protein, mi-
tochondrial OS=Rattus norve-
gicus GN=Hspd1 PE=1 SV=1 
60.9 109.0 14 26.7 
Cer MS DDZ EAA1_RAT Excitatory amino acid trans-
porter 1 OS=Rattus norvegicus 
GN=Slc1a3 PE=1 SV=2 
59.7 
105.0 15 18.2 
Cer MS/MS DDZ EAA1_RAT 77.2 2 6.4 
Cer MS/MS DDZ EAA1_RAT 100.4 2 6.4 
Cbrum MS DDZ CH60_RAT 60 kDa heat shock protein, mi-
tochondrial OS=Rattus norve-
gicus GN=Hspd1 PE=1 SV=1 
60.9 
77.6 16 32.6 
Cbrum MS/MS DDZ CH60_RAT 124.1 2 7.5 
Cbrum MS DDZ EAA1_RAT 
Excitatory amino acid trans-
porter 1 OS=Rattus norvegicus 
GN=Slc1a3 PE=1 SV=2 
59.7 56.6 12 20.4 
68 
Cer MS DDZ CH60_RAT 60 kDa heat shock protein, 
mitochondrial OS=Rattus 
norvegicus GN=Hspd1 PE=1 
SV=1 
60.9 
69.9 15 33.7 
Hip MS DDZ CH60_RAT 74.8 14 28.8 
Hip MS/MS DDZ CH60_RAT 88.6 1 4.4 
Cbrum MS DDZ CH60_RAT 110.0 20 39.8 
69 Cer MS DDZ PDIA4_RAT 
Protein disulfide-isomerase A4 
OS=Rattus norvegicus 
GN=Pdia4 PE=1 SV=2 
72.7 110.0 19 26.1 
70 
Cer MS DDZ GRP78_RAT 78 kDa glucose-regulated 
protein OS=Rattus norvegicus 
GN=Hspa5 PE=1 SV=1 
72.3 
217.0 29 51.4 
Cer MS/MS DDZ GRP78_RAT 54.1 1 2.6 
 
For cerebellum and hippocampus, two (alpha and beta) of three subunits from Na+/K+-
ATPase (UniProt databases) were identified and listed in Table 4.26. Na+/K+-ATPase 
transports actively three sodium ions out of the cell and imports simultaneously two 
potassium ions into the cell by splitting ATP into ADP and phosphate for this energy 
consuming step. Na+/K+-ATPase is necessary to maintain the resting potential of the nerve 
cells and consumes up to 70 % of the produced ATP (Voet et al. 2002).  
Table 4.26: RBM: identified protein spots of Na
+
/K
+
 ATPase 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
48 
Cer MS DDZ AT1A3_RAT Sodium/potassium-transporting 
ATPase subunit alpha-3 
OS=Rattus norvegicus 
GN=Atp1a3 PE=1 SV=2 
111.6 
83.6 26 30.3 
Cer MS/MS DDZ AT1A3_RAT 80.5 1 1.8 
Hip MS/MS DDZ AT1A3_RAT 61.1 1 1.8 
61 
Cer MS DDZ AT1B1_RAT Sodium/potassium-transporting 
ATPase subunit beta-1 
OS=Rattus norvegicus 
GN=Atp1b1 PE=1 SV=1 
35.2 
82.2 12 28.6 
Cer MS/MS DDZ AT1B1_RAT 73.1 2 7.2 
Hip MS/MS DDZ AT1B1_RAT 44.5 1 3.6 
 
Four other proteins were identified and listed in Table 4.27. Mitochondrial glutamate 
dehydrogenase (DHE3) catalyses the transformation of glutamate into α-ketoglutarate, as a 
precursor stage for the TCA cycle, as well as urea cycle, and is supposed to control the 
glutamate concentration on nerve terminals (Michaelis et al. 2011). Clathrin is involved in 
membrane trafficking by endocytosis. It stabilises by formation of clathrin coated vesicles at 
Golgi apparatus as well as at synapses (Voet et al. 2002). For spot no. 58 from hippocampus 
mitochondria, different subunits of tubulin were found and listed in order of the Mascot score. 
Tubulin is the major part of microtubules, which are part of the cytoskeleton of the cell. They 
are involved in transport of organelles as mitochondria (Koolman et al. 2003). Syntaxin-
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binding protein 1 (STXB1) is associated with the regulation of synaptic vesicle docking and 
fusion (UniProt databases).  
Table 4.27: RBM: additionally identified proteins 
spot 
no. 
tissue MS type accession protein 
MW 
[kDa] 
Mascot 
Score 
pep-
tides 
SC [%] 
01 
Cer MS DDZZ CLH1_RAT Clathrin heavy chain 1 
OS=Rattus norvegicus 
GN=Cltc PE=1 SV=3 
191.5 
154.0 24 13.9 
Cer MS/MS DDZ CLH1_RAT 79.9 2 1.8 
Cbrum MS DDZ CLH1_RAT 68.6 20 15.1 
45 
Cer MS DDZ DHE3_RAT 
Glutamate dehydrogenase 1, 
mitochondrial OS=Rattus 
norvegicus GN=Glud1 PE=1 
SV=2 
61.4 
142.0 16 28.9 
Cer MS/MS DDZ DHE3_RAT 172.4 2 6.6 
58 
Hip MS DDZ TBB2A_RAT 
Tubulin beta-2A chain 
OS=Rattus norvegicus 
GN=Tubb2a PE=1 SV=1 
49.9 136.0 20 46.1 
Hip MS DDZ TBB2B_RAT 
Tubulin beta-2B chain 
OS=Rattus norvegicus 
GN=Tubb2b PE=1 SV=1 
49.9 123.0 20 46.1 
Hip MS DDZ TBB4B_RAT 
Tubulin beta-4B chain 
OS=Rattus norvegicus 
GN=Tubb4b PE=1 SV=1 
49.8 113.0 19 39.8 
Hip MS DDZ TBB5_RAT 
Tubulin beta-5 chain 
OS=Rattus norvegicus 
GN=Tubb5 PE=1 SV=1 
49.6 101.0 19 40.5 
Hip MS DDZ TBB3_RAT 
Tubulin beta-3 chain 
OS=Rattus norvegicus 
GN=Tubb3 PE=1 SV=1 
50.4 95.2 18 33.1 
Hip MS DDZ TBA1A_RAT 
Tubulin alpha-1A chain 
OS=Rattus norvegicus 
GN=Tuba1a PE=1 SV=1 
50.1 79.5 15 41.7 
Hip MS DDZ TBA3_RAT 
Tubulin alpha-3 chain 
OS=Rattus norvegicus 
GN=Tuba3a PE=2 SV=1 
49.9 70.9 15 41.6 
Hip MS DDZ TBA1B_RAT 
Tubulin alpha-1B chain 
OS=Rattus norvegicus 
GN=Tuba1b PE=1 SV=1 
50.1 69.9 14 38.8 
Hip MS DDZ TBA1C_RAT 
Tubulin alpha-1C chain 
OS=Rattus norvegicus 
GN=Tuba1c PE=1 SV=1 
49.9 69.4 16 47.9 
Hip MS DDZ TBA8_RAT 
Tubulin alpha-8 chain 
OS=Rattus norvegicus 
GN=Tuba8 PE=2 SV=1 
50.0 60.9 14 37.2 
62 
Cbrum MS DDZ STXB1_RAT Syntaxin-binding protein 1 
OS=Rattus norvegicus 
GN=Stxbp1 PE=1 SV=1 
67.5 
78.5 18 33.2 
Cbrum MS/MS DDZ STXB1_RAT 74.5 2 4.4 
 
As already found for BHM, also for RBM not all of the identified proteins are currently 
proposed mitochondrial (membrane) proteins. This is in line with the isolation of crude 
mitochondrial fraction from tissue (3.1). But most of the identified proteins are associated 
with energy metabolism, involved in stress management or are part of the processes at 
synapses.  
Of more than 80 known subunits of OxPhos complexes 16 subunits were identified for RBM 
and 17 for BHM in this thesis. 
For the in Fig. 4.18A assigned OxPhos complexes or the different metabolic pathways or 
other assigned proteins in Fig. 4.18B, the total number of identified protein spots of RBM was 
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depicted as well as the number of spots identically identified in different rat brain areas. For 
this it was differentiated whether the spots were identified for all brain areas (cerebellum, 
hippocampus, cerebrum) or two of them or only for one area.  
For OxPhos complexes (Fig. 4.18A), most of the spots were identically identified in two or 
more brain areas. 17 of 39 were found in all three areas and 13 in two areas. Eight spots were 
found in just one brain area, while respective spots of the other areas gave no result. The 
identification of only one spot of CV (no. 39) resulted in two different subunits (d and O), 
which belong both to the peripheral stalk of ATP synthase. 
According to Fig. 4.18B, only a few spots originating from proteins of metabolic pathways or 
other proteins were found in more than one brain area. Of 18 identified spots in total, seven 
were identically identified in two or three brain areas. The identification of only one protein 
spot (no. 43, stress management of the cell) resulted in two possible proteins (CH60 or 
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Fig. 4.18: Number of identically identified protein spots by PMF for the different rat brain areas. The 
total number of identified spots for the assigned OxPhos complex or for each assigned metabolic pathway 
was calculated. The number of spots was determined, which were identical in all rat brain areas 
(cerebellum, hippocampus and cerebrum), in two of them or just identified in one area. Also, the number 
for not identical spots was plotted. A: spots belonging to OxPhos complexes, B: spots from different 
metabolic pathways: TCA cycle, glycolysis or proteins of cellular stress management and others.  
CI = complex I, CII = complex II, CIII = complex III, CIV = complex IV, CV = complex V 
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EAA1), but for both originating brain areas, most likely explained by an overlay of the protein 
spots in the 2D gel.  
In total, 13 subunits of OxPhos complexes were identified identically for 26 protein spots 
compared to Reifschneider et al. (2006). Even, 13 additional protein spots in the 2D gel were 
assigned to the same subunits. Four extra subunits of OxPhos proteins were assigned for 
seven protein spots.  
From non-OxPhos proteins, ten subunits or proteins were identified identically to 
Reifschneider et al. (2006) and six additional subunits were found. However, the area of lower 
mass proteins in the 2D-BN/SDS gel (upper right corner) is difficult to assign, because of 
many very small, often smeared, protein spots, which are difficult to distinguish. Therefore 
the assignment has to be handled with care for this area.  
The identically identification of so many mitochondrial protein subunits all-over the 2D-
BN/SDS gel gives further evidence for the comparability of the migration pattern of those 
described by Reifschneider et al. (2006) to those of the three analysed brain areas. Additional 
spots (36, 42a, 51 and 54a) could be assigned by relating the previous results from PMF of 
RBM by Reifschneider et al. (2006) to the current results of RBM for further analysis such as 
quantitation. For CIII three additional spots were assigned: spot no. 36 as “Rieske Fe-S 
protein precursor” (NCBInr 206681) and spot no. 42a as “similar to ubichinone-cytochrome c 
oxidoreductase, binding protein” (NCBInr 34866011), both from Reifschneider et al. (2006). 
Spot no. 35a was assigned as “cytochrome b” (CYB) by comparison with the results from 
PMF of BHM (Table 4.10). For CIV one additional subunit was assigned for spot 54a as 
“cytochrome c oxidase subunit Via (85AA)” (NCBInr 818021). An additional spot, no. 51, 
was assigned as “lipophilin” (proteolipid protein) (NCBInr 206224), (both Reifschneider et al. 
(2006)). Lipophilin is a membrane protein and involved in formation of the myelin sheath 
(UniProt databases).  
Five subunits of OxPhos complexes of RBM were additionally identified by WB analyses 
(Fig. 4.19). For each applied antibody 40 µg (b. sol. d/p: 8g/g) RBM (cerebellum, OAL) were 
solubilised (3.3), separated by 2D-BN/SDS PAGE (3.5) and WB analysis (3.10). M. Sc. Olga 
Ankudin performed the analyses as contract work. Fig. 4.19A displays the image of a silver 
stained 10.0 cm by 10.5 cm sized performed 2D-BN/SDS gel after WB analysis. The image of 
the CBBG stained BN gel lane was attached horizontally above for assignment of bands 
respectively OxPhos complexes. The mass standard LMW was marked. The assigned protein 
spots are connected to the results of the WBs by coloured squares as in Fig. 4.19B-F. The 
subunits NDUS1 (CI, Fig. 4.19B), DHSA (CII, Fig. 4.19C), QCR2 (CIII, Fig. 4.19D), COX1 
(CIV, Fig. 4.19E) and alpha (CV, Fig. 4.19F) could be assigned and are in line with the 
findings of the PMF analysis (see current chapter). By comparison of Fig. 4.19 to Fig. 4.15, 
Fig. 4.16 and Fig. 4.17, NDUS1 could be assigned to spot no. 04, 05, 06 and 07, DHSA to no. 
49 and 81, QCR2 to no. 16, 17, 20, 22 and 24, COX1 to no. 29, 30 and 47 and alpha to no. 02, 
10 and 12.  
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Fig. 4.19: WB analysis of OxPhos complexes from RBM. 40 µg (b. sol. d/p: 8g/g) RBM (cerebellum, OAL) 
were separated by 2D-BN/SDS PAGE (10.0 cm by 10.5 cm sized gel) followed by WB analysis. .A: silver 
stained 2D-BN/SDS gel (after WB), B: WB, anti CI (NDUS1), C: WB, anti CII (DHSA), D: WB, anti CIII (QCR2), 
E: WB, anti CIV (COX1), F: WB, anti CV (alpha). A-F: The image of the CBBG stained BN gel lane was 
arranged horizontally above the images of gel and WBs for assignment of bands. LMW and MM were marked.  
A B 
C D 
E F 
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Provided that proteins of BHM and RBM show the same electrophoretic migration behaviour 
in 2D-BN/SDS gels, the results of WB analysis for BHM described by Decker (presumably 
2016) could be transferred to RBM samples, as well as the results from PMF (see above). 
When subunit COX1 from CIV of BHM is compared to RBM the protein spots 29, 30 and 47 
of RBM can be assigned to COX1. 
To compare the results of the protein spot identification of BHM to those of RBM, the 
number of identical protein spots for OxPhos complexes was analysed (Fig. 4.20).  
The number of all protein spots, 
which were identified for BHM 
and RBM, was plotted as “total 
spots” for each OxPhos 
complex in Fig. 4.20. The red 
bars depict, how many spots 
were identified identically for 
BHM and RBM. The number of 
not identically identified spots 
was also calculated and plotted 
in Fig. 4.20 for each complex. 
Only for two spots of CV the 
results did not match. These 
were spot no. 39 and no. 41. 
The identification of spot no. 39 
resulted in subunits O and d for 
RBM, both belonging to the 
peripheral stalk of ATP synthase, while the analysis of the same spot of BHM resulted only in 
subunit O. Spot no. 41 was identified as subunit O for RBM and subunit d for BHM. This 
reflects the close structural association of both subunits.  
To summarise, out of 22 identified protein spots in both samples (BHM and RBM) only two 
did not match, however originated from subunits of the same protein subunit. This provides 
evidence for the comparability of the protein migration pattern in 2D-BN/SDS gels of BHM 
to RBM. 
  
Fig. 4.20: Matching of identified protein spots from BHM to RBM 
for OxPhos complexes. The total number of corresponding identified 
protein spots of BHM and RBM was plotted for the OxPhos complexes. 
From these spots, the number of identical and non-identical spots was 
depicted. 
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4.2.4 Quantitation of protein amount in bands of CBBG stained BN gels 
Two different techniques have been used for quantitation of the amount of mitochondrial 
proteins in gels for years now. On the one hand, quantitation of mitochondrial proteins was 
performed by densitometric analysis of gel bands from BN PAGE, amongst others by 
Schagger (1995), Sabar et al. (2005), Gómez et al. (2009), Lombardi et al. (2009), Frenzel 
(2011) and Silvestri et al. (2015). On the other hand, quantitation of mitochondrial proteins 
was applied by densitometric examination of protein spots, equivalent to the subunits of the 
proteins, originating from 2D-BN/SDS PAGE, amongst others applied by Schagger (1995), 
Andringa et al. (2010), Frenzel (2011)and Verma et al. (2015). 
To compare those two techniques for quantitation of mitochondrial protein amount, bands of 
CBBG stained BN gels were analysed and compared (end of this chapter) to protein spot 
quantitation from 2D-BN/SDS gels (4.2.5). Please keep in mind that printed images differ 
from evaluated original grey scale images as described in 3.11. 
For each brain region (cerebellum, hippocampus and cerebrum), pooled mitochondria of the 
animal groups YAL, YCR, OAL and OCR were solubilised with a ratio of 8 g digitonin per 
1 g protein (d/p: 8g/g) (3.3.1). 100 µg before solubilisation (b. sol.) of mitochondrial protein 
were loaded per BN gel lane. 70 µg BHM (b. sol. d/p: 3g/g) and 3 µL HMW were loaded 
additionally to serve as standard. Three BN gels were performed as technical repeats as 
described in 3.4. After the run, they were stained with CBBG (3.7.2) and coloured and grey 
scale images were taken (3.7.3). The latter were quantitatively analysed (3.11.2). The bands of 
complexes I1IV2 and V2 could not be evaluated, because of their overlap in BN gel. The bars 
in the diagrams represent the mean of the technical repeats (n=3), the error bars the standard 
error. The grey units are given for each band respectively complex. Statistically significant 
changes are marked with asterisks. Black asterisks show age-related changes and red ones 
mark changes caused by calorie restriction. Significance levels are 0.05 (*) and 0.01 (**).  
The three entire gel images and the fused image for quantitation are shown in 
“7 Supplements”, Fig. 7.1 and Fig. 7.2, sections of the images in this chapter below. The 
OxPhos complexes and supercomplexes are marked in the images for BHM and for one rat 
brain sample, representatively for all rat brain samples. The allocation (Fig. 4.21, Fig. 4.23, 
Fig. 4.25) was carried out according to 4.2.3. The masses of HMW are labelled in orange.  
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Cerebellum 
In Fig. 4.21 the left section of one of the 
BN gel images is shown. The entire 
image (BN3) is attached in 
“7 Supplements”, Fig. 7.2. The separated 
mitochondrial proteins from cerebellum 
of the four groups (YAL, YCR, OAL, 
OCR) are visible. The standards BHM 
and HMW are also assigned. By eye, no 
pronounced differences in intensities 
between the four groups of cerebellum 
rat brain are visible. Only complex IV1 
seems to be more intense in old animals 
than in young ones. It is clearly visible 
that the standard BHM shows slightly 
different migration behaviour compared 
to the rat brain samples (see 4.2.3). 
Latter show identical migration 
behaviour. By eye, some of the bands 
cannot be exactly distinguished, but it is 
possible with the software Delta2D in 
the tool “Rollups 3D Spots” on the fused 
grey scale images. A figure of the fused 
image is attached in “7 Supplements”, 
Fig. 7.2. Concerning HMW (Table 3.6), 
the band at 232 kDa of catalase is 
missing or just weakly smeared visible, 
as already observed by members of our 
working group e.g. Thilmany (2013). Another fact is, that the (water soluble) standard 
proteins of HMW run faster through the gel (to lower masses), than the marked (membrane) 
complexes (4.2.3). 
For the cerebellum samples, the results of the quantitative evaluation (3.11.2 and 3.11.3) of 
the grey scale BN gel images are depicted in Fig. 4.22. In Fig. 4.22 it is observable for 
mitochondria of cerebellum that the protein amount decreases with age (black asterisks) of ad 
libitum fed animals (YAL vs. OAL) for complexes I1 (-28.5 % stat. high sig.), III2IV1 
(-15.7 % stat. sig.) and I1III2 (-19.5 %, stat. sig.) and for III2 (-10.4 %), I1III2IV2 (-19.8 %) and 
V1 (-9.2 %, all not stat. sig.). For aged animals under calorie restriction (YCR vs. OCR), a 
decrease is observable for supercomplexes III2IV1 (-10.0 %) and I1III2IV3 (-12.7 %, both not 
stat. sig.). In contrast to that, ageing in calorie restricted rats (YCR vs. OCR) increases the 
protein amount for complex IV1 (+29.5 %, stat. high sig.) and II1 (+18.9 %, not stat. sig.) and 
for I1III2IV1 (+7.7 %, not stat. sig.) from ad libitum fed rats (YAL vs. OAL).  
Short-term calorie restriction (YAL vs. YCR, red asterisks) decreases the protein amount of 
complex I1 (-21.9 %, stat. sig.) and in complexes I1III2 (-11.1 %), I1III2IV2 (-20.5 %) and V1 
(-12.2 %, all not stat. sig.). Long-term calorie restriction leads to decreased protein amount for 
Fig. 4.21: BN gel for quantification of protein amount
from RBM of cerebellum. From each cerebellum animal 
group (YAL, YCR, OAL, OCR) 100 µg mitochondrial proteins 
were solubilised with d/p: 8g/g and separated by BN PAGE, 
followed by CBBG staining. 70 µg (b. sol. d/p: 3g/g) BHM and 
HMW (marked in orange) served as standard, OxPhos 
complexes and supercomplexes are marked. a = I1III2, 
b = I1III2IV1, c = I1III2IV2, d = I1III2IV3. The vertical zig-zag
line indicates the intersection of the image. 
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complex I1III2IV1 (-9.7 %, stat. sig.), whereas the protein amount of complexes II1 (+15.0 %), 
IV1 (+12.6 %) and I1III2 (+12.5 %) increases (all stat. sig.).  
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Fig. 4.22: Cerebellum, protein amount (BN PAGE) From each 
cerebellum animal group (YAL, YCR, OAL, OCR) 100 µg (b. sol. 
d/p: 8g/g) mitochondrial proteins were separated by BN PAGE, 
followed by CBBG staining, grey scale images were analysed 
quantitatively.  
A, B and C show bar plots of the staining intensities (in grey units) of 
the different bands from OxPhos complexes. A: homooligomers, B: 
supercomplexes, C: ATP synthase 
bar plots: mean of technical repeats (n=3) 
error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; 
 YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, 
 (YAL vs. YCR; OAL vs. OCR) 
A 
B 
C 
III2IV1 I1  I1  I1  I1III2  
I1 1 2 1 2 
V1 
 4 Results and discussion 109 
Hippocampus 
In Fig. 4.23 the middle section of a BN gel 
(BN3) image is shown. The entire image is 
attached in “7 Supplements”, Fig. 7.2. The 
solubilised and separated mitochondrial 
protein samples of hippocampus are 
labelled in blue. The standards BHM and 
HMW (orange) are also marked. As 
already mentioned above for cerebellum 
samples, the standard BHM shows the 
same differences in migration behaviour 
compared to the RBM samples. By eye, 
there seems to be no difference between 
the intensities of the bands of the four 
animal groups of hippocampus RBM 
samples.  
In Fig. 4.24 quantitative results from the 
evaluation of the fused image (compare 
“7 Supplements”, Fig. 7.2) with Delta2D 
are shown (for details see 3.11.2, 3.11.3).  
As observable in Fig. 4.24 ageing (black 
asterisks) of ad libitum fed rats (YAL vs. 
OAL) increases the amount of mito-
chondrial protein from hippocampus for 
complexes II1 (+27.8 %), I1III2IV3 
(+24.7 %) and ATP synthase monomer V1 
(+15.7 %, all stat. sig.) and IV1 (+8.4 %), I1III2IV1 (+16.2 %) and I1III2IV2 (+22.4 %, all not 
stat. sig.).  
Ageing under conditions of calorie restriction (YCR vs. OCR) decreases the mitochondrial 
protein amount in hippocampus for the complexes II1 (-27.2 %), III2 (-13.8 %), IV1 (-27.5 %), 
and ATP synthase monomer V1 (-13.7 %, all stat. sig.), and for I1 (-20.3 %), IV2 (-16.3 %) 
and the supercomplexes I1III2IV1 (-6.2 %), I1III2IV2 (-17.5 %) and I1III2IV3 (-8.8 %, all not 
stat. sig.). 
Short-term calorie restriction (YAL vs. YCR, red asterisks, Fig. 4.24) increases the protein 
amount for III2 (+24.6 %), I1III2IV1 (+5.2 %), I1III2IV3 (+16.2 %) and ATP synthase 
monomer V1 (19.9 %, all stat. sig.) and for I1 (+17.4 %), II1 (+13.0 %), IV1 (+23.9 %), I1III2 
(+13.1 %) and I1III2IV2 (+16.5 %, all not stat. sig.).  
Long-term calorie restriction (OAL vs. OCR, red asterisks) reduces the protein amount in 
hippocampus as indicated for II1 (-35.6 %), IV1 (-17.1 %), the supercomplexes I1III2IV1 
(-15.1 %), I1III2IV2 (-21.5 %) and I1III2IV3 (-15.0 %) and ATP synthase monomer V1 
(-10.5 %, all stat. sig.), and for IV2 (-14.5 %) and III2IV1 (-7.7 %, both not stat. sig.). In 
Fig. 4.23: Hippocampus, BN gel for quantification of 
protein amount, from each hippocampus animal group 
(YAL, YCR, OAL, OCR) 100 µg mitochondrial proteins 
(b. sol. d/p: 8g/g) were separated by BN PAGE, followed 
by CBBG staining. 70 µg (b. sol. d/p: 3g/g) BHM and HMW 
(marked in orange) served as standard, OxPhos com-
plexes and supercomplexes are marked. a = I1III2, 
b = I1III2IV1, c = I1III2IV2, d = I1III2IV3. The vertical zig-zag
line indicates the intersection of the image. 
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contrast to that, exclusively the amount of I1III2 is increased (+8.7 %, not stat. sig.) during 
long-term calorie restriction. 
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Fig. 4.24: Hippocampus, protein amount (BN PAGE) 
From each hippocampus animal group (YAL, YCR, OAL, OCR) 
100 µg (b. sol. d/p: 8g/g) mitochondrial proteins were separated on 
BN PAGE, followed by CBBG staining, grey scale images were 
analysed quantitatively.  
A, B and C show bar plots of the staining intensities (in grey units) 
of the different bands from OxPhos complexes.  
A: homooligomers, B: supercomplexes, C: ATP synthase 
bar plots: mean of technical repeats (n=3) 
error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; 
 YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, 
 (YAL vs. YCR; OAL vs. OCR) 
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Cerebrum 
Cerebrum mitochondrial proteins were separated 
by BN PAGE. The right section of the image of 
the CBBG stained BN gel (BN3) is shown in Fig. 
4.25. The entire image is attached at 
“7 Supplements”, Fig. 7.2. The different animal 
groups are marked in red, the standards BHM and 
HMW (orange) are also labelled. As already 
described for cerebellum and hippocampus, the 
same shifts and running behaviour for BHM and 
HMW are visible. The running behaviour seems 
to be identical for the four different cerebrum 
animal groups. By eye, there are no visible 
changes in the intensity of the bands of the four 
different rat groups, only in the area above the 
supercomplex I1III2IV3 (=d) of OCR, the 
unknown higher bands seem to be more intense.  
The results of the quantitative evaluation of the 
band intensities from the fused image (see 
“7 Supplements”, Fig. 7.2) are depicted in Fig. 
4.26.  
In cerebrum of ad libitum fed animals (YAL vs. 
OAL) ageing (black asterisks) increases the 
protein amount of the complexes I1 (+45.0 %), III2 
(+33.8 %), III2IV1 (+31.2 %), I1III2IV2 (+27.6 %) 
and I1III2IV3 (+25.1 %), ATP synthase monomer 
V1 (+23.5 %, all stat. sig.) and for the complexes 
IV2 (+28.3 %), I1III2 (+36.1 %) and I1III2IV1 (+16.9 %, all not stat. sig.) according to Fig. 
4.26.  
For cerebrum of calorie restricted animals (YCR vs. OCR), the protein amount of I1 
(+34.8 %), III2 (+79.2 %), IV2 (+30.5 %), III2IV1 (+29.8 %), I1III2IV1 (+31.9 %), I1III2IV2 
(+52.3 %), I1III2IV3 (+77.1 %) and ATP synthase monomer V1 (+41.6 %) increase (all stat. 
sig.) with age (black asterisks), even for complex II1 (+21.1 %, not stat. sig.). In contrast to 
the observed increase in protein amount, only complex I1III2 decreases (-10.0 %, not stat. sig).  
According to short-term calorie restriction (YAL vs. YCR), the cerebrum protein amount of 
complex II1 (-23.7 %) is decreased (not stat. sig.), whereas for complex I1III2 (+33.4 %) an 
increased protein amount is observable (not stat. sig.). 
Long-term calorie restriction (OAL vs. OCR, red asterisks) leads to an increase of cerebrum 
protein amount for complexes III2 (+41.7 %), I1III2IV1 (+9.9 %), I1III2IV2 (+15.0 %), I1III2IV3 
(+27.1 %) and ATP synthase monomer V1 (+21.6 %, all stat. sig.) and for I1 (+10.0 %) and 
III2IV1 (+4.3 %, both not stat. sig.). Only complex I1III2 (-11.8 %) shows a decreased protein 
amount (stat. sig.).  
Fig. 4.25: Cerebrum, BN gel for quantification 
of protein amount, from each cerebrum animal 
group (YAL, YCR, OAL, OCR) 100 µg (b.  sol. 
d/p: 8g/g) mitochondrial proteins were separated 
by BN PAGE, followed by CBBG staining. 70 µg 
(b. sol. d/p: 3g/g) BHM and HMW (marked in 
orange) served as standard, OxPhos complexes 
and supercomplexes are marked. a = I1III2, 
b = I1III2IV1, c = I1III2IV2, d = I1III2IV3. 
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Fig. 4.26: Cerebrum, protein amount (BN PAGE) 
From each cerebrum animal group (YAL, YCR, OAL, OCR) 100 µg 
(b. sol. d/p: 8g/g) mitochondrial proteins were separated on BN 
PAGE, followed by CBBG staining, grey scale images were analysed 
quantitatively.  
A, B and C show bar plots of the staining intensities (in grey units) of 
the different bands from OxPhos complexes.  
A: homooligomers, B: supercomplexes, C: ATP synthase 
bar plots: mean of technical repeats (n=3) 
error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) asterisks in black: 
changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, 
 (YAL vs. YCR; OAL vs. OCR) 
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Summary 
Table 4.28 gives an overview of the quantitative results of the BN gel analysis as described 
above in the separate chapters for the different brain parts. For each tissue sample, the results 
for changes in age for ad libitum fed animals (AL: YAL vs. OAL) and under calorie 
restriction (CR: YCR vs. OCR) are presented as well as the effects of short-term (ST: YAL 
vs. YCR) and long-term (LT: OAL vs. OCR) calorie restriction. The arrows represent the 
increasing ( ) or decreasing ( ) protein amount for the compared animal groups as a 
summary of the findings. Both arrows are used in grey (not stat. sig.), orange (stat. sig.) and 
red (stat. high sig.). Black dashes ( ) were placed, where no variation could be examined. ▬
Main tendencies are described below. For more details, see the chapters about the different 
brain parts. 
In cerebellum it is observable that the protein amount is decreasing during ageing of ad 
libitum fed rats (Table 4.28). Calorie restriction during ageing increases the protein amount of 
specific homooligomers and decreases the amount of some supercomplexes. Short-term 
calorie restriction reduces the protein amount in cerebellum, while for animals under the 
influence of long-term calorie restriction the protein amount is mainly increased.  
In hippocampus the protein amount rises in ad libitum fed animals caused by ageing, whereas 
in calorie restricted animals the amount is decreased. Short-term calorie restriction causes 
increased protein amount in hippocampus but a decrease is observed for long-term calorie 
restriction.  
The cerebrum protein amount rises with age, independently from ad libitum or calorie 
restricted nutrition. The same tendency is visible for long-term calorie restriction. Short-term 
calorie restriction effects only complexes II1 ( ) and I1III2 ( ).  
In general, it is important to note, that changes occur in individual or homooligomeric 
complexes in the same way as in their oligomeric or supercomplex assemblies.  
Table 4.28: Overview of the changes in protein amount as observed in BN PAGE analysis 
figures entity 
Cerebellum Hippocampus Cerebrum 
AL CR ST LT AL CR ST LT AL CR ST LT 
4.22A 
4.24A 
4.26A 
I1   ▬   ▬  ▬    ▬    ▬  
II1  ▬   ▬       ▬    ▬
III2   ▬  ▬  ▬  ▬    ▬    ▬  
IV1  ▬   ▬       ▬  ▬  ▬  ▬
IV2  ▬  ▬  ▬  ▬  ▬   ▬     ▬  ▬
4.22B 
4.24B 
4.26B 
III2IV1    ▬  ▬  ▬  ▬  ▬     ▬  
I1III2   ▬    ▬  ▬       
I1III2IV1   ▬  ▬         ▬  
I1III2IV2   ▬   ▬        ▬  
I1III2IV3  ▬   ▬  ▬        ▬  
4.22C 
4.24C 
4.26C 
V1   ▬   ▬        ▬  
symbols: “ ”: increase, “ ”: decrease, “ “: no change;  ▬
colours of symbols: red: stat. high sig., orange: stat. sig., grey: not stat. sig. 
colours of shades:  pink: opposed to 2D analysis,  green: conform with 2D analysis, 
     turquoise: not included in 2D analysis 
abbrev.: AL: ad libitum, CR: calorie restriction, ST: short-term calorie restriction, LT: long-term 
calorie restriction  
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Comparison of quantitation of protein amount in BN gels and 2D-BN/SDS gels 
The results of the quantitative BN PAGE analysis (4.2.4) were compared to the results of 2D-
BN/SDS PAGE (4.2.5). When trends of changes in amount of protein from analysed BN gels 
conformed to analysis of 2D gels, they were shaded in green in Table 4.28. Opposed results 
were shaded in pink. Results, which were not shaded, did not contradict. There, the amount of 
protein remained unchanged for one of the analysis methods and the other showed a trend. 
Results shaded in turquoise were not included in 2D analysis, because the associated spots 
were not identified (4.2.3).  
Out of 108 comparable protein complexes for BN gel analysis and 2D-BN/SDS gel analysis, 
the trends of changes due to ageing and calorie restriction conformed in 47 cases. In 45 cases, 
the results did not contradict. However, in 16 cases the results were opposed. The opposed 
results differed in average by ∆ = 32.3 %, with a minimum of ∆ = 17.5 % and a maximum of 
∆ = 68.2 %. The quantified changes for ageing and calorie restriction are in the threshold of 
the average differences of the two methods. This would mean, that the quantified changes for 
both methods are not trustworthy. But there are some facts, which have to be considered, for 
decision which method is the appropriate for quantitation of proteins: 
- SyproRuby staining is more sensitive to the spot amount (Table 3.14, 4.1) than CBBG 
staining (-BN, +2D) 
- it is difficult to distinguish, whether a protein band from a BN gel contains only one 
protein or one protein complex or an undesired overlay of more than one (-BN, +2D) 
- provided that the protein band of a BN gel contains only one protein, it would be the whole 
protein and not only several subunits, which would be quantified finally (+BN, -2D) 
- the spots can be directly related to identified subunits of proteins in 2D gels, which would 
exclude the problem of overlaid proteins, provided that the quantitation of the subunit 
performs as like as the whole protein amount (-BN, +2D) 
- a more detailed analysis is possible in 2D gels, for example the performance of one 
complex in individual form can be compared to the performance of this complex in its 
different supercomplex assemblies (-BN, +2D) 
- the analysis of BN gels is less time consuming, than the analysis of 2D-BN/SDS gels 
(+BN, -2D) 
The disadvantages for BN gel analysis (-BN, +2D) predominate the advantages (+BN, -2D), 
especially the facts, that SyproRuby staining is more sensitive and that protein bands in BN 
gels could overlay, argue strongly against the method of BN gel analysis for quantitation of 
protein amount in BN gel bands.  
Therefore the results of 2D-BN/SDS PAGE are regarded as more trustworthy and used for 
evaluation of the changes by ageing and calorie restriction. 
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4.2.5 Quantitation of proteins spots by 2D-BN/SDS PAGE analysis 
As already described in 4.2.4, two different gel based techniques for protein quantitation have 
been used for publications about mitochondrial proteome changes. On the one hand, 
quantitation by densitometric analysis of gel bands from BN PAGE (4.2.4) and on the other 
hand, by densitometric examination of protein spots, equivalent to the subunits of the proteins 
originating from 2D-BN/SDS PAGE (details see 4.2.3).  
To compare those two techniques for quantitation of age and calorie restriction alterations in 
mitochondrial protein amount, bands of CBBG stained BN gels were analysed and compared 
(end of chapter 4.2.4) to protein spot quantitation from SYPRO® Ruby stained 2D-BN/SDS 
gels (see below). Please keep in mind that printed images differ from evaluated original grey 
scale images as described in 3.11. 
120 µg (b. sol. d/p: 8g/g, 3.3.1) mitochondrial proteins were separated by BN PAGE as 
described in 3.4. The lanes were cut and handled as in 3.5 to obtain 2D-BN/SDS gels, which 
were stained with SYPRO® Ruby and, after taking grey scale images (3.7.4), with silver. The 
images of the silver stained gels are depicted in “7 Supplements”, Fig. 7.3-Fig. 7.8. From each 
animal group (YAL, YCR, OAL, OCR) of cerebellum, hippocampus and cerebrum, 2D-
BN/SDS PAGE was performed in triplicates (n=3), resulting in 36 2D gels. Analysis of the 
data was performed with Delta2D and Excel (3.11.1, 3.11.3). For each animal group (YAL, 
YCR, OAL, OCR) the mean and the standard error of the spot intensities (relative grey units) 
of the technical repeats (n=3) were calculated and are shown as bar plots. Significant changes 
were marked with asterisks: * = p < α (0.05), ** = p < α (0.01). Asterisks in black show 
changes caused by ageing, (YAL vs. OAL; YCR vs. OCR), asterisks in red changes by calorie 
restriction, (YAL vs. YCR; OAL vs. OCR). The fused images are attached in 
“7 Supplements”, Fig. 7.9. Only identified spots (4.2.3) were used for quantitation of protein 
amount as marked in Fig. 4.27.  
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Spots were combined into entities, representing individual, homooligomeric and 
heterooligomeric OxPhos complexes and other mitochondrial proteins to compile bar plots, as 
described in Table 4.29.  
  
Fig. 4.27: Evaluated protein spots for quantitation (2D gels). Fused image (cerebellum) of 2D-BN/SDS gel 
images was taken as example. The image of the CBBG stained BN gel lane was arranged horizontally above the 
fused image, for assignment of bands (4.2.3). Spots are marked in different colours as specified in legend. Mass 
standard LMW is shown.  
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Table 4.29: Combined spots for bar plots (quantitation of 2D gel spots) 
figures entity examined subunits*1 spot no. 
4.28A 
4.36A 
4.44A 
I1 
NDUS1, 
NDUS2, 
NDUA9 
7, 19, 28 
I1IV2 6, 18, 27 
I1III2 5, 15, 26 
I1III2IV1 4, 14, 25 
total CI all identified 4, 5, 6, 7, 14, 15, 18, 19, 25, 26, 27, 28, 80 
4.28B 
4.36B 
4.44B 
III2 
QCR2 
24 
III2IV1 22 
III4 20 
I1III2 17 
I1III2IV1 16 
total CIII all identified 16, 17, 20, 21, 22, 23, 24, 35a, 36*2, 42a*2 
4.28C 
4.36C 
4.44C 
IV1 
COX1 
47*3 
IV2 30
*3 
III2IV1 29
*3 
total CIV all identified 29*3, 30*3, 47*3, 50, 53, 54, 54a*2 
4.29 
4.37 
4.45 
total III2IV1 all identified for III2IV1 21, 22, 29 
total I1III2 all identified for I1III2 5, 15, 17, 26 
total I1III2IV1 all identified for I1III2IV1 4, 14, 16, 25, 80 
4.30 
4.38 
4.46 
total CII all identified 49, 81 
4.31A 
4.39A 
4.47A 
total CV all identified 
02, 03, 10, 11, 12, 13, 31, 32, 33, 35b, 39, 
40, 41 
V1 all identified for V1 12, 13, 32, 33, 35b, 39 
V2 all identified for V2 10, 11, 31, 40, 41 
V3 all identified for V3 02, 03 
4.31B 
4.39B 
4.47B 
alpha all α subunits 02, 10, 12, 44 
beta all β subunits 03, 11, 13, 46 
alpha+beta all α + all β subunits 02, 03, 10, 11, 12, 13, 44, 46 
Fo portion all identified for Fo 35b, 40, 41, 39 
F1 portion α + β subunits for F1 44, 46 
4.32 
4.40 
4.48 
mtDNA encoded 
subunits 
CYB 35a 
COX2 50 
4.33 
4.41 
4.49 
Stress proteins 
CH60 43, 68 
PDIA4 69 
GRP78 70 
4.34A 
4.42A 
4.50A 
TCA cycle 
MDHM 57 
CISY 60 
ACON 63 
ODO1 84 
4.34B 
4.42B 
4.50B 
TCA cycle & 
Glycolysis 
DLDH 71, 82 
4.34C 
4.42C 
4.50C 
Glycolysis 
KPYM 67 
ALDOA/C 73 
4.35 
4.43 
4.51 
Na+/K+ ATPase AT1A3, AT1B1 48, 61 
lipophilin PLP1 51*2 
tubulin TBB2A 58 
syntaxinBP STXB1 62 
GLDH DHE3 45 
Assignment of spots: *
1
: by PMF, see 4.2.3  *
2
: by Reifschneider et al. (2006) *
3
: by WB analysis, see 4.2.3 
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Cerebellum 
In Fig. 4.28A the sum of the spot intensities of the CI subunits NADH-ubiquinone 
oxidoreductase 75 kDa subunit (NDUS1), NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 2 (NDUS2) and NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9 
(NDUA9) are plotted for the complexes I1, I1IV2, I1III2 and I1III2IV1 in comparison with the 
spot intensities for total CI. This enables to compare changes in amount of individual CI to 
supercomplex assemblies containing CI and to the sum of all identified spots containing CI 
(total CI). Detailed information about the spots (location and no.) are displayed in Fig. 4.27 
and Table 4.29 
For ad libitum nourished animals (YAL vs. OAL), there are no changes in amount of CI 
caused by ageing (black asterisks) in cerebellum (Fig. 4.28A). But the protein amount of CI is 
increased for old calorie restricted animals compared to young ones (YCR vs. OCR) for 
complexes I1 (+41.0 %), I1III2 (+21.0 %) and total CI (+23.7 %, all stat. sig.) and for complex 
I1IV2 (+64.8 %, not stat. sig.).   
Short-term calorie restriction (YAL vs. YCR, red asterisks) leads to a lower protein amount of 
CI for complexes I1 (-29.5 %) and I1III2 (-21.7 %, both stat. sig.) and for total CI (-14.4 %, not 
stat. sig.). Long-term calorie restriction (OAL vs. OCR, red asterisks) increases the protein 
amount of CI in I1IV2 (+49.5 %, not stat. sig.).  
Fig. 4.28B shows the spot intensities for the CIII subunit cytochrome b-c1 complex subunit 2 
(QCR2) for the homooligomeric complexes III2 and III4, and for the supercomplexes III2IV1, 
I1III2 and I1III2IV1 compared to the sum of the intensities of all identified spots of CIII (total 
CIII). This permits to compare the changes in CIII protein amount in individual complexes to 
supercomplexes versus the protein amount of total CIII.  
Ageing decreases the protein amount of CIII of ad libitum fed animals (YAL vs. OAL) for 
complexes III2 (-10.8 %), I1III2 (-10.9 %) and total CIII (-6.6 %, all not stat. sig.). In complex 
III2IV1 the protein amount of CIII increases (+10.1 %, not stat. sig.). Aged calorie restricted 
animals (YCR vs. OCR) show an increased protein amount for complexes III2IV1 (+21.7 %), 
I1III2 (+17.7 %) and for total CIII (+10.2 %, all not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR, red asterisks) reduces CIII protein amount for 
complexes III2 (-17.6 %), I1III2 (-20.9 %) and total CIII (-15.3 %, all stat. sig.) and for 
complex III2IV1 (-7.3 %, stat. high. sig.). Long-term calorie restriction (OAL vs. OCR, red 
asterisks) does not influence the protein amount.   
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Fig. 4.28: Cerebellum: protein amount in 2D spots for CI, CIII and CIV. A: The sum of the intensities of 
subunits NDUS1, NDUS2 and NDUA9 for individual complex I1 and supercomplexes are compared with the sum 
of the intensities of all identified subunits of CI (total CI); B: intensities of subunit QCR2 for complex III2 and 
supercomplexes are compared with the sum of the intensities of all identified subunits of CIII (total CIII); C:
intensities of subunit COX1 for homooligomeric complexes IV1 and IV2 and supercomplex III2IV1 are compared 
with the sum of the intensities of all identified subunits of total CIV.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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The spot intensities of cytochrome c oxidase subunit 1 (COX1) were plotted for analysis of 
the different complexes in homooligomeric form (IV1, IV2) and the supercomplex III2IV1 for 
comparison to the spot intensity of total CIV in Fig. 4.28C.  
Only for aged calorie restricted animals (YCR vs. OCR, black asterisk) the protein amount of 
CIV in cerebellum is for complex IV1 increased (+6.4 %, stat. high. sig.).  
For short-term (YAL vs. YCR, -12.4 %) and long-term (OAL vs. OCR, -4.9 %) calorie 
restriction, a declined protein amount (not stat. sig.) is observable for complex IV1 for both 
compared animal groups. 
 
The sum of the intensities in rel. grey units of all identified subunits for the supercomplexes 
III2IV1, I1III2 and I1III2IV1 are plotted in Fig. 4.29. Age-related differences can be observed 
for the protein amount of complex III2IV1, which rises (+11.3 %, not stat. sig.) in old ad 
libitum nourished rats (YAL vs. OAL). Old calorie restricted animals exhibit increase of 
protein amount (stat. sig.) in complexes III2IV1 (+20.7 %) and I1III2 (+19.9 %) during ageing 
(black asterisks, YCR vs. OCR). 
Decline of protein amount of supercomplexes I1III2 (-21.4 %, stat. high. sig.) and III2IV1 
(-5.8 %, not stat. sig.) is observable for short-term calorie restriction (YAL vs. YCR, red 
asterisk). Long-term calorie restriction (OAL vs. OCR) decreases the protein amount of 
supercomplex I1III2IV1 (-7.7 %, not stat. sig.).  
  
Fig. 4.29: Cerebellum: protein amount in 2D spots for supercomplexes containing 
CI, CIII and CIV. For each animal group, the sum of intensities (rel. grey units) of all 
identified subunits are plotted for the supercomplexes III2IV1, I1III2 and I1III2IV1.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Fig. 4.30 depicts the sum of 
the spot intensities in relative 
grey units for all identified 
subunits of CII in cerebellum 
mitochondria. No significant 
changes of the protein amount 
for any of the animal groups 
(YAL, YCR, OAL, OCR) 
caused by ageing or calorie re-
striction are observable.  
 
 
In Fig. 4.31A intensities of all identified spots of ATP synthase (total CV) are compared with 
homooligomeric assemblies of ATP synthases, monomer V1, dimer V2 and next higher 
homooligomer V3. The exact assembly of the next higher oligomer of ATP synthase is not 
clearly identified yet, it is assigned as trimer by Krause et al. (2005) or tetramer by Wittig and 
Schagger (2008). The large standard error for V3 of OAL is based on one divergent value of 
the technical repeats. 
Changes in ageing (black asterisks) are present only for calorie restricted animals (YCR vs. 
OCR) as increased protein amount for total CV (+15.9 %), V2 (+23.6 %) and V3 (+19.2 %, all 
stat. sig.), as well as for V1 (+10.3 %, not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR, red asterisk) decreases the protein amount for 
total CV (-12.2 %) and V1 (-9.9 %, not stat. sig.) and in V2 (-20.3 %, stat. sig.). Long-term 
calorie restriction (OAL vs. OCR) does not show any effect. 
Fig. 4.31B illustrates the spot intensities for ATP synthase’s subunits α, β, the sum α+β, for 
Fo and F1 portion. As expected, it is observable that α- and β-subunits show the similar 
distribution and intensities.  
Only for animals nourished with calorie restriction (YCR vs. OCR) ageing (black asterisks) 
leads to increased protein amount for subunits α+β (+17.0 %) and F1 portion (+29.4 %, both 
stat. sig.) and for individual subunit α (+17.8 %), individual subunit β (+16.3 %) and Fo 
portion (+16.5 %, all three not stat. sig.). 
Short-term calorie restriction (YAL vs. YCR, red asterisks) declines the protein amount of 
individual subunit α (-14.4 %) and the Fo portion (-10.7 %, both stat. sig.) and for all the other 
illustrated ATP synthase subunits, individual β (-14.0 %), the sum α+β (-14.2 %) and 
F1 portion (-17.5 %, all not stat. sig.). Long-term calorie restriction (OAL vs. OCR) increases 
the protein amount of F1 portion (+17.9 %, not stat. sig.).  
  
Fig. 4.30: Cerebellum: protein 
amount in 2D spots for CII. Sum 
of intensities in rel. grey units of total 
CII are presented for each animal 
group. 
bar plots:  
mean of technical repeats (n=3),  
error bars: 
standard error of technical repeats, 
significance: 
* = p < α (0.05); ** = p < α (0.01),  
asterisks in black:  
changes caused by ageing,  
(YAL vs. OAL; YCR vs. OCR) 
asterisks in red:  
changes caused by calorie restric-
tion, (YAL vs. YCR; OAL vs. OCR) 
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For analysis of the influences of ageing and calorie restriction on proteins encoded by the 
mtDNA, the spots for the identified subunits cytochrome b (CYB) of CIII and cytochrome c 
oxidase subunit 2 (COX2) of CIV were quantified. The result is shown in Fig. 4.32. Ageing 
(no black asterisks) seems to have no influences on the mtDNA encoded proteins in 
cerebellum, neither under ad libitum nutrition nor under calorie restriction. Short-term calorie 
restriction (YAL vs. YCR, red asterisk) decreases the CYB amount (-16.4 %, stat. sig.). 
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Fig. 4.31: Cerebellum: protein amount in 2D spots for CV, A: intensities of total ATP synthase (total 
CV) are compared with those of identified subunits of monomer (V1), dimer (V2) and homooligomer V3; the 
large standard error of V3 of OAL is due to one divergent value of the technical repeats. B: intensities (in 
rel. grey units) of ATP synthase‘s subunits α, β and α+β are plotted, as well as Fo and F1 portion. 
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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In Fig. 4.33, Fig. 4.34 and Fig. 4.35 the spot intensities (in rel. grey units) of 15 non-OxPhos 
proteins are depicted.  
In Fig. 4.33 the changes in amount of the mitochondrial 60 kDa heat shock protein (CH60), 
the protein disulfide-isomerase A4 (PDIA4) and the 78 kDa glucose-regulated protein 
(GRP78) are displayed for the different animal groups. They are involved in stress 
management of the cell. 
Ageing (black asterisks) decreases the protein amount only in calorie restricted animals (YCR 
vs. OCR) for CH60 (-13.6 %) and PDIA4 (-32.7 %, both stat. sig.) and also for GRP78 
(-9.5 %, not stat. sig.). Ad libitum fed animals show no changes of these stress proteins. 
Short-term calorie restriction (YAL vs. YCR, red asterisk) increases the protein amount of 
CH60 (+13.7 %, stat. sig.), PDIA4 (+12.4 %) and GRP78 (+42.6 %, not stat. sig.), while long-
term calorie restriction (OAL vs. OCR) has no effects on these stress proteins.  
 
In Fig. 4.34 spot intensities (in rel. grey units) of proteins from TCA cycle (Fig. 4.34A), one 
protein involved in TCA cycle and glycolysis, mitochondrial dihydrolipoyl dehydrogenase 
(DLDH) (Fig. 4.34B), and proteins involved in glycolysis (Fig. 4.34C) are depicted. In Fig. 
4.34A changes of the mitochondrial proteins from TCA cycle, malate dehydrogenase 
(MDHM), citrate synthase (CISY), aconitate hydratase (ACON) and 2-oxoglutarate dehydro-
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Fig. 4.33: Cerebellum: protein 
amount in 2D spots of proteins of 
cellular stress management. Inten-
sities in rel. grey units of diverse 
stress proteins are presented for 
each animal group. 
bar plots: mean of technical repeats 
(n=3), error bars: standard error of 
technical repeats 
significance: * = p < α (0.05); 
** = p < α (0.01) 
asterisks in black: changes caused 
by ageing, (YAL vs. OAL; 
YCR vs. OCR) 
asterisks in red: changes caused by 
calorie restriction, (YAL vs. YCR; 
OAL vs. OCR) 
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Fig. 4.32: Cerebellum: protein amount 
in 2D spots for mtDNA encoded 
OxPhos subunits CYB and COX2.
Intensities in rel. grey units of CYB and 
COX2 are presented for each animal 
group. 
bar plots:  
mean of technical repeats (n=3),  
error bars: 
standard error of technical repeats,  
significance: 
* = p < α (0.05); ** = p < α (0.01),  
asterisks in black:  
changes caused by ageing,  
(YAL vs. OAL; YCR vs. OCR) 
asterisks in red:  
changes caused by calorie restriction, 
(YAL vs. YCR; OAL vs. OCR) 
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genase (ODO1) are displayed. MDHM does not change under any condition. Ageing 
decreases (not stat. sig.) the protein amount of CISY (-16.0 %) and ACON (-8.1 %) only in 
calorie restricted animals (YCR vs. OCR).  
Short-term calorie restriction (YAL vs. YCR) increases the protein amount of CISY 
(+12.4 %) and ACON (+19.6 %, both not stat. sig.), while for ODO1 the amount is decreased 
(-25.9 %, not stat. sig.). Long-term calorie restriction (OAL vs. OCR) does not change any 
amount of these proteins involved in TCA cycle.  
In Fig. 4.34B changes of DLDH are shown. Ageing of animals under calorie restriction (YCR 
vs. OCR) reduces the protein amount (-9.7 %, not stat. sig.), while ad libitum fed animals 
show no changes. Short-term (YAL vs. YCR, -7.4 %) as well as long-term (OAL vs. 
OCR, -14.5 %) calorie restriction decreases the protein amount of DLDH (both not stat. sig.). 
In Fig. 4.34C changes of the proteins pyruvate kinase isozymes M1/M2 (KPYM) and 
fructose-bisphosphate aldolase A/C (ALDOA/C) are depicted. Both proteins involved in 
glycolysis do not change by ageing or calorie restriction.  
0.0
0.4
0.8
1.2
MDHM CISY ACON ODO1
re
la
ti
v
e
 g
re
y
 u
n
it
s
YAL
YCR
OAL
OCR
0.0
0.1
0.2
ODO1
re
la
ti
v
e
 g
re
y
 u
n
it
s
YAL
YCR
OAL
OCR
0.0
1.0
2.0
3.0
DLDH
re
la
ti
v
e
 g
re
y
 u
n
it
s
YAL
YCR
OAL
OCR
0.0
0.4
0.8
1.2
KPYM ALDOA/C
re
la
ti
v
e
 g
re
y
 u
n
it
s
YAL
YCR
OAL
OCR
A 
B C 
Fig. 4.34: Cerebellum:protein amount in 2D spots of proteins involved in TCA cycle and 
glycolysis. A: Intensities (in rel. grey units) of proteins from TCA cycle are presented for each 
animal group. B: Intensity (in rel. grey units) of DLDH protein, which is involved in TCA cycle 
and glycolysis, is depicted for each animal group. C: Intensities (in rel. grey units) of proteins
involved in glycolysis are depicted for each animal group.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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In Fig. 4.35 the spot intensities (rel. grey units) of lipophilin (PLP1), tubulin (TBB2A), 
syntaxin binding protein (STXB1), glutamate dehydrogenase (GLDH) and Na+/K+ ATPase 
are plotted. Ageing (black asterisks) increases (not stat. sig.) the protein amount for ad libitum 
nourished animals (YAL vs. OAL) of PLP1 (+23.5 %), TBB2A (+35.1 %) and GLDH 
(+31.3 %). But for calorie restricted animals (YCR vs. OCR) ageing leads to a decreased 
protein amount for PLP1 (-27.9 %, stat. sig.), TBB2A (-13.4 %, not stat. sig.), for STXB1 
(-53.6 %, stat. high. sig.) and for Na+/K+ ATPase (-1.6 %, not stat. sig.). Only for GLDH an 
increase (+54.1 %, not stat. sig.) is visible, but with a large error bar for YCR.  
Short-term calorie restriction (YAL vs. YCR, red asterisk) increases the protein amount for 
PLP1 (+95.0 %, stat. high. sig.), TBB2A (+36.8 %) and STXB1 (+31.5 %, both not stat. sig.), 
while for Na+/K+ ATPase the amount is diminished (-6.3 %, not stat. sig.). Long-term calorie 
restriction (OAL vs. OCR) leads to lower protein amount of STXB1 (-31.2 %), GLDH 
(-15.3 %) and Na+/K+ ATPase (-8.2 %, all not stat. sig.).  
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Fig. 4.35: Cerebellum: protein amount in 2D spots of diverse non-OxPhos proteins. Intensities (in rel. 
grey units) of the proteins lipophilin (PLP1), tubulin (TBB2A), syntaxin binding protein (STXB1) and 
glutamate dehydrogenase (GLDH resp. DHE3) and Na
+
/K
+
 ATPase from cerebellum are depicted.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Hippocampus 
In Fig. 4.36A for hippocampus of all animal groups (YAL, YCR, OAL, OCR) the sum of the 
intensities of CI subunits NDUS1, NDUS2 and NDUA9 are plotted for complexes I1, I1IV2, 
I1III2 and I1III2IV1. The intensity of the sum of all identified subunits for CI (total CI) is also 
shown. Ageing (black asterisks) decreases the protein amount of CI for ad libitum fed animals 
(YAL vs. OAL) in complexes I1 (-32.9 %), I1III2 (-11.7 %, both stat. high sig.), for total CI 
(-20.4 %, stat. sig.) and for I1IV2 (-16.6 %) and I1III2IV1 (-22.7 %, both not stat. sig.). The 
protein amount of CI decreases during ageing for animals kept under calorie restriction (YCR 
vs. OCR) for smaller complexes as I1 (-22.2 %) and I1IV2 (-30.5 %, both not stat. sig.) but 
rises for supercomplex I1III2IV1 (+27.6 %, not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR, red asterisks) reduces the CI protein quantity in 
supercomplexes I1III2 (-13.5 %), I1III2IV1 (-23.3 %) and total CI (-15.8 %, not stat. sig.). 
Long-term calorie restriction (OAL vs. OCR, red asterisks) increases the protein amount for 
I1III2 (19.2 %) and total CI (+16.2 %, both not stat. sig.) and for I1III2IV1 (26.7 %, stat. sig.).  
The spot intensities of the CIII subunit QCR2 for the homooligomeric complexes III2 and III4, 
for the supercomplexes III2IV1, I1III2 and I1III2IV1 and total CIII are shown in Fig. 4.36B. 
Decreased protein amount in ageing (black asterisks) is observable for ad libitum animals 
(YAL vs. OAL) for III4 (-63.6 %) and I1III2IV1 (-19.9 %, both not stat. sig.), and for III2IV1 
(-25.5 %) and total CIII (-12.2 %, both stat. sig.). Ageing under calorie restriction (YCR vs. 
OCR) leads to a declined CIII protein amount for smaller complexes III2IV1 (-25.9 %) and III4 
(-31.0 %, both not stat. sig.), and to an increased amount for larger complexes as I1III2 
(+42.1 %) and I1III2IV1 (+43.5 %, both not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR) reduces CIII protein amount for super-
complexes I1III2 (-16.7 %) and I1III2IV1 (-21.3 %, both not stat. sig.). Long-term calorie 
restriction (OAL vs. OCR, red asterisk) increases CIII protein amount in supercomplexes 
I1III2 (+19.4 %, not stat. sig.), I1III2IV1 (+40.9 %, stat. sig.) and in total CIII (+7.3 %, not stat. 
sig.). 
Fig. 4.36C shows the effects of ageing and calorie restriction on the subunit COX1 for the 
individual complex IV1, the dimer IV2 and the heteromer III2IV1, in comparison to the sum of 
all identified subunits for CIV (total CIV). Ageing of ad libitum fed animals (YAL vs. OAL, 
black asterisk) lowers CIV protein amount in complexes IV1 (-9.7 %) and IV2 (-22.4 %, both 
not stat. sig.), and in total CIV (-9.3 %, stat. sig.). Ageing decreases the CIV protein quantity 
in calorie restricted old animals (YCR vs. OCR) for total CIV (-20.6 %, both not stat. sig.).  
Short-term (YAL vs. YCR, +8.7 %) and long-term (OAL vs. OCR, +16.6 %) calorie 
restriction increase the protein amount of the subunit COX1 of complex IV1 (both not stat. 
sig., Fig. 4.36C). 
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Fig. 4.36: Hippocampus: protein amount in 2D spots for CI, CIII and CIV. A: The sum of the intensities of 
subunits NDUS1, NDUS2 and NDUA9 for individual complex I1 and supercomplexes are compared with the sum 
of the intensities of all identified subunits of CI (total CI); B: intensities of subunit QCR2 for complex III2 and 
supercomplexes are compared with the sum of the intensities of all identified subunits of total CIII; C: intensities 
of subunit COX1 for homooligomeric complexes IV1 and IV2 and supercomplex III2IV1 are compared with the 
sum of the intensities of all identified subunits of total CIV.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by  ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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In Fig. 4.37 the sum of the spot intensities in rel. grey units of all identified subunits for the 
supercomplexes III2IV1, I1III2 and I1III2IV1 are illustrated. Ageing (black asterisks) decreases 
the protein amount of ad libitum nourished rats (YAL vs. OAL) for III2IV1 (-31.3 %) and 
I1III2 (-8.1 %, both stat. high sig.) and I1III2IV1 (-24.3 %, not stat. sig.). Aged animals under 
calorie restriction (YCR vs. OCR) show a reduced protein quantity for the smaller complex 
III2IV1 (-21.9 %, not stat. sig.), while for supercomplexes I1III2 (+28.2 %) and I1III2IV1 
(+29.3 %) the amount is raised (both not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR, red asterisks) lowers the protein quantity for 
supercomplexes I1III2 (-14.5 %) and I1III2IV1 (-24.8 %, both not stat. sig.) while long-term 
calorie restriction leads to increased protein amount of supercomplexes I1III2 (+19.3 %, not 
stat. sig.) and I1III2IV1 (+28.4 %, stat. sig.).  
 
Fig. 4.38 shows the sum of the 
intensities for all identified 
subunits of CII for each 
animal group (YAL, YCR, 
OAL, OCR) from hippo-
campus. Ageing leads in both 
animal groups, ad libitum 
(YAL vs. OAL, -13.3 %) and 
restricted to food (YCR vs. 
OCR, -18.4 %), to a decreased 
protein amount (both not stat. 
sig.). Short-term calorie re-
striction (YAL vs. YCR, red 
Fig. 4.37: Hippocampus: protein amount in 2D spots for supercomplexes 
containing CI, CIII and CIV. The sum of intensities (rel. grey units) of all identified 
spots (=total) for the supercomplexes III2IV1, I1III2 and I1III2IV1 are plotted for each 
animal group.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Fig. 4.38: Hippocampus: protein 
amount in 2D spots for CII.  
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asterisk) increases protein quantity (+31.3 %, stat. sig.), as well as long-term calorie 
restriction (OAL vs. OCR) (+23.6 %, not stat. sig.).  
 
The spot intensities of ATP synthase subunits are illustrated in Fig. 4.39. Fig. 4.39A indicates 
all identified subunits of CV (total CV) in comparison with the identified subunits of the 
monomer V1, dimer V2 and the next higher homooligomer V3 for hippocampus from all 
animal groups (YAL, YCR, OAL, OCR).  
Ageing (black asterisks) of ad libitum nourished animals (YAL vs. OAL) decreases the 
protein amount for total CV (-12.1 %) and complex V1 (-12.3 %, both stat. sig.) and for V2 
(-13.2 %, not stat. sig.). For aged animals under calorie restriction (YCR vs. OCR), protein 
quantity is increased for total CV (+15.0 %) and V2 (+42.6 %, both stat. sig.). 
Short-term calorie restriction (YAL vs. YCR) lowers the protein amount for total CV (-9.3 %) 
and V2 (-20.3 %, both not stat. sig.), whereas long-term calorie restriction (YAL vs. YCR, red 
asterisk) increases the amount for total CV (+18.7 %, stat. sig.) and for V1 (+13.1 %) and V2 
(+30.9 %, not stat. sig.).  
In Fig. 4.39B the spot intensities of ATP synthase’s subunits α, β and the sum α+β as well as 
Fo portion and F1 portion from hippocampus are illustrated. As expected, it is apparent that 
subunits α and β inhibit similar distribution and intensities.  
Ageing (black asterisks) decreases the protein amount for ad libitum animals (YAL vs. OAL) 
for subunit α (-16.6 %) and the sum α+β (-12.8 %, both stat. sig.) and for β (-8.3 %) and Fo 
portion (-12.6 %, both not stat. sig.). Aged animals grown under calorie restriction (YCR vs. 
OCR) show an increase of protein amount for α (+33.2%), β (+33.3 %) and α+β (+33.3 %, all 
stat. sig.), whereas the amount of Fo portion is reduced (-12.9 %, not stat. sig.). 
Short-term calorie restriction (YAL vs. YCR) decreases the protein amount of α (-14.4 %), β 
(-11.6 %) and α+β (-13.1 %, all not stat. sig.). Long-term calorie restriction (OAL vs. OCR, 
red asterisk) increases the protein amount for α (+36.8 %, stat. sig.) and for β (+28.5 %) and 
α+β (+32.8 %, both not stat. sig.).  
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In Fig. 4.40 the protein spot intensities of mtDNA encoded protein subunits CYB (CIII) and 
COX2 (CIV) of hippocampus are depicted. Due to large error bars, no changes of the amount 
of CYB based on ageing or calorie restriction are observable. Ageing of calorie restricted 
animals (YCR vs. OCR) decreases the protein amount for COX2 (-15.9 %, not stat. sig.), as 
well as long-term calorie restriction (OAL vs. OCR, -14.2 %, not stat. sig.). 
A 
B 
Fig. 4.39: Hippocampus: protein amount in 2D spots for CV. A: intensities of total ATP synthase (total 
CV) are compared with those of identified subunits of monomer (V1), dimer (V2) and next higher 
homooligomer V3; B: intensities (in rel. grey units) of ATP synthase‘s subunits α, β and α+β are plotted, as 
well as Fo and F1 portion. 
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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15 non-OxPhos proteins of hippocampus were analysed and their spot intensities (in rel. grey 
units) depicted in Fig. 4.41, Fig. 4.42 and Fig. 4.43.  
Fig. 4.41 shows the intensities for the mitochondrial 60 kDa heat shock protein (CH60), the 
protein disulfide-isomerase A4 (PDIA4) and the 78 kDa glucose-regulated protein (GRP78). 
All of them are involved in cellular stress management. Ageing (black asterisk) of ad libitum 
nourished animals (YAL vs. OAL) reduces the protein amount of PDIA4 only (-17.9 %, not 
stat. sig.), while in aged animals under calorie restriction (YCR vs. OCR) the amount of 
CH60 (+40.1 %, stat. sig.) and PDIA4 (+23.1 %, not stat. sig.) is increased.  
Short-term calorie restriction (YAL vs. YCR) decreases the protein amount of PDIA4 
(-24.7 %, not stat. sig.) only. Long-term calorie restriction (OAL vs. OCR, red asterisk) 
increases the protein amount of CH60 (+44.5 %, stat. sig.) and PDIA4 (+12.8 %, not stat. 
sig.).  
Due to large error bars, GRP78 of hippocampus does not show any changes in protein 
amount. 
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Fig. 4.41: Hippocampus: protein 
amount in 2D spots of proteins 
of cellular stress management. 
Intensities in rel. grey units of 
diverse stress proteins are pre-
sented for each animal group. 
 
bar plots: mean of technical 
repeats (n=3), error bars: standard 
error of technical repeats 
significance: * = p < α (0.05); 
** = p < α (0.01) 
asterisks in black: changes 
caused by ageing, (YAL vs. OAL; 
YCR vs. OCR) 
asterisks in red: changes caused 
by calorie restriction, 
(YAL vs. YCR; OAL vs. OCR) 
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Fig. 4.40: Hippocampus: protein 
amount in 2D spots for mtDNA 
encoded OxPhos subunits CYB 
and COX2. Intensities in rel. grey
units of CYB and COX2 are presented 
for each animal group. 
bar plots:  
mean of technical repeats (n=3),  
error bars: 
standard error of technical repeats,  
significance: 
* = p < α (0.05); ** = p < α (0.01),  
asterisks in black:  
changes caused by ageing,  
(YAL vs. OAL; YCR vs. OCR) 
asterisks in red:  
changes caused by calorie restriction, 
(YAL vs. YCR; OAL vs. OCR) 
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In Fig. 4.42 spot intensities (in rel. grey units) of proteins involved in TCA cycle and 
glycolysis are displayed. In Fig. 4.42A the spot intensities of the mitochondrial proteins 
malate dehydrogenase (MDHM), citrate synthase (CISY), aconitate hydratase (ACON) and 
2-oxoglutarate dehydrogenase (ODO1) are depicted. They are proteins involved in the TCA 
cycle. Ageing (black asterisks) of ad libitum fed animals (YAL vs. OAL) increases the protein 
amount of MDHM (+66.8 %, stat. sig.) and ACON (+12.6 %, not stat. sig.). Aged animals 
under calorie restriction (YCR vs. OCR) show an increase in protein amount for ACON 
(+36.9 %, stat. sig.) and a decrease for ODO1 (-40.6 %, not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR) reduces the protein amount of CISY (-14.2 %) 
and ACON (-14.5 %, both not stat. sig.). Long-term calorie restriction (OAL vs. OCR) 
decreases the amount of MDHM (-30.7 %) and ODO1 (-40.2 %, both not stat. sig.).  
Fig. 4.42B shows the spot intensities of the mitochondrial dihydrolipoyl dehydrogenase 
(DLDH) for the different animal groups, which is involved in TCA cycle and glycolysis. 
Aged ad libitum animals (YAL vs. OAL) show a reduced DLDH amount (-17.5 %, not stat. 
sig.), as well as animals under the influence of short-term calorie restriction (YAL vs. 
YCR, -18.0 %, not stat. sig.). Calorie restriction during ageing (YCR vs. OCR, black asterisk) 
leads to an increased DLDH amount (+24.8 %, stat. sig.), as well as long-term calorie 
restriction (OAL vs. OCR, red asterisk, +24.0 %, stat. sig.). 
In Fig. 4.42C the pyruvate kinase isozymes M1/M2 (KPYM) and fructose-bisphosphate 
aldolase A/C (ALDOA/C) are depicted. Both are proteins involved in glycolysis. Only for 
aged animals under calorie restriction (YCR vs. OCR, +62.8 %) and for long-term calorie 
restriction (OAL vs. OCR, +21.8 %) an increase of protein amount for KPYM is visible (both 
not stat. sig.). Short-term calorie restriction (YAL vs. YCR) lowers the protein amount of 
KPYM (-28.2 %, not stat. sig.). The amount of ALDOA/C is reduced under the influence of 
long-term calorie restriction (OAL vs. OCR, -31.2 %, not stat. sig.).  
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In Fig. 4.43 the spot intensities (rel. grey units) of the proteins lipophilin (PLP1), tubulin 
(TBB2A), syntaxin binding protein (STXB1), glutamate dehydrogenase (GLDH) and 
Na+/K+ ATPase from hippocampus are plotted.  
Ageing (black asterisks) of ad libitum fed animals (YAL vs. OAL) increases the protein 
amount of PLP1 (+202.3 %, stat. high. sig.) and GLDH (+24.1 %, not stat. sig.). Under the 
influence of calorie restriction (YCR vs. OCR) the protein amount is increased for TBB2A 
(+35.4 %) and Na+/K+ ATPase (+11.9 %, both not stat. sig.) during ageing, whereas it is 
declined by the effect of calorie restriction, for PLP1 (-42.6 %, stat. high. sig.) and GLDH 
(-27.7 %, not stat. sig.).  
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Fig. 4.42: Hippocampus: protein amount in 2D spots of proteins involved in TCA cycle 
and glycolysis. A: Intensities (in rel. grey units) of proteins from TCA cycle are presented for 
each animal group. B: Intensity (in rel. grey units) of DLDH protein, which is involved in TCA 
cycle and glycolysis, is depicted for each animal group. C: Intensities (in rel. grey units) of 
proteins involved in glycolysis are depicted for each animal group.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Short-term calorie restriction (YAL vs. YCR, red asterisks) increases the protein amount of 
PLP1 (+62.6 %, stat. sig.) and GLDH (+25.4 %, not stat. sig.). Long-term calorie restriction 
(OAL vs. OCR, red asterisks) reduces the protein amount of PLP1 (-69.1 %, stat. high. sig.) 
and GLDH (-27.0 %, not stat. sig.), whereas the amount of TBB2A is increased (+29.4 %, 
stat. sig.). STXB1 of hippocampus is not influenced at all.   
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Fig. 4.43: Hippocampus: protein amount in 2D spots of diverse non-OxPhos proteins. Intensities (in 
rel. grey units) of the proteins lipophilin (PLP1), tubulin (TBB2A), syntaxin binding protein (STXB1) and 
glutamate dehydrogenase (GLDH resp. DHE3) and Na
+
/K
+
 ATPase from hippocampus are depicted.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Cerebrum 
In Fig. 4.44A the sum of the intensities (rel. grey units) of CI subunits NDUS1, NDUS2 and 
NDUA9 are depicted for complexes I1, I1IV2, I1III2 and I1III2IV1 from all cerebrum animal 
groups (YAL, YCR, OAL, OCR). The intensities for all identified subunits for CI (total CI) 
were summed and also plotted in Fig. 4.44A for comparison. This illustration enables to 
compare the effects on the protein amount of CI as individual complex or in supercomplex 
assembly.  
Ageing (black asterisk) decreases the protein amount of individual complex I1 (-23.2 %, stat. 
sig.) in cerebrum of ad libitum fed animals (YAL vs. OAL). Ageing of animals kept under 
calorie restriction (YCR vs. OCR) increases the protein amount of CI in complexes I1 
(+10.8 %), I1IV2 (+11.8 %), I1III2IV1 (+15.9 %) and total CI (+7.1 %, not stat. sig.), whereas 
the amount of complex I1III2 is decreased (-7.8 %, not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR, red asterisks) increases the protein amount for 
individual complex I1 (+12.2 %, stat. sig.). Long-term calorie restriction (OAL vs. OCR, red 
asterisk) raises the protein amount for complex I1 (+61.9 %, stat. high sig.), and for super-
complexes I1IV2 (+28.1 %), I1III2IV1 (+9.4 %) and total CI (+7.9 %, all not stat. sig.).  
The intensities of subunit QCR2 are presented in Fig. 4.44B for complexes III2, III2IV1, III4, 
I1III2 and I1III2IV1. Total CIII represents the sum of the rel. grey units of all identified subunits 
of CIII. This allows a comparison between homooligomeric and supercomplex assembly of 
CIII. Ageing (black asterisks) decreases the protein amount of CIII in cerebrum of ad libitum 
nourished rats (YAL vs. OAL) for III2 (-8.7 %) and III2IV1 (-11.9 %, both not stat. sig.), 
whereas in I1III2 the protein amount is increased (+27.4 %, not stat. sig.). Aged calorie 
restricted animals (YCR vs. OCR) exhibit an increased CIII quantity for all shown complexes 
except for I1III2; for III2 (+20.0 %, stat. sig.) and III4 (+36.4 %, stat. high sig.), III2IV1 
(+7.8 %), I1III2IV1 (+14.3 %) and total CIII (+8.5 %, all not stat. sig.). The amount of I1III2 is 
decreased only (-12.3 %, not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR) has no effects on CIII. Under conditions of 
long-term calorie restriction (OAL vs. OCR, red asterisks) the protein amount of CIII is 
increased for complexes III2IV1 (+24.5 %) and III4 (+47.9 %, both stat. high sig.), for total 
CIII (+17.9 %, stat. sig.) and for III2 (+20.5 %) and I1III2IV1 (+12.4 %, both not stat. sig.). 
Only I1III2 exhibits a lower CIII protein amount for long-term calorie restriction (-11.5 %, not 
stat. sig.).  
Fig. 4.44C depicts the changes of the protein amount of subunit COX1 of CIV in monomer 
IV1, dimer IV2 and heteromer III2IV1 in comparison to the sum of the intensities of all 
identified subunits of CIV (total CIV). Ageing (black asterisks) of ad libitum fed rats (YAL 
vs. OAL) increases the protein amount of COX1 in IV1 (+5.9 %, stat. high sig.). But for total 
CIV the amount is decreased (-21.4 %, stat. sig.). Aged animals under calorie restriction 
(OAL vs. OCR) show a reduced amount of COX1 in IV1 (-9.4 %, not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR, red asterisks) increases the amount for COX1 in 
IV1 (+13.0 %, stat. sig.) and for total CIV (+10.0 %, not stat. sig.). Long-term calorie 
restriction (OAL vs. OCR) raises the protein amount of total CIV (+29.1 %, not stat. sig.).  
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Fig. 4.44: Cerebrum: protein amount in 2D spots for CI, CIII and CIV. A: The sum of intensities of subunits 
NDUS1, NDUS2 and NDUA9 for individual complex I1 and supercomplexes are compared with the sum of the 
intensities of all identified subunits of CI (total CI); B: intensities of subunit QCR2 for complex III2 and 
supercomplexes are compared with the sum of the intensities of all identified subunits of CIII (total CIII); C:
intensities of subunit COX1 for homooligomeric complexes IV1 and IV2 and supercomplex III2IV1 are compared 
with the sum of the intensities of all identified subunits of CIV (total CIV).  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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In Fig. 4.45 the sum of the intensities of all identified spots for the supercomplexes III2IV1, 
I1III2 and I1III2IV1 is depicted. Ageing (black asterisks) decreases the protein amount in ad 
libitum nourished animals (YAL vs. OAL) for III2IV1 (-8.6 %, not stat. sig.). Animals under 
the condition of calorie restriction (YCR vs. OCR) show an increase of supercomplex 
I1III2IV1 (+14.8 %, stat. sig.) during ageing whereas the protein amount of I1III2 decreases 
(-9.3 %, not stat. sig.).  
Short-term calorie restriction (YAL vs. YCR) has no influence on the protein amount, while 
long-term calorie restriction (OAL vs. OCR, red asterisk) increases the amount of complex 
I1III2IV1 (+8.6 %, stat. high sig., Fig. 4.45). 
 
In Fig. 4.46 the sum of the 
spot intensities of all iden-
tified subunits of CII are 
depicted for cerebrum of all 
animal groups (YAL, YCR, 
OAL, OCR). Ageing has no 
effect on the protein amount 
of CII. Only for long-term 
calorie restriction (OAL vs. 
OCR) a decreased protein 
amount is observable 
(-7.7 %, not stat. sig.).  
 
The changes of protein amount of ATP synthase in cerebrum is shown in Fig. 4.47. Fig. 
4.47A depicts the sum of the intensities of all identified subunits for CV (total CV) compared 
with the identified subunits for monomer V1, dimer V2 and next higher homooligomer V3. 
Fig. 4.45: Cerebrum: protein amount in 2D spots for supercomplexes containing 
CI, CIII and CIV. The sum of intensities (rel. grey units) of all identified spots (=total) for 
the supercomplexes III2IV1, I1III2 and I1III2IV1 are plotted for each animal group.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Fig. 4.46: Cerebrum: protein amount 
in 2D spots for CII. The sum of the 
intensities in rel. grey units of total CII
are presented for each animal group. 
bar plots:  
mean of technical repeats (n=3),  
error bars: 
standard error of technical repeats,  
significance: 
* = p < α (0.05); ** = p < α (0.01),  
asterisks in black:  
changes caused by  ageing,  
(YAL vs. OAL; YCR vs. OCR) 
asterisks in red:  
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Ageing (black asterisks) increases the protein amount of total CV (+7.1 %), V1 (+6.5 %, 
Frenzel: -1.5-fold) and V3 (+26.1 %, all not stat. sig.) in ad libitum nourished rats (YAL vs. 
OAL) as well as for rats grown under calorie restriction (YCR vs. OCR) for total CV 
(+13.4 %) and V1 (+13.7 %, both stat. high sig.) and for V2 (+12.9 %, stat. sig.) and for V3 
(+39.8 %, not stat. sig.). Neither short-term nor long-term calorie restriction has an effect on 
the protein amount of ATP synthase homooligomers (Fig. 4.47A).  
Fig. 4.47B illustrates the spot intensity of the subunits α, β and the sum α+β as well as Fo and 
F1 portion of mitochondrial ATP synthase from cerebrum. As expected, it is observable that 
the intensities, respectively the amounts of the subunits α and β are similar and almost equal 
in intensity. Ageing (black asterisks) increases the protein amount in both cases, for ad 
libitum fed animals (YAL vs. OAL) and those under conditions of calorie restriction (YCR vs. 
OCR). This can be observed for ad libitum fed animals for α (+11.8 %), β (+13.5 %), 
α+β (+12.6 %, all not stat. sig.) as well as for F1 portion (+18.1 %, stat. sig.). For aged calorie 
restricted rats, the protein amount is enhanced for α (+18.5 %), β (+19.1 %), and α+β 
(+18.8 %, all stat. high sig.). Long-term calorie restriction (OAL vs. OCR) decreases the 
amount of F1 portion (-17.8 %, not stat. sig.). 
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Fig. 4.47: Cerebrum: protein amount in 2D spots for CV. A: The sum of the intensities of all identified 
subunits of total ATP synthase (CV) are compared with those of identified subunits of monomer (V1), 
dimer (V2) and next higher homooligomer V3; B: intensities (in rel. grey units) of ATP synthase‘s subunits 
α, β and α+β are plotted, as well as Fo and F1 portion. 
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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In Fig. 4.48 the spot intensities for the mtDNA encoded subunits CYB (CIII) and COX2 
(CIV) of cerebrum mitochondria are depicted. The protein amount of the mtDNA encoded 
subunit CYB is increased with age under ad libitum feeding (YAL vs. OAL, +21.9 %, not 
stat. sig.).  
The amount of COX2 is decreased (-15.0 %, stat. sig.) under ageing and ad libitum feeding 
(YAL vs. OAL, black asterisk). Short-term (YAL vs. YCR, red asterisk, +19.0 %, stat. sig.) as 
well as long-term calorie restriction (OAL vs. OCR, +20.3 %, not stat. sig.) increase the 
protein amount of COX2. 
 
15 non-OxPhos proteins of cerebrum were analysed and their spot intensities (in rel. grey 
units) diagrammed in Fig. 4.49, Fig. 4.50 and Fig. 4.51.  
In Fig. 4.49 the intensities for three proteins involved in cellular stress management are 
depicted. These are the mitochondrial 60 kDa heat shock protein (CH60), the protein 
disulfide-isomerase A4 (PDIA4) and the 78 kDa glucose-regulated protein (GRP78).  
Ageing of ad libitum fed rats (YAL vs. OAL, +18.5 %) and also of calorie restricted rats 
(YCR vs. OCR, +11.7 %) increases the protein amount for CH60 (both not stat. sig.). For 
PDIA4 and GRP78 no changes caused by ageing are visible. 
Calorie restriction has no effects on the analysed stress proteins, except a lowered protein 
amount of GRP78 under the influence of long-term calorie restriction (OAL vs. 
OCR, -22.6 %, not stat. sig.). 
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Fig. 4.49: Cerebrum: protein amount 
in 2D spots of proteins of cellular 
stress management. Intensities in rel. 
grey units of diverse stress proteins are 
presented for each animal group. 
bar plots: mean of technical repeats 
(n=3), error bars: standard error of 
technical repeats 
significance: * = p < α (0.05); 
** = p < α (0.01) 
asterisks in black: changes caused by 
ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by 
calorie restriction, (YAL vs. YCR; 
OAL vs. OCR) 
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Fig. 4.48: Cerebrum: protein amount 
in 2D spots for mtDNA encoded 
OxPhos subunits CYB and COX2.
Intensities in rel. grey units of CYB and 
COX2 are presented for each animal 
group. 
bar plots:  
mean of technical repeats (n=3),  
error bars: 
standard error of technical repeats,  
significance: 
* = p < α (0.05); ** = p < α (0.01),  
asterisks in black:  
changes caused by ageing,  
(YAL vs. OAL; YCR vs. OCR) 
asterisks in red:  
changes caused by calorie restriction, 
(YAL vs. YCR; OAL vs. OCR) 
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In Fig. 4.50 the changes of the protein amounts of several proteins from cerebrum involved in 
TCA cycle and glycolysis are displayed. Fig. 4.50A depicts the spot intensities of the 
mitochondrial proteins: malate dehydrogenase (MDHM), citrate synthase (CISY), aconitate 
hydratase (ACON) and 2-oxoglutarate dehydrogenase (ODO1).  
Ageing (black asterisk) reduces the protein amount of MDHM (-38.4 %, stat. sig.) and ODO1 
(-38.0 %, not stat. sig.) for ad libitum nourished animals (YAL vs. OAL). The protein amount 
is also decreased in aged calorie restricted rats (YCR vs. OCR, (black asterisks) for 
CISY(-15.4 %) and ACON (-19.0 %, both stat. sig.). For MDHM, the protein amount is 
increased (+60.3 %, stat. sig.) during ageing under calorie restriction (YCR vs. OCR, black 
asterisk). 
Short-term calorie restriction (YAL vs. YCR, red asterisk) decreases the protein amount of 
MDHM (-47.6 %, stat. sig.) and increases the amount of ACON (+17.2 % not stat. sig.). 
Long-term calorie restriction (OAL vs. OCR, red asterisks) increases the protein amount of 
MDHM (+36.5 %, not stat. sig.) and ODO1 (+108.3 %, stat. sig.) and decreases the amount of 
CISY (-7.1 %, not stat. sig.) and ACON (-13.7 %, stat. sig.).  
The mitochondrial dihydrolipoyl dehydrogenase (DLDH) is involved in TCA cycle as well as 
in glycolysis. The spot intensities are displayed in Fig. 4.50B. Ageing (black asterisk) 
decreases the DLDH amount (-30.0 %, stat. high sig.) only for animals kept under calorie 
restriction (YCR vs. OCR). Short-term calorie restriction (YAL vs. YCR, red asterisk) 
increases the protein amount (+21.5 %, stat. sig.), whereas long-term calorie restriction (OAL 
vs. OCR, red asterisk) decreases it (-18.0 %, stat. sig.).  
In Fig. 4.50C the spot intensities of pyruvate kinase isozymes M1/M2 (KPYM) and fructose-
bisphosphate aldolase A/C (ALDOA/C) are shown. Ageing (black asterisk) of animals under 
calorie restriction (YCR vs. OCR) reduces the protein amount of both, KPYM (-13.8 %, not 
stat. sig.) and ALDOA/C (-10.8 %, stat. sig.).  
Short-term calorie restriction (YAL vs. YCR) causes an increase in amount of KPYM 
(+21.4 %, not stat. sig.). Animals under the influence of long-term calorie restriction show no 
changes. 
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In Fig. 4.51 the spot intensities (in rel. grey units) of several non-OxPhos proteins from 
cerebrum are depicted. The changes of lipophilin (PLP1), tubulin (TBB2A), syntaxin binding 
protein (STXB1), glutamate dehydrogenase (GLDH) and Na+/K+ ATPase are shown.  
Ageing (black asterisks) of ad libitum fed animals (YAL vs. OAL) reduces the protein 
amount of PLP1 (-39.0 %, stat. high sig.) and of TBB2A (-13.0 %, not stat. sig.), whereas for 
STXB1 (+22.7 %, not stat. sig.) and Na+/K+ ATPase (+10.8 %, stat. sig.) it is increased.  
Ageing of calorie restricted animals (YCR vs. OCR) decreases the protein amount of TBB2A 
(-60.9 %, stat. high sig.) and GLDH (-25.0 %, not stat. sig.), whereas the quantity of PLP1 
(+26.5 %, not stat. sig.) and Na+/K+ ATPase (+13.5 %, stat. sig.) is increased.  
Fig. 4.50: Cerebrum: protein amount in 2D spots of proteins involved in TCA cycle and 
glycolysis. A: Intensities (in rel. grey units) of proteins from TCA cycle are presented for each 
animal group. B: Intensity (in rel. grey units) of DLDH protein, which is involved in TCA cycle 
and glycolysis, is depicted for each animal group. C: Intensities (in rel. grey units) of proteins
involved in glycolysis are depicted for each animal group.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Short-term calorie restriction (YAL vs. YCR, red asterisks) decreases the protein amount of 
PLP1 (-37.8 %, stat. high sig.) and increases it for TBB2A (+44.2 %, stat. high sig.). Long-
term calorie restriction (OAL vs. OCR, red asterisks) increases the amount of PLP1 (+29.2 %, 
not stat. sig.) and reduces the amount of TBB2A (-35.1 %, stat. high sig.) and STXB1 
(-8.8 %, stat. sig.).  
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Fig. 4.51: Cerebrum: protein amount in 2D spots of diverse non-OxPhos proteins. Intensities (in rel. 
grey units) of the proteins lipophilin (PLP1), tubulin (TBB2A), syntaxin binding protein (STXB1) and 
glutamate dehydrogenase (GLDH resp. DHE3) and Na
+
/K
+
 ATPase from cerebrum are depicted.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01) 
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Summary 
A summary of the results from 2D-BN/SDS PAGE analysis is given in Table 4.30. For each 
tissue sample, the results for changes in age for ad libitum fed animals (AL: YAL vs. OAL) 
and under calorie restriction kept animals (CR: YCR vs. OCR) are presented as well as the 
effects of short-term (ST: YAL vs. YCR) and long-term (LT: OAL vs. OCR) calorie 
restriction. An increase of protein amount is marked with an upward-pointing arrow ( ), a 
decrease with a downward-pointing arrow ( ). Both symbols are used in grey (not stat. 
sig.), orange (stat. sig.) and red (stat. high sig.). Black dashes ( ) were placed, where no ▬
variation could be examined. Main tendencies are quoted below. 
Ageing has no general influence on the protein amount in cerebellum of ad libitum nourished 
rats (AL), while for hippocampus the same group exhibits a predominant decrease of the 
protein amount, observable also for cerebrum, except for the amount of ATP synthase, which 
shows an increase of protein quantity.  
Aged calorie restricted rats (CR) show a trend for mainly raised protein amount in cerebellum 
and cerebrum. The protein amount of only some of the non-OxPhos proteins is decreased. For 
proteins of hippocampus, two trends are observable for the same group: OxPhos complexes I 
to IV decrease in amount while ATP synthase and the non-OxPhos proteins increase in 
quantity, as also observed for cerebellum and cerebrum.  
Short-term calorie restriction (ST) reduces mainly the protein amount in cerebellum and 
hippocampus, whereas in cerebrum most of the proteins do not change, only a tendency of 
enhanced protein quantity prevails.  
Long-term calorie restriction (LT) causes no general variation of the protein quantity in 
cerebellum. In hippocampus and cerebrum the protein amount is mainly increased, but in 
cerebrum only for OxPhos proteins.  
To bring into focus the ATP synthase, ageing under ad libitum conditions (AL) reduces its 
amount in hippocampus only (Table 4.30). The combination of age and calorie restriction 
leads to an increased ATP synthase amount in cerebellum and cerebrum (CR) and in 
hippocampus (CR and LT). Short-term calorie restriction (ST) leads to a decreased quantity of 
ATP synthase in cerebellum and hippocampus.  
The mtDNA encoded protein subunits CYB and COX2 do not show specific trends. The 
changes in amounts seem to follow the trends of total CIII respectively total CIV. 
Proteins involved in stress management of the cell are increased in cerebellum during ST and 
are decreased during ageing under calorie restriction (CR) to the same level as animals aged 
under ad libitum feeding (AL). In hippocampus CR and LT lead to increased amount of stress 
proteins. In cerebrum, the amount of stress proteins stays at the same level during ageing for 
AL and CR. 
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Table 4.30: Summary of the results from 2D-BN/SDS PAGE spot analysis 
figures entity 
examined 
subunits 
Cerebellum Hippocampus Cerebrum 
AL CR ST LT AL CR ST LT AL CR ST LT 
4.28A 
4.36A 
4.44A 
I1 
NDUS1, 
NDUS2, 
NDUA9 
 ▬    ▬    ▬  ▬     
I1IV2  ▬   ▬     ▬  ▬  ▬   ▬  
I1III2  ▬    ▬   ▬    ▬   ▬  ▬
I1III2IV1  ▬  ▬  ▬  ▬      ▬   ▬  
total CI all  ▬    ▬   ▬    ▬   ▬  
4.28B 
4.36B 
4.44B 
III2 
QCR2 
  ▬   ▬  ▬  ▬  ▬  ▬    ▬  
III2IV1     ▬    ▬  ▬    ▬  
III4  ▬  ▬  ▬  ▬    ▬  ▬  ▬   ▬  
I1III2     ▬  ▬       ▬  
I1III2IV1  ▬  ▬  ▬  ▬      ▬   ▬  
total CIII all     ▬   ▬  ▬   ▬   ▬  
4.28C 
4.36C 
4.44C 
IV1 
COX1 
 ▬      ▬       ▬
IV2  ▬  ▬  ▬  ▬   ▬  ▬  ▬  ▬  ▬  ▬  ▬
III2IV1  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬
total CIV all  ▬  ▬  ▬  ▬    ▬  ▬   ▬   
4.29 
4.37 
4.45 
total III2IV1 all for III2IV1     ▬    ▬  ▬   ▬  ▬  ▬
total I1III2 all for I1III2  ▬    ▬      ▬   ▬  ▬
total I1III2IV1 all for I1III2IV1  ▬  ▬  ▬       ▬   ▬  
4.30 
4.38 
4.46 
total CII all  ▬  ▬  ▬  ▬      ▬  ▬  ▬  
4.31A 
4.39A 
4.47A 
total CV all  ▬    ▬        ▬  ▬
V1 all for V1  ▬    ▬   ▬  ▬     ▬  ▬
V2 all for V2  ▬    ▬      ▬   ▬  ▬
V3 all for V3  ▬   ▬  ▬  ▬  ▬  ▬  ▬    ▬  ▬
4.31B 
4.39B 
4.47B 
alpha all α  ▬    ▬        ▬  ▬
beta all β  ▬    ▬        ▬  ▬
alpha+beta all α + all β  ▬    ▬        ▬  ▬
Fo portion all for Fo  ▬    ▬    ▬  ▬  ▬  ▬  ▬  ▬
F1 portion α + β for F1  ▬     ▬  ▬  ▬  ▬   ▬  ▬  
4.32 
4.40 
4.48 
mtDNA encoded 
subunits 
CYB  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬
COX2  ▬  ▬ ▬  ▬ ▬ ▬ ▬   
4.33 
4.41 
4.49 
Stress proteins 
CH60  ▬    ▬  ▬   ▬     ▬  ▬
PDIA4  ▬    ▬      ▬  ▬  ▬  ▬
GRP78  ▬    ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  
4.34A 
4.42A 
4.50A 
TCA cycle 
MDHM  ▬  ▬  ▬  ▬   ▬  ▬      
CISY  ▬    ▬  ▬  ▬   ▬  ▬   ▬  
ACON  ▬    ▬     ▬  ▬    
ODO1  ▬  ▬   ▬  ▬   ▬    ▬  ▬  
4.34B 
4.42B 
4.50B 
TCA cycle & 
Glycolysis 
DLDH  ▬         ▬    
4.34C 
4.42C 
4.50C 
Glycolysis 
KPYM  ▬  ▬  ▬  ▬  ▬     ▬    ▬
ALDOA/C  ▬  ▬  ▬  ▬  ▬  ▬  ▬   ▬   ▬  ▬
4.35 
4.43 
4.51 
Na
+
/K
+
 ATPase AT1A3, AT1B1  ▬     ▬   ▬  ▬    ▬  ▬
lipophilin PLP1     ▬         
tubulin TBB2A     ▬  ▬   ▬      
syntaxinBP STXB1  ▬     ▬  ▬  ▬  ▬   ▬  ▬  
GLDH DHE3    ▬       ▬   ▬  ▬
symbols: “ ”: increase, “ ”: decrease, “ “: no change; colours: stat. high sig., stat. sig., not stat. sig. ▬
abbrev.: AL: ad libitum, CR: calorie restriction, ST: short-term calorie restriction, LT: long-term calorie restriction  
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Proteins in energy metabolism (glycolysis and TCA cycle) show in cerebellum the same 
tendency as the stress proteins. During ST the proteins are increased and decreased during 
ageing under calorie restriction (CR) to reach the same level after LT as under AL. In 
hippocampus the proteins of energy metabolism are decreased under ST but during ageing 
this effect compensates (CR) and is even overcompensated by increased protein amount of 
DLDK and KPYM (LT). Other changes in hippocampus seem to vary with no specific trend. 
In cerebrum the amount of two of the TCA cycle proteins is reduced during ageing (AL). ST 
leads to increased amount of proteins of energy metabolism in cerebrum, are decreased during 
ageing under CR and remain mainly at a lower level after LT, compared to AL.  
Na+/K+ ATPase, lipophilin, tubulin, syntaxinBP and glutamate dehydrogenase in the broader 
sense are all involved in neuronal composition, their function and trafficking at synapses. For 
cerebellum an age (AL) induced increase of these proteins is visible, which is also present for 
ST but ageing under CR and LT decreases the amount of these proteins. A loss of neurons or 
synapses or their activity in cerebellum under calorie restriction could explain these findings. 
A comparison to the tissue weight or amount of mitochondrial proteins does not correlate. 
Trends are not pronounced for the same proteins from hippocampus and cerebrum.  
 
For comparison of the results, it is referred to the findings of Olgun et al. (2002), Groebe et al. 
(2007), Frenzel (2011), Cerqueira et al. (2012) and Thilmany (2013), as they all analysed 
mitochondria of brain tissue. 
Frenzel (2011) analysed the effects of ageing on 5 and 30 months old male Wistar rats. She 
analysed mitochondria from cerebral cortex, hippocampus and striatum. Cerebral cortex is a 
large part of cerebrum, therefore it will be compared to cerebrum in this thesis, albeit 
cerebrum also includes striatum, but the latter is just a little part of cerebrum. In cerebral 
cortex, ageing decreased amounts of individual complexes (III2, IV1, II1 and V1) and super-
complexes I1III2, I1III2IV1, and increased the amount of supercomplex III2IV1. In hippo-
campus, the amount of individual and supercomplexes increased, except for individual IV1, 
whereof the quantity decreased. The findings on quantitation of OxPhos (super-) complexes 
by Frenzel (2011) were mostly contrary to the findings in this thesis. For the F1 portion she 
found an increase for both tissues, as found for cerebrum. CH60 (no change) and ACON 
(increase) showed the same effects for hippocampus, while in cerebral cortex a decrease of 
CH60 was found by Frenzel (2011) contrary to the increase in cerebrum. ACON in cerebral 
cortex did not change as in cerebrum. She found the quantity of Na+/K+ ATPase increased in 
hippocampus, which has not changed in this thesis, and decreased in cerebral cortex, contrary 
to the findings for cerebrum in this thesis. Maybe the findings differ because of the different 
animal models used as also supposed by Silvestri et al. (2011). Wistar rats are outbred strains 
and Fischer 344 inbred. Van Der Staay and Blokland (1996) showed differences in behaviour 
of adult rats from Wistar, Fischer 344, Brown Norway and hybrid Fischer 344 x Brown 
Norway rats and analysed, whether they are suitable as animal model of ageing. They suggest 
to favour inbred strains as Fischer 344, Brown Norway and the F1 hybrid Fischer 344 x 
Brown Norway. Kacew and Festing (1996) note that “[…] Individual samples of rats from an 
outbred colony may differ markedly in their genetic characteristics […]”.  
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Thilmany (2013) analysed heart mitochondria and, together with her diploma student 
Michaela Söhn, cerebrum mitochondria from the same animals as used in this thesis. 
However, problems with the quantitation of the whole mitochondrial protein amount of the 
cerebrum mitochondria occurred, and that is why these analyses were repeated with a new 
Bradford quantitation. Deviations to the findings of Söhn (2010) were in average at -33.0 % 
for single values (maxima: +11.8 % and -62.1 %) (4.2.1). Therefore, it is no wonder that in 
most cases the changes of ageing and calorie restriction in cerebrum observed in this thesis do 
not conform with the findings documented by Thilmany (2013) and Söhn (2010). 
Cerqueira et al. (2012) analysed the effects of calorie restriction (60 %, supplemented with 
micronutrients) on brain form mice. They found large increased amounts of cytochrome c 
oxidase and mitofusin-1, as well as strongly increased activity of citrate synthase, and 
concluded that mitochondrial mass in the brains of animals under calorie restriction must be 
increased. Increased amount of CIV was found in this thesis only for individual IV1 in 
cerebellum in aged rats under calorie restriction (CR) and in hippocampus for rats under ST 
and LT as well as for cerebrum under ST. Total CIV is increased under ST and LT in 
cerebrum.  
Olgun et al. (2002) analysed brain mitochondria from mice under calorie restriction (alternate 
day feeding). They found that the amount of total CI and total CIII did not change, while the 
quantity of total CIV increased under calorie restriction (+ 16%). The latter is in line with the 
findings for the amount of total CIV of cerebrum for ST and LT. Cerebrum as the biggest 
analysed part, could be the most similar to the whole mouse brain. 
Groebe et al. (2007) analysed the effects of ageing on rat brain mitochondria from 5-, 17- and 
31-months old Fischer rats. They found for several mitochondrial proteins that the amount 
decreased with age, among them ATP synthase subunit beta (ATPB), tubulin, cytochrome c 
oxidase subunit Va (COX5A) and malate dehydrogenase (MDHM). These proteins were also 
analysed in this thesis. COX5A is included in total CIV, of which the amount is decreased due 
to ageing (AL) in hippocampus and cerebrum, and not changed in cerebellum. ATPB is 
included in the analysis of all beta subunits of ATP synthase, of which the amount decreased 
with age (AL) in hippocampus but increased in cerebrum and is not changed in cerebellum. 
The amount of MDHM is found here to decrease with age (AL) in cerebrum, but increases in 
hippocampus and is unchanged in cerebellum. Tubulin shows decreased amount in cerebrum, 
but increased in cerebellum and no change in hippocampus. Mainly the tendency for 
decreased mitochondrial protein amount is the same in hippocampus and cerebrum. There are 
obviously differences regarding the analysed single brain parts compared to the whole brain 
analysed by Groebe et al. (2007).  
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4.2.6 Quantitation of complex I and IV in-gel activity 
Below, the analysis of the results is explained on the basis of the CI in-gel activity test of the 
hippocampus samples. The procedure is similar for cerebellum and cerebrum samples and 
likewise CIV in-gel activity.  
All animal groups were examined in triplicates. 100 µg (b. sol. d/p: 8g/g, 3.3.1) of RBM 
proteins were loaded on each lane of an 18 cm by 16 cm sized imidazole BN gel in addition 
with three lanes of 70 µg (b. sol. d/p: 3g/g) BHM as standard. BN PAGE was performed as 
described in 3.4, followed by CI in-gel activity test (3.8, respectively CIV in-gel activity test). 
Images were taken at different time points (see 3.7.3). Evaluation took place as described in 
3.11.2. Please keep in mind that printed images differ from evaluated original grey scale 
images as described in 3.11. 
In Fig. 4.52 images of the BN gel with the hippocampus samples (triplicates of YAL, YCR, 
OAL, OCR) are presented. For one hippocampus sample and for BHM, the complexes and 
supercomplexes are marked. The abbreviations for the supercomplexes are: a = I1III2, 
b = I1III2IV1, c = I1III2IV2, d = I1III2IV3. An image of the BN gel at time point zero is shown 
in Fig. 4.52A. In Fig. 4.52B the same BN gel is depicted, but 120 min after start of CI in-gel 
activity test. The fused image from Delta2D analysis, containing all grey scale images of 
every time point, is depicted in Fig. 4.52C.  
A B 
C Fig. 4.52: CI in-gel activity test: hippocampus 
samples on BN gels. 100 µg (b. sol. d/p: 8g/g) 
mitochondrial proteins were separated by BN PAGE
for each hippocampus sample (YAL, YCR, OAL, 
OCR). 70 µg (b. sol. d/p: 3g/g) BHM were loaded as 
standard. OxPhos complexes and supercomplexes 
are marked.  
a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3. 
A: BN gel at t = 0 min 
B: BN gel at t = 120 min 
C: fused image of all grey scale BN gel images (all 
scanned time points) 
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As control for unspecific staining 
of the bands during time, the in-
tensities of the bands (their grey 
value pixel volume V [grey units]) 
of ATP synthase monomer (V1) 
are plotted versus time [min] in 
Fig. 4.53 for all hippocampus 
samples. It is apparent, that the 
intensities remain nearly constant 
between the threshold values 
±0.25 for all samples and time 
points. 
 
 
For every time point, the 
intensities of the bands for all 
hippocampus samples are given in 
Fig. 4.54 and Fig. 4.55. The 
figures illustrate plots of the 
intensities of the bands [grey 
units] versus time [min]. Lines of 
best fit, their linear equation and 
coefficient of determination are 
given for all triplicates of the 
samples. The slopes reflect the 
specific activity in grey units per 
minute for each band. They were 
normalised for quantitation as 
described in 3.11.2.  
In Fig. 4.54 the development of 
the bands of individual complex I1 
and of the CI containing complex 
I1IV2 for duration of the in-gel 
activity test is presented.  
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Fig. 4.53: CI in-gel activity test: plot of the intensities of the
complex V1 bands for all time points. All hippocampus samples 
are shown. The V1 band serves as a control for unspecific staining 
during time. Intensities are given in V values (grey units). 
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Fig. 4.54: CI in-gel activity test: plots of the intensities of the 
bands from complex I1 and I1IV2 during time. All hippocampus 
samples (YAL, YCR, OAL, OCR, three repeats each) are shown for 
every scanned time point. Lines of best fit, their linear equation and 
coefficient of determination are given. Slopes are used for 
quantitation. Intensities are shown in V values [grey units]. 
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Fig. 4.55: CI in-gel activity test:
plots of the band intensities from 
supercomplexes I1III2, I1III2IV1, 
I1III2IV2 and I1III2IV3 versus time. 
All hippocampus samples (YAL, 
YCR, OAL, OCR, three repeats each) 
are shown for every scanned time 
point. Intensities are depicted in V 
values [grey units], time in min. Lines 
of best fit, their linear equation and 
coefficient of determination are given.
Slopes are used for quantitation.  
 
Fig. 4.55 depicts similar plots for 
the development of the CI contain-
ing supercomplexes (I1III2, 
I1III2IV1, I1III2IV2, I1III2IV3).  
In all plots of Fig. 4.54 and Fig. 
4.55, the linear development of the 
band intensities during time is ap-
parent.  
Coefficients of determination 
show good matches of the lines of 
best fit with the experimental data. 
Linear equations display the 
slopes, which are needed for nor-
malisation and final quantitation of 
the specific activity (3.11.2). 
Normalised specific activities of 
CI and CIV (in grey units per min) 
are presented as bar plots (see be-
low). The bars represent the mean 
of the triplicates. The error bars 
show the standard errors of the 
mean. Statistics were performed as 
described in 3.11.3. Black aster-
isks indicate changes in ageing 
and red asterisks in calorie restric-
tion. Significance levels are 
0.05 (*) and 0.01 (**).  
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Cerebellum 
CI in-gel activity test was performed 
(3.8) for cerebellum samples and 
evaluated quantitatively as described 
before on the example of hippo-
campus samples and as outlined in 
3.11.2. In Fig. 4.56 the left part of the 
colour scale image of the BN gel after 
incubation for 120 min in CI activity 
test solution is shown. The complete 
image is attached in “7 Supplements”, 
Fig. 7.10, as well as the analysed 
fused image in Fig. 7.11. Triplicates 
of each cerebellum animal group were 
analysed (not shown in Fig. 4.56). 
Each sample lane contained 100 µg 
(b. sol. d/p: 8g/g) RBM protein. An 
additional lane of 70 µg (b. sol. 
d/p: 3g/g) of the standard BHM were 
loaded too. By eye, the blue/purple 
precipitate of NBT diformazan is 
visible, which correlates with the activity of CI in individual complex I1 and in the 
supercomplexes I1IV2, I1III2, I1III2IV1, I1III2IV2 and I1III2IV3. Differences between the four 
animal groups are not observable by eye. Some weak blue/purple bands in the lower area of 
the gel are also observable, but cannot be related to a specific complex, and are therefore not 
considered for evaluation. Complexes V1 and V2 are visible as CBBG stained bands only, 
therefore they can be used as control for unspecific background staining (see above). A larger 
intensity of the CI staining is observable for BHM, although a smaller amount of BHM 
protein was loaded than of RBM, hence BHM show a higher CI in-gel activity than RBM. 
The most intense CI staining is observable for BHM in supercomplex I1III2IV1 and for RBM 
in supercomplex I1III2.  
Fig. 4.57 illustrates the specific activities in grey units per minute for CI in individual 
complex I1 and in the supercomplexes I1IV2, I1III2, I1III2IV1, I1III2IV2 and I1III2IV3. All four 
animal groups are depicted.  
In comparison of the specific activities of CI in all supercomplexes to complex I1 (Fig. 4.57), 
an overall trend for all animal groups (YAL, YCR, OAL, OCR) is observable. The specific 
activity of CI in I1IV2 is for all groups smaller (-37 % in average) than for I1, while for the 
supercomplexes I1III2 (+60 %), I1III2IV1 (+114 %), I1III2IV2 (+168 %) and I1III2IV3 (+190 %, 
all in average) the specific activity of CI rises with increased mass.  
When considering the changes of ageing and calorie restriction in a certain complex, no 
pronounced changes in specific activity occur. Animals aged under calorie restriction (YCR 
vs. OCR, black asterisk) show a lower activity of CI in complex I1IV2 (-9.3 %, stat. sig.). 
Fig. 4.56: Cerebellum, 
cut image of BN gel
after 120 min in CI
activity test solution. 
From each cerebellum 
sample (YAL, YCR, 
OAL, OCR), 100 µg 
(b. sol. d/p: 8g/g) mito-
chondrial proteins were 
separated by BN PAGE, 
followed by CI in-gel 
activity test. 70 µg 
(b. sol. d/p: 3g/g) of BHM 
were also loaded as 
standard. CI activity 
generates blue / purple 
precipitate of NBT 
diformazan. OxPhos 
complexes and super-
complexes are marked.  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3. 
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Long-term calorie restriction (OAL vs. OCR) increases the specific CI activity for the 
supercomplexes I1III2 (+15.1 %), I1III2IV1 (+14.4 %) and I1III2IV2 (+13.7 %, all not stat. sig.). 
 
For CIV in-gel activity test, 100 µg (b. sol. d/p: 8g/g) of RBM proteins were loaded on the 
BN gel for each cerebellum sample lane (YAL, YCR, OAL, OCR) in triplicates. Lanes of 
70 µg (b. sol. d/p: 3g/g) BHM were added as standard. After gel run, CIV in-gel activity test 
was executed as described in 3.8 and the grey scale images evaluated according to 3.11.2. Fig. 
4.58 illustrates the colour scale image of the left part of the BN gel after 150 min of 
incubation in CIV activity test 
solution. The entire image is 
shown in “7 Supplements”, Fig. 
7.12. The brownish precipitate of 
polymerised / oxidised DAB on 
the bands of complexes and 
supercomplexes is caused by 
reaction of CIV. Already by eye 
the precipitate is visible (Fig. 
4.58), but variations in activity of 
the different RBM samples are 
only apparent, when analysed 
with the software Delta2D in 
fused images (Fig. 7.13) on basis 
of the grey scale images.  
In Fig. 4.58 it is observable that 
the total CIV activity of the lanes 
with cerebellum RBM is lower 
compared to the BHM lane, 
Fig. 4.58: Cerebellum, 
cut image of BN gel 
after 150 min in CIV ac-
tivity test solution. For 
each sample lane, 
100 µg (b. sol. d/p: 8g/g) 
of mitochondrial protein 
from every cerebellum 
sample were loaded on 
the BN gel. 70 µg  (b. sol. 
d/p: 3g/g) BHM were 
loaded as standard. Fin-
ished gel was put in CIV
activity test solution.
Brownish precipitate of 
polymerised / oxidised 
DAB shows CIV activity. 
OxPhos complexes and 
supercomplexes are 
marked.  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3. 
Fig. 4.57: Cerebellum, CI in-gel activity: specific activities of CI in individual and supercomplexes.
For each cerebellum animal group (YAL, YCR, OAL, OCR), the specific activity (in grey units per minute) 
of CI in each analysed gel band is plotted.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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although the loaded amount of BHM protein was lower than of RBM, hence the CIV activity 
of BHM is higher than of RBM. For all RBM samples, complexes IV1, I1III2IV2 and I1III2IV3 
show the most intense precipitate, whereas it is weak developed for complexes IV2, III2IV1, 
I1IV2 and I1III2IV1. Non-active complexes, V1, V2 and I1III2, exhibit no brownish precipitate, 
only initial blue CBBG stain is apparent.  
The results of quantitative evaluation are depicted as bar plots in Fig. 4.59. Fig. 4.59A 
expresses the specific activity of CIV in its homooligomeric and heteromeric assemblies. Fig. 
4.59B reflects the specific activity, but normalised to one copy of CIV per analysed (super-) 
complex.  
When comparing the specific activity of CIV monomer IV1 to all other CIV containing 
complexes, an overall trend is visible for all analysed animal groups. In Fig. 4.59A the 
specific activity of CIV in the dimer IV2 (-57 %) and in I1IV2 (-34 %, both in average) is 
lower than in the individual IV1, approximately on the same level for complex III2IV1 (-4 %), 
and increases with mass of the supercomplexes I1III2IV1 (+78 %), I1III2IV2 (+367 %) and 
I1III2IV3 (+300 % all in average).  
If specific activity is normalised to one copy of CIV, for comparison of the different forms of 
assembly (Fig. 4.59B), the specific CIV activity of IV1 equals to the activity of III2IV1 (-4 %) 
and I1III2IV3 (+33 %, both in average). The dimer IV2 (-78 %) and I1IV2 (-67 %, both in 
average) show less than half of the specific CIV activity of the monomer. The specific activity 
of CIV in the supercomplexes I1III2IV1 (+78 %) and I1III2IV2 (+133 %, both in average) is 
raised compared to IV1. For the old animals (OAL, OCR) the CIV activity of complex 
I1III2IV1 and for all rat groups the activity of CIV in I1III2IV2 is even more than doubled.  
Concerning the analysis of ageing or calorie restriction, both plots of CIV specific activity 
(Fig. 4.59) lack stat. sig. differences between the analysed animal groups. Only for the effect 
of ageing, stat. not sig. tendencies for increased activity of CIV in age are visible, especially 
for complex I1IV2 (+61.9 %, ageing under calorie restriction YCR vs. OCR) and I1III2IV1 
(+56.8 %, ageing of ad libitum fed animals, YAL vs. OAL).  
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Fig. 4.59: Cerebellum, CIV in-gel activity test, specific activities of CIV in homooligomers and 
supercomplexes. For each cerebellum animal group (YAL, YCR, OAL, OCR), the specific activity (in grey 
units per minute) of CIV in each analysed gel band is plotted. A: specific activities of total CIV in the 
visualised complex, B: specific activities of CIV, normalised to its portion of the displayed complex.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Hippocampus 
For each hippocampus sample 
lane, 100 µg (b. sol. d/p: 8g/g) of 
RBM protein were loaded on the 
BN gel. The different animal 
groups (YAL, YCR, OAL, OCR) 
were triplicated. Additional lanes 
with 70 µg (b. sol. d/p: 3g/g) BHM 
were loaded as standard. The gel 
image in Fig. 4.60 was taken after 
incubation in CI activity test 
solution for 120 min. Only the left 
part of the gel is shown. The entire 
image is given in Fig. 4.52 and in 
“7 Supplements”, Fig. 7.10. The 
analysed fused image is depicted in 
Fig. 7.11. The blue/purple pre-
cipitate of NBT diformazan, as a 
result of CI activity, is apparent for 
individual complex I1 and the 
supercomplexes I1IV2, I1III2, 
I1III2IV1, I1III2IV2 and I1III2IV3. By eye, changes between animal groups of hippocampus are 
not visible. As already seen for cerebellum samples, some weak blue/purple bands in the 
lower area of the gel appear, but cannot be related to a specific complex, and are therefore not 
considered for evaluation. As already seen for cerebellum samples, a larger intensity of the CI 
staining is observable for BHM, although a smaller amount of BHM protein was loaded than 
of RBM. Therefore, BHM show a higher CI activity than RBM. The most intense CI staining 
is observable for BHM in supercomplex I1III2IV1 and for RBM in supercomplex I1III2.  
Quantitative evaluation of the formation of the precipitate was performed as described above 
and in 3.11.2 on the basis of the grey scale images. The results in form of specific activity of 
CI (in grey units per minute) are given for individual complex I1 and the supercomplexes 
I1IV2, I1III2, I1III2IV1, I1III2IV2 and I1III2IV3 in Fig. 4.61.  
An overall trend is visible in Fig. 4.61. When the specific activity of CI for individual 
complex I1 is compared to the supercomplexes, it is apparent for each animal group that the 
specific activity of CI is lower in I1IV2 (-31 % in average) than in complex I1, but higher in 
the supercomplexes I1III2 (+66 %), I1III2IV1 (+117 %), I1III2IV2 (+140 %) and I1III2IV3 
(+145 %, all in average). The specific activity of CI rises with increased masses of 
supercomplexes. This trend is in line with the findings for cerebellum (see above). 
Ageing leads to decreased CI activity in ad libitum nourished rats (YAL vs. OAL, black 
asterisks) for individual complex I1 (-31.1 %) and supercomplex I1IV2 (-32.1 %, both stat. 
sig.), as well as for supercomplex I1III2IV1 (-13.5 %, not stat. sig.). Likewise animals aged 
under calorie restriction (YCR vs. OCR, black asterisk) show decreased CI activity for I1IV2 
(-26.9 %, stat. high sig.) and individual complex I1 (-12.2 %, not stat. sig.) (Fig. 4.61). 
Fig. 4.60: Hippocampus, 
cut image of BN gel 
after 120 min in CI
activity test solution. 
From each hippocampus 
sample (YAL, YCR, OAL, 
OCR), 100 µg (b. sol. 
d/p: 8g/g) mitochondrial 
proteinswere separated 
by BN PAGE, followed by 
CI in-gel activity test. 
70 µg (b. sol. d/p: 3g/g) of 
BHM were also loaded as 
standard. CI activity gen-
erates blue / purple 
precipitate of NBT 
diformazan. OxPhos com-
plexes and supercom-
plexes are marked.  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3. 
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Short-term calorie restriction (YAL vs. YCR) reduces the specific activity of CI for 
supercomplexes I1III2 (-11.8 %), I1III2IV1 (-16.2 %) and I1III2IV2 (-11.1 %, all not stat. sig.). 
Long-term calorie restriction (OAL vs. OCR, red asterisk) decreases the activity of CI in 
supercomplex I1III2 (-10.8 %, stat. sig.).  
 
For CIV in-gel activity test, triplicates of 100 µg (b. sol. d/p: 8g/g, 3.3.1) proteins of hippo-
campus RBM per BN gel lane were separated with additional lanes of 70 µg (b. sol. d/p: 3g/g) 
BHM as standard on BN PAGE. 
In-gel activity test was per-
formed as described in 3.8.  
In Fig. 4.62 the left side of the 
coloured image of the BN gel 
after 150 min of incubation in 
CIV activity test solution is 
given. The complete image is 
attached in “7 Supplements”, 
Fig. 7.12. The analysed fused 
image is depicted in Fig. 7.13.  
Just as shown above for cere-
bellum samples, lanes with 
hippocampus RBM have a lower 
specific activity of CIV than 
lanes containing BHM, even 
though the loaded protein 
amount of BHM was smaller 
Fig. 4.62: Hippocampus, 
cut image of BN gel 
after 150 min in CIV ac-
tivity test solution. For 
each sample lane, 100 µg 
(b. sol. d/p: 8g/g) of mito-
chondrial protein from 
every hippocampus sam-
ple were loaded on the 
BN gel. 70 µg BHM 
(b. sol. d/p: 3g/g) were 
loaded as standard. Fin-
ished gel was put CIV ac-
tivity test solution.
Brownish precipitate of 
polymerised / oxidised 
DAB shows CIV activity. 
OxPhos complexes and 
supercomplexes are 
marked.  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3. 
Fig. 4.61: Hippocampus, CI in-gel activity: specific activities of CI in individual and super-
complexes. For each hippocampus animal group (YAL, YCR, OAL, OCR), the specific activity (in grey 
units per minute) of CI in each analysed gel band is plotted.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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than of RBM. This is apparent due to the brownish precipitate of polymerised / oxidised DAB 
on top of the bands. By eye the brownish precipitate is observable for the complexes IV1, 
I1III2IV2 and I1III2IV3, and only weakly for IV2, III2IV1, I1IV2 and I1III2IV1. Bands of V1, V2 
and I1III2 exhibit only blue staining, originated from bound CBBG from the cathode buffer.  
Quantitative analysis of specific activity of CIV in hippocampus RBM was performed on the 
basis of grey scale images (see 3.11.2). Results are shown in Fig. 4.63. 
Fig. 4.63A displays the specific activity of CIV in its homooligomeric and supercomplex 
assemblies from hippocampus mitochondria. In Fig. 4.63B, this specific activity is normalised 
to the number of copies of CIV in each analysed complex. Although large error bars are 
present, an overall trend is observable for the comparison of the specific activity of individual 
complex IV1 to the specific CIV activity from dimer IV2 or the supercomplexes. As 
observable in Fig. 4.63A, complex IV2 (-55 %) and supercomplex I1IV2 (-20 %) have lower 
specific CIV activity than IV1, while for CIII containing supercomplexes, the CIV activity 
increases with mass: III2IV1 (+34 %) and I1III2IV1 (+87 %), I1III2IV2 (+280 %) and I1III2IV3 
(+260 %, all in average).  
If normalised to the number of copies of CIV in the analysed (super-)complex (Fig. 4.63B), 
the differences in specific CIV activities of the supercomplexes become smaller. The CIV 
activities in the dimer IV2 (-77 %) and complex I1IV2 (-60 %) stay lower compared to IV1, 
while CIV activities of supercomplexes III2IV1 (+34 %) and I1III2IV3 (+20 %) are slightly 
increased and CIV activity of supercomplexes I1III2IV1 (+87 %) and I1III2IV2 (+90 %, all in 
average) are almost double the activity of IV1. In both plots, the monomer IV1 of YAL RBM 
shows a little lower activity than all the others.  
Due to the large error bars (Fig. 4.63), observable variations in ageing and calorie restriction 
have to be taken with caution. In aged ad libitum fed animals (YAL vs. OAL) an increase of 
specific CIV activity in individual complex IV1 (+54.7 %, not. stat. sig.) is visible. The CIV 
activity in complex III2IV1 is increased (+50.1 %, stat. sig.) for aged animals under calorie 
restriction (YCR vs. OCR, black asterisk).  
Short-term calorie restriction (YAL vs. YCR) increases CIV activity in complex IV1 
(+80.5 %, not stat. sig.), while the CIV activity is decreased for III2IV1 (-41.8 %, not stat. 
sig.). Long-term calorie restriction (OAL vs. OCR) decreases the specific CIV activity in 
complex III2IV1 (-19.7 %, not stat. sig.).  
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Fig. 4.63: Hippocampus, CIV in-gel activity test, specific activities of CIV in homooligomers and 
supercomplexes. For each hippocampus animal group (YAL, YCR, OAL, OCR), the specific activity (in 
grey units per minute) of CIV in each analysed gel band is plotted. 
A: specific activities of total CIV in the visualised complex, B: specific activities of CIV, normalised to its 
portion of the displayed complex.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Cerebrum 
From each cerebrum animal group 
(YAL, YCR, OAL, OCR) 100 µg 
(b. sol. d/p: 8g/g) were loaded onto 
the BN gel in triplicates. Lanes of 
70 µg (b. sol. d/p: 3g/g) BHM were 
added as standard. In Fig. 4.64 the 
left part of the BN gel image is 
depicted after incubation in CI 
activity test solution for 120 min. 
The entire image is attached in 
“7 Supplements”, Fig. 7.10, and the 
analysed fused image in Fig. 7.11. 
CI activity is visible by formation of 
the blue/purple precipitate of NBT 
diformazan. Individual complex I1 
and the supercomplexes I1IV2, I1III2, 
I1III2IV1, I1III2IV2 and I1III2IV3 can 
be related. The bands of complexes 
V1 and V2 remained blueish from 
CBBG, they can be used as control 
for unspecific activity staining. By eye, no variations between animal groups of cerebrum are 
visible. Additionally some weak blue/purple bands in the lower area of the gel appear, as 
already mentioned for cerebellum and hippocampus samples, but they cannot be related to 
any specific complex, and are therefore not considered for evaluation. 
A larger intensity of the CI staining is observable for BHM, although a smaller amount of 
BHM protein was loaded than of RBM. Therefore, BHM show a higher CI in-gel activity than 
RBM. The most intense CI staining is observable for BHM in supercomplex I1III2IV1 and for 
RBM in supercomplex I1III2.  
Evaluation of results was executed for cerebrum, as exemplified above for the hippocampus 
samples, and as explained in 3.11.2 on the basis of grey scale images. The resulting specific 
activity of CI (in grey units per minute) of cerebrum is plotted in Fig. 4.65 for individual 
complex I1 and the supercomplexes I1IV2, I1III2, I1III2IV1, I1III2IV2 and I1III2IV3.  
When the specific activity of CI in individual complex I1 is compared to the CI activity in 
supercomplexes (Fig. 4.65), the same trend is observable for cerebrum as mentioned above 
for cerebellum and hippocampus. Specific activity of CI in individual complex I1 is always 
higher than in complex I1IV2 (-42 % in average), but for the supercomplexes I1III2 (+70 %), 
I1III2IV1 (+93 %), I1III2IV2 (+166 %) and I1III2IV3 (+210 % all in average) enhancement of 
specific activity becomes apparent with increasing mass of the supercomplex.  
In Fig. 4.65 no pronounced changes are observable for the analysis of CI activity in cerebrum 
during ageing or calorie restriction. Ageing reduces specific CI activity in ad libitum 
nourished animals (YAL vs. OAL) for complex I1 (-18.6 %, not stat. sig.) and for animals 
Fig. 4.64: Cerebrum, cut 
image of BN gel after 
120 min in CI activity 
test solution. From each 
cerebrum sample (YAL, 
YCR, OAL, OCR), 100 µg 
(b. sol. d/p: 8g/g) mito-
chondrial proteins were 
separated by BN PAGE, 
followed by CI in-gel ac-
tivity test. 70 µg (b. sol. 
d/p: 3g/g) BHM proteins 
were also loaded as 
standard. CI activity 
generates blue / purple 
precipitate of NBT di-
formazan. OxPhos com-
plexes and supercom-
plexes are marked.  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3. 
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grown under calorie restriction (YCR vs. OCR) for complexes I1 (-26.8 %) and I1IV2 
(-21.7 %, both not stat. sig.).  
Long-term calorie restriction (OAL vs. OCR) increases CI specific activity for supercomplex 
I1III2IV3 (+11.5 %, not stat. sig.). No other variations can be examined for cerebrum. 
 
The CIV in-gel activity test was 
performed on a BN gel with 
100 µg (b. sol. d/p: 8g/g) mito-
chondrial protein per cerebrum 
sample lane. Each sample (YAL, 
YCR, OAL, OCR) was trip-
licated. Lanes with 70 µg (b. sol. 
d/p: 3g/g) BHM were added as 
standard. The activity test was 
conducted for 150 min (3.8.1). 
The left part of the BN gel, after 
150 min incubation time, is 
shown in Fig. 4.66. The entire 
image is attached in 
“7 Supplements”, Fig. 7.12.  
The amount of the brown 
precipitate of polymerised / oxi-
dised DAB on top of bands is 
related to the specific activity of 
Fig. 4.66: Cerebrum,
cut image of BN gel 
after 150 min in CIV ac-
tivity test solution. For 
each sample lane, 
100 µg (b. sol. d/p: 8g/g) 
of mitochondrial protein 
from every cerebrum 
sample were loaded on 
the BN gel. 70 µg BHM 
(b. sol. d/p: 3g/g) were 
loaded as standard. Fin-
ished gel was put in CIV
activity test solution.
Brownish precipitate of 
polymerised / oxidised 
DAB shows CIV activity. 
OxPhos complexes and 
supercomplexes are 
marked.  
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3. 
Fig. 4.65: Cerebrum, CI in-gel activity: specific activities of CI in individual and supercomplexes.
For each cerebrum animal group (YAL, YCR, OAL, OCR), the specific activity (in grey units per minute) of 
CI in each analysed gel band is plotted.  
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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CIV, and can even be allocated by eye, as visible in Fig. 4.66. Homooligomeric complexes 
IV1, IV2, and supercomplexes III2IV1, I1IV2, I1III2IV1, I1III2IV2 and I1III2IV3 can be assigned. 
The latter two show the most intensity of brownish precipitate. Bands of V1, V2 and I1III2 
remain blueish from CBBG. The lane of BHM exhibits more precipitate than the RBM 
sample lanes, which was seen for cerebellum and hippocampus samples, too. Hence the 
activity of BHM is highter than of RBM, although a smaller amount of BHM was loaded.  
For quantitative analysis, the grey scale images were examined as described in 3.11.2, the 
fused image is depicted in Fig. 7.13. The results are plotted in Fig. 4.67. In Fig. 4.67A, the 
specific in-gel activity for CIV in its homooligomeric and supercomplex assemblies is plotted. 
Fig. 4.67B illustrates the specific activity of CIV normalised to its number of copies in the 
displayed (super-)complexes. By comparison of specific CIV activity of the monomer IV1 to 
the activities of the other CIV containing complexes, overall trends are as follows (Fig. 
4.67A): the specific CIV activity of complex IV2 (-32 %, in average) is decreased compared 
to IV1, while for all other complexes the CIV activity is increased. The CIV activity of 
complex I1IV2 (+56 %) is slightly increased, while for CIII containing supercomplexes the 
increase is stronger and increases with mass of the supercomplex: III2IV1 (+208 %), I1III2IV1 
(+218 %), I1III2IV2 (+592 %) and I1III2IV3 (+497 %, all in average).  
After normalisation to the number of copies of CIV in the analysed (super-)complex, the 
specific CIV activities of complex IV2 (-66 %) and complex I1IV2 (-22 %) are lower than the 
from IV1. The specific activity of CIV in supercomplexes III2IV1 (+208 %), I1III2IV1 
(+218 %) and I1III2IV2 (+246 %) are approximately at the same level, while the activity of 
supercomplex I1III2IV3 is less increased (+99 %, all in average).  
Changes caused by ageing are present for animals under calorie restriction only (YCR vs. 
OCR, Fig. 4.67). The activity of CIV is statistically non-significantly reduced for the 
monomer IV1 (-20.3 %) and supercomplex III2IV1 (-22.8 %, both not stat. sig.), whereas for 
the supercomplexes I1IV2 (+66.2 %, not stat. sig.) and I1III2IV1 (+60.0 %, stat. sig.) an 
increase of activity is observable.  
Short-term calorie restriction (YAL vs. YCR, red asterisk) increases specific CIV activity, for 
IV2 (+48.8 %, stat. sig.) and for III2IV1 (+40.5 %, not stat. sig.) and long-term calorie 
restriction (OAL vs. OCR) for supercomplex I1III2IV1 (+27.8 %, not stat. sig.). 
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Fig. 4.67: Cerebrum, CIV in-gel activity test, specific activities of complex IV in homooligomers 
and supercomplexes. For each cerebrum animal group (YAL, YCR, OAL, OCR), the specific activity (in 
grey units per minute) of CIV in each analysed gel band is plotted. A: specific activities of total CIV in the 
visualised complex, B: specific activities of complex IV, normalised to its portion of the displayed complex. 
bar plots: mean of technical repeats (n=3), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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Summary 
The results of the CI and CIV in-gel activity tests are summarised in Table 4.31 and Table 
4.32. For comparison of specific CI (or CIV) activity in individual complex I1 (or IV1) to 
(super-)complexes, the changes in specific CI (or CIV) activities normalised to individual 
complex I1 (or IV1) of the analysed (super-)complexes, averaged on the four animal groups, 
are listed in Table 4.31. 
In Table 4.31 it is observable that specific CI activity in complex I1IV2 is decreased compared 
to individual I1, while for the other supercomplexes I1III2, I1III2IV1, I1III2IV2 and I1III2IV3 the 
specific CI activity increases with mass of the respective supercomplex. The highest activities 
of CI are found in supercomplex I1III2IV3 for all three brain tissues. 
Thilmany (2013) found the highest activity of CI in the supercomplexes as well, but the 
activity of the supercomplexes seems to be tissue specific, as she found the highest CI 
activities predominantly for I1III2IV1 in subsarcolemmal (sub) and predominantly for I1III2IV2 
in intrafibrillar (int) rat heart mitochondria (RHM).  
It seems also to be strain specific, as Frenzel (2011) found in her analysis of cerebral cortex 
mitochondria from Wistar rats the highest CI activity in I1III2IV1.  
Table 4.31: Comparison of specific CI and CIV activity  
of the respective monomer to the respective (super-) complex 
specific CI activity 
normalised to I1 [%] 
(all groups in average) 
I1IV2 I1III2 I1III2IV1 I1III2IV2 I1III2IV3  
Cerebellum -37 +60 +114 +168 +190  
Hippocampus -31 +66 +117 +140 +145  
Cerebrum -42 +70 +93 +166 +210  
Mean -37 +65 +108 +158 +182  
       
specific CIV activity 
normalised to IV1 [%] 
(all groups in average) 
IV2 I1IV2 III2IV1 I1III2IV1 I1III2IV2 I1III2IV3 
Cerebellum -57 -34 -4 +78 +367 +300 
Hippocampus -55 -20 +34 +87 +280 +260 
Cerebrum -32 +56 +208 +218 +592 +479 
Mean -48 +1 +79 +101 +413 +346 
Mean 
after normalisation to  
no. of CIV copies 
-24 +0 +79 +101 +207 +115 
 
After normalisation to one copy of CIV, it is observable for specific CIV activity, that the 
dimer IV2 is less active than the individual IV1, while specific CIV activity of I1IV2 is at the 
same level as for individual IV1. For all CIII containing supercomplexes (III2IV1, I1III2IV1, 
I1III2IV2 and I1III2IV3) the CIV activity is increased with mass of the respective 
supercomplex, only for I1III2IV3 the activity is at the same level as I1III2IV1. The highest 
activities of CIV are found in supercomplex I1III2IV2 for all three brain tissues (Table 4.31). 
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Thilmany (2013) found for subsarcolemmal and intrafibrillar rat heart mitochondria the 
highest CIV activity for I1III2IV2. But she analysed only supercomplexes III2IV1, I1III2IV1 and 
I1III2IV2.  
It is remarkable that for CI and CIV activity the presence of CIII increases the activity in such 
a strong way. This is in line with the finding of Schäfer et al. (2006) that CIII is essential for 
CI assembly and stability as well as the suggested role of CIV to stabilise the supercomplex 
formation.  
 
For each tissue sample, the results for changes in age for ad libitum fed animals (AL: YAL vs. 
OAL) and under calorie restriction kept animals (CR: YCR vs. OCR) are presented as well as 
the effects of short-term (ST: YAL vs. YCR) and long-term (LT: OAL vs. OCR) calorie 
restriction. The arrows represent the increasing ( ) or decreasing ( ) specific activity for CI 
or CIV of the compared animal groups as a summary of the findings. Both arrows are used in 
grey (not stat. sig.), orange (stat. sig.) and red (stat. high sig.). Black dashes ( ) were ▬
placed, where no variation could be examined. Main tendencies are quoted below. For more 
details, see the chapters about the different brain parts. 
 
For all analysed tissues, the changes in specific activity of CI and CIV due to ageing or 
calorie restriction are not very pronounced. Most of the observed variations are statistically 
non-significant tendencies.  
Under the influence of ageing, specific CI activity seems to decrease for complexes I1 and 
small supercomplex I1IV2 in hippocampus and cerebrum and only under calorie restriction 
(CR) in cerebellum. Only in hippocampus (AL) the decreasing effect is apparent for the larger 
supercomplex I1III2IV1. Apart from that the CI activity does not change for the CIII 
containing supercomplexes, I1III2IV0-3.  
Short-term (ST) and long term (LT) calorie restriction have no influence on the specific CI 
activity of complexes I1 and I1IV2 in all tissues. LT calorie restriction increases specific CI 
activity in cerebellum for the supercomplexes I1III2IV0-2, whereas in hippocampus ST calorie 
restriction decreases CI activity for the supercomplexes I1III2IV0-2 and likewise for complex 
I1III2 under LT calorie restriction. Specific CI activity in cerebrum causes only one change: 
activity is increased in complex I1III2IV3 under LT calorie restriction.  
Just as CI specific activity test does not show large variances for the influences ageing and 
calorie restriction, CIV activity test does not reveal many changes. Most shown in Table 4.32 
are only statistically non-significant tendencies. In cerebellum the effects are marginal. In 
hippocampus, the CIV activity is not varied for supercomplexes of greater equal mass as I1IV2 
and I1III2IV0-3. For aged animals under calorie restriction (CR), a statistically significant 
increase in CIV activity for complex III2IV1 of hippocampus is observed.  
In animals under calorie restriction, only slight tendencies are present for hippocampus. In 
cerebrum, LT calorie restriction leads to a reduced CIV activity in complexes with lower 
mass, IV1 and III2IV1, but to an increase of CIV activity in supercomplexes with higher mass, 
I1IV2 and I1III2IV1. ST calorie restriction increases the CIV specific activity for the complexes 
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of lower mass (IV2 and III2IV1) in cerebrum, while supercomplexes of higher mass are not 
stat. sig. effected.  
Table 4.32: Summary of the results from in-gel activity tests for analysis of 
ageing and calorie restriction 
CI in-gel activity 
Cerebellum Hippocampus Cerebrum 
AL CR ST LT AL CR ST LT AL CR ST LT 
I1  ▬  ▬  ▬  ▬    ▬  ▬    ▬  ▬
I1IV2  ▬   ▬  ▬    ▬  ▬  ▬   ▬  ▬
I1III2  ▬  ▬  ▬   ▬  ▬    ▬  ▬  ▬  ▬
I1III2IV1  ▬  ▬  ▬    ▬   ▬  ▬  ▬  ▬  ▬
I1III2IV2  ▬  ▬  ▬   ▬  ▬   ▬  ▬  ▬  ▬  ▬
I1III2IV3  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  
CIV in-gel activity 
Cerebellum Hippocampus Cerebrum 
AL CR ST LT AL CR ST LT AL CR ST LT 
IV1  ▬  ▬  ▬  ▬   ▬   ▬  ▬   ▬  ▬
IV2  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬   ▬
III2IV1  ▬  ▬  ▬  ▬  ▬     ▬    ▬
I1IV2  ▬   ▬  ▬  ▬  ▬  ▬  ▬  ▬   ▬  ▬
I1III2IV1   ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬   ▬  
I1III2IV2  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬
I1III2IV3  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬  ▬
symbols: “ ”: increase, “ ”: decrease, “ : no change;  ▬”
colours: red: stat. high sig., orange: stat. sig., grey: not stat. sig. 
abbrev.: AL: ad libitum, CR: calorie restriction,  
 ST: short-term calorie restriction, LT: long-term calorie restriction  
 
The results of this thesis are compared to the findings of Thilmany (2013), because she 
analysed the activity from subsarcolemmal (sub) and intrafibrillar (int) rat heart mitochondria 
(RHM) of the same animals (Fischer 344 rats), which were used for this thesis. The changes 
in activities of CI and CIV from RHM for the different (super)complexes were averaged for 
comparison below.  
Dr. Thilmany found increased CI (sub +58 %, int +4 %) and CIV (sub +68 %, int +15 %) 
activity for aged animals under AL in both types of RHM, contrary to the findings in this 
thesis for RBM, where the CI and CIV activity is predominantly not changing under AL, with 
the exception of decreased CI activity in hippocampus under AL.  
Ageing under CR decreased CI activity in both types of RHM (sub -14 %, int -32 %), as well 
as CIV in sub RHM (-22 %), while in int RHM the CIV activity was increased (int +43 %). 
This is in line with the findings in this thesis for RBM, wherein CI activity in complex I1 and 
in the small supercomplex I1IV2 is decreasing likewise. However, CIV activity is 
predominantly not changed in cerebellum and hippocampus of animals aged under CR. In 
cerebrum, the found decreased CIV activity for smaller complexes as IV1 and I1III2IV1 and 
the increased CIV activity for supercomplexes I1IV2 and I1III2IV1 conform with the findings 
of Thilmany (2013) in int RHM. 
ST increased the CI (sub +25 %, int +8 %) and CIV activity (sub +68 %, int +1 %) in both 
types of RHM, only the activity of supercomplex I1III2IV1 was decreased in int RHM. In 
contrast to that ST showed predominantly no change in CI and CIV activity in RBM. Only in 
hippocampus the CI activity was decreased for larger supercomplexes. 
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Under LT the activities of CI (sub -32 %, int -30 %) and CIV (sub -22 %, ) were decreased for 
both types of RHM, only the CIV activity of int RBM (+26 %) was increased. This is in 
contrast to the predominantly not changed activity of RBM in this thesis and to the increase in 
CI activity as observable for larger supercomplexes in cerebellum. 
Tatarkova et al. (2011) analysed whole Wistar rat heart and found the activities of CI, CII, 
CIII and CIV decreased under the influence of ageing (AL), likewise Lombardi et al. (2009) 
found for CI, CII, CIV and CV in skeletal muscle of aged Wistar rats.  
Ojaimi et al. (1999) found decreased activities for CI, CII and CIV for aged human brain.  
Dani et al. (2010) analysed liver mitochondria from Wistar rats and found increased CIV 
activity for rats under AL and decreased CIV activity for animals under LT. 
Drew et al. (2003) analysed mitochondria from skeletal muscle and from heart of aged Fischer 
rats kept ad libitum and under calorie restriction and found ATP content and rate of ATP 
production decreased in skeletal muscle while in heart the content and rate were not changed. 
They found, that calorie restriction has no incluence on the content and rate of ATP 
production in both tissues. For mitochondria from liver and frontal cortex of brain, they could 
show just as well, that calorie restriction has no influence on the ATP content and rate of 
production for these tissues (Drew and Leeuwenburgh 2003). 
The findings for other tissues are difficult to compare to the results of rat brain. In summary, a 
tendency for decreased activity of OxPhos complexes as cause of ageing as well as calorie 
restriction is found in the other tissues.  
For comparison with brain, other studies on rat brain or rat brain areas are of interest. 
Therefore further comparison refers to publications on changes in brain. 
In their analysis of mitochondria from cerebral cortex during ageing (AL) Cocco et al. (2005) 
and Frenzel et al. (2010) did not find any changes in activity of CI, CIV (both publications) 
and CII, CII+CIII and CV (Cocco et al.). Gilmer et al. (2010) analysed cerebral cortex too, 
and found the respiration rates not changed for aged Fischer rats. Cerebral cortex is included 
in the cerebrum of the studies of this thesis. Cerebrum predominantly did not show any 
changes in CI or CIV activity under the influence of ageing (AL). This is in line with the 
findings of Filburn et al. (1996), who analysed whole rat brain homogenates of Wistar rats 
and found no changes in activity of CI, CIV and CV.  
These results are in contrast to the findings of Tian et al. (1998), Haripriya et al. (2004) and 
Boveris and Navarro (2008). Boveris and Navarro (2008) summarise that decreased electron 
transfer activity is found for CI and CIV of mitochondria from tissues such as brain, liver, 
heart and kidney of aged rats and mice, while the activity of CII and CIII remains unchanged. 
They show in their analyses of whole brain mitochondria from aged mice, kept ad libitum or 
calorie restricted, that CI and CIV activity is decreased with age for both animal groups and 
that CI and CIV activity is increased in calorie restricted animals compared to ad libitum fed 
ones. Haripriya et al. (2004) found decreased activity of CI and CIV in striatum, cerebral 
cortex and hippocampus of aged Wistar rats and Tian et al. (1998) decreased activity of CIV 
in whole brain of aged Fischer rats. Only the trend of decreased CI activity in hippocampus of 
aged rats (AL) is also observable in this thesis.   
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4.2.7  Mitochondrial membrane “fluidity” 
All steady-state fluorescence anisotropy measurements and evaluations were carried out by 
M. Sc. Stefanie Kern during and after her master thesis (Kern 2013).  
After the intercalation of the membrane probe DPH into the hydrophobic domain of 
mitochondrial membranes, the steady-state fluorescence anisotropy was measured. Steady 
state anisotropy measurement provides the information about the order parameter and the 
rotational dynamics of the membrane (Sugawa et al. 1996). The changes in anisotropy of the 
probe give information about the surrounding membrane order (Lentz 1993) and its viscosity 
(Heyn 1979). Membrane viscosity is inversely proportional to the “fluidity” of the membrane 
(Eckmann et al. (2014), 3.12).  
0.01 µg of proteins in their mitochondrial membranes (according to the results of Bradford 
protein assay, 4.2.1) of each animal sample (YAL, YCR, OAL, OCR) of each tissue 
(cerebellum, hippocampus, cerebrum) were incubated with 0.02 ng DPH per µL PBS and ten 
times measured by S. Kern as described in 3.12. The results are illustrated in Fig. 4.68. The 
bars show the mean of the ten technical repeats for each sample. The error bars represent the 
standard error of means. Statistics were performed by me as in 3.11.3. Changes in ageing are 
marked with black asterisks and red asterisks stand for variations based on calorie restriction. 
Significance levels are 0.05 (*) and 0.01 (**).  
As visible in Fig. 4.68, the measured anisotropies of DPH in the mitochondrial membranes of 
all three analysed tissues are between 0.200 and 0.350. The mitochondrial membrane for 
cerebellum of young animals (YAL 0.216, YCR 0.256) exhibit much lower anisotropy values 
of DPH, than all the other analysed samples (mean = 0.330). For YAL RBM of cerebellum 
the DPH anisotropy is about 35 % smaller and for YCR about 22 % smaller than the mean of 
the other samples. The changes in anisotropy of the other samples are mainly highly 
statistically significant, but very small.  
Considering Fig. 4.68, ageing of ad libitum fed animals (YAL vs. OAL, black asterisks) leads 
to an increased DPH anisotropy for RBM of cerebellum (+44.7 %) and cerebrum (+3.4 %, 
both stat. high sig.).  
Ageing under calorie restriction (YCR vs. OCR, black asterisks), increases the DPH 
anisotropy in RBM of cerebellum (+26.4 %, stat. high sig.) and decreases it in hippocampus 
(-4.7 %, stat. high sig.).  
Short-term calorie restriction (YAL vs. YCR, red asterisks) increases the DPH anisotropy in 
RBM of cerebellum (+18.8 %, stat. high sig.) and hippocampus (+7.5 %, stat. sig.).  
Long-term calorie restriction (OAL vs. OCR, red asterisks) increases the DPH anisotropy in 
RBM of cerebellum (+3.8 %, stat. sig.) and hippocampus (+3.8 %, stat. high sig.), while the 
DPH anisotropy is reduced in cerebrum (-5.3 %, stat. high sig.).  
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The results of the DPH anisotropy measurements are summarised in Table 4.33. Ageing and 
calorie restriction decreased in all analysed cases the membrane “fluidity” in cerebellum 
mitochondria. The “fluidity” of mitochondrial membranes from hippocampus is increased 
while ageing under calorie restriction (CR) and decreased by the influence of short-term (ST) 
and long-term (LT) calorie restriction. In cerebrum, the “fluidity” of the mitochondrial 
membranes is decreased by ageing (ad libitum, AL) and increases under long-term calorie 
restriction.However, all changes were very small.  
Table 4.33: Results of steady-state fluorescence anisotropy measurement of DPH 
 
Cerebellum Hippocampus Cerebrum 
AL CR ST LT AL CR ST LT AL CR ST LT 
DPH anisotropy      ▬      ▬  ▬  
“fluidity” of membrane      ▬      ▬  ▬  
symbols: “ ”: increase, “ ”: decrease, “ : no change;  ▬”
colours: red: stat. high sig., orange: stat. sig., grey: not stat. sig. 
abbrev.: AL: ad libitum, CR: calorie restriction,  
 ST: short-term calorie restriction, LT: long-term calorie restriction  
 
Mitochondrial membranes are maily composed of phospholipids, whereof the most are 
phosphatidylcholines, phosphatidylethanolamines and cardiolipins. Sterols and sphingolipids 
are only found in small quantity (Daum 1985). The fatty acid composition of phospholipids in 
mitochondrial membranes from liver and skeletal muscle varies under the influence of calorie 
restriction in similar way as from the surrounding tissue (Faulks et al. 2006). Assuming that 
this is applicable to other tissues, the analyses of synaptosomal plasma membranes from 
specific parts of the brain can be compared to the findings in this thesis. Increased anisotropy 
in synaptosomal membranes of cerebellum, cerebral cortex and striatum of very aged Wistar 
rats (40 months) was found by Sugawa et al. (1996) and explained by increased membrane 
content of cholesterol. This is in line with the findings by Choi and Yu (1995) for analysis of 
Fig. 4.68: Results of steady-state fluorescence anisotropy measurements of the membrane 
probe DPH, which was intercalated into the mitochondrial membranes of each animal group (YAL, 
YCR, OAL, OCR) of each tissue (cerebellum, hippocampus, cerebrum). Anisotropy of DPH is 
inversely related to the “fluidity” of the surrounding membrane. 
bar plots: mean of technical repeats (n=10), error bars: standard error of technical repeats 
significance: * = p < α (0.05); ** = p < α (0.01)  
asterisks in black: changes caused by ageing, (YAL vs. OAL; YCR vs. OCR) 
asterisks in red: changes caused by calorie restriction, (YAL vs. YCR; OAL vs. OCR) 
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cerebral cortex of Fischer rats. They found decreased membrane fluidity for aged rats and no 
change in membrane fluidity for rats aged under calorie restriction. The membrane fluidity of 
synaptosomal membranes from calorie restricted animals was usually higher than from ad 
libitum fed animals. They also observed a decreased cholesterol amount in aged CR animals. 
The findings in this thesis for mitochondria from cerebellum and cerebrum of ad libitum fed 
rats (AL) are in line with these observations, provided that cerebral cortex can be compared to 
cerebrum in this thesis, which consisted of cerebral cortex, basal ganglia and limbic system, 
whereof the hippocampus was removed and analysed separately. Wood et al. (2002) detected 
no change in the fluidity of annular lipids from synaptic plasma membranes of cerebral 
cortex, cerebellum and hippocampus in aged rats, while in striatum a decreased fluidity of the 
annular lipids was found. The finding for hippocampus is in line with this thesis, however the 
findings for cerebellum and cerebral cortex do differ from Choi and Yu (1995), Sugawa et al. 
(1996) and this thesis. 
Mitochondrial membranes are special in their lipid composition. They have a high content of 
cardiolipin and only small quantity of cholesterol. However in RBM, the amount of 
cardiolipin is below the amount in liver or heart mitochondria. The brain cardiolipin has a 
higher content of polyunsaturated fatty acyls such as linoleic (18:2) and linolenic (18:3) acyls 
as well as arachidonic (20:4) and docosahexanoic (22:6) acyls. Therefore the brain cardiolipin 
is more sensitive to peroxidation (Paradies et al. 2011). Cardiolipin is of great importance for 
formation and stability of supercomplexes (Pfeiffer et al. 2003, Acin-Perez and Enriquez 
2014) and for activity of OxPhos complexes (Lesnefsky and Hoppel 2006). Therefore, the 
findings for mitochondrial membranes of RBM in this thesis are compared to analyses on 
mitochondrial membranes of other tissues from rats:  
According to Grinna (1977) the amount of cholesterol is increased (+35 % in liver, +70 % in 
kidney) and cardiolipin is decreased (about -20 %) in mitochondria from liver and kidney of 
aged (24 months) Sprague-Dawley rats . She observed an increased rate of oleic acid (18:1) in 
liver and kidney mitochondria of aged rats as well as of arachadonic acid (20:4) for kidney 
mitochondria. She concluded that more unsaturated fatty acids would lead to increased 
fluidity in aged rat mitochondrial membranes, maybe as compensation to the increased 
amount of cholesterol, which decreases the fluidity. Overall decreased fluidity was observed 
in kidney and liver mitochondria of aged rats. These findings are in line with the analyses of 
Vorbeck et al. (1982), who analysed liver mitochondria from Fischer rats under the influence 
of ageing and found an increase of cholesterol and decreased amount of phospholipids and 
cardiolipin (-39 %). The anisotropy from steady-state fluorescence polarization measurement 
of the aged mitochondrial membranes was increased. The findings of Grinna (1977) and 
Vorbeck et al. (1982) are in line with the results for cerebellum and cerebrum of this thesis.  
Lee et al. (1999) analysed heart mitochondria from Fischer rats and found the membrane 
fluidity decreased under the influence of ageing while calorie restriction had no influence on 
the fluidity of the mitochondrial membrane. An increase of unsaturated fatty acid (22:4) and a 
decrease of linoleic acid (18:2) were observed in aged mitochondrial membrane, while calorie 
restriction did not change both. This seems to be in line with the findings for cerebrum in this 
thesis.  
Frenzel et al. (2010) analysed cerebral cortex from Wistar rats and found a need of a higher 
detergent to protein ratio for solubilisation of proteins from aged mitochondrial membranes 
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and concluded that the membrane fluidity is decreased in aged state, in line with the findings 
of decreased fluidity of membranes from aged cerebrum mitochondria. 
Gabbita et al. (1997) observed in mitochondria and synaptosomal membranes of the neocortex 
of Brown Norway rats an increased membrane rigidity, which was not altered in animals 
under calorie restriction. But calorie restricted animals showed a lower rigidity of 
mitochondrial membranes than ad libitum fed animals. These findings are in line with the 
results for cerebrum in this thesis. 
Studies of the lipid composition of the same cerebrum samples as used in this thesis were 
performed by Saager (2010) for her diploma thesis. She found no changes by ageing or 
calorie restriction in the lipid composition (phosphatidylcholine, phosphatidylinositol, cardio-
lipin, phosphatidylethanolamine, sphingomyelin and cholesterol) of the mitochondrial 
membranes. However she observed increased peroxidation in aged membranes for AL and 
CR. But she did not analyse the saturation level of the acyl chains. According to Choe et al. 
(1995) peroxidised lipids contribute stronger to the rigidity of membranes than incorporation 
of cholesterol. It might be that the observed increased membrane viscosity in this thesis is 
correlated with the stronger peroxidation in aged membranes.  
The decrease in fluidity of mitochondrial membranes from cerebellum and hippocampus of 
short- and long-term calorie restricted animals could not be explained yet. Further analyses 
are required. 
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4.3 Influence from NADPH oxidase 4 on mitochondrial function 
Late-passage HUVECs (2.6.4) were isolated and treated by Dr. Rafal Koziel as described in 
our publication (Koziel et al. 2013). Nox4 was knocked down (Nox4 KD) in HUVEC cells by 
lentiviral shRNA vectors. Control cells were infected with non Nox4 specific shRNA vectors 
(control). Mitochondria were freshly isolated and shock frozen in liquid nitrogen by Dr. 
Koziel at IBA. The total protein amount was determined by Bradford protein assay (3.2.1). 
The comparability of the Bradford results from both laboratories (IBA and TUD) was tested 
before and gave similar results (data not shown). The frozen mitochondria were transported 
on dry ice to TUD, where subsequent studies were carried out by me. Solubilisation of 
mitochondrial protein (3.3) was performed with d/p: 8g/g, final concentration of 1 % (w/v) 
dig., as described for cell culture by Colindres et al. (2007) and Cavlovic (2015). 120 µg 
(b. sol. d/p: 8g/g) mitochondrial protein of Nox4 KD and of control were loaded per lane on 
18 cm by 16 cm sized BN gels for electrophoretic separation (3.4) and subsequent CBBG 
staining (3.7.2) as well as CI in-gel activity test (3.8.1). The development of the precipitate 
was followed in seven time steps up to 80 min. CI in-gel activity was quantitated as in 4.2.6. 
For CIV in-gel activity test (3.8.1), 50 µg (b. sol. d/p: 8g/g) of mitochondrial protein per lane 
were separated by BN PAGE (10.0 cm by 10.5 cm sized gel). Additional lanes of 70 µg 
(b. sol. d/p: 3g/g; 18 cm by 16 cm sized BN gel) respectively 30 µg (b. sol. d/p: 3g/g; 10.0 cm 
by 10.5 cm sized gel) of BHM were loaded as standard. For analysis of proteins in 2D-
BN/SDS (3.5) gels, 150 µg (b. sol. d/p: 8g/g) of mitochondrial protein from Nox4 KD and of 
control were separated by BN PAGE (3.4), followed by 2D-BN/SDS PAGE (3.5). Gels were 
stained with SyproRuby (3.7.4) for quantitation and afterwards with silver (3.7.1) for 
visualisation. Protein spots were assigned referring to Colindres et al. (2007) and 
Reifschneider et al. (2006).  
The results are described in our publication (Koziel et al. 2013), attached below to this 
chapter. Additional information is presented in Fig. 4.69 and Fig. 4.70. In Fig. 6A (Koziel et 
al. 2013) the image of the CBBG stained BN gel is depicted for assignment of bands with 
help of BHM and HWM as standards (compare 4.2.3 in which bands of BHM and RBM 
where assigned). Control and Nox4 KD showed the same pattern of band migration in BN 
PAGE. Additional bands were found and assigned as heat shock protein HSP60 and HSP60*, 
which were also present in the 2D-BN/SDS gel (Fig. 6C, Koziel et al. (2013), purple circles) 
as two separated protein spots. This was also observed for human fibroblasts by Colindres et 
al. (2007). They supposed that heptamers and hexamers of HSP60 were found. In tissue such 
as RBM or BHM the protein band and spots of HSP60* were 
not observed, only HSP60 (=CH60, 4.2.3). 
Fig. 6B (Koziel et al. 2013) depicts an image of the BN gel 
after 80 min of incubation in CI in-gel activity test solution 
and a diagram showing the quantified development of the 
blue/purple precipitate of NBT diformazan (3.8.1), charac-
teristic for CI activity. The activity was normalised to the 
amount of CI in the respective band (3.11.2). The mean of 
CI activities of the supercomplexes I1III2 and I1III2IV1 were 
diagrammed for seven different timepoints between 0 min 
and 80. CI activity of control remains below Nox4 KD. The 
Fig. 4.69: Specific CI activities for 
Nox4 KD and control were calcu-
lated (3.11.2). Specific CI activity of 
Nox4 KD is higher than of control.  
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specific CI activity of Nox4 KD is much higher than of the control (+219 %, Fig. 4.69).  
Fig. 6C (Koziel et al. 2013) depicts images of silver stained 2D-BN/SDS gels with 
mitochondrial proteins from Nox4 KD and control. Several spots were marked in colour. Red 
spots mark CI and CIII subunits of OxPhos supercomplexes. For BHM and RBM they were 
assigned as NDUS1, QCR2 and NDUS2 (top to bottom, 4.2.3). Orange spots mark subunits of 
CIV from individual complex IV1. For BHM and RBM they were assigned to COX1 and 
COX2 (top to bottom, 4.2.3). The subunits were quantified in the grey scale images of the 
SyproRuby stained gels. The results are depicted in Fig. 4.70. The sum of the subunits 
NDUS1 & 2, of NDUS1 & 2 + QCR2 and of COX1 & 2 (in grey units) are diagrammed. It is 
observable that the control 
cells contain less protein 
amount in all three bar plots. 
The relative changes for 
Nox4 KD compared to the 
control are +111 % for 
NDUS1&2, +167 % for 
NDUS1&2+QCR2 and 
+17 % for (COX1&2). This 
shows an increased CI and 
CIII protein amount for 
supercomplexes in Nox4 KD, 
while the protein amount for 
CIV is only slightly 
increased. The CIV in-gel acitivity is visible as brownish precipitate in the gel image depicted 
in Fig. 6D (Koziel et al. 2013). No changes between Nox4 KD and control are observable.  
To sum up, the results show that Nox4 KD increased the protein amount and the activity of 
CI. Additionally mitochondrial morphology was changed, the potential of the inner 
mitochondrial membrane was stabilised and less H2O2 was produced than in control cells 
(Koziel et al. 2013).  
 
  
Fig. 4.70: Quantitation of subunits NDUS1&2 and NDUS1&2+QCR2 
from supercomplexes and COX1&2 of individual IV1 for Nox4 KD and 
control. For Nox4 KD the protein amount of all depicted subunits is higher 
than for control. The relative ratios are much higher for subunits of CI and 
CI+CIII than for CIV. 
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4.4 Changes of the mitochondrial proteome in an animal model of early 
Parkinson’s disease 
Proteome studies were performed on male Wistar rats. Substantia nigra (SN) and striatum 
(STR) of both hemispheres from six animals each, sham operated (SH) as control, four days 
after injection with 6-OHDA (4DL) and four weeks after injection with 6-OHDA (4WL), 
were dissected, frozen in liquid nitrogen and stored at -80°C by Dr. Kuter at IF-PAN, Krakow 
(2.6.2). Frozen tissues were transported by her on dry ice to our institute (TUD).  
I introduced Dr. Kuter to the methods of our laboratory by performing the proteome analyses 
on SN together with her. Together we isolated the mitochondria (3.1), determined the total 
protein content by Bradford protein assay in wellplates (3.2.2), solubilised mitochondrial 
proteins with d/p: 8g/g (3.3.1, 3.3.2), performed BN PAGE on 10.0 cm by 10.5 cm sized gels 
for separation of proteins (3.4) and subsequent CI in-gel acitivity test (3.8.1), DIGE labelling 
(3.7.5) and subsequent 2D-BN/SDS PAGE on 18 cm by 16 cm sized gels (3.5.3), as well as 
staining of gels (3.7), and PMF for identification of protein spots on 2D-BN/SDS gels (3.9). I 
also introduced her to the methods for evaluation of the data (3.11). Thereafter Dr. Kuter 
performed CIV in-gel activity and all proteome studies on STR by herself under my 
mentorship. 
We chose the Bradford protein assay in wellplates, BN PAGE on 10.0 cm by 10.5 cm sized 
gels and DIGE labelling and subsequent 2D-BN/SDS PAGE as methods for analyses of SN 
and STR, because of the small SN tissue size and therefore the resulting low total 
mitochondrial protein amount. For example, for one DIGE gel 52.5 µg (b. sol.) of RBM 
protein of one sample was used, while for one SyproRuby stained gel of the same size 120 µg 
(b. sol.) would have been needed. Additional amount of samples is saved because of 
application of the internal standard (IS) is supposed to diminish the differences between the 
different gels, from this follows that less number of gels (technical repeats) is needed. 
In total, 18 DIGE-gels of the six animals per group were performed for quantitative analysis 
of the mitochondrial proteins from SN. Because of dye-swap (3.7.5) two technical repeats of 
each animal sample, stained with two different G-dyes (G-Dye200 and G-Dye300), were 
included. The IS consisted of a mixture of all animal samples, labelled with another G-Dye 
(G-Dye100, 3.7.5). One DIGE gel contained three different samples labelled with G-Dye100, 
G-Dye200 and G-Dye300 respectively. Therefore, from these 18 gels, the information of 
54 images was obtained. For each sample the labelled mitochondrial protein amount was 
35 µg (b. sol. d/p: 8g/g) for each dye, in total 105 µg were used of each animal sample for the 
DIGE experiment.  
16 DIGE gels were performed by Dr. Kuter for the quantitative analysis of mitochondrial 
proteins from STR, resulting in 48 images for quantitation.  
The evaluation of the results of the DIGE gel experiments is still in progress and a publication 
is planned. 
For identification of protein spots, PMF (3.9) of SN and STR was performed. 300 µg 
mitochondrial protein of each tissue sample were solubilised (d/p: 8g/g, 3.3.1) and 2D-
BN/SDS gels were performed (3.5). Gels were stained with silver (3.7.1), and protein spots 
were cut and destained (3.9.2) at our institute (TUD) by Dr. Kuter and me. The subsequent 
preparation of the samples and measurements of MALDI-MS-MS spectra as well as 
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evaluation was performed by Dr. S. Hartwig, Dipl. Ing. S. H. Marx and me at the Proteome 
Analysis Unit of Dr. S. Lehr at DDZ.  
The manuscript containing this data is in preparation together with results from PMF 
identification from other samples of this thesis (cerebellum, cerebrum, hippocampus of rat 
2.6.1 and BHM 2.6.3) as well as samples from Dipl. Ing. S. H. Marx (heart mitochondria of 
house pig, wild boar, deer, mouse, and kidney of deer) and the data for cell culture from Dr. 
L. Cavlovic (OLN-93) and Dipl. Biochem. V. Decker (SH-SY5Y). This manuscript will also 
include Western blot analyses of the OxPhos complexes in 2D-BN/SDS PAGE from most of 
these samples. 
The results of the in-gel activity tests (CI and CIV) are described in our manuscript (Kuter et 
al. submitted: September 2015), which was submitted and is currently under review. It is not 
attached for copyright reasons but the abstract below in this chapter. CI and CIV in-gel 
activities of SN and STR were analysed. STR of all six individual animals were analysed 
separately, while for SN tissues from three animals were pooled, because of the small amount 
of mitochondria from this brain structure, in addition to one lane of mitochondria from one 
individual animal sample.  
Dr. Kuter performed additional studies on this animal model. Together with M.Sc. S. Kern 
she analysed the membrane fluidity of the mitochondria of SN and STR at our institute 
(TUD). Besides the proteome investigations at our institute, Dr. Kuter performed additional 
analyses at IF-PAN: behavioural analyses of the rats, HPLC analyses of the dopamine 
concentration and its metabolites as well as immunohistochemical staining of brain sections 
and stereological counting of dopaminergic and non-dopaminergic neurons.  
For copyright reasons the data obtained is not shown here, but the abstract of the submitted 
manuscript (Kuter et al. submitted: September 2015) is attached below. 
  
 4 Results and discussion 183 
 
 
  
Manuscript submitted: 
K. Kuter, M. Kratochwil, K. Berghauzen-Maciejewska, U. Głowacka, M. D. Sugawa, 
K. Ossowska, N. A. Dencher 
Adaptation within mitochondrial oxidative phosphorylation supercomplexes and 
membranes viscosity during degeneration of dopaminergic neurons in an animal model 
of early Parkinson’s Disease. 
Journal of Molecular Biology 
Abstract:  
In Parkinson’s disease (PD) motor symptoms are not observed until the loss of approx. 
70 % of dopaminergic neurons in substantia nigra (SN). Mitochondrial dysfunction has 
been indicated in the neuropathological process already at the early PD stages. 
In presented 6-OHDA rat model, selective, medium-sized dopaminergic lesion was used 
to study mitochondrial membrane adaptations at the level of oxidative phosphorylation 
complexes (Cxs) and their higher assembled states - supercomplexes (SCxs), during the 
early degeneration processes and after it. We observed loss of dopaminergic phenotype in 
SN and decreased dopamine level in striatum (STR) before actual death of neurons in SN. 
Interestingly, behavioural deficits induced by lesion were reversed despite progressing 
neurodegeneration. 
Along with degeneration process in STR, mitochondrial Cx I performance and amount 
decreased after 6-OHDA toxin injection in almost all analysed SCxs. Also, progressing 
decrease of Cx IV performance in few forms of SCxs (I1III2IV3-1, I1IV2-1) in STR was 
observed during degeneration. In SN, SCxs containing Cx I showed significant increase in 
protein amount and a shift of individual Cx I1 into superassembled states. Importantly, 
mitochondrial membrane viscosity changed in parallel with altered SCxs performance in 
dopaminergic structures. These results show for the first time adaptations at the level of 
mitochondrial membranes viscosity corresponding to SCxs function after dopaminergic 
system degeneration. It implicates that altered mitochondrial membrane viscosity, could 
play an important role in pathomechanisms of PD. The data obtained are also discussed in 
relationship to compensatory processes observed. 
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5 Conclusions 
5.1 Methodical aspects 
5.1.1 Identification of proteins in BN gels and 2D-BN/SDS gels 
The migration pattern in BN-PAGE and 2D-BN/SDS-PAGE of mitochondrial proteins from 
whole rat brain is highly comparable to the pattern of proteins from the rat brain areas 
cerebellum, hippocampus and cerebrum, especially when the same detergent, in this thesis 
digitonin, is used for solubilisation of proteins in the same detergent to protein ratio (8 g / g 
for brain mitochondria).  
The migration pattern of BHM proteins is highly comparable to the pattern of proteins from 
RBM. In the first dimension (BN) a difference in migration pattern is visible, caused by the 
different applied detergent to protein ratios (3 g / g for BHM and 8 g / g for RBM). This leads 
to the conclusion that mitochondrial proteins are highly conserved in mammals although little 
differences in molecular weight or posttranslational modifications occur. The band and spot 
pattern are mainly transferable between samples of mammals. 
5.1.2 Comparison of different methods for protein visualisation and quantitation in 
2D-BN/SDS gels 
In general, which method is the appropriate to visualise the protein spots in 2D gels depends 
on the experimental setup, the available budget and the samples themselves, especially on the 
available amount of analysable protein. Each stain or label has its own characteristics for 
protein binding and visualising. Certainly, the staining has to be reproducible and to provide a 
sufficient linear range as well as enough sensitivity, especially when quantitation is planned. 
For this purpose DIGE-labelling or SyproRuby staining are the appropriate methods from the 
ones tested in this thesis. In any case, it is important to stay with the same method for 
conclusions about compared analyses.  
5.1.3 Comparison of methods for quantitation of proteins 
Quantitation of proteins in bands on CBBG stained BN gels is less accurate and can give 
varying result in comparison to the analysis of protein spots in 2D-BN/SDS gels. Protein 
bands in BN gels could overlay and make it impossible to distinguish between the different 
proteins. Applied SyproRuby staining of 2D-BN/SDS gels is more sensitive than CBBG 
staining. Therefore the results of 2D-BN/SDS PAGE are regarded as more trustworthy and 
used for evaluation of the changes by ageing and calorie restriction in this thesis. 
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5.2 Effects of ageing and calorie restriction on the mitochondrial proteome 
5.2.1 Cerebellum 
Ageing of ad libitum fed rats reduced the tissue weight and the average total protein content 
of mitochondria from cerebellum. The amount of proteins involved in neuronal composition 
increased, while for all other analysed proteins no changes were observed. The activities of CI 
and CIV were not altered. The membrane fluidity decreased with ageing. 
The reduced tissue weight correlates with the decreased total protein content. The not changed 
amount of OxPhos (incl. CV) complexes and not changed activity indicate an ongoing 
compensation, as well as the fact, that the decreased fluidity seems to have no influence on 
the activity. 
Ageing under calorie restriction (CR) reduced the average total protein content of cerebellum 
mitochondria, while the tissue weight was not changed. The amount of OxPhos proteins 
inclusive CV increased, while the amount of proteins of stress management, energy 
metabolism and those involved in neuronal composition decreased. The activities of CI and 
CIV were predominantly not altered under calorie restriction (CR) in cerebellum. The 
membrane fluidity decreased with ageing under CR. 
CR seems to compensate the age dependent decline of the tissue weight. It is interesting that 
aged animals under CR show a lower total protein content while the amount of OxPhos 
complexes (incl. CV) increases in a tissue, of which the weight stays the same. This might be 
a compensation process to eliminate the effects of lower membrane fluidity and for the not 
altered CI and CIV activity.  
ST decreased the tissue weight of cerebellum while the average total protein content of 
mitochondria increased. The amount of OxPhos proteins inclusive CV decreased, while the 
amount of proteins of stress management, energy metabolism and those involved in neuronal 
composition increased. The activities of CI and CIV were not changed. The fluidity of 
cerebral mitochondrial membranes decreased under ST.  
The tissue weight of cerebellum was not changed under LT. LT increased the average total 
protein content of mitochondria from cerebellum. The amount of OxPhos complexes inclusive 
CV, as well as proteins of stress management and energy metabolism did not change. Proteins 
involved in neuronal composition decreased. LT increased the specific CI activity for the 
supercomplexes I1III2IV0-2. A decrease in fluidity of mitochondrial membranes was observed 
under LT. 
ST and LT show the differences compared to animals kept ad libitum which occur during 
time. An increased total protein content is observeable in ST, maybe caused by the increased 
amounts of proteins of stress management, energy metabolism (which could compensate for 
the decreased OxPhos protein amount) and the proteins for neuronal composition. 
Under LT the total protein content is still increased but the amount of OxPhos complexes 
increased again to the normal level and the proteins of stress management, energy metabolism 
and those involved in neuronal composition decreased to their normal level. 
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Ageing leads to decreased cerebellum weight independently from nutrition. Calorie restriction 
seems to stress the body in the beginning, observable by increased amounts for proteins of 
stress management and energy metabolism and maybe also in later phase, as a higher total 
protein content is visible for ST and LT. The decrease in fluidity of mitochondrial membranes 
under ST and LT would also support this theory. 
It is of interest, whether the functions of cerebellum, such as balance and spatial orientation, 
fine motor skills and planning movement, remained unaltered under these conditions. 
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5.2.2 Hippocampus 
Ageing of ad libitum fed animals (AL) decreased the tissue weight and the average total 
protein content of mitochondria from hippocampus. This is in line with the finding that the 
amount of all analysed proteins decreased. Remarkable is the decrease of CV amount. The 
specific CI activity decreased in hippocampus. The fluidity of the membrane did not change. 
Ageing under calorie restriction (CR) decreased the average total protein content of 
mitochondria from hippocampus as well as slightly the tissue weight. Mainly the amount of 
OxPhos proteins inclusive CV and proteins of energy metabolism and stress management 
were increased. The specific CI activity was decreased for smaller complexes. CR increased 
the fluidity of the mitochondrial membrane. 
Calorie restriction reduced heavily the tissue weight already in young animals (ST). Also, the 
average total protein content of mitochondria from hippocampus decreased, likewise mainly 
all proteins of hippocampus mitochondria. ST decreased CI activity for the larger 
supercomplexes I1III2IV0-2, as well as the fluidity of the membranes. 
LT decreased the tissue weight and the average total protein content of mitochondria from 
hippocampus, however the amount of almost all analysed proteins was increased. LT 
decreased CI activity for complex I1III2, as well as the fluidity of the membranes. 
Hippocampus tissue is decreased by ageing and the total protein content too, both 
independently from type of feeding. The protein amount of OxPhos complexes is decreased 
during ageing and ST, but increased under CR and LT. CI activity decreased in hippocampus 
for all analysed states but differed in the affected (super-)complexes. CIV activity was not 
changed in any state. As expected, the fluidity of the membranes decreased with age under ad 
libitum feeding as well as under ST and LT. Only when the calorie restricted animals were 
compared, the fluidity increased with age (CR). It is remarkable, that all measured parameters 
such as tissue weight, total protein content, amounts of single proteins, CI activity and the 
fluidity of the membranes are decreased in ST rats. Maybe ST calorie restriction has a strong 
negative influence on hippocampus mitochondria and hippocampus content. 
The decreased tissue weight, amount of total protein, the loss in CI activity and the decreased 
fluidity of the membranes indicate that destructive processes seem to occur in the aged rats 
independently from nutrition. The increased amount of OxPhos and proteins of energy 
metabolism and stress management under CR could be part of compensation processes.  
It would be of interest, whether hippocampus still was able to perform in an appropriate way, 
as it is known to transfer short-term into long-term memory and the disorder of this function 
is a characteristic symptom for age-associated diseases like dementia.   
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5.2.3 Cerebrum 
Ageing reduced the tissue weight of cerebrum from rats under ad libitum feeding. A decrease 
in protein amount of OxPhos complexes (excl. CV) as well as for several proteins of energy 
metabolism was observed. Only the amount of CV increased. The proteins of stress 
management showed no change. The activities of CI and CIV were predominantly not altered. 
The fluidity of the mitochondrial membrane decreased. 
Ageing under calorie restriction (CR) decreased the tissue weight slightly and increased the 
protein amount of OxPhos complexes inclusive CV. The amount of proteins of energy 
metabolism was partly decreased and increased. The activities of CI and CIV were decreased 
for smaller (super-)complexes and CIV activity increased for supercomplexes I1IV2 and 
I1III2IV1. The fluidity of the mitochondrial membrane did not change under CR.  
ST reduced the tissue weight. No changes of protein amount except for some increased 
proteins of energy metabolism were observed for ST. The specific CIV activity was increased 
for smaller complexes. The fluidity of the mitochondrial membrane did not change.  
Under LT the tissue weight was slightly decreased and the amount of OxPhos complexes 
(excl. CV) increased, while some proteins of energy metabolism and some of those involved 
in neuronal composition decreased. The specific activities of CI and CIV were predominantly 
not changed under LT. The fluidity of mitochondrial membranes was increased.  
Under ST only the CIV activity is changed (increased) and all the other measured parameters 
remained on the same level as in ad libitum fed animals. Therefore ST seems to have no 
influence on the cerebrum mitochondria. An increase of the amount of the OxPhos complexes 
under LT and CR while the activity of CI and CIV nearly remains at the same level as before / 
as in ad libitum rats indicates a compensation process. Although the fluidity of the 
mitochondrial membrane is decreased in aged ad libitum fed animals and a lower amount of 
OxPhos protein is available, the activity of CI and CIV is maintained.  
 
5.2.4 Additonal common changes 
Young animals under calorie restriction (YCR) compared to young ad libitum (YAL) ones 
developed a smaller body weight. Ageing under CR increased the body weight to the same 
extent as under AL.  
The mtDNA encoded protein subunits CYB (CIII) and COX2 (CIV) do not show specific 
trends. The changes in amounts seem to follow the trends of total CIII respectively total CIV. 
The highest activities of CI are found in supercomplex I1III2IV3 and for CIV in supercomplex 
I1III2IV2 for all three brain tissues. It is observable that for CI and CIV activity the presence of 
CIII increases the activity in a strong way. For all analysed tissues, the changes in specific 
activity of CI and CIV due to ageing or calorie restriction are not very pronounced. Therefore 
the activity of the respiratory chain is maintained while ageing under both types of nutrition.  
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5.2.5 Remarks and outlook 
Present results demonstrate how important studies of separate brain areas are. Each brain 
tissue has a different function and therefore the mitochondria differ as well. Additional 
criteria, which are important to consider for comparison of results, are the differences of 
analysed rat strains like Fischer, Wistar, Brown-Dawley amongst others. Of course, the 
comparability of different animal models is also important. But even methodical aspects, 
which could influence the results, have to be considered, such as the method for isolation of 
mitochondria. For example, in this thesis crude mitochondrial fraction as yielded from 
differential centrifugation was used and in other works isopycnic density gradient 
centrifugation is applied. Both lead to different ratios of purities and application of the 
gradient could even discard not fully intact mitochondria, which are important to analyse if in 
research for affected mitochondria. More examples are the chosen method of the subsequent 
protein determination or the detergent to protein ratio for solubilisation, which could influence 
strongly the results of the whole experiment, and of course the influence of freezing on the 
activity of enzymes. 
According to the results in this thesis for brain ageing, calorie restriction, as a tool to live a 
longer and healthier life, cannot be recommended, because of the destructive impact on the 
brain tissues, especially of hippocampus.  
It has to be analysed in the future, why the increased total protein amounts are necessary for 
the tissue under calorie restriction and which proteins are those increased ones. It is also of 
interest to study the lipid composition of the membranes to understand the changes in fluidity. 
And behavioural studies would also be interesting, to find out, how much the specific brain 
tissue is affected and to see differences between calorie restriction and ad libitum nutrition.  
Finally the transfer of results from animal studies to human models is not even trivial. 
Volunteers would be needed and because of the long lifespan of humans, results cannot be 
expected in short time.  
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BN1 
BN2 
Fig. 7.1: Images BN1 and BN2 of CBBG stained BN gels. For each brain area, and each animal group (YAL, 
YCR, OAL, OCR) 100 µg proteins were solubilised with 8 g dig. / g and separated by BN PAGE, followed by 
CBBG staining. 70 µg BHM (b. sol. d/p: 3g/g) and HMW (marked in orange) served as standard, OxPhos 
complexes and supercomplexes are marked. a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3. 
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Fused  
Image 
BN3 
Fig. 7.2: Image BN3 of CBBG stained BN gel and fused image of grey scale images BN1-3. BN1: For each 
brain area, and each animal group (YAL, YCR, OAL, OCR) 100 µg proteins were solubilised with 8 g dig. / g and 
separated by BN PAGE, followed by CBBG staining. 70 µg BHM (b. sol. d/p: 3g/g) and HMW (marked in orange) 
served as standard. Fused image: Grey scale images of BN gels (BN1, BN2 and BN3) were fused and analysed 
in Delta2D for quantitation of protein amount. OxPhos complexes and supercomplexes are marked. a = I1III2,
b = I1III2IV1, c = I1III2IV2, d = I1III2IV3. 
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Fig. 7.3: Cerebellum, YAL and YCR: Images of silver stained2D-BN/SDS gels. 120 µg mitochondrial proteins 
(b. sol. d/p: 8g/g) of each sample were separated by 2D-BN/SDS PAGE. The image of the CBBG stained BN gel 
lane was arranged horizontally above the image of the silver stained SDS gel, for assignment of bands. Masses 
of LMW were marked. a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3 
 204 7 Supplements 
 
Fig. 7.4: Cerebellum, OAL and OCR: Images of silver stained2D-BN/SDS gels. 120 µg mitochondrial proteins 
(b. sol. d/p: 8g/g) of each sample were separated by 2D-BN/SDS PAGE. The image of the CBBG stained BN gel 
lane was arranged horizontally above the image of the silver stained SDS gel, for assignment of bands. Masses 
of LMW were marked. a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3 
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Fig. 7.5: Hippocampus, YAL and YCR: Images of silver stained2D-BN/SDS gels. 120 µg mitochondrial 
proteins (b. sol. d/p: 8g/g) of each sample were separated by 2D-BN/SDS PAGE. The image of the CBBG 
stained BN gel lane was arranged horizontally above the image of the silver stained SDS gel, for assignment of 
bands. Masses of LMW were marked. a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3 
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Fig. 7.6: Hippocampus, OAL and OCR: Images of silver stained2D-BN/SDS gels. 120 µg mitochondrial 
proteins (b. sol. d/p: 8g/g) of each sample were separated by 2D-BN/SDS PAGE. The image of the CBBG 
stained BN gel lane was arranged horizontally above the image of the silver stained SDS gel, for assignment of 
bands. Masses of LMW were marked. a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3 
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Fig. 7.7: Cerebrum, YAL and YCR: Images of silver stained2D-BN/SDS gels. 120 µg mitochondrial proteins 
(b. sol. d/p: 8g/g) of each sample were separated by 2D-BN/SDS PAGE. The image of the CBBG stained BN gel 
lane was arranged horizontally above the image of the silver stained SDS gel, for assignment of bands. Masses 
of LMW were marked. a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3 
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Fig. 7.8: Cerebrum, OAL and OCR: Images of silver stained2D-BN/SDS gels. 120 µg mitochondrial proteins 
(b. sol. d/p: 8g/g) of each sample were separated by 2D-BN/SDS PAGE. The image of the CBBG stained BN gel 
lane was arranged horizontally above the image of the silver stained SDS gel, for assignment of bands. Masses 
of LMW were marked. a = I1III2, b = I1III2IV1, c = I1III2IV2, d = I1III2IV3 
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Fig. 7.9: Fused images of 2D-
BN/SDS grey scale images for 
cerebellum, hippocampus and 
cerebrum. Protein spots were 
marked as well as the protein 
marker LMW. The image of the 
CBBG stained BN gel lane was 
arranged horizontally above the 
image of the first fused image. 
a = I1III2, b = I1III2IV1, 
c = I1III2IV2, d = I1III2IV3 
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Fig. 7.10: Images of BN gels, stained in complex I in-gel activity test solution for each 
brain tissue. Each lane contained 100 µg of RBM proteins (b. sol. d/p: 8g/g). Three lanes of 
70 µg (b. sol. d/p: 3g/g) BHM each served as standard. 
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Fig. 7.11: Fused images of grey scale images from CI in-gel activity test for 
cerebellum, hippocampus and cerebrum.  
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Fig. 7.12: Images of BN gels, stained in complex IV in-gel activity test solution for each 
brain tissue. Each lane contained 100 µg of RBM proteins (b. sol. d/p: 8g/g). Three lanes of 
70 µg (b. sol. d/p: 3g/g) BHM each served as standard. 
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Fig. 7.13: Fused images of grey scale images from CIV in-gel activity test for cerebellum, hippocampus 
and cerebrum.  
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